data_1c9f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c9f _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.5 139.7 28.89 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.905 1.476 . . . . 0.0 110.44 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 2.0 ttpt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.1 t -118.05 148.55 42.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.545 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 24' ' ' VAL . 22.4 m -142.37 127.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.922 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 4.0 mmpt? -82.7 107.54 15.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.976 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.496 HD22 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -88.46 86.2 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.383 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.1 tpt180 -86.94 157.46 19.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -136.42 128.87 30.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.048 -1.032 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mt -72.54 -26.87 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.808 . . . . 0.0 109.716 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 36.5 t60 -85.14 13.52 6.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.408 -0.807 . . . . 0.0 109.995 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -133.69 -160.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.377 -0.827 . . . . 0.0 109.998 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . -129.54 35.88 4.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 4.8 p 174.69 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -168.07 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.0 109.9 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 2.1 t80 -143.96 90.81 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' CA ' ' HE2' ' A' ' 12' ' ' LYS . . . -64.61 91.72 0.11 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 32' ' ' LEU . 3.1 p -99.41 134.51 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -1.154 . . . . 0.0 110.126 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.48 ' CA ' HD22 ' A' ' 32' ' ' LEU . . . -117.46 149.51 40.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -168.48 145.08 3.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -59.03 -58.56 8.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.066 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 m -80.27 98.07 7.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -0.864 . . . . 0.0 109.93 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 26.0 p -40.56 -29.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -0.787 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' SER . 31.9 tt0 -60.14 -28.98 68.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.4 -45.01 66.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.802 . . . . 0.0 109.845 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.538 ' CD2' HG11 ' A' ' 24' ' ' VAL . 4.8 mt -57.8 -43.43 85.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 110.001 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.429 HD21 ' CD2' ' A' ' 63' ' ' PHE . 2.6 mt -61.85 -65.92 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HG2' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -43.61 -69.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -47.24 -27.36 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.49 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.42 -55.37 12.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.57 -11.64 17.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 0.0 110.032 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.7 t -85.33 -71.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.197 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -23.51 5.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.347 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.561 ' CD2' HD23 ' A' ' 74' ' ' LEU . 2.7 m-85 -102.99 -16.57 15.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 54.01 85.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -129.08 99.95 21.21 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.558 . . . . 0.0 110.171 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.14 0.495 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER 172.75 148.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 60' ' ' ASP . 2.1 mt -118.22 168.85 10.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.1 p -154.97 139.65 17.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 110.848 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -68.08 127.01 31.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 110.292 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -80.85 1.3 31.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.35 -46.38 88.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.0 15.52 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 94.02 28.97 10.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.06 164.64 25.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -1.222 . . . . 0.0 109.402 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 mt-10 -121.46 130.67 53.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.929 -1.107 . . . . 0.0 110.497 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 63' ' ' PHE . 57.3 t -153.1 173.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.401 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 36.9 p -123.35 164.95 17.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.525 ' N ' HD12 ' A' ' 49' ' ' LEU . 3.0 p30 -67.61 -12.17 59.81 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.325 -0.859 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -105.35 -5.41 20.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.3 t -107.42 17.2 23.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.168 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CE1' HG13 ' A' ' 58' ' ' VAL . 6.6 m-85 -100.99 96.54 5.8 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.392 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.5 Cg_endo -72.13 -91.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.782 1.411 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -112.48 68.63 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 63' ' ' PHE . 1.5 mt -42.84 152.76 0.35 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 0.0 110.343 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.44 164.51 32.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.986 1.519 . . . . 0.0 110.132 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -49.13 148.94 2.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER 43.12 37.33 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.721 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.86 127.6 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 110.035 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 108.72 19.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 63' ' ' PHE . 1.2 mp -117.85 145.41 44.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -128.58 137.25 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.455 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 40' ' ' PHE . 9.9 tp -77.4 138.94 39.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.881 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD21 ' N ' ' A' ' 76' ' ' THR . 1.6 tt -156.0 162.33 40.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.524 ' N ' HD21 ' A' ' 75' ' ' LEU . 71.2 p -153.99 171.92 18.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.718 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.57 -25.48 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 23.35 34.13 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 17' ' ' HIS . 2.2 mt-10 -156.36 162.66 40.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -1.165 . . . . 0.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.16 151.31 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.647 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.456 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 7.5 t-105 -124.23 126.32 45.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.878 . . . . 0.0 109.791 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -66.82 -71.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 163.65 175.85 34.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 5.5 t80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.4 -1.059 . . . . 0.0 110.104 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.2 Cg_endo -72.69 120.82 6.91 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.937 1.493 . . . . 0.0 111.107 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.36 -166.02 1.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.684 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.8 t -153.23 154.53 34.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 24' ' ' VAL . 32.8 m -147.04 146.26 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -107.01 96.76 6.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 HD22 ' CE1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -77.82 90.98 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.532 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.7 tpt180 -91.73 152.8 20.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.015 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.94 131.81 31.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.858 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.492 ' CB ' ' OE1' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.1 -28.15 64.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.782 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -79.83 3.05 20.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.983 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 t -123.97 -163.04 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 110.048 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.83 33.2 5.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 110.107 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 172.95 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.747 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.04 166.7 23.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.752 . . . . 0.0 109.87 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 6.3 t80 -112.48 97.74 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 110.459 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.81 98.5 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG12 ' CG2' ' A' ' 11' ' ' VAL . 4.1 p -115.5 150.75 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -1.175 . . . . 0.0 110.569 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -125.65 167.0 15.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 110.229 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.75 150.1 0.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.642 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mmm180 -62.79 -57.33 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.11 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.8 m -82.99 95.99 8.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.368 -0.833 . . . . 0.0 110.01 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 28.2 p -41.61 -28.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -55.55 -38.59 69.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.837 . . . . 0.0 109.741 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.6 tp10 -63.46 -43.95 95.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD23 ' CG1' ' A' ' 24' ' ' VAL . 8.4 mt -55.24 -47.62 75.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.87 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 63' ' ' PHE . 15.8 mt -63.29 -64.48 0.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.882 . . . . 0.0 109.938 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 7.4 tpp85 -47.75 -68.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.907 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -44.93 -30.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.541 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -64.02 -55.36 24.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.4 t -60.17 -14.36 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.865 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 57.4 t -84.83 -60.35 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.377 -0.827 . . . . 0.0 110.28 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -25.32 68.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 110.339 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.549 ' CE1' HD22 ' A' ' 13' ' ' LEU . 3.1 m-85 -101.45 -17.49 16.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.86 84.22 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.5 OUTLIER -123.94 105.72 31.95 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.874 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.808 0 O-C-N 124.008 1.531 . . . . 0.0 110.71 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 1.3 mtt85 -179.25 117.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 60' ' ' ASP . 13.0 mt -89.57 101.45 14.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.34 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 56' ' ' THR . 94.3 m -89.61 178.88 6.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 111.006 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' CB ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -108.4 131.11 55.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.445 -0.784 . . . . 0.0 110.081 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -80.74 2.55 25.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.792 . . . . 0.0 110.495 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 4.5 tt0 -66.28 -59.5 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -141.54 22.39 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.333 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 83.68 48.79 5.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.33 166.2 12.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -1.183 . . . . 0.0 109.715 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -118.98 126.84 52.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.058 . . . . 0.0 110.544 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 10.3 t -144.67 179.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.4 p -138.88 158.5 44.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.522 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.1 p30 -61.96 -11.49 13.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 110.26 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -106.67 -5.74 18.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 t -98.18 -48.62 5.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.441 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.627 ' CE1' ' CD2' ' A' ' 66' ' ' LEU . 10.1 m-85 -41.17 100.53 0.22 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 110.493 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.7 Cg_endo -79.47 -48.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.036 1.545 . . . . 0.0 110.431 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.86 69.55 0.18 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 1.7 mt -48.33 161.39 0.38 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 44.0 Cg_endo -72.13 -167.31 0.31 Allowed 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 124.097 1.578 . . . . 0.0 110.116 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 44.9 t30 -70.02 144.57 52.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' CYS . 54.6 t0 56.88 33.98 24.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.982 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -45.46 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.57 -0.706 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' HD11 ' A' ' 72' ' ' LEU . 1.2 tt0 -78.16 111.02 13.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 7.4 mp -115.06 162.79 16.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 109.99 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD11 ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -136.98 122.11 19.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.416 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.475 ' HG ' HD21 ' A' ' 42' ' ' LEU . 8.5 tp -68.3 115.55 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.803 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -132.63 159.03 40.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 7.6 p -149.05 171.49 16.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 110.158 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.34 -25.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.848 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.25 14.73 62.9 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 76' ' ' THR . 2.9 mt-10 -153.6 144.42 22.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.444 ' CA ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -135.68 131.13 35.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.485 ' CZ2' ' O ' ' A' ' 83' ' ' GLY . 5.7 t-105 -101.85 130.68 48.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -43.75 18.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 110.429 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.522 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 131.7 -172.34 20.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 26.8 t80 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.139 . . . . 0.0 110.27 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.7 Cg_endo -74.37 133.52 17.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.882 1.464 . . . . 0.0 110.495 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.49 166.29 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 27.8 m -139.19 155.32 47.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 24' ' ' VAL . 22.3 m -150.32 131.71 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.2 mmtt -89.3 85.34 6.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.938 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.491 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.1 tp -65.29 85.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.842 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tpt180 -82.52 153.05 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 109.42 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' CZ ' ' A' ' 14' ' ' ARG . . . -136.0 133.02 37.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.411 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.81 -16.58 53.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -0.87 47.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 110.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -129.98 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.78 34.85 5.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.93 -160.63 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -138.29 -160.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.243 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.6 t80 -149.59 84.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -67.26 93.58 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.3 p -107.59 151.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -1.106 . . . . 0.0 110.171 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -125.33 153.05 43.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.51 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -167.09 132.93 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.2 mmt180 -48.42 -62.29 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.107 -0.996 . . . . 0.0 110.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -76.07 96.48 3.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.017 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.0 p -42.07 -33.32 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -32.06 58.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.536 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -72.4 -39.23 68.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.83 . . . . 0.0 109.404 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 15.9 mt -56.25 -45.36 80.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.764 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD23 ' CB ' ' A' ' 63' ' ' PHE . 23.6 mt -65.87 -64.69 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.33 -70.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.937 . . . . 0.0 109.827 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 9.0 mtpt -48.95 -22.97 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.979 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.37 -45.71 45.84 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 15.5 t -76.06 -15.71 60.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -1.129 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.8 t -79.47 -50.17 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.795 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.11 -39.36 78.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.491 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.4 m-30 -83.24 -15.22 51.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 57.41 80.3 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -120.62 110.23 35.61 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.361 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 124.039 1.547 . . . . 0.0 110.335 179.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 175.99 141.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.093 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 2.5 mt -109.13 166.71 10.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.976 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.4 m -150.14 169.17 21.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 110.41 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.6 129.33 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.404 -0.81 . . . . 0.0 110.16 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -80.57 -8.68 59.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' HD21 ' A' ' 51' ' ' LEU . 7.5 tt0 -58.29 -48.62 79.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.9 10.87 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 88.08 46.33 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.19 171.89 9.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -1.208 . . . . 0.0 109.709 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 1.1 pt-20 -118.43 129.02 55.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.058 -1.026 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 21.4 t -152.71 176.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 7.3 p -126.37 172.52 10.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 110.214 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 18.7 p-10 -81.61 -4.39 55.99 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.238 -0.913 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.64 0.85 14.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.125 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 t -107.43 -40.15 5.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 66' ' ' LEU . 4.8 m-85 -42.26 101.64 0.25 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 43.6 Cg_endo -72.41 -63.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.057 1.556 . . . . 0.0 111.063 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.68 62.47 0.34 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 40.3 mt -44.86 164.46 0.18 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -1.187 . . . . 0.0 110.071 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_endo -69.53 -168.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.16 1.61 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 69' ' ' ASP . 59.7 t30 -68.53 152.33 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.17 -0.956 . . . . 0.0 110.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 10' ' ' CYS . 1.1 m-20 44.04 37.26 1.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.461 -0.774 . . . . 0.0 110.13 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -48.76 106.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.0 109.492 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 27.6 mt-10 -72.97 105.62 4.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.917 . . . . 0.0 110.837 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' N ' HD13 ' A' ' 72' ' ' LEU . 3.2 mp -100.94 169.85 8.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.515 HD12 ' CG ' ' A' ' 14' ' ' ARG . 2.5 tp -143.05 137.45 29.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.911 -1.118 . . . . 0.0 110.916 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.506 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 9.0 tp -85.61 130.1 34.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.82 . . . . 0.0 109.687 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.2 tt -146.41 158.07 43.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.987 -1.07 . . . . 0.0 109.924 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' GLU . 5.9 p -150.67 171.06 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.67 -29.87 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.054 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.16 14.9 59.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 76' ' ' THR . 1.8 mt-10 -147.75 159.68 43.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 110.49 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.91 139.71 13.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.433 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 8.0 t-105 -111.56 133.72 53.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.22 -59.52 2.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.06 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 141.12 163.29 9.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 t80 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 179.887 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 1.8 pt20 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.7 Cg_endo -73.22 138.54 27.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.844 1.444 . . . . 0.0 110.659 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -91.12 138.9 31.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASP . 98.2 m -115.18 149.42 37.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.424 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 24' ' ' VAL . 10.9 m -143.28 146.87 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 10.5 mmtp -105.12 92.18 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.47 97.85 2.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.757 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.7 tpt180 -94.95 155.74 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -139.87 121.48 15.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.849 -1.157 . . . . 0.0 110.821 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -65.32 -21.34 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.158 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' CG ' ' OE2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -79.53 0.83 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.5 -162.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.0 27.88 7.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 7.7 p -170.76 -161.55 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.627 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -169.11 2.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.511 -0.743 . . . . 0.0 109.707 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.7 t80 -135.81 85.89 2.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -64.86 94.49 0.17 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 32' ' ' LEU . 4.1 p -110.58 140.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -1.095 . . . . 0.0 110.424 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' HB1' ' SG ' ' A' ' 10' ' ' CYS . . . -109.65 162.42 14.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.306 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.51 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . 178.38 134.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.88 -58.39 8.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 t -80.26 98.83 7.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.941 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 22.7 p -41.85 -28.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.397 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 29.3 mt-30 -57.85 -29.62 65.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -41.42 64.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.825 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 29' ' ' CYS . 7.3 mt -58.14 -43.08 87.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.776 . . . . 0.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 36' ' ' GLY . 14.9 mt -65.6 -66.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -42.84 -69.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.782 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -47.71 -25.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.43 -0.794 . . . . 0.0 109.504 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.78 -51.81 28.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.2 t -66.5 -14.12 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.101 -1.235 . . . . 0.0 109.816 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.99 -56.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -64.38 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.994 -1.066 . . . . 0.0 110.106 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.486 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 3.3 m-85 -103.17 -13.61 16.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 80.7 mm-40 56.46 88.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.593 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.71 93.4 44.48 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.187 -0.946 . . . . 0.0 109.879 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 O-C-N 124.02 1.537 . . . . 0.0 110.038 -179.815 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 1.2 mtt180 175.99 158.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.215 -0.928 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 2.0 mp -115.09 168.06 10.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.909 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' THR . 54.2 m -153.11 147.13 25.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 110.379 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -69.69 127.18 32.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.804 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -74.56 0.64 14.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.425 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -61.23 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.08 -1.013 . . . . 0.0 110.2 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.61 22.79 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.542 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.55 45.09 38.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.7 167.9 14.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 109.612 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 pt-20 -113.12 131.69 55.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.933 -1.104 . . . . 0.0 111.175 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.6 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 77.4 t -157.02 173.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.563 -0.711 . . . . 0.0 109.52 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 49' ' ' LEU . 39.9 p -131.83 160.41 35.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.057 -1.027 . . . . 0.0 110.605 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.18 -10.96 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.02 -7.29 20.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 110.55 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -98.05 -42.31 7.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 0.0 110.411 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.6 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 45.8 m-85 -41.7 101.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 110.63 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -76.14 -87.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.93 74.11 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 HD12 ' CD1' ' A' ' 72' ' ' LEU . 58.7 mt -58.58 160.18 10.71 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.175 -1.191 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.34 -161.36 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 109.799 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.33 150.47 36.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 10' ' ' CYS . 17.0 m-20 47.52 37.29 6.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.06 96.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 109.928 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -62.46 98.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.718 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' CD2' ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -111.87 161.66 16.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 110.17 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.523 ' CD2' HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.81 133.13 31.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 110.434 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.593 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 9.8 tp -86.86 143.34 27.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.998 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -151.88 158.55 43.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.644 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.528 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 70.4 p -139.7 168.76 19.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.38 -22.24 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.07 21.76 40.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.5 mt-10 -160.59 141.3 11.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 110.594 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.512 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -135.26 146.96 49.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.818 . . . . 0.0 109.834 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.542 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.5 t-105 -116.29 130.26 56.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 110.291 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.68 -75.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -178.26 166.15 35.96 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.342 -1.093 . . . . 0.0 110.168 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.2 Cg_endo -71.66 132.79 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.999 1.526 . . . . 0.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -83.13 148.11 27.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.81 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' C ' HG11 ' A' ' 11' ' ' VAL . 15.5 t -116.77 144.7 44.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 32' ' ' LEU . 3.8 m -139.44 144.54 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.7 mmmm -99.0 91.3 4.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.976 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.85 87.44 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.576 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 4.4 tpt180 -90.86 159.4 16.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.735 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 14' ' ' ARG . . . -149.61 130.67 14.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -84.41 -14.54 49.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.891 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.96 -4.0 53.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 110.022 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -143.93 25.42 1.6 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 0.0 110.413 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 29.4 53.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 120.966 0.412 . . . . 0.0 111.6 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -163.53 172.78 13.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.985 -1.072 . . . . 0.0 110.603 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.04 165.53 28.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.997 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -143.33 99.15 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -68.47 95.85 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.527 ' CG1' HD23 ' A' ' 32' ' ' LEU . 5.4 p -101.01 141.72 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.158 . . . . 0.0 110.451 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' CA ' HD12 ' A' ' 32' ' ' LEU . . . -121.34 146.14 47.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.336 -0.853 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -163.77 140.1 6.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -52.23 -59.36 4.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.308 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -83.42 97.13 8.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.156 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 10.9 p -41.72 -29.62 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 28' ' ' SER . 4.3 mm-40 -57.89 -24.69 58.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.8 mt-10 -72.61 -55.35 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 110.052 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD23 ' CG1' ' A' ' 24' ' ' VAL . 37.3 mt -56.54 -35.19 67.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 0.0 110.068 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD22 HD13 ' A' ' 66' ' ' LEU . 52.8 mt -65.48 -65.85 0.62 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.33 -0.856 . . . . 0.0 110.152 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -57.75 -68.69 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 109.97 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 20.5 mtmt -42.84 -37.39 1.8 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.399 -0.813 . . . . 0.0 109.908 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.63 -48.43 84.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.1 t -63.18 -19.4 64.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.237 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 52.1 t -77.24 -41.95 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.462 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 1.8 tmt_? -81.05 -28.82 35.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.761 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.469 ' HB3' HD21 ' A' ' 74' ' ' LEU . 1.9 m-30 -92.58 -8.15 45.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 74.2 mm-40 49.19 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -131.04 95.63 24.66 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.093 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.4 Cg_endo . . . . . 0 C--N 1.306 -1.696 0 O-C-N 124.063 1.559 . . . . 0.0 110.321 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.204 0.525 . . . . 0.0 110.287 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -178.75 143.2 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 60' ' ' ASP . 1.4 mt -111.97 164.9 12.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.869 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' THR . 3.5 p -155.09 149.08 25.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 110.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -76.09 105.12 6.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.826 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.436 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 85.8 t80 -56.27 -22.35 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.359 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -51.63 -52.42 47.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.987 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -128.22 0.25 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.542 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 86.9 30.23 21.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.516 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.54 167.28 21.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.15 . . . . 0.0 109.857 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 16.8 pt-20 -115.45 133.23 56.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.932 -1.105 . . . . 0.0 109.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.638 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 59.1 t -155.52 173.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 110.508 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.566 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.5 p -119.01 159.6 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' N ' HD13 ' A' ' 49' ' ' LEU . 44.8 p30 -70.12 -2.72 13.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.95 -23.14 10.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.588 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 m -80.19 -37.6 32.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 110.221 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.638 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 20.8 m-85 -39.07 99.14 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.531 -0.73 . . . . 0.0 110.53 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 50.5 Cg_endo -76.93 -39.41 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.989 1.521 . . . . 0.0 110.415 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . 178.51 66.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.561 HD23 ' CE1' ' A' ' 63' ' ' PHE . 1.8 mp -42.5 161.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.272 -1.134 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 44.7 Cg_endo -72.85 -174.13 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.071 1.564 . . . . 0.0 110.259 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -58.41 152.64 17.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.108 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLU . 8.5 m-20 42.85 37.86 1.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 0.0 109.924 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -42.24 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -69.49 96.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.777 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.616 ' CD2' ' CE2' ' A' ' 63' ' ' PHE . 4.8 tp -106.48 153.16 22.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD2' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -133.68 140.02 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 110.61 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 42' ' ' LEU . 11.8 tp -80.35 132.66 35.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.509 -0.744 . . . . 0.0 109.9 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 1.8 tt -145.67 159.03 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.838 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 69.1 p -149.76 -159.96 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.29 73.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.431 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.38 18.01 40.04 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -145.77 148.18 32.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 0.0 110.457 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.443 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -149.9 139.8 21.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.542 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t-105 -117.0 128.86 55.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -76.73 -61.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.81 147.0 4.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.283 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.7 Cg_endo -72.59 125.15 10.37 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.734 1.386 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.97 137.16 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 110.234 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ASP . 35.3 m -108.19 157.85 17.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.499 ' CG1' ' HB3' ' A' ' 70' ' ' ALA . 34.9 m -152.46 137.85 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.9 . . . . 0.0 109.976 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -96.32 107.7 20.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.272 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -84.53 83.2 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.4 tpt180 -80.26 157.24 26.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.352 -0.843 . . . . 0.0 109.877 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 40' ' ' PHE . . . -142.25 123.0 14.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.552 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.433 ' CD1' HD23 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -74.48 -20.44 60.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 110.16 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.48 -1.5 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.88 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -128.42 -160.76 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 0.0 109.951 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.45 38.82 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.48 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.62 -159.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.048 -1.032 . . . . 0.0 110.69 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.69 -161.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -145.6 98.05 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.406 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.19 101.27 1.03 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 32' ' ' LEU . 2.9 p -116.26 149.07 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -1.149 . . . . 0.0 110.291 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.506 ' N ' HD23 ' A' ' 32' ' ' LEU . . . -134.95 159.28 41.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.004 . . . . 0.0 110.262 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . 177.84 132.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 25.1 mmm-85 -46.21 -56.15 6.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 110.212 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -82.47 97.94 8.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.036 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 28.2 p -40.26 -27.56 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 21.7 mp0 -62.27 -28.55 69.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 4.4 tt0 -66.38 -44.62 82.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 110.249 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.531 ' CD2' HG13 ' A' ' 24' ' ' VAL . 38.2 mt -67.13 -35.65 80.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 87.4 mt -65.23 -60.75 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -55.23 -69.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 26.0 mtpp -46.08 -29.62 1.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -60.57 -52.37 52.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.7 t -67.13 -16.24 64.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -1.181 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.493 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 54.1 t -81.73 -52.57 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -66.94 -39.7 87.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.743 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 1.9 m-30 -83.28 -19.55 36.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.853 . . . . 0.0 109.783 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 44.7 mm-40 60.34 77.74 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.475 -0.766 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -121.33 97.52 47.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 123.946 1.498 . . . . 0.0 109.714 179.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.089 0.471 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 176.23 154.23 0.2 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.113 -0.992 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -111.76 165.83 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 109.414 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' SG ' HD22 ' A' ' 73' ' ' LEU . 6.5 p -156.97 133.69 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.58 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.53 HD11 ' CG2' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -63.3 126.43 27.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.404 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 84.6 t80 -77.13 2.02 16.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.939 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -50.82 50.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.433 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.08 54.77 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.532 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 51.98 40.81 51.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.519 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.37 159.03 18.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.048 -1.266 . . . . 0.0 109.495 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 mp0 -117.34 136.75 52.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 110.468 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.608 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 82.1 t -156.8 175.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 72.2 p -130.83 160.39 34.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.402 ' N ' HD11 ' A' ' 49' ' ' LEU . 6.3 p-10 -62.58 -30.53 71.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.37 -0.831 . . . . 0.0 110.471 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.4 22.39 6.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 110.346 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 32.0 t -130.84 -35.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.198 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 66' ' ' LEU . 34.2 m-85 -44.16 104.22 0.37 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.209 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.4 Cg_endo -72.96 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.009 1.531 . . . . 0.0 110.344 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.12 64.53 0.59 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.63 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 52.2 mt -43.71 162.81 0.18 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.303 -1.116 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ASN . 44.3 Cg_endo -72.51 164.44 35.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.169 1.615 . . . . 0.0 110.134 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' PRO . 8.8 p30 -44.49 151.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.945 . . . . 0.0 109.978 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.9 m-20 45.64 37.72 3.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.861 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.7 107.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.649 . . . . 0.0 110.186 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' C ' HD11 ' A' ' 72' ' ' LEU . 12.3 tt0 -83.25 97.87 9.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 110.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 9.0 mp -105.06 159.07 16.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.892 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.494 HD11 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -129.53 113.36 14.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.394 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.508 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 12.8 tp -67.89 133.47 49.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -145.98 157.7 43.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.117 -0.989 . . . . 0.0 109.493 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 39.6 p -132.6 -174.98 3.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.0 -12.13 46.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.92 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.3 25.17 27.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -156.37 163.14 39.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -1.153 . . . . 0.0 110.813 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.541 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.63 139.02 14.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.539 ' CZ2' ' CE1' ' A' ' 52' ' ' TYR . 8.3 t-105 -103.94 137.01 42.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.756 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -69.41 -79.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.324 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.532 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . -160.64 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 18.5 t80 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.162 -1.199 . . . . 0.0 110.179 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.1 Cg_endo -71.58 127.11 12.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.943 1.496 . . . . 0.0 110.403 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 153.12 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 24.9 m -121.48 140.5 52.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.5 HG23 HG13 ' A' ' 24' ' ' VAL . 5.2 m -134.38 136.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.937 . . . . 0.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.18 92.33 5.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -73.55 94.11 2.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.59 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.6 tpt180 -88.96 158.14 18.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.442 -0.786 . . . . 0.0 109.64 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.51 135.8 35.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.651 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' CD1' HD22 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.7 -24.22 56.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.224 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 7.99 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.0 t -138.26 -164.88 1.7 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.133 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.07 24.25 8.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -161.14 -163.43 1.02 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 0.0 110.592 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -140.44 -162.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.494 -0.754 . . . . 0.0 110.177 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 6.9 t80 -138.47 79.54 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -63.94 84.3 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.522 ' CG1' HD22 ' A' ' 32' ' ' LEU . 1.4 p -104.57 141.3 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.138 . . . . 0.0 110.122 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.33 146.97 43.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.448 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.452 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -160.96 144.16 13.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mmt180 -57.9 -61.87 2.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.095 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 1.5 t -77.97 96.89 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 22.0 p -42.57 -31.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 mm-40 -52.39 -30.93 31.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.106 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 9.5 mt-10 -72.31 -46.01 57.5 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.604 0.716 . . . . 0.0 109.422 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.522 HD22 ' CG1' ' A' ' 24' ' ' VAL . 12.1 mt -56.26 -43.82 79.11 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.75 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.514 HD13 ' CB ' ' A' ' 63' ' ' PHE . 70.5 mt -67.09 -69.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.691 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.76 -70.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.546 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 1.9 mtmp? -46.13 -26.36 0.75 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.166 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.28 -46.01 66.72 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.24 -16.51 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -1.153 . . . . 0.0 109.78 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.23 -47.6 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.776 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -35.84 78.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.4 m-85 -91.14 -13.51 32.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.57 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 1.7 mt-30 56.44 83.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 110.764 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.9 OUTLIER -118.17 113.62 37.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.016 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.7 Cg_endo . . . . . 0 C--N 1.306 -1.658 0 O-C-N 124.015 1.534 . . . . 0.0 110.726 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.116 0.484 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 172.84 150.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 110.154 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 1.7 mt -115.39 168.56 9.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.0 p -157.02 146.38 20.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -70.92 118.83 14.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 53' ' ' GLU . 63.1 t80 -76.34 -21.23 56.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.381 -0.824 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' TYR . 2.9 tp10 -43.38 -45.94 6.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 110.352 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -137.13 -49.53 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.383 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.24 49.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.522 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.71 164.98 12.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -1.149 . . . . 0.0 109.916 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 5.5 pt-20 -118.18 131.42 56.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.042 -1.037 . . . . 0.0 110.543 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 52.6 t -154.64 170.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 22.7 p -119.44 157.65 27.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 11.3 p-10 -62.44 -16.62 56.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 110.596 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -102.17 6.23 40.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.5 m -112.19 -34.62 5.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.636 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 13.6 m-85 -45.57 104.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 110.399 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.8 Cg_endo -76.52 -86.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.071 1.564 . . . . 0.0 110.338 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.74 64.22 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 94.5 mt -45.18 160.84 0.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.289 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.39 178.36 6.24 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -56.76 152.01 13.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 0.0 110.218 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' CYS . 6.1 m-20 44.36 38.85 2.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.797 . . . . 0.0 109.782 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.42 105.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -73.18 103.02 3.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.642 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 70' ' ' ALA . 7.0 mp -113.19 159.74 18.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 109.623 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -140.09 132.91 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.032 -1.043 . . . . 0.0 110.475 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' CD1' HD22 ' A' ' 49' ' ' LEU . 11.1 tp -72.29 135.27 45.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.786 . . . . 0.0 109.889 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -146.04 155.33 42.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 75' ' ' LEU . 10.9 p -146.33 178.29 8.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.57 70.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.09 7.95 53.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 160.02 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.219 -1.165 . . . . 0.0 110.54 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.522 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.01 140.69 12.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.437 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.6 t-105 -111.61 131.41 55.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.122 -0.986 . . . . 0.0 110.32 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -83.37 -61.69 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 150.53 159.62 8.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD1' ' CE2' ' A' ' 52' ' ' TYR . 2.5 t80 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.62 133.52 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.803 1.423 . . . . 0.0 110.575 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -81.59 -179.59 7.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 69' ' ' ASP . 23.5 t -150.54 148.68 28.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.41 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.464 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.3 m -144.86 136.49 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 23.6 mmtt -95.83 94.51 7.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.064 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.49 HD22 ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -72.24 89.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.593 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.538 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.8 tpt180 -86.7 150.85 23.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 14' ' ' ARG . . . -135.36 137.63 42.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.69 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -22.79 57.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.903 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 15' ' ' ALA . 28.5 p80 -84.34 6.93 21.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -161.38 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.058 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.56 27.02 6.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.38 -161.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -134.38 -176.26 4.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.82 . . . . 0.0 110.194 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -120.79 99.32 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.58 85.59 0.35 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 32' ' ' LEU . 3.5 p -104.14 136.87 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -121.36 146.08 47.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -163.32 133.44 4.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.099 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -50.43 -30.55 12.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 110.458 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -104.25 94.53 5.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.9 p -41.88 -31.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -30.9 71.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.928 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 68.1 tt0 -68.94 -32.06 71.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CD2' HG11 ' A' ' 24' ' ' VAL . 16.5 mt -77.44 -31.47 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 94.1 mt -66.15 -57.74 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -59.0 -55.86 29.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 29.7 mtpp -55.02 -27.19 42.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.633 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.49 ' CA ' HD22 ' A' ' 13' ' ' LEU . . . -68.52 -51.55 30.71 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 29.1 t -65.67 -14.37 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -1.163 . . . . 0.0 109.604 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.69 -45.71 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -24.1 60.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.9 m-30 -102.6 -16.54 16.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.507 -0.746 . . . . 0.0 109.64 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 61.99 88.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -133.82 97.44 15.49 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.939 . . . . 0.0 110.034 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--N 1.304 -1.777 0 O-C-N 123.912 1.48 . . . . 0.0 110.264 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.151 0.501 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' O ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 176.05 154.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 110.922 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -114.9 116.77 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' THR . 29.0 m -94.41 -179.2 4.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD1' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.72 122.94 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 110.247 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -68.72 -7.61 35.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.17 -46.34 90.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 33.35 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 110.503 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 69.22 33.31 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.58 165.75 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -1.191 . . . . 0.0 109.834 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -119.54 128.45 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.39 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.634 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 14.3 t -150.08 -179.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.467 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 22.9 p -131.4 159.82 36.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.002 . . . . 0.0 110.39 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.521 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 3.3 p30 -73.61 0.15 13.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.291 -0.881 . . . . 0.0 110.44 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -115.11 -1.29 13.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 110.515 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.6 t -108.07 -36.08 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.923 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 19.8 m-85 -39.62 99.29 0.19 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.436 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.5 Cg_endo -77.7 -33.28 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.044 1.55 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.84 68.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 63' ' ' PHE . 1.1 mp -50.0 163.61 0.41 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.242 -1.152 . . . . 0.0 110.075 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 42.2 Cg_endo -69.43 178.67 4.14 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.109 1.584 . . . . 0.0 110.172 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.72 150.03 20.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.2 m-20 48.84 35.88 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.455 -0.778 . . . . 0.0 110.198 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -50.2 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.74 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 8.4 mm-40 -72.58 96.93 2.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 63' ' ' PHE . 2.9 mp -96.4 164.8 12.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 1.4 tp -134.96 118.7 17.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.966 -1.084 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.55 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 15.4 tp -69.43 127.47 33.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -140.46 158.45 43.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 32.1 p -141.92 174.23 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.99 19.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.43 23.47 21.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.31 149.0 25.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 110.593 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -144.25 158.62 43.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 0.0 109.696 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.563 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -125.48 122.57 37.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.312 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.26 -82.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 0.0 110.115 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 55' ' ' GLY . . . -175.75 172.93 45.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 67.8 t80 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.317 -1.107 . . . . 0.0 110.087 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.7 Cg_endo -75.17 132.05 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.974 1.513 . . . . 0.0 110.789 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -80.39 159.81 25.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 69' ' ' ASP . 42.8 t -135.15 149.6 50.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.7 m -146.95 134.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.323 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 69' ' ' ASP . 37.6 mmtt -86.27 89.33 7.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -70.79 79.96 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.998 . . . . 0.0 110.201 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 6.5 tpt180 -83.8 159.12 21.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' N ' ' HG3' ' A' ' 14' ' ' ARG . . . -150.8 122.44 8.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.278 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' CD1' HD22 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -76.79 -8.66 57.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 6.5 t-80 -94.54 10.44 34.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.512 ' O ' ' C ' ' A' ' 19' ' ' ALA . 4.5 m -149.49 30.28 0.75 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.514 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 27.28 49.86 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.095 0.474 . . . . 0.0 111.744 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -174.06 -176.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -145.03 -171.67 3.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 110.0 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 10.5 t80 -153.21 84.54 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.8 94.65 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.538 ' CG1' HD21 ' A' ' 32' ' ' LEU . 5.4 p -102.89 151.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -1.104 . . . . 0.0 110.769 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.46 ' CA ' HD12 ' A' ' 32' ' ' LEU . . . -132.43 151.86 51.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.441 -0.787 . . . . 0.0 110.012 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.517 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -171.8 136.0 0.89 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.71 -61.43 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.063 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 29' ' ' CYS . 17.7 m -78.3 96.71 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' C ' ' O ' ' A' ' 28' ' ' SER . 25.8 p -41.29 -28.73 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.524 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' SER . 6.9 tt0 -59.56 -25.6 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 110.192 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -70.53 -52.12 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.538 HD21 ' CG1' ' A' ' 24' ' ' VAL . 32.1 mt -60.46 -34.61 74.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.867 . . . . 0.0 110.207 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 66' ' ' LEU . 11.0 mt -67.54 -64.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.066 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -64.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' NZ ' ' CB ' ' A' ' 35' ' ' LYS . 7.6 mtmp? -49.45 -28.92 5.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.7 -48.78 78.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -71.42 -14.56 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.0 109.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.509 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 94.4 t -79.69 -49.43 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.929 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -28.9 62.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.019 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.8 m-30 -93.51 -11.56 31.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 30.4 mm-40 51.16 83.89 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.962 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.3 OUTLIER -128.37 109.12 19.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.953 . . . . 0.0 110.779 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 47' ' ' SER . 47.4 Cg_endo . . . . . 0 C--N 1.305 -1.76 0 O-C-N 123.929 1.489 . . . . 0.0 110.205 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.279 0.561 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -179.87 140.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.733 . . . . 0.0 109.892 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 4.4 mt -109.26 165.81 11.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.059 -1.026 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 4.7 p -154.46 157.38 38.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.431 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -85.97 124.44 32.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.456 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 35.7 t80 -73.44 -14.3 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.25 -57.06 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.84 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.99 5.09 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.473 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.538 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 95.46 32.88 6.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.8 176.78 8.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -1.231 . . . . 0.0 109.706 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 40.4 mt-10 -125.29 138.11 54.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.03 . . . . 0.0 110.775 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.1 t -156.46 173.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.408 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 29.9 p -121.52 158.37 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.1 p-10 -66.07 -7.81 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -108.62 -18.09 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.5 t -84.05 -39.34 19.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.569 ' CE1' HG11 ' A' ' 58' ' ' VAL . 24.9 m-85 -42.32 101.6 0.25 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.1 Cg_endo -79.18 -90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.048 1.552 . . . . 0.0 110.666 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.98 66.37 0.3 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.539 HD13 ' CG ' ' A' ' 63' ' ' PHE . 3.6 mt -43.94 149.92 0.63 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.403 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -161.06 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.976 1.514 . . . . 0.0 110.115 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ASP . 31.6 p-10 -77.2 150.93 35.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . 5.8 t0 42.08 37.05 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.74 . . . . 0.0 110.016 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -46.43 120.27 2.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 3.4 mp0 -83.2 106.94 15.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.943 . . . . 0.0 110.85 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 3.2 mp -110.92 154.59 23.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -138.73 127.99 24.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.014 -1.054 . . . . 0.0 110.662 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 42' ' ' LEU . 10.2 tp -74.08 134.82 42.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 110.24 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.9 OUTLIER -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.628 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 79' ' ' GLU . 4.4 p -147.51 169.66 19.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.072 . . . . 0.0 109.843 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.14 -33.67 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.3 17.97 39.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -1.193 . . . . 0.0 110.544 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.19 172.39 13.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.223 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.7 t-105 -141.24 122.88 15.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -70.15 -79.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.485 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . 179.09 171.87 42.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.218 -1.166 . . . . 0.0 110.239 -179.947 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.1 Cg_endo -72.87 125.53 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.835 1.439 . . . . 0.0 110.537 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 160.2 24.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 69' ' ' ASP . 37.3 m -130.76 152.96 49.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.502 ' CG2' HD23 ' A' ' 32' ' ' LEU . 9.2 m -141.55 125.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . 10.0 mmtt -87.95 85.45 7.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -74.81 81.41 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.607 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.0 tpt180 -79.72 160.47 26.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.815 . . . . 0.0 109.325 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -135.06 124.24 24.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.773 -1.204 . . . . 0.0 110.679 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' CD1' HD21 ' A' ' 73' ' ' LEU . 2.2 mt -75.72 -20.88 58.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -79.41 2.88 20.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.884 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -140.66 -175.12 4.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.873 . . . . 0.0 109.783 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.04 33.42 4.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.267 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.04 -167.91 2.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.513 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.62 -164.88 1.97 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.911 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 8.5 t80 -144.58 77.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.44 92.54 0.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -116.96 151.58 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.499 ' CA ' HD22 ' A' ' 32' ' ' LEU . . . -128.25 173.79 9.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.386 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.1 126.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.035 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.94 -55.98 3.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -81.42 97.82 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -41.6 -30.79 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -0.824 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.23 -34.95 59.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 1.6 mp0 -67.11 -46.46 74.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.689 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD23 ' CG2' ' A' ' 11' ' ' VAL . 18.0 mt -54.42 -42.46 70.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -63.17 -70.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.11 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -59.64 2.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -49.45 -26.6 3.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -70.39 -58.08 6.26 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 44.6 t -64.85 -13.65 56.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' GLN . 31.1 t -85.76 -72.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 109.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -29.82 1.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.51 ' CD2' HD23 ' A' ' 13' ' ' LEU . 4.5 m-30 -96.69 -17.94 20.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.567 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.4 mt-30 57.11 84.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.744 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.526 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -124.08 101.57 35.16 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 109.977 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.177 -179.781 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 34.7 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.275 0.559 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.41 158.23 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 110.514 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -110.59 165.9 11.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 109.228 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 6.1 p -159.35 133.33 7.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.099 . . . . 0.0 110.769 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CB ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -62.4 120.92 11.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.484 -0.76 . . . . 0.0 110.3 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -70.31 -6.2 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 19.4 tt0 -54.11 -65.58 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.35 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -131.6 23.86 4.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 83.2 28.52 36.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.512 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.39 165.11 25.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.183 -1.186 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 35.5 mt-10 -119.24 135.54 54.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.598 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 49.3 t -154.3 175.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 42.8 p -122.39 166.66 14.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p-10 -66.57 -7.37 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.288 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -22.43 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.7 m -84.24 13.89 4.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 4.8 m-85 -100.42 97.82 7.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.017 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.9 Cg_endo -71.3 -92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.896 1.472 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -128.95 64.86 0.6 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 63' ' ' PHE . 12.0 mt -42.92 161.78 0.18 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -1.096 . . . . 0.0 110.174 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.6 Cg_endo -71.95 162.91 40.46 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.075 1.566 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -42.29 150.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.59 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 42.98 38.35 1.4 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.881 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.85 110.35 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 110.175 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 12' ' ' LYS . 2.3 tp10 -70.48 99.76 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.357 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD23 HD11 ' A' ' 66' ' ' LEU . 6.5 mp -114.6 158.09 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -140.14 116.86 10.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 110.434 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 6.8 tp -70.64 149.12 47.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -153.51 155.3 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.091 -1.005 . . . . 0.0 110.007 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.536 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 19.2 p -135.88 172.46 12.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.08 -31.77 31.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.865 . . . . 0.0 110.291 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.92 17.47 41.04 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' CA ' ' OE1' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -149.97 149.38 30.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -1.21 . . . . 0.0 110.574 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.26 134.84 22.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.508 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . 7.1 t-105 -103.16 133.25 48.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -83.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -169.82 158.11 30.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 34.7 t80 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.455 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.8 Cg_endo -72.58 133.85 21.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.977 1.514 . . . . 0.0 110.586 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.69 -171.91 3.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 50.6 t -149.16 149.45 31.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.001 -1.062 . . . . 0.0 110.505 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 24' ' ' VAL . 6.2 m -148.26 134.71 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 mmtp -97.28 95.15 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD23 ' CE2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -74.25 89.45 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.984 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.8 tpt180 -89.39 151.72 21.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.963 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.05 131.31 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 110.576 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -24.47 62.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.117 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' HB2' ' OE2' ' A' ' 79' ' ' GLU . 3.6 t-160 -86.72 16.08 5.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -135.1 -161.28 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.43 29.79 5.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.296 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 174.84 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 110.666 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.37 164.37 30.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -102.5 79.66 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -61.92 87.84 0.04 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.54 HG13 ' CD2' ' A' ' 32' ' ' LEU . 8.6 p -103.37 140.59 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.616 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.15 39.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.761 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 32' ' ' LEU . . . -173.99 148.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 11.0 mmt180 -62.97 -48.16 80.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -84.57 89.19 7.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 110.104 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 28' ' ' SER . 6.6 p -42.64 -31.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.08 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.14 -36.09 78.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 109.907 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 2.7 tp10 -62.41 -51.41 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.778 . . . . 0.0 110.019 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' CD2' HG13 ' A' ' 24' ' ' VAL . 43.7 mt -53.41 -39.26 64.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 63' ' ' PHE . 4.5 mt -57.26 -69.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 110.148 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -60.14 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.849 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 14.0 mtpt -46.97 -27.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.486 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -69.98 -56.09 8.53 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.6 -15.18 25.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.196 . . . . 0.0 109.937 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.5 t -87.97 -55.48 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.733 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.64 70.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.521 ' CE2' HD23 ' A' ' 13' ' ' LEU . 3.2 m-30 -95.79 -21.99 17.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.382 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.26 84.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.516 -0.74 . . . . 0.0 110.732 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.15 98.47 38.8 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 110.159 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--N 1.306 -1.694 0 O-C-N 123.958 1.504 . . . . 0.0 109.774 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.538 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 49.1 m . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.362 0.601 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER 178.61 150.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' VAL . 5.1 mp -115.81 115.15 25.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 56' ' ' THR . 99.9 m -92.46 -171.13 2.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 111.058 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.481 HD12 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -121.72 126.85 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.647 -0.658 . . . . 0.0 109.729 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -15.45 63.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 110.816 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -44.9 -68.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.995 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 54' ' ' ASP . 26.3 t70 -143.07 40.09 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.467 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.526 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 72.23 38.5 58.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' CYS . 0.3 OUTLIER -80.47 160.03 25.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -1.193 . . . . 0.0 109.834 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -114.49 128.77 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 110.383 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.555 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 3.1 t -147.93 -171.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 p -145.41 165.51 28.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.049 . . . . 0.0 110.251 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.462 ' HB3' HD23 ' A' ' 49' ' ' LEU . 4.7 p-10 -79.23 8.65 5.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -124.92 5.52 8.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 110.354 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t -119.78 -36.56 3.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.573 ' CD1' HD21 ' A' ' 66' ' ' LEU . 4.8 m-85 -40.86 100.58 0.22 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.6 Cg_endo -76.67 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.039 1.547 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -110.47 67.68 0.22 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 63' ' ' PHE . 3.6 mp -41.95 146.13 0.66 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 110.425 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.65 158.08 43.77 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.116 1.587 . . . . 0.0 110.281 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 12.4 p30 -44.27 147.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 109.89 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.7 OUTLIER 43.88 36.4 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.684 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.98 119.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -82.49 101.51 10.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.479 ' CD2' ' CE2' ' A' ' 63' ' ' PHE . 1.2 mp -110.24 152.76 25.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.9 OUTLIER -131.02 104.83 7.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.59 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD12 ' HG ' ' A' ' 42' ' ' LEU . 10.2 tp -60.5 126.66 28.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -139.16 158.57 43.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.982 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.538 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 49.8 p -134.24 176.39 8.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.16 -32.51 36.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.85 20.95 29.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' C ' HD13 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -145.3 148.62 33.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.538 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.76 138.0 24.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.451 -0.781 . . . . 0.0 109.855 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.455 ' HB2' ' CD2' ' A' ' 73' ' ' LEU . 5.5 t-105 -107.89 123.94 49.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.991 -1.068 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -67.33 -62.47 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 153.69 6.07 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.348 -1.089 . . . . 0.0 110.171 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.46 130.79 16.59 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.871 1.459 . . . . 0.0 110.566 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 4.3 ttpt -79.98 155.13 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.85 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ASP . 7.4 t -129.52 153.46 47.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.622 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.472 ' CG2' HG13 ' A' ' 24' ' ' VAL . 10.6 m -148.66 135.0 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.08 96.21 10.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 110.355 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -76.33 81.58 3.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.92 . . . . 0.0 110.024 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 5.3 tpt180 -80.59 158.72 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 18' ' ' SER . . . -140.26 112.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.5 -30.38 71.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.857 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 17' ' ' HIS . 52.1 t60 -82.19 8.1 11.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 19' ' ' ALA . 28.6 t -121.2 -160.59 0.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -119.23 19.51 12.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 175.84 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.108 -0.995 . . . . 0.0 110.781 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.97 168.8 18.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.552 -0.718 . . . . 0.0 109.883 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -122.52 99.85 6.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.323 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.41 92.58 0.27 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 32' ' ' LEU . 4.1 p -97.39 146.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 0.0 110.354 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' N ' HD22 ' A' ' 32' ' ' LEU . . . -134.92 144.88 47.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.37 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -170.51 123.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.5 mtt180 -42.29 -29.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -100.67 95.64 6.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.277 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 30' ' ' GLN . 21.1 p -44.98 -33.27 1.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.449 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 8.5 mp0 -62.55 -20.64 64.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.73 -48.3 16.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.934 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 ' CG2' ' A' ' 24' ' ' VAL . 22.3 mt -58.98 -38.86 80.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' CD2' ' CD1' ' A' ' 66' ' ' LEU . 52.8 mt -66.36 -63.63 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.687 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -52.78 -65.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.804 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -50.61 -24.21 3.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.607 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.7 -52.55 11.93 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -63.28 -16.11 59.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -1.203 . . . . 0.0 110.056 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 99.3 t -78.16 -59.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.008 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -35.1 79.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.942 . . . . 0.0 109.982 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.7 m-30 -84.87 -14.72 46.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 58.2 mm-40 53.1 78.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.398 -0.814 . . . . 0.0 110.554 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.541 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -116.82 97.63 50.77 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.9 Cg_endo . . . . . 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.693 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.528 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -177.63 146.52 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.01 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 60' ' ' ASP . 2.2 mt -114.65 169.12 9.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' THR . 3.6 p -151.98 161.92 41.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.945 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -92.47 115.97 28.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.65 -0.656 . . . . 0.0 109.955 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 7.5 t80 -64.22 -15.43 59.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.409 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -48.77 -51.69 27.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.47 20.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 82.57 22.26 58.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.8 174.34 2.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.127 -1.22 . . . . 0.0 109.672 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 4.9 mm-40 -126.17 137.05 53.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.513 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.545 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 90.5 t -156.64 173.96 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.193 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 22.7 p -121.87 159.9 25.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.896 . . . . 0.0 110.023 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.517 ' N ' HD13 ' A' ' 49' ' ' LEU . 7.7 p-10 -64.57 -7.79 11.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.637 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -15.38 14.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.02 -1.05 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.2 m -88.34 -40.63 13.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.045 . . . . 0.0 110.45 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' THR . 47.8 m-85 -39.77 99.75 0.2 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.462 -0.774 . . . . 0.0 110.357 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.8 Cg_endo -76.74 -87.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.071 1.563 . . . . 0.0 110.406 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -117.63 67.31 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 ' CD1' ' A' ' 63' ' ' PHE . 1.6 mt -43.03 143.23 1.31 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.957 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.32 167.36 27.12 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.019 1.537 . . . . 0.0 110.47 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ASP . 4.2 t-20 -52.1 152.91 2.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 110.457 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER 42.49 38.92 1.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.809 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 11' ' ' VAL . . . -54.33 116.9 2.88 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' O ' HD11 ' A' ' 72' ' ' LEU . 1.5 mt-10 -89.12 108.06 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.438 HD11 ' O ' ' A' ' 71' ' ' GLU . 4.6 mp -117.08 159.75 22.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 110.004 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -134.7 139.97 45.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.646 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 12.2 tp -79.99 144.73 33.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 3.1 tt -154.02 159.96 41.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 79' ' ' GLU . 21.9 p -152.17 167.81 27.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -45.89 -29.89 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.147 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.81 22.45 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -155.81 152.69 28.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.613 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.44 ' HA ' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.789 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.507 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 9.5 t-105 -107.8 135.28 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.008 -1.058 . . . . 0.0 110.786 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -78.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.336 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.483 ' O ' ' CZ2' ' A' ' 81' ' ' TRP . . . 174.22 177.92 43.74 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 61.2 t80 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.258 -1.142 . . . . 0.0 110.271 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 7' ' ' GLN . 43.9 Cg_endo -71.15 134.14 24.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.924 1.487 . . . . 0.0 110.814 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 152.5 22.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.969 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 69' ' ' ASP . 39.2 m -121.75 153.67 37.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 110.383 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.499 ' CG2' HG11 ' A' ' 24' ' ' VAL . 11.3 m -147.2 132.77 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -97.46 99.59 11.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.919 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.573 HD22 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -81.52 95.04 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.639 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.7 tpt180 -91.61 157.59 16.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.572 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.78 120.06 10.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -64.86 -17.44 64.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.893 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -79.69 -0.54 34.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -134.18 -159.17 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.858 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.16 34.2 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.435 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 6.7 p -177.18 -162.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 110.706 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -140.21 -169.15 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.522 -0.736 . . . . 0.0 110.038 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t80 -130.41 81.29 2.0 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 110.28 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.27 85.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG13 ' CD2' ' A' ' 32' ' ' LEU . 2.1 p -107.21 146.6 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -1.14 . . . . 0.0 110.117 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -124.13 163.63 21.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.002 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . 179.45 135.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -0.863 . . . . 0.0 110.202 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -52.39 -61.69 2.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' CYS . 70.7 m -75.22 93.87 2.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.868 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 28' ' ' SER . 21.3 p -40.98 -30.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -38.49 58.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -68.07 -43.16 79.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.751 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 24' ' ' VAL . 17.0 mt -53.75 -46.81 71.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.563 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 66' ' ' LEU . 27.8 mt -66.87 -67.18 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 109.898 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -43.73 -68.31 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.61 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 5.6 mtpp -46.83 -27.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.87 -55.64 16.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.22 -13.77 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.179 . . . . 0.0 109.714 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 78.4 t -87.27 -52.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.77 . . . . 0.0 109.997 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -63.83 -29.25 70.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.573 ' CD2' HD22 ' A' ' 13' ' ' LEU . 4.4 m-30 -99.24 -18.86 17.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 109.503 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER 60.34 85.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 110.699 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.521 ' CD2' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -124.89 92.4 47.74 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.07 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 124.009 1.531 . . . . 0.0 110.153 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.516 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 39.4 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.1 OUTLIER 176.41 167.62 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.49 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 60' ' ' ASP . 0.6 OUTLIER -120.57 170.25 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 109.556 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 56' ' ' THR . 74.1 m -148.36 -178.99 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.477 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -116.1 120.08 37.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.973 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -5.98 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 110.538 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -50.05 -62.59 1.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.471 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -147.53 20.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 110.724 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 96.33 44.56 2.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -94.88 167.57 11.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 109.985 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.489 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 9.5 mm-40 -122.03 136.81 54.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 11.7 t -151.73 179.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 18.4 p -129.91 164.76 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 49' ' ' LEU . 17.5 p-10 -73.96 1.2 11.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.44 -23.95 7.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 37.4 t -79.96 -41.24 26.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.401 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 58' ' ' VAL . 12.6 m-85 -40.49 99.78 0.21 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.488 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.9 Cg_endo -80.59 -87.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 110.595 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.8 67.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 63' ' ' PHE . 3.3 mp -44.38 148.16 0.9 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.305 -1.115 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.81 157.58 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.935 1.492 . . . . 0.0 109.976 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.98 146.46 0.81 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.038 -1.039 . . . . 0.0 110.067 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.9 m-20 45.58 36.47 2.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.709 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.58 116.45 0.86 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.85 95.45 9.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.0 mp -103.92 162.8 12.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -136.43 106.5 6.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.551 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.521 HD12 ' CD2' ' A' ' 42' ' ' LEU . 17.1 tp -55.3 148.35 14.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.65 156.57 32.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 21.5 p -138.83 165.74 26.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 110.359 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 76' ' ' THR . . . -43.76 -32.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.98 27.79 7.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -154.73 155.87 35.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 110.587 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.539 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.1 141.07 16.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.847 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.488 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.1 t-105 -110.69 130.1 55.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.0 110.338 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -72.54 -61.79 1.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.93 . . . . 0.0 110.099 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.52 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.7 162.7 10.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 26.3 t80 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.407 -1.055 . . . . 0.0 110.218 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 120.707 0.289 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.4 Cg_endo -73.77 126.3 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 110.314 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -79.61 152.57 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 0.0 110.034 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -124.36 151.01 44.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.504 ' CG2' HG12 ' A' ' 24' ' ' VAL . 22.8 m -148.02 141.03 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.73 102.61 15.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.3 tp -78.63 89.52 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.531 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.1 tpt180 -91.49 154.68 18.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -140.34 113.1 8.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.036 -1.04 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 HD12 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -58.09 -20.8 42.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -81.5 -0.18 40.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -127.1 -160.91 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.98 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.76 28.54 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.347 -0.845 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -179.39 -159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.603 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.38 -176.03 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 110.033 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -133.83 91.13 2.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.97 95.02 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.504 HG12 ' CG2' ' A' ' 11' ' ' VAL . 4.2 p -101.56 147.14 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -1.083 . . . . 0.0 110.3 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.476 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -128.09 147.74 50.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 110.35 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 32' ' ' LEU . . . -169.79 150.84 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 mmt180 -62.0 -55.94 24.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 7.8 p -83.49 96.97 8.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.2 p -41.29 -29.65 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' SER . 24.8 mm100 -60.34 -23.55 64.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.076 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.12 -46.78 40.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 26' ' ' ALA . 24.3 mt -59.7 -38.25 81.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.976 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.416 HD23 HD12 ' A' ' 66' ' ' LEU . 18.4 mt -67.16 -54.98 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.859 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -65.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.764 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -49.9 -29.37 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.43 -53.04 23.09 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.6 t -57.53 -17.0 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.554 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.24 -56.3 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.985 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -62.92 -33.54 75.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 4.7 m-30 -94.13 -13.25 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.88 84.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.698 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.54 HD22 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -127.34 96.78 32.76 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.0 -1.062 . . . . 0.0 110.257 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 47' ' ' SER . 43.7 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 124.086 1.572 . . . . 0.0 110.332 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.197 0.523 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 175.99 153.74 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.182 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 74' ' ' LEU . 1.1 mt -122.84 160.08 26.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.647 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 56' ' ' THR . 63.7 m -147.78 139.18 23.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 110.348 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.533 HD11 ' CG2' ' A' ' 58' ' ' VAL . 0.3 OUTLIER -67.32 120.3 13.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.487 -0.758 . . . . 0.0 110.463 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 21.5 t80 -69.54 -12.58 61.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.765 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.06 -41.14 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 110.319 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.58 40.2 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.182 -0.948 . . . . 0.0 110.645 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.509 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 57.38 29.75 60.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.53 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -74.2 161.08 30.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.249 . . . . 0.0 109.7 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.6 pt-20 -114.75 133.0 56.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.048 -1.032 . . . . 0.0 110.599 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.602 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 81.3 t -156.67 173.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 24.2 p -122.58 158.81 29.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 6.1 p-10 -63.16 -16.19 59.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 110.405 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -1.49 31.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.0 t -101.06 -41.46 6.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.602 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 35.2 m-85 -39.61 99.27 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.726 . . . . 0.0 110.246 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.5 Cg_endo -73.65 -55.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.008 1.531 . . . . 0.0 110.462 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.6 68.51 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 1.5 mp -48.09 160.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.126 . . . . 0.0 109.879 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.12 165.6 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -44.64 150.38 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.248 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.0 m-20 47.43 35.74 4.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -52.22 125.84 17.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.753 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 69' ' ' ASP . 31.5 mp0 -96.25 110.24 22.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.163 -0.96 . . . . 0.0 110.914 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.51 HD11 ' CD2' ' A' ' 66' ' ' LEU . 2.7 mm? -114.48 141.26 47.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 0.0 109.788 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -115.9 149.25 38.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 0.0 110.416 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.54 ' CG ' HD22 ' A' ' 42' ' ' LEU . 10.7 tp -86.98 147.1 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.824 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.3 tt -158.99 157.06 30.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.488 ' CG2' ' C ' ' A' ' 75' ' ' LEU . 11.8 p -152.29 173.21 15.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.59 -36.14 6.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -87.36 23.24 12.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.4 mt-10 -157.65 150.71 23.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.093 -1.239 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.512 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.53 133.17 20.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.509 ' NE1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -96.88 125.52 41.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.248 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.418 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 26.4 m80 -67.8 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 110.166 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.5 128.65 1.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.979 179.753 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 120.72 0.295 . . . . 0.0 110.268 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.0 Cg_endo -71.65 137.53 30.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.864 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 169.24 16.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.745 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' C ' ' CG1' ' A' ' 11' ' ' VAL . 26.5 m -141.38 152.32 44.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' CG2' HG11 ' A' ' 24' ' ' VAL . 3.6 m -148.07 142.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 55.2 mmtt -98.33 92.4 5.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -72.61 84.31 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 110.382 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.0 tpt180 -81.59 159.82 23.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.825 . . . . 0.0 109.693 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB3' ' CE2' ' A' ' 40' ' ' PHE . . . -141.31 126.64 18.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 110.589 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -68.57 -24.51 64.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.951 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -79.93 5.98 12.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -150.81 148.88 29.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 110.019 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.42 54.94 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 110.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.2 p -173.65 -172.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.25 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.473 -0.767 . . . . 0.0 109.931 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 24' ' ' VAL . 14.2 t80 -147.71 79.0 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.0 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -62.49 81.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 32' ' ' LEU . 4.8 p -93.83 144.99 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -1.102 . . . . 0.0 110.728 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -123.68 154.42 39.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 110.059 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -177.12 130.05 0.17 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 ttp180 -45.51 -57.15 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.2 p -82.26 97.18 8.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.5 p -41.83 -29.42 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' OE1' ' SG ' ' A' ' 29' ' ' CYS . 1.4 mp0 -56.69 -24.02 46.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -46.2 42.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.373 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 24' ' ' VAL . 20.4 mt -61.68 -39.46 91.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 29.1 mt -63.03 -58.78 6.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.053 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 4.4 mmt180 -59.42 -71.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 0.0 109.86 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' ARG . 32.6 mtpt -42.96 -34.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.776 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -63.96 -54.66 29.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.0 t -61.5 -13.5 21.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.15 -1.206 . . . . 0.0 109.872 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.6 -49.98 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.0 109.687 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -25.51 63.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.534 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -99.63 -18.96 17.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.797 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 60.57 83.23 0.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.4 OUTLIER -125.06 102.85 30.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.99 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.9 Cg_endo . . . . . 0 C--N 1.303 -1.831 0 O-C-N 123.938 1.494 . . . . 0.0 110.531 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.019 0.438 . . . . 0.0 109.993 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.2 147.05 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.893 -1.129 . . . . 0.0 110.948 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mp -110.09 175.76 5.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.36 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.9 p -159.07 146.6 17.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 0.0 110.673 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -71.55 111.51 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 110.121 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.452 ' CD1' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -68.97 -14.54 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -53.05 -44.51 67.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.285 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t70 -136.47 -33.78 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 131.3 38.59 0.27 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.514 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.3 171.5 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.102 . . . . 0.0 110.018 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.7 mm-40 -121.24 135.94 55.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 109.73 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 82.5 t -155.38 168.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.601 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.416 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 55.0 p -110.14 159.46 17.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 110.12 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.47 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.8 p-10 -67.06 -8.01 27.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 110.433 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.32 -17.1 14.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.6 m -84.58 -41.61 16.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 58' ' ' VAL . 18.6 m-85 -40.0 100.18 0.21 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.401 -0.812 . . . . 0.0 110.57 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -75.84 -89.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.07 1.563 . . . . 0.0 110.36 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -125.98 65.83 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 17.5 mt -42.76 163.37 0.15 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -73.0 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.214 1.639 . . . . 0.0 109.921 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -74.44 150.28 40.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.126 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 70' ' ' ALA . 38.7 m-20 42.75 37.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.86 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.03 100.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.63 . . . . 0.0 110.253 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.7 tt0 -71.35 106.07 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.367 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 72' ' ' LEU . 6.0 mp -111.37 166.42 11.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -142.39 138.33 31.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -80.89 146.23 30.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.82 159.45 36.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.092 -1.005 . . . . 0.0 109.899 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 75' ' ' LEU . 5.2 p -150.98 174.08 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.41 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.931 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.28 18.47 57.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -151.49 161.22 43.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -1.145 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.13 142.64 17.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.827 . . . . 0.0 110.166 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.7 t-105 -116.26 133.12 56.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.125 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.28 -80.23 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -168.36 154.19 23.85 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.14 . . . . 0.0 110.28 -179.798 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.809 0.337 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.3 Cg_endo -73.3 123.58 8.84 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.129 1.594 . . . . 0.0 110.953 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 1.9 ttpm? -80.92 155.87 26.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.743 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' ASP . 25.0 t -125.38 151.84 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' VAL . 8.9 m -144.53 149.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 3.5 mmtt -99.31 101.24 12.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -79.27 75.28 5.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.431 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.8 tpt180 -83.73 157.31 22.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.83 122.4 20.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.049 -1.032 . . . . 0.0 110.661 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.36 -30.6 66.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.475 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 61.0 t-80 -79.89 5.76 12.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 110.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -127.18 -163.79 1.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.961 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.14 33.05 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -171.88 -162.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.822 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.95 -164.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.769 . . . . 0.0 109.853 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -156.08 89.56 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.447 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.56 96.1 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 32' ' ' LEU . 2.3 p -105.74 151.83 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 110.43 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -134.06 161.81 33.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.059 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -178.52 141.91 0.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 0.0 110.478 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.38 -65.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.99 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.3 OUTLIER -79.72 95.03 5.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.846 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.463 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 29.5 p -41.44 -28.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.808 . . . . 0.0 110.423 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 13.0 tt0 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 1.2 tp10 -74.41 -46.13 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.385 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 24' ' ' VAL . 22.0 mt -60.97 -36.89 80.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD21 ' CD1' ' A' ' 66' ' ' LEU . 63.8 mt -66.37 -59.89 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.838 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -70.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 24.0 mtpp -45.48 -32.03 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.598 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.27 58.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.3 t -65.76 -15.78 63.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.696 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 82.5 t -80.53 -46.5 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -32.57 64.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.671 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CD2' HD22 ' A' ' 74' ' ' LEU . 2.0 m-30 -90.6 -10.55 42.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.77 82.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.322 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.3 OUTLIER -124.63 111.26 27.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 110.153 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 47' ' ' SER . 46.7 Cg_endo . . . . . 0 C--N 1.304 -1.779 0 O-C-N 124.015 1.534 . . . . 0.0 110.301 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.143 0.497 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 178.95 140.03 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 60' ' ' ASP . 2.0 mp -112.1 118.73 36.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.374 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 56' ' ' THR . 71.6 m -103.34 155.11 18.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.056 -1.028 . . . . 0.0 110.753 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -83.27 124.09 30.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.014 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -73.93 1.24 11.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.741 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.414 ' HB2' HD21 ' A' ' 51' ' ' LEU . 1.1 tp10 -59.73 -54.97 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.35 21.19 1.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.507 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 87.63 35.9 9.0 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 50' ' ' CYS . 0.2 OUTLIER -82.11 163.15 22.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -1.175 . . . . 0.0 110.013 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 14.7 pt-20 -116.04 134.81 54.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 21.2 t -153.09 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 44.5 p -131.48 161.44 32.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.003 -1.061 . . . . 0.0 109.99 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.504 ' N ' HD11 ' A' ' 49' ' ' LEU . 5.7 p-10 -72.61 -0.75 13.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 110.579 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -113.0 -11.52 13.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.379 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 3.3 t -98.39 -38.2 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.48 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 66' ' ' LEU . 6.9 m-85 -39.99 99.48 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.2 Cg_endo -81.35 -67.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.935 1.492 . . . . 0.0 110.349 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -147.97 64.78 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.615 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 4.7 mt -42.31 163.45 0.13 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 43.5 Cg_endo -71.24 161.98 44.01 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.209 1.636 . . . . 0.0 110.2 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.45 153.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 4.8 m-20 45.02 37.22 2.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -49.54 112.83 0.7 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.406 -0.808 . . . . 0.0 109.864 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' C ' HD11 ' A' ' 72' ' ' LEU . 4.6 mt-10 -82.07 111.64 18.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 72' ' ' LEU . 4.7 mp -109.22 148.32 31.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.752 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 1.1 tp -132.18 126.03 32.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.943 -1.098 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.488 HD22 ' CD2' ' A' ' 40' ' ' PHE . 9.0 tp -67.74 131.24 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 109.929 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 1.3 tt -147.77 159.48 43.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 109.656 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.3 p -146.79 -178.03 5.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.94 73.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.14 11.13 58.82 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER -141.96 154.16 44.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -1.184 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.59 141.61 23.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -114.51 129.53 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.351 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -66.81 -69.92 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.235 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.507 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 131.81 2.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.4 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.191 -1.182 . . . . 0.0 110.477 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.3 Cg_endo -72.0 125.52 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.981 1.517 . . . . 0.0 110.97 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -85.89 153.35 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' ASP . 13.5 t -127.61 158.83 36.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.381 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.498 HG23 ' CG1' ' A' ' 24' ' ' VAL . 5.4 m -149.02 135.87 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -92.89 96.47 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -75.84 82.42 2.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.546 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.5 tpt180 -81.01 160.53 24.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 14' ' ' ARG . . . -142.39 132.31 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 110.519 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.497 ' CD1' HD23 ' A' ' 73' ' ' LEU . 4.6 mt -74.55 -20.86 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 109.941 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.529 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 21.4 t60 -79.96 3.34 20.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.899 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 165.48 31.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.96 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 53.2 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -174.98 -172.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 111.09 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -145.62 -162.11 1.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.501 -0.749 . . . . 0.0 109.919 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 9.0 t80 -144.86 87.23 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 110.491 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.07 83.47 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.55 ' CG1' HD22 ' A' ' 32' ' ' LEU . 7.5 p -95.1 152.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -1.158 . . . . 0.0 110.239 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.475 ' N ' HD23 ' A' ' 32' ' ' LEU . . . -132.57 164.29 26.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB1' ' HG ' ' A' ' 32' ' ' LEU . . . 177.92 133.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mtm180 -50.14 -33.41 18.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' GLN . 3.2 m -107.35 93.74 4.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.898 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 13.9 p -38.77 -28.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.581 -0.699 . . . . 0.0 110.466 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.12 -33.88 72.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 3.5 tt0 -68.13 -31.33 70.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.55 HD22 ' CG1' ' A' ' 24' ' ' VAL . 30.0 mt -76.38 -34.34 58.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.94 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 79.9 mt -66.91 -61.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -53.25 -53.8 45.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtpm? -56.78 -28.25 60.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.341 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -65.46 -51.98 43.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.9 t -67.09 -18.07 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -1.228 . . . . 0.0 109.84 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.9 t -81.11 -53.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.891 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -66.79 -42.03 86.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.535 ' CD2' HD21 ' A' ' 13' ' ' LEU . 2.5 m-30 -84.95 -13.22 51.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.558 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.77 80.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.437 -0.789 . . . . 0.0 110.281 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.5 OUTLIER -111.5 105.13 56.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 124.048 1.552 . . . . 0.0 110.495 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.211 0.529 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.57 142.55 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.925 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 74' ' ' LEU . 3.5 mt -108.72 162.49 14.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.594 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.3 p -149.78 162.59 39.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.614 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' CB ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.36 115.7 27.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -70.19 -5.96 31.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.376 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.64 -54.26 47.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.5 8.56 3.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 91.5 29.0 12.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -74.66 176.65 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 109.888 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 12.2 mt-10 -126.83 137.06 53.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 110.733 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 63' ' ' PHE . 49.0 t -155.77 174.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 43.3 p -122.92 165.22 17.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 110.261 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 p-10 -69.79 -4.1 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.892 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.87 -8.12 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.315 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.7 m -105.07 18.69 21.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.197 -0.939 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 10.9 m-85 -100.87 98.58 8.68 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -72.98 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -127.45 66.54 0.56 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 16.1 mt -41.44 162.98 0.12 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.311 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.1 Cg_endo -70.75 154.89 63.57 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.232 1.649 . . . . 0.0 109.854 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.3 t-20 -41.91 143.99 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 10' ' ' CYS . 2.6 m-20 54.38 36.18 24.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.713 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.81 111.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.586 -0.696 . . . . 0.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 98.23 5.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 66' ' ' LEU . 1.4 mp -108.34 156.03 19.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.911 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.497 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -139.11 123.99 18.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.53 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 11.5 tp -67.77 138.45 56.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 110.184 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.7 OUTLIER -148.76 157.67 43.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.47 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -148.02 176.8 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.25 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.46 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.42 15.03 52.87 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 2.4 mt-10 -143.42 145.88 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -1.13 . . . . 0.0 110.513 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.509 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.77 157.77 43.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.822 . . . . 0.0 109.812 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.519 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.7 t-105 -129.73 126.69 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.459 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.54 -59.28 3.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.391 -0.818 . . . . 0.0 110.11 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.46 161.34 8.69 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 45.6 t80 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 110.144 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 4.9 pt20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -73.16 125.73 10.54 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.945 1.497 . . . . 0.0 110.794 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -80.92 171.4 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.917 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ASP . 44.5 m -138.68 151.16 46.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.464 HG21 HG13 ' A' ' 24' ' ' VAL . 5.5 m -146.32 129.51 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 13.7 mmmt -85.65 96.69 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 87.21 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 110.698 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.6 tpt180 -81.99 154.83 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.705 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -143.43 117.23 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 HD13 HD22 ' A' ' 73' ' ' LEU . 1.5 mt -60.81 -27.44 68.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.201 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -83.1 10.77 7.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.13 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 8.0 m -128.19 -161.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.82 14.17 15.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.399 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 -155.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -130.36 176.0 8.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 110.301 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 24' ' ' VAL . 19.2 t80 -120.19 84.93 2.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -59.82 85.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.551 ' CG2' ' CD2' ' A' ' 32' ' ' LEU . 7.0 p -96.3 148.4 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -1.096 . . . . 0.0 110.41 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -130.25 151.09 51.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -171.93 142.35 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 110.468 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -47.03 -66.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 110.008 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.9 OUTLIER -81.59 96.24 7.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 24.7 p -41.94 -31.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -29.24 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 4.0 tp10 -72.79 -35.43 67.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.501 -0.749 . . . . 0.0 109.817 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.551 ' CD2' ' CG2' ' A' ' 24' ' ' VAL . 18.1 mt -69.1 -32.84 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD22 ' CB ' ' A' ' 63' ' ' PHE . 42.3 mt -67.98 -53.41 26.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.0 mmt180 -61.29 -61.8 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.826 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 11.2 mtpt -53.79 -27.95 32.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.61 -44.07 95.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 20.7 t -73.81 -20.65 60.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -1.199 . . . . 0.0 110.169 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 55.0 t -70.94 -49.3 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.469 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -75.72 -26.92 57.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 74' ' ' LEU . 2.5 m-30 -92.76 -3.72 54.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 78.3 mm-40 46.32 72.18 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -115.45 105.34 52.31 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 110.466 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 47' ' ' SER . 40.9 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.862 1.454 . . . . 0.0 110.281 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.45 0.643 . . . . 0.0 110.67 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -178.01 137.04 0.18 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 3.4 mt -109.63 163.88 13.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.719 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' THR . 7.2 p -154.97 136.95 14.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.947 . . . . 0.0 110.368 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -66.3 112.22 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.75 -17.84 38.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.274 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.67 -53.54 30.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.178 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.13 23.17 2.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.54 26.38 71.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -67.8 165.43 17.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -1.221 . . . . 0.0 109.791 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 11.4 pm0 -113.88 135.56 53.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.003 -1.061 . . . . 0.0 110.96 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 63' ' ' PHE . 98.7 t -157.53 173.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.685 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 58.0 p -128.45 158.83 37.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 52.3 p30 -62.2 -11.47 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.7 t0 -107.63 4.45 25.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 37.7 t -112.21 -40.24 4.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.176 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 58' ' ' VAL . 44.6 m-85 -40.04 99.95 0.21 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -74.41 -90.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.005 1.529 . . . . 0.0 110.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.73 66.27 0.57 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 63' ' ' PHE . 40.2 mt -44.62 163.73 0.18 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.31 -1.112 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.26 -174.34 1.76 Allowed 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.173 1.617 . . . . 0.0 109.847 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 69' ' ' ASP . 33.6 p30 -63.79 154.05 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 110.039 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.5 m-20 42.65 38.79 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.855 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.34 112.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.493 -0.755 . . . . 0.0 109.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.76 103.59 11.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.502 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.467 HD13 ' CD1' ' A' ' 66' ' ' LEU . 8.7 mp -114.86 156.63 24.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.32 -0.863 . . . . 0.0 110.106 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -133.21 125.89 30.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.476 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 12.3 tp -71.79 133.66 45.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.465 -0.772 . . . . 0.0 109.949 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 1.5 tt -147.47 160.82 42.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.134 -0.979 . . . . 0.0 109.547 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.479 ' N ' HD22 ' A' ' 75' ' ' LEU . 4.6 p -148.83 173.11 13.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 109.96 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.47 -24.34 7.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.959 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.98 16.52 60.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -150.72 156.59 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -1.081 . . . . 0.0 110.242 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.27 153.84 39.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.224 -0.923 . . . . 0.0 110.401 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.475 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.3 t-105 -130.9 116.95 18.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.347 -0.845 . . . . 0.0 110.254 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -63.47 -72.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.058 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.42 167.01 19.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 12.9 t80 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.183 -1.186 . . . . 0.0 110.349 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 43.9 Cg_endo -71.88 124.15 9.91 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.98 1.516 . . . . 0.0 110.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 158.71 23.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.699 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.8 t -127.85 151.64 48.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 HD21 ' A' ' 32' ' ' LEU . 3.0 m -140.06 152.7 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.977 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -110.32 99.28 8.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 HD23 ' CA ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -82.23 88.79 6.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.975 . . . . 0.0 110.689 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.537 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.4 tpt180 -95.4 157.31 15.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.03 139.27 44.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 81' ' ' TRP . 1.6 mt -76.26 -21.14 56.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -79.38 -2.04 39.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -155.79 138.13 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.94 53.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.19 167.36 29.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 110.606 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.88 162.32 40.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.512 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.514 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 8.4 t80 -115.66 87.74 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.93 95.57 0.28 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 32' ' ' LEU . 6.0 p -108.68 154.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -1.193 . . . . 0.0 110.903 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -124.8 166.44 16.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.63 147.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.5 mtm180 -66.86 -53.99 26.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 110.033 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' CYS . 73.9 m -83.82 97.14 9.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . 7.2 p -41.65 -30.55 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.105 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -54.87 -27.49 43.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.17 -44.03 39.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 24' ' ' VAL . 11.5 mt -57.34 -42.36 81.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 63' ' ' PHE . 68.2 mt -67.21 -59.83 3.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -54.03 -70.48 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.795 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 27.8 mtpt -47.29 -24.59 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.472 ' CA ' HD23 ' A' ' 13' ' ' LEU . . . -73.48 -53.44 7.5 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.3 t -66.64 -11.87 55.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -1.107 . . . . 0.0 109.748 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 97.5 t -82.5 -69.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.967 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -51.77 -31.89 28.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.685 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.9 m-85 -89.82 -17.95 27.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.58 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 5.5 mt-30 56.56 80.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.518 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -118.2 105.33 46.93 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 110.175 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 123.968 1.51 . . . . 0.0 110.212 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.173 0.511 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER 179.01 146.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 110.595 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mt -116.35 170.7 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.257 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.2 p -160.21 131.24 5.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.85 -1.156 . . . . 0.0 111.137 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -53.63 133.4 41.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.772 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 25.1 t80 -92.45 -13.26 30.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 110.37 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -53.7 -24.86 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 1.6 t0 -156.46 -43.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.652 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.53 54.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.486 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.59 160.88 14.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.964 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -111.16 130.74 55.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 0.0 110.278 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 51' ' ' LEU . 52.3 t -148.8 172.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.483 ' HA ' HD12 ' A' ' 49' ' ' LEU . 35.3 p -115.16 158.44 22.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p-10 -70.47 -13.36 62.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -102.44 6.24 40.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.3 t -112.33 -36.99 5.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 66' ' ' LEU . 25.6 m-85 -40.59 100.62 0.22 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.461 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -75.38 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.105 1.582 . . . . 0.0 110.275 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.32 69.29 0.52 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 63' ' ' PHE . 17.7 mt -50.37 161.76 0.58 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.209 -1.171 . . . . 0.0 110.051 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.59 167.27 26.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -45.75 153.02 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 110.103 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 27.1 m-20 43.89 37.37 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.2 117.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.761 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -82.88 107.69 15.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 110.501 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 HD22 ' CE2' ' A' ' 63' ' ' PHE . 1.3 mp -118.25 137.64 52.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.805 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -115.87 131.7 56.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.926 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.518 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 11.7 tp -77.12 139.74 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -155.07 163.71 39.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.2 p -147.79 168.25 22.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.09 -25.44 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.74 15.42 61.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 0.4 OUTLIER -151.96 151.65 31.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 110.344 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.91 144.26 30.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.103 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . 9.6 t-105 -110.95 135.87 50.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -79.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 166.95 147.17 5.14 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -72.49 123.06 8.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.824 1.434 . . . . 0.0 110.183 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.69 139.91 37.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.7 t -108.1 149.06 28.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.12 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 24' ' ' VAL . 30.2 m -143.95 126.13 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -83.51 97.4 8.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -78.04 79.35 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 5.1 tpt180 -80.56 160.36 25.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.835 . . . . 0.0 109.705 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.93 116.93 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.041 -1.037 . . . . 0.0 110.709 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' CD1' HD23 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -69.28 -19.77 63.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.79 2.05 24.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.9 -161.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.38 39.86 3.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.9 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.9 p -173.41 -161.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 13.7 ptpt -150.61 -162.03 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 0.0 109.981 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -151.89 90.61 1.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.08 89.89 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG11 ' CD2' ' A' ' 32' ' ' LEU . 3.7 p -97.97 144.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -1.205 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' C ' HD13 ' A' ' 32' ' ' LEU . . . -128.21 148.32 50.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.488 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -172.2 154.09 3.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mtm180 -63.04 -59.3 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.456 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -84.92 96.2 9.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -42.32 -34.14 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.42 -30.87 42.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.404 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -74.19 -32.87 63.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.503 -0.748 . . . . 0.0 109.779 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.527 ' CD2' HG11 ' A' ' 24' ' ' VAL . 14.8 mt -75.8 -37.52 59.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.11 -60.65 2.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.93 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -58.58 7.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.765 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -51.33 -32.93 27.09 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.405 -0.81 . . . . 0.0 109.355 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.17 -51.94 53.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -61.36 -19.38 61.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.178 . . . . 0.0 109.864 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 89.1 t -78.96 -48.08 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -76.43 -33.14 58.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.058 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -89.7 -12.45 39.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -0.882 . . . . 0.0 109.616 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 82.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 110.424 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.547 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.31 108.76 37.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.374 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.2 Cg_endo . . . . . 0 C--N 1.305 -1.711 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.168 0.509 . . . . 0.0 110.15 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.8 116.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 110.318 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.514 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.2 mt -99.62 111.26 23.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.3 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 73' ' ' LEU . 26.4 p -96.33 168.51 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.947 . . . . 0.0 110.768 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.43 116.66 31.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.552 -0.718 . . . . 0.0 110.173 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' CB ' ' OE1' ' A' ' 71' ' ' GLU . 15.3 t80 -62.26 -14.41 38.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -56.49 15.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.28 42.98 1.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.495 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.44 33.9 78.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -76.81 164.22 26.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.103 -1.233 . . . . 0.0 109.619 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 58' ' ' VAL . 16.9 pt-20 -116.94 131.89 56.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.97 -1.081 . . . . 0.0 110.241 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 25.9 t -151.04 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.478 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 19.3 p -130.71 165.09 23.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.471 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 10.7 p-10 -70.95 -11.86 61.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.603 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.24 -2.42 20.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.052 -1.03 . . . . 0.0 110.524 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 47.9 t -103.01 -39.55 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.636 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 16.4 m-85 -40.46 100.0 0.21 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 110.59 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.5 Cg_endo -81.9 -79.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.027 1.541 . . . . 0.0 110.491 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.79 70.91 0.51 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.566 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 5.5 mt -51.93 161.55 0.92 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.334 -1.098 . . . . 0.0 110.473 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.438 ' HD2' HD21 ' A' ' 66' ' ' LEU . 44.6 Cg_endo -73.42 178.85 6.13 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.19 1.626 . . . . 0.0 109.996 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 69' ' ' ASP . 28.5 t-20 -59.82 150.27 28.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.205 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 44.35 39.03 2.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 109.723 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.81 109.62 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.564 -0.71 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -78.7 95.29 5.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -103.96 152.92 21.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -132.65 124.76 28.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.446 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.547 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 11.6 tp -72.67 121.84 20.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.539 -0.726 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 76' ' ' THR . 0.3 OUTLIER -138.69 157.45 46.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 10.6 p -135.68 179.86 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.56 63.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.75 17.35 50.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -147.23 162.64 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -1.186 . . . . 0.0 110.514 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.418 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -154.71 141.61 19.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.466 ' CE2' ' HA2' ' A' ' 83' ' ' GLY . 2.8 t-105 -115.7 125.44 52.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.449 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 3.7 t60 -62.18 -60.14 4.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 81' ' ' TRP . . . 130.67 143.52 5.33 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.851 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 29.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.246 0.546 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER 66.02 -172.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 179.87 63.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.358 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.13 150.15 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.914 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.22 98.29 8.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 2.8 mmt180 -87.47 48.29 1.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.817 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 6.3 pt20 172.73 113.57 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.038 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.5 139.7 28.89 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.905 1.476 . . . . 0.0 110.44 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 2.0 ttpt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.1 t -118.05 148.55 42.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.545 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 24' ' ' VAL . 22.4 m -142.37 127.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.922 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 4.0 mmpt? -82.7 107.54 15.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.976 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.496 HD22 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -88.46 86.2 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.383 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.1 tpt180 -86.94 157.46 19.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -136.42 128.87 30.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.048 -1.032 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mt -72.54 -26.87 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.808 . . . . 0.0 109.716 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 36.5 t60 -85.14 13.52 6.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.408 -0.807 . . . . 0.0 109.995 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -133.69 -160.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.377 -0.827 . . . . 0.0 109.998 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . -129.54 35.88 4.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 4.8 p 174.69 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -168.07 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.0 109.9 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 2.1 t80 -143.96 90.81 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' CA ' ' HE2' ' A' ' 12' ' ' LYS . . . -64.61 91.72 0.11 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 32' ' ' LEU . 3.1 p -99.41 134.51 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -1.154 . . . . 0.0 110.126 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' CA ' HD22 ' A' ' 32' ' ' LEU . . . -117.46 149.51 40.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -168.48 145.08 3.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -59.03 -58.56 8.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.066 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 m -80.27 98.07 7.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -0.864 . . . . 0.0 109.93 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 26.0 p -40.56 -29.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -0.787 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' SER . 31.9 tt0 -60.14 -28.98 68.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.4 -45.01 66.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.802 . . . . 0.0 109.845 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.538 ' CD2' HG11 ' A' ' 24' ' ' VAL . 4.8 mt -57.8 -43.43 85.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 110.001 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD21 ' CD2' ' A' ' 63' ' ' PHE . 2.6 mt -61.85 -65.92 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HG2' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -43.61 -69.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -47.24 -27.36 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.49 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.42 -55.37 12.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.57 -11.64 17.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 0.0 110.032 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.7 t -85.33 -71.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.197 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -23.51 5.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.347 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.561 ' CD2' HD23 ' A' ' 74' ' ' LEU . 2.7 m-85 -102.99 -16.57 15.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 54.01 85.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -129.08 99.95 21.21 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo -73.45 154.05 50.31 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.558 . . . . 0.0 110.171 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.89 -51.29 65.32 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.457 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 44' ' ' MET . 47.2 Cg_endo -76.61 157.03 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.886 1.466 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 44.06 44.71 7.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -167.98 178.0 5.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.136 . . . . 0.0 110.007 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER 172.75 148.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 60' ' ' ASP . 2.1 mt -118.22 168.85 10.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.1 p -154.97 139.65 17.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 110.848 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -68.08 127.01 31.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 110.292 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -80.85 1.3 31.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.35 -46.38 88.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.0 15.52 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 94.02 28.97 10.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.06 164.64 25.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -1.222 . . . . 0.0 109.402 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 mt-10 -121.46 130.67 53.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.929 -1.107 . . . . 0.0 110.497 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 63' ' ' PHE . 57.3 t -153.1 173.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.401 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 36.9 p -123.35 164.95 17.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.525 ' N ' HD12 ' A' ' 49' ' ' LEU . 3.0 p30 -67.61 -12.17 59.81 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.325 -0.859 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -105.35 -5.41 20.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.3 t -107.42 17.2 23.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.168 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CE1' HG13 ' A' ' 58' ' ' VAL . 6.6 m-85 -100.99 96.54 5.8 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.392 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.5 Cg_endo -72.13 -91.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.782 1.411 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -112.48 68.63 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 63' ' ' PHE . 1.5 mt -42.84 152.76 0.35 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 0.0 110.343 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.44 164.51 32.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.986 1.519 . . . . 0.0 110.132 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -49.13 148.94 2.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER 43.12 37.33 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.721 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.86 127.6 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 110.035 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 108.72 19.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 63' ' ' PHE . 1.2 mp -117.85 145.41 44.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -128.58 137.25 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.455 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 40' ' ' PHE . 9.9 tp -77.4 138.94 39.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.881 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD21 ' N ' ' A' ' 76' ' ' THR . 1.6 tt -156.0 162.33 40.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.524 ' N ' HD21 ' A' ' 75' ' ' LEU . 71.2 p -153.99 171.92 18.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.718 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.57 -25.48 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 23.35 34.13 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 17' ' ' HIS . 2.2 mt-10 -156.36 162.66 40.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -1.165 . . . . 0.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.16 151.31 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.647 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.456 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 7.5 t-105 -124.23 126.32 45.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.878 . . . . 0.0 109.791 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -66.82 -71.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 163.65 175.85 34.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 5.5 t80 -114.2 53.21 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.4 -1.059 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.56 179.1 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 0.0 110.3 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.17 59.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.202 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 1.9 ttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.364 0.602 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 171.25 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.034 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.9 78.81 0.84 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.3 126.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.168 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -132.54 135.86 46.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 15.2 mmt-85 -100.43 46.51 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 10.1 pt20 178.4 114.68 0.18 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.888 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.2 Cg_endo -72.69 120.82 6.91 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.937 1.493 . . . . 0.0 111.107 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.36 -166.02 1.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.684 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.8 t -153.23 154.53 34.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 24' ' ' VAL . 32.8 m -147.04 146.26 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -107.01 96.76 6.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 HD22 ' CE1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -77.82 90.98 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.532 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.7 tpt180 -91.73 152.8 20.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.015 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.94 131.81 31.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.858 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.492 ' CB ' ' OE1' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.1 -28.15 64.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.782 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -79.83 3.05 20.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.983 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 t -123.97 -163.04 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 110.048 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.83 33.2 5.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 110.107 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 172.95 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.747 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.04 166.7 23.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.752 . . . . 0.0 109.87 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 6.3 t80 -112.48 97.74 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 110.459 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.81 98.5 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG12 ' CG2' ' A' ' 11' ' ' VAL . 4.1 p -115.5 150.75 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -1.175 . . . . 0.0 110.569 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -125.65 167.0 15.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 110.229 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.75 150.1 0.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.642 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mmm180 -62.79 -57.33 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.11 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.8 m -82.99 95.99 8.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.368 -0.833 . . . . 0.0 110.01 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 28.2 p -41.61 -28.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -55.55 -38.59 69.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.837 . . . . 0.0 109.741 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.6 tp10 -63.46 -43.95 95.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD23 ' CG1' ' A' ' 24' ' ' VAL . 8.4 mt -55.24 -47.62 75.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.87 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 63' ' ' PHE . 15.8 mt -63.29 -64.48 0.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.882 . . . . 0.0 109.938 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 7.4 tpp85 -47.75 -68.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.907 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -44.93 -30.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.541 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -64.02 -55.36 24.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.4 t -60.17 -14.36 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.865 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 57.4 t -84.83 -60.35 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.377 -0.827 . . . . 0.0 110.28 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -25.32 68.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 110.339 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.549 ' CE1' HD22 ' A' ' 13' ' ' LEU . 3.1 m-85 -101.45 -17.49 16.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.86 84.22 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.5 OUTLIER -123.94 105.72 31.95 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.874 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo -73.52 145.05 37.02 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.008 1.531 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -56.43 -50.49 87.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 110.116 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.1 Cg_endo -79.54 158.0 25.34 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.1 1.579 . . . . 0.0 110.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 44.34 51.81 7.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -172.38 174.99 3.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.136 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 1.3 mtt85 -179.25 117.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 60' ' ' ASP . 13.0 mt -89.57 101.45 14.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.34 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 56' ' ' THR . 94.3 m -89.61 178.88 6.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 111.006 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' CB ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -108.4 131.11 55.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.445 -0.784 . . . . 0.0 110.081 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -80.74 2.55 25.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.792 . . . . 0.0 110.495 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 4.5 tt0 -66.28 -59.5 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -141.54 22.39 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.333 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 83.68 48.79 5.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.33 166.2 12.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -1.183 . . . . 0.0 109.715 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -118.98 126.84 52.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.058 . . . . 0.0 110.544 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 10.3 t -144.67 179.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.4 p -138.88 158.5 44.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.1 p30 -61.96 -11.49 13.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 110.26 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -106.67 -5.74 18.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 t -98.18 -48.62 5.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.441 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' CE1' ' CD2' ' A' ' 66' ' ' LEU . 10.1 m-85 -41.17 100.53 0.22 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 110.493 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.7 Cg_endo -79.47 -48.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.036 1.545 . . . . 0.0 110.431 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.86 69.55 0.18 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 1.7 mt -48.33 161.39 0.38 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 44.0 Cg_endo -72.13 -167.31 0.31 Allowed 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 124.097 1.578 . . . . 0.0 110.116 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 44.9 t30 -70.02 144.57 52.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' CYS . 54.6 t0 56.88 33.98 24.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.982 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -45.46 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.57 -0.706 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' HD11 ' A' ' 72' ' ' LEU . 1.2 tt0 -78.16 111.02 13.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 7.4 mp -115.06 162.79 16.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 109.99 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD11 ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -136.98 122.11 19.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.416 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.475 ' HG ' HD21 ' A' ' 42' ' ' LEU . 8.5 tp -68.3 115.55 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.803 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -132.63 159.03 40.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 7.6 p -149.05 171.49 16.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 110.158 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.34 -25.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.848 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.25 14.73 62.9 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 76' ' ' THR . 2.9 mt-10 -153.6 144.42 22.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.444 ' CA ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -135.68 131.13 35.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.485 ' CZ2' ' O ' ' A' ' 83' ' ' GLY . 5.7 t-105 -101.85 130.68 48.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -43.75 18.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 110.429 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.522 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 131.7 -172.34 20.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 26.8 t80 -118.7 62.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.139 . . . . 0.0 110.27 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.32 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 110.424 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.7 m -112.85 56.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 0.0 110.05 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.215 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.9 mtt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.286 0.565 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 169.98 149.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.37 56.21 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 4' ' ' VAL . 32.9 m -82.3 151.51 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.34 114.13 9.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.922 . . . . 0.0 110.436 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 6.8 mtt-85 -94.04 40.37 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.945 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 3.2 pt20 171.58 132.74 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.013 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.7 Cg_endo -74.37 133.52 17.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.882 1.464 . . . . 0.0 110.495 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.49 166.29 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 27.8 m -139.19 155.32 47.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 24' ' ' VAL . 22.3 m -150.32 131.71 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.2 mmtt -89.3 85.34 6.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.938 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.491 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.1 tp -65.29 85.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.842 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tpt180 -82.52 153.05 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 109.42 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' CZ ' ' A' ' 14' ' ' ARG . . . -136.0 133.02 37.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.411 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.81 -16.58 53.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.02 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -0.87 47.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 110.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -129.98 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.78 34.85 5.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.93 -160.63 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -138.29 -160.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.243 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.6 t80 -149.59 84.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -67.26 93.58 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 22' ' ' PHE . 1.3 p -107.59 151.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -1.106 . . . . 0.0 110.171 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -125.33 153.05 43.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.51 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -167.09 132.93 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.2 mmt180 -48.42 -62.29 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.107 -0.996 . . . . 0.0 110.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -76.07 96.48 3.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.017 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.0 p -42.07 -33.32 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -32.06 58.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.536 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -72.4 -39.23 68.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.83 . . . . 0.0 109.404 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 15.9 mt -56.25 -45.36 80.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.764 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD23 ' CB ' ' A' ' 63' ' ' PHE . 23.6 mt -65.87 -64.69 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.33 -70.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.937 . . . . 0.0 109.827 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 9.0 mtpt -48.95 -22.97 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.979 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.37 -45.71 45.84 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 15.5 t -76.06 -15.71 60.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -1.129 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.8 t -79.47 -50.17 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.795 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.11 -39.36 78.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.491 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.4 m-30 -83.24 -15.22 51.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 57.41 80.3 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -120.62 110.23 35.61 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.361 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.07 167.28 27.58 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.039 1.547 . . . . 0.0 110.335 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.28 -48.53 0.59 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.557 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.6 Cg_endo -80.97 136.04 10.22 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.813 1.428 . . . . 0.0 110.741 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.48 76.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -141.61 178.23 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -1.16 . . . . 0.0 110.05 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 175.99 141.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.093 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 2.5 mt -109.13 166.71 10.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.976 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.4 m -150.14 169.17 21.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 110.41 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.6 129.33 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.404 -0.81 . . . . 0.0 110.16 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -80.57 -8.68 59.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' HD21 ' A' ' 51' ' ' LEU . 7.5 tt0 -58.29 -48.62 79.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.9 10.87 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 88.08 46.33 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.19 171.89 9.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -1.208 . . . . 0.0 109.709 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 1.1 pt-20 -118.43 129.02 55.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.058 -1.026 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 21.4 t -152.71 176.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 7.3 p -126.37 172.52 10.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 110.214 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.523 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 18.7 p-10 -81.61 -4.39 55.99 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.238 -0.913 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.64 0.85 14.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.125 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 t -107.43 -40.15 5.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 66' ' ' LEU . 4.8 m-85 -42.26 101.64 0.25 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 43.6 Cg_endo -72.41 -63.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.057 1.556 . . . . 0.0 111.063 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.68 62.47 0.34 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 40.3 mt -44.86 164.46 0.18 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -1.187 . . . . 0.0 110.071 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_endo -69.53 -168.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.16 1.61 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 69' ' ' ASP . 59.7 t30 -68.53 152.33 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.17 -0.956 . . . . 0.0 110.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 10' ' ' CYS . 1.1 m-20 44.04 37.26 1.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.461 -0.774 . . . . 0.0 110.13 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -48.76 106.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.0 109.492 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 27.6 mt-10 -72.97 105.62 4.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.917 . . . . 0.0 110.837 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' N ' HD13 ' A' ' 72' ' ' LEU . 3.2 mp -100.94 169.85 8.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.515 HD12 ' CG ' ' A' ' 14' ' ' ARG . 2.5 tp -143.05 137.45 29.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.911 -1.118 . . . . 0.0 110.916 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.506 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 9.0 tp -85.61 130.1 34.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.82 . . . . 0.0 109.687 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.2 tt -146.41 158.07 43.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.987 -1.07 . . . . 0.0 109.924 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' GLU . 5.9 p -150.67 171.06 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.67 -29.87 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.054 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.16 14.9 59.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 76' ' ' THR . 1.8 mt-10 -147.75 159.68 43.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 110.49 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.91 139.71 13.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.433 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 8.0 t-105 -111.56 133.72 53.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.22 -59.52 2.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.06 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 141.12 163.29 9.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.58 88.89 6.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.46 -169.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m 50.92 53.42 13.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 110.183 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.255 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 146.34 15.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 110.339 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.98 70.12 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 110.186 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -93.74 112.18 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -162.4 119.72 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 6.1 mmt-85 -94.45 41.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 1.8 pt20 173.52 120.99 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.51 -0.744 . . . . 0.0 109.996 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.7 Cg_endo -73.22 138.54 27.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.844 1.444 . . . . 0.0 110.659 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -91.12 138.9 31.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASP . 98.2 m -115.18 149.42 37.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.424 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 24' ' ' VAL . 10.9 m -143.28 146.87 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 10.5 mmtp -105.12 92.18 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.47 97.85 2.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.757 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.7 tpt180 -94.95 155.74 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -139.87 121.48 15.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.849 -1.157 . . . . 0.0 110.821 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -65.32 -21.34 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.158 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' CG ' ' OE2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -79.53 0.83 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.5 -162.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.0 27.88 7.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 7.7 p -170.76 -161.55 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.627 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -169.11 2.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.511 -0.743 . . . . 0.0 109.707 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.7 t80 -135.81 85.89 2.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -64.86 94.49 0.17 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 32' ' ' LEU . 4.1 p -110.58 140.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -1.095 . . . . 0.0 110.424 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' HB1' ' SG ' ' A' ' 10' ' ' CYS . . . -109.65 162.42 14.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.306 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.51 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . 178.38 134.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.462 ' O ' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.88 -58.39 8.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 t -80.26 98.83 7.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.941 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 22.7 p -41.85 -28.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.397 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 29.3 mt-30 -57.85 -29.62 65.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -41.42 64.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.825 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 29' ' ' CYS . 7.3 mt -58.14 -43.08 87.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.776 . . . . 0.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 36' ' ' GLY . 14.9 mt -65.6 -66.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -42.84 -69.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.782 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -47.71 -25.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.43 -0.794 . . . . 0.0 109.504 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.78 -51.81 28.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.2 t -66.5 -14.12 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.101 -1.235 . . . . 0.0 109.816 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.99 -56.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -64.38 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.994 -1.066 . . . . 0.0 110.106 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.486 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 3.3 m-85 -103.17 -13.61 16.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 80.7 mm-40 56.46 88.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.593 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.71 93.4 44.48 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.187 -0.946 . . . . 0.0 109.879 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 49.7 Cg_endo -73.0 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.02 1.537 . . . . 0.0 110.038 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 38.4 ttp -120.72 43.82 0.65 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.069 -1.019 . . . . 0.0 111.222 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' MET . 52.6 Cg_endo -77.08 -2.36 12.59 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.49 1.258 . . . . 0.0 109.791 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.14 2.66 10.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -61.07 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -1.127 . . . . 0.0 110.353 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 1.2 mtt180 175.99 158.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.215 -0.928 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 2.0 mp -115.09 168.06 10.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.909 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' THR . 54.2 m -153.11 147.13 25.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 110.379 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -69.69 127.18 32.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.804 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -74.56 0.64 14.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.425 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -61.23 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.08 -1.013 . . . . 0.0 110.2 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.61 22.79 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.542 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.55 45.09 38.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.7 167.9 14.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 109.612 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 pt-20 -113.12 131.69 55.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.933 -1.104 . . . . 0.0 111.175 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.6 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 77.4 t -157.02 173.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.563 -0.711 . . . . 0.0 109.52 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 49' ' ' LEU . 39.9 p -131.83 160.41 35.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.057 -1.027 . . . . 0.0 110.605 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.18 -10.96 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.02 -7.29 20.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 110.55 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -98.05 -42.31 7.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 0.0 110.411 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.6 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 45.8 m-85 -41.7 101.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 110.63 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -76.14 -87.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.93 74.11 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 HD12 ' CD1' ' A' ' 72' ' ' LEU . 58.7 mt -58.58 160.18 10.71 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.175 -1.191 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.34 -161.36 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 109.799 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.33 150.47 36.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 10' ' ' CYS . 17.0 m-20 47.52 37.29 6.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.06 96.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 109.928 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -62.46 98.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.718 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' CD2' ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -111.87 161.66 16.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 110.17 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' CD2' HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.81 133.13 31.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 110.434 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.593 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 9.8 tp -86.86 143.34 27.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.998 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -151.88 158.55 43.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.644 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.528 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 70.4 p -139.7 168.76 19.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.38 -22.24 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.07 21.76 40.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.5 mt-10 -160.59 141.3 11.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 110.594 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.512 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -135.26 146.96 49.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.818 . . . . 0.0 109.834 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.542 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.5 t-105 -116.29 130.26 56.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 110.291 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.68 -75.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -178.26 166.15 35.96 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 85' ' ' VAL . 5.0 t80 -118.16 142.82 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -1.093 . . . . 0.0 110.168 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 33.2 m -80.33 167.04 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 t -99.44 63.26 1.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.128 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.262 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.7 tpt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.221 0.534 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.1 OUTLIER 170.92 175.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.264 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 2' ' ' CYS . . . 67.31 83.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 4' ' ' VAL . 5.5 p -137.29 79.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.7 93.78 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 110.316 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -84.67 44.98 1.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 179.39 105.32 0.16 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.2 Cg_endo -71.66 132.79 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.999 1.526 . . . . 0.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -83.13 148.11 27.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.81 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.424 ' C ' HG11 ' A' ' 11' ' ' VAL . 15.5 t -116.77 144.7 44.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 32' ' ' LEU . 3.8 m -139.44 144.54 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.7 mmmm -99.0 91.3 4.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.976 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.85 87.44 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.576 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 4.4 tpt180 -90.86 159.4 16.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.735 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 14' ' ' ARG . . . -149.61 130.67 14.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -84.41 -14.54 49.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.891 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.96 -4.0 53.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 110.022 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -143.93 25.42 1.6 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 0.0 110.413 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 29.4 53.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 120.966 0.412 . . . . 0.0 111.6 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -163.53 172.78 13.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.985 -1.072 . . . . 0.0 110.603 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.04 165.53 28.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.997 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -143.33 99.15 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -68.47 95.85 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.527 ' CG1' HD23 ' A' ' 32' ' ' LEU . 5.4 p -101.01 141.72 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.158 . . . . 0.0 110.451 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' CA ' HD12 ' A' ' 32' ' ' LEU . . . -121.34 146.14 47.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.336 -0.853 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -163.77 140.1 6.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -52.23 -59.36 4.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.308 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -83.42 97.13 8.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.156 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 10.9 p -41.72 -29.62 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 28' ' ' SER . 4.3 mm-40 -57.89 -24.69 58.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.8 mt-10 -72.61 -55.35 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 110.052 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD23 ' CG1' ' A' ' 24' ' ' VAL . 37.3 mt -56.54 -35.19 67.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 0.0 110.068 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD22 HD13 ' A' ' 66' ' ' LEU . 52.8 mt -65.48 -65.85 0.62 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.33 -0.856 . . . . 0.0 110.152 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -57.75 -68.69 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 109.97 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 20.5 mtmt -42.84 -37.39 1.8 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.399 -0.813 . . . . 0.0 109.908 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.63 -48.43 84.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.1 t -63.18 -19.4 64.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.237 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 52.1 t -77.24 -41.95 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.462 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 1.8 tmt_? -81.05 -28.82 35.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.761 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.469 ' HB3' HD21 ' A' ' 74' ' ' LEU . 1.9 m-30 -92.58 -8.15 45.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 74.2 mm-40 49.19 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -131.04 95.63 24.66 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.093 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.4 Cg_endo -73.23 144.55 37.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.063 1.559 . . . . 0.0 110.321 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -51.7 -49.43 83.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.569 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 44' ' ' MET . 50.2 Cg_endo -79.05 159.36 27.05 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.903 1.475 . . . . 0.0 110.66 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 43.63 45.88 7.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -171.55 171.4 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -1.189 . . . . 0.0 110.287 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -178.75 143.2 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 60' ' ' ASP . 1.4 mt -111.97 164.9 12.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.869 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' THR . 3.5 p -155.09 149.08 25.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 110.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -76.09 105.12 6.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.826 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 85.8 t80 -56.27 -22.35 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.359 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -51.63 -52.42 47.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.987 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -128.22 0.25 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.542 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 86.9 30.23 21.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.516 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.54 167.28 21.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.15 . . . . 0.0 109.857 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 16.8 pt-20 -115.45 133.23 56.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.932 -1.105 . . . . 0.0 109.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.638 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 59.1 t -155.52 173.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 110.508 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.566 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.5 p -119.01 159.6 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' N ' HD13 ' A' ' 49' ' ' LEU . 44.8 p30 -70.12 -2.72 13.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.95 -23.14 10.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.588 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 m -80.19 -37.6 32.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 110.221 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.638 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 20.8 m-85 -39.07 99.14 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.531 -0.73 . . . . 0.0 110.53 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 50.5 Cg_endo -76.93 -39.41 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.989 1.521 . . . . 0.0 110.415 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . 178.51 66.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.561 HD23 ' CE1' ' A' ' 63' ' ' PHE . 1.8 mp -42.5 161.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.272 -1.134 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 44.7 Cg_endo -72.85 -174.13 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.071 1.564 . . . . 0.0 110.259 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -58.41 152.64 17.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.108 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLU . 8.5 m-20 42.85 37.86 1.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 0.0 109.924 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -42.24 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -69.49 96.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.777 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.616 ' CD2' ' CE2' ' A' ' 63' ' ' PHE . 4.8 tp -106.48 153.16 22.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD2' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -133.68 140.02 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 110.61 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 42' ' ' LEU . 11.8 tp -80.35 132.66 35.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.509 -0.744 . . . . 0.0 109.9 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 1.8 tt -145.67 159.03 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.838 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 69.1 p -149.76 -159.96 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.29 73.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.431 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.38 18.01 40.04 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -145.77 148.18 32.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 0.0 110.457 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.443 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -149.9 139.8 21.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.542 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t-105 -117.0 128.86 55.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -76.73 -61.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.81 147.0 4.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.05 144.69 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.283 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.56 143.14 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 110.331 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 46.3 p -108.56 53.07 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 86' ' ' SER . 13.5 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.245 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 1.8 tpp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.307 0.575 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 171.26 148.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 43.23 49.68 5.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 p -161.85 75.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 mt -142.38 158.87 43.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -125.11 42.09 3.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 167.39 124.56 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.7 Cg_endo -72.59 125.15 10.37 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.734 1.386 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.97 137.16 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 110.234 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ASP . 35.3 m -108.19 157.85 17.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.499 ' CG1' ' HB3' ' A' ' 70' ' ' ALA . 34.9 m -152.46 137.85 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.9 . . . . 0.0 109.976 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -96.32 107.7 20.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.272 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -84.53 83.2 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.4 tpt180 -80.26 157.24 26.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.352 -0.843 . . . . 0.0 109.877 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 40' ' ' PHE . . . -142.25 123.0 14.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.552 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.433 ' CD1' HD23 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -74.48 -20.44 60.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 110.16 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.48 -1.5 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.88 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -128.42 -160.76 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 0.0 109.951 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.45 38.82 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.48 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.62 -159.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.048 -1.032 . . . . 0.0 110.69 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.69 -161.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -145.6 98.05 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.406 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.19 101.27 1.03 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 32' ' ' LEU . 2.9 p -116.26 149.07 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -1.149 . . . . 0.0 110.291 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.506 ' N ' HD23 ' A' ' 32' ' ' LEU . . . -134.95 159.28 41.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.004 . . . . 0.0 110.262 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . 177.84 132.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 25.1 mmm-85 -46.21 -56.15 6.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 110.212 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -82.47 97.94 8.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.036 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 28.2 p -40.26 -27.56 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 21.7 mp0 -62.27 -28.55 69.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 4.4 tt0 -66.38 -44.62 82.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 110.249 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.531 ' CD2' HG13 ' A' ' 24' ' ' VAL . 38.2 mt -67.13 -35.65 80.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 87.4 mt -65.23 -60.75 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -55.23 -69.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 26.0 mtpp -46.08 -29.62 1.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -60.57 -52.37 52.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.7 t -67.13 -16.24 64.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -1.181 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 54.1 t -81.73 -52.57 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -66.94 -39.7 87.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.743 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 1.9 m-30 -83.28 -19.55 36.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.853 . . . . 0.0 109.783 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 44.7 mm-40 60.34 77.74 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.475 -0.766 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -121.33 97.52 47.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.505 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 50.5 Cg_endo -75.16 -162.67 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.946 1.498 . . . . 0.0 109.714 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 1.2 ptt? -123.62 45.53 1.2 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.008 -1.058 . . . . 0.0 111.393 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 44' ' ' MET . 50.7 Cg_endo -76.29 -1.38 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.66 1.347 . . . . 0.0 109.764 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.09 5.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -63.15 -161.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -1.077 . . . . 0.0 110.232 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 176.23 154.23 0.2 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.113 -0.992 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -111.76 165.83 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 109.414 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' SG ' HD22 ' A' ' 73' ' ' LEU . 6.5 p -156.97 133.69 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.58 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.53 HD11 ' CG2' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -63.3 126.43 27.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.404 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 84.6 t80 -77.13 2.02 16.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.939 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -50.82 50.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.433 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.08 54.77 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 51.98 40.81 51.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.519 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.37 159.03 18.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.048 -1.266 . . . . 0.0 109.495 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 mp0 -117.34 136.75 52.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 110.468 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.608 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 82.1 t -156.8 175.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 72.2 p -130.83 160.39 34.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.402 ' N ' HD11 ' A' ' 49' ' ' LEU . 6.3 p-10 -62.58 -30.53 71.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.37 -0.831 . . . . 0.0 110.471 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.4 22.39 6.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 110.346 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 32.0 t -130.84 -35.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.198 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 66' ' ' LEU . 34.2 m-85 -44.16 104.22 0.37 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.209 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.4 Cg_endo -72.96 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.009 1.531 . . . . 0.0 110.344 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.12 64.53 0.59 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.63 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 52.2 mt -43.71 162.81 0.18 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.303 -1.116 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ASN . 44.3 Cg_endo -72.51 164.44 35.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.169 1.615 . . . . 0.0 110.134 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' PRO . 8.8 p30 -44.49 151.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.945 . . . . 0.0 109.978 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.9 m-20 45.64 37.72 3.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.861 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.7 107.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.649 . . . . 0.0 110.186 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' C ' HD11 ' A' ' 72' ' ' LEU . 12.3 tt0 -83.25 97.87 9.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 110.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 9.0 mp -105.06 159.07 16.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.892 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.494 HD11 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -129.53 113.36 14.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.394 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.508 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 12.8 tp -67.89 133.47 49.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -145.98 157.7 43.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.117 -0.989 . . . . 0.0 109.493 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 39.6 p -132.6 -174.98 3.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.0 -12.13 46.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.92 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.3 25.17 27.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -156.37 163.14 39.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -1.153 . . . . 0.0 110.813 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.541 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.63 139.02 14.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.539 ' CZ2' ' CE1' ' A' ' 52' ' ' TYR . 8.3 t-105 -103.94 137.01 42.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.756 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -69.41 -79.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.324 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.532 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . -160.64 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 18.5 t80 174.88 84.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.162 -1.199 . . . . 0.0 110.179 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.17 -179.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.18 -0.95 . . . . 0.0 110.136 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.59 62.01 7.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.139 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.278 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 1.3 mtp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.176 0.512 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 1' ' ' MET . 24.4 p -179.58 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.274 -0.891 . . . . 0.0 110.338 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.86 62.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 t -103.88 157.4 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.8 mt -132.62 176.45 8.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 19.4 mmt180 -84.64 58.79 5.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.555 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.1 mp0 70.29 158.27 0.16 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.622 -0.674 . . . . 0.0 109.991 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.1 Cg_endo -71.58 127.11 12.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.943 1.496 . . . . 0.0 110.403 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 153.12 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 24.9 m -121.48 140.5 52.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.5 HG23 HG13 ' A' ' 24' ' ' VAL . 5.2 m -134.38 136.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.937 . . . . 0.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.18 92.33 5.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -73.55 94.11 2.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.59 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.6 tpt180 -88.96 158.14 18.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.442 -0.786 . . . . 0.0 109.64 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.51 135.8 35.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.651 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' CD1' HD22 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.7 -24.22 56.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.224 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 7.99 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.0 t -138.26 -164.88 1.7 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.133 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.07 24.25 8.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -161.14 -163.43 1.02 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 0.0 110.592 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -140.44 -162.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.494 -0.754 . . . . 0.0 110.177 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 6.9 t80 -138.47 79.54 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -63.94 84.3 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.522 ' CG1' HD22 ' A' ' 32' ' ' LEU . 1.4 p -104.57 141.3 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.138 . . . . 0.0 110.122 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.33 146.97 43.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.448 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -160.96 144.16 13.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mmt180 -57.9 -61.87 2.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.095 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 1.5 t -77.97 96.89 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 22.0 p -42.57 -31.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 mm-40 -52.39 -30.93 31.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.106 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 9.5 mt-10 -72.31 -46.01 57.5 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.604 0.716 . . . . 0.0 109.422 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.522 HD22 ' CG1' ' A' ' 24' ' ' VAL . 12.1 mt -56.26 -43.82 79.11 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.75 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.514 HD13 ' CB ' ' A' ' 63' ' ' PHE . 70.5 mt -67.09 -69.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.691 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -45.76 -70.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.546 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 1.9 mtmp? -46.13 -26.36 0.75 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.166 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.28 -46.01 66.72 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.24 -16.51 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -1.153 . . . . 0.0 109.78 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.23 -47.6 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.776 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -35.84 78.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.4 m-85 -91.14 -13.51 32.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.57 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 1.7 mt-30 56.44 83.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 110.764 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.9 OUTLIER -118.17 113.62 37.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.016 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.7 Cg_endo -72.57 173.51 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.015 1.534 . . . . 0.0 110.726 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 1.2 ttm -90.69 -44.42 0.39 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.354 -0.841 . . . . 0.0 111.173 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' MET . 47.3 Cg_endo -80.84 140.32 12.77 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.655 1.345 . . . . 0.0 110.367 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.91 36.56 60.48 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -142.71 164.42 30.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -1.004 . . . . 0.0 110.128 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 172.84 150.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 110.154 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 1.7 mt -115.39 168.56 9.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.0 p -157.02 146.38 20.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -70.92 118.83 14.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 53' ' ' GLU . 63.1 t80 -76.34 -21.23 56.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.381 -0.824 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' TYR . 2.9 tp10 -43.38 -45.94 6.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 110.352 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -137.13 -49.53 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.383 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.24 49.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.522 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.71 164.98 12.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -1.149 . . . . 0.0 109.916 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 5.5 pt-20 -118.18 131.42 56.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.042 -1.037 . . . . 0.0 110.543 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 52.6 t -154.64 170.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 22.7 p -119.44 157.65 27.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 11.3 p-10 -62.44 -16.62 56.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 110.596 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -102.17 6.23 40.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.5 m -112.19 -34.62 5.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.636 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 13.6 m-85 -45.57 104.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 110.399 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.8 Cg_endo -76.52 -86.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.071 1.564 . . . . 0.0 110.338 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.74 64.22 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 94.5 mt -45.18 160.84 0.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.289 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.39 178.36 6.24 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -56.76 152.01 13.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 0.0 110.218 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' CYS . 6.1 m-20 44.36 38.85 2.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.797 . . . . 0.0 109.782 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.42 105.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -73.18 103.02 3.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.642 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 70' ' ' ALA . 7.0 mp -113.19 159.74 18.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 109.623 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -140.09 132.91 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.032 -1.043 . . . . 0.0 110.475 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' CD1' HD22 ' A' ' 49' ' ' LEU . 11.1 tp -72.29 135.27 45.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.786 . . . . 0.0 109.889 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -146.04 155.33 42.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 75' ' ' LEU . 10.9 p -146.33 178.29 8.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.57 70.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.09 7.95 53.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 160.02 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.219 -1.165 . . . . 0.0 110.54 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.522 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.01 140.69 12.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.437 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.6 t-105 -111.61 131.41 55.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.122 -0.986 . . . . 0.0 110.32 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -83.37 -61.69 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 150.53 159.62 8.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD1' ' CE2' ' A' ' 52' ' ' TYR . 2.5 t80 -86.62 94.34 9.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 163.51 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.6 p -104.75 60.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.228 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.308 0.575 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p -42.95 134.75 3.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.254 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.46 51.91 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -82.38 53.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 46.76 41.56 10.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 5' ' ' LEU . 5.7 mmm-85 39.84 52.31 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 21.5 mt-30 58.06 163.83 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 109.674 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.62 133.52 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.803 1.423 . . . . 0.0 110.575 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -81.59 -179.59 7.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 69' ' ' ASP . 23.5 t -150.54 148.68 28.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.41 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.464 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.3 m -144.86 136.49 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 23.6 mmtt -95.83 94.51 7.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.064 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.49 HD22 ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -72.24 89.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.593 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.538 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.8 tpt180 -86.7 150.85 23.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 14' ' ' ARG . . . -135.36 137.63 42.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.69 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -22.79 57.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.903 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 15' ' ' ALA . 28.5 p80 -84.34 6.93 21.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -161.38 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.058 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.56 27.02 6.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.38 -161.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -134.38 -176.26 4.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.82 . . . . 0.0 110.194 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -120.79 99.32 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.58 85.59 0.35 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 32' ' ' LEU . 3.5 p -104.14 136.87 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -121.36 146.08 47.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -163.32 133.44 4.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.099 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -50.43 -30.55 12.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 110.458 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -104.25 94.53 5.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.9 p -41.88 -31.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -30.9 71.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.928 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 68.1 tt0 -68.94 -32.06 71.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CD2' HG11 ' A' ' 24' ' ' VAL . 16.5 mt -77.44 -31.47 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 94.1 mt -66.15 -57.74 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -59.0 -55.86 29.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 29.7 mtpp -55.02 -27.19 42.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.633 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' CA ' HD22 ' A' ' 13' ' ' LEU . . . -68.52 -51.55 30.71 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 29.1 t -65.67 -14.37 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -1.163 . . . . 0.0 109.604 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.69 -45.71 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -24.1 60.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.9 m-30 -102.6 -16.54 16.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.507 -0.746 . . . . 0.0 109.64 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 61.99 88.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -133.82 97.44 15.49 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.939 . . . . 0.0 110.034 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 49.6 Cg_endo -74.86 -162.84 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.912 1.48 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.565 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 3.8 ttm -121.35 44.51 0.77 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.9 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.503 1.265 . . . . 0.0 109.836 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.9 -2.09 5.94 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 48.9 m -63.56 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -1.09 . . . . 0.0 110.148 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' O ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 176.05 154.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 110.922 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -114.9 116.77 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' THR . 29.0 m -94.41 -179.2 4.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD1' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.72 122.94 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 110.247 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -68.72 -7.61 35.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.17 -46.34 90.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 33.35 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 110.503 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 69.22 33.31 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.58 165.75 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -1.191 . . . . 0.0 109.834 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -119.54 128.45 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.39 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.634 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 14.3 t -150.08 -179.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.467 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 22.9 p -131.4 159.82 36.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.002 . . . . 0.0 110.39 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.521 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 3.3 p30 -73.61 0.15 13.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.291 -0.881 . . . . 0.0 110.44 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -115.11 -1.29 13.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 110.515 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.6 t -108.07 -36.08 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.923 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 19.8 m-85 -39.62 99.29 0.19 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.436 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.5 Cg_endo -77.7 -33.28 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.044 1.55 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.84 68.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 63' ' ' PHE . 1.1 mp -50.0 163.61 0.41 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.242 -1.152 . . . . 0.0 110.075 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 42.2 Cg_endo -69.43 178.67 4.14 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.109 1.584 . . . . 0.0 110.172 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.72 150.03 20.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.2 m-20 48.84 35.88 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.455 -0.778 . . . . 0.0 110.198 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -50.2 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.74 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 8.4 mm-40 -72.58 96.93 2.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 63' ' ' PHE . 2.9 mp -96.4 164.8 12.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 1.4 tp -134.96 118.7 17.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.966 -1.084 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.55 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 15.4 tp -69.43 127.47 33.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -140.46 158.45 43.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 32.1 p -141.92 174.23 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.99 19.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.43 23.47 21.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.31 149.0 25.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 110.593 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -144.25 158.62 43.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 0.0 109.696 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.563 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -125.48 122.57 37.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.312 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.26 -82.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 0.0 110.115 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 55' ' ' GLY . . . -175.75 172.93 45.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -113.63 67.54 0.67 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -1.107 . . . . 0.0 110.087 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -80.02 169.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.937 . . . . 0.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ASP . 2.9 p -151.92 67.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 86' ' ' SER . 18.6 t0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.246 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.278 0.561 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.5 OUTLIER -45.54 139.04 4.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 2' ' ' CYS . . . 173.63 101.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 32.8 t -118.05 162.43 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER 63.98 93.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 110.46 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 1.9 mmt180 -84.44 45.43 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.91 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 170.85 124.22 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 0.0 110.047 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.7 Cg_endo -75.17 132.05 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.974 1.513 . . . . 0.0 110.789 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -80.39 159.81 25.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 69' ' ' ASP . 42.8 t -135.15 149.6 50.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.7 m -146.95 134.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.323 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 69' ' ' ASP . 37.6 mmtt -86.27 89.33 7.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -70.79 79.96 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.998 . . . . 0.0 110.201 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 6.5 tpt180 -83.8 159.12 21.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' N ' ' HG3' ' A' ' 14' ' ' ARG . . . -150.8 122.44 8.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.278 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' CD1' HD22 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -76.79 -8.66 57.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 6.5 t-80 -94.54 10.44 34.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.512 ' O ' ' C ' ' A' ' 19' ' ' ALA . 4.5 m -149.49 30.28 0.75 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.514 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 27.28 49.86 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.095 0.474 . . . . 0.0 111.744 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -174.06 -176.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -145.03 -171.67 3.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 110.0 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 10.5 t80 -153.21 84.54 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.8 94.65 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' CG1' HD21 ' A' ' 32' ' ' LEU . 5.4 p -102.89 151.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -1.104 . . . . 0.0 110.769 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.46 ' CA ' HD12 ' A' ' 32' ' ' LEU . . . -132.43 151.86 51.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.441 -0.787 . . . . 0.0 110.012 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.517 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -171.8 136.0 0.89 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.71 -61.43 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.063 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 29' ' ' CYS . 17.7 m -78.3 96.71 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' C ' ' O ' ' A' ' 28' ' ' SER . 25.8 p -41.29 -28.73 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.524 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' SER . 6.9 tt0 -59.56 -25.6 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 110.192 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -70.53 -52.12 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.538 HD21 ' CG1' ' A' ' 24' ' ' VAL . 32.1 mt -60.46 -34.61 74.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.867 . . . . 0.0 110.207 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 66' ' ' LEU . 11.0 mt -67.54 -64.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.066 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -64.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' NZ ' ' CB ' ' A' ' 35' ' ' LYS . 7.6 mtmp? -49.45 -28.92 5.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.7 -48.78 78.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -71.42 -14.56 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.0 109.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.509 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 94.4 t -79.69 -49.43 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.929 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -28.9 62.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.019 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.8 m-30 -93.51 -11.56 31.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 30.4 mm-40 51.16 83.89 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.962 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.3 OUTLIER -128.37 109.12 19.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.953 . . . . 0.0 110.779 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 47' ' ' SER . 47.4 Cg_endo -77.24 167.8 24.14 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.929 1.489 . . . . 0.0 110.205 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -87.42 -45.37 0.51 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.5 Cg_endo -80.39 127.38 6.57 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.824 1.434 . . . . 0.0 110.699 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.23 -40.77 3.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -84.98 -177.31 6.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.42 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -179.87 140.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.733 . . . . 0.0 109.892 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 4.4 mt -109.26 165.81 11.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.059 -1.026 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 4.7 p -154.46 157.38 38.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.431 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -85.97 124.44 32.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.456 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 35.7 t80 -73.44 -14.3 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.25 -57.06 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.84 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.99 5.09 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.473 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 95.46 32.88 6.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.8 176.78 8.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -1.231 . . . . 0.0 109.706 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 40.4 mt-10 -125.29 138.11 54.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.03 . . . . 0.0 110.775 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.1 t -156.46 173.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.408 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 29.9 p -121.52 158.37 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.1 p-10 -66.07 -7.81 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -108.62 -18.09 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.5 t -84.05 -39.34 19.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.569 ' CE1' HG11 ' A' ' 58' ' ' VAL . 24.9 m-85 -42.32 101.6 0.25 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.1 Cg_endo -79.18 -90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.048 1.552 . . . . 0.0 110.666 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.98 66.37 0.3 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD13 ' CG ' ' A' ' 63' ' ' PHE . 3.6 mt -43.94 149.92 0.63 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.403 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -161.06 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.976 1.514 . . . . 0.0 110.115 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ASP . 31.6 p-10 -77.2 150.93 35.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . 5.8 t0 42.08 37.05 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.74 . . . . 0.0 110.016 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -46.43 120.27 2.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 3.4 mp0 -83.2 106.94 15.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.943 . . . . 0.0 110.85 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 3.2 mp -110.92 154.59 23.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -138.73 127.99 24.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.014 -1.054 . . . . 0.0 110.662 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 42' ' ' LEU . 10.2 tp -74.08 134.82 42.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 110.24 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.9 OUTLIER -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.628 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 79' ' ' GLU . 4.4 p -147.51 169.66 19.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.072 . . . . 0.0 109.843 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.14 -33.67 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.3 17.97 39.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -1.193 . . . . 0.0 110.544 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.19 172.39 13.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.223 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.7 t-105 -141.24 122.88 15.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -70.15 -79.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.485 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . 179.09 171.87 42.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -98.17 118.44 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -1.166 . . . . 0.0 110.239 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.21 156.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.939 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.82 80.14 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.125 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.257 0.551 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 1' ' ' MET . 25.3 p -179.66 163.29 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 110.131 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 42.75 48.39 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.207 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.01 139.68 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 110.364 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.24 118.54 14.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.855 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 1.7 mmm180 -101.02 44.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 174.68 116.1 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.279 -0.888 . . . . 0.0 110.205 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.1 Cg_endo -72.87 125.53 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.835 1.439 . . . . 0.0 110.537 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 160.2 24.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 69' ' ' ASP . 37.3 m -130.76 152.96 49.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.502 ' CG2' HD23 ' A' ' 32' ' ' LEU . 9.2 m -141.55 125.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . 10.0 mmtt -87.95 85.45 7.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -74.81 81.41 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.607 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.0 tpt180 -79.72 160.47 26.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.815 . . . . 0.0 109.325 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -135.06 124.24 24.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.773 -1.204 . . . . 0.0 110.679 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' CD1' HD21 ' A' ' 73' ' ' LEU . 2.2 mt -75.72 -20.88 58.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -79.41 2.88 20.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.884 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -140.66 -175.12 4.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.873 . . . . 0.0 109.783 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.04 33.42 4.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.267 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.04 -167.91 2.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.62 -164.88 1.97 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.911 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 8.5 t80 -144.58 77.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.44 92.54 0.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -116.96 151.58 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.499 ' CA ' HD22 ' A' ' 32' ' ' LEU . . . -128.25 173.79 9.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.386 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.1 126.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.035 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.94 -55.98 3.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -81.42 97.82 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -41.6 -30.79 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -0.824 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.23 -34.95 59.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 1.6 mp0 -67.11 -46.46 74.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.689 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD23 ' CG2' ' A' ' 11' ' ' VAL . 18.0 mt -54.42 -42.46 70.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -63.17 -70.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.11 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -59.64 2.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -49.45 -26.6 3.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -70.39 -58.08 6.26 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 44.6 t -64.85 -13.65 56.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' GLN . 31.1 t -85.76 -72.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 109.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -29.82 1.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.51 ' CD2' HD23 ' A' ' 13' ' ' LEU . 4.5 m-30 -96.69 -17.94 20.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.567 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.4 mt-30 57.11 84.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.744 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.526 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -124.08 101.57 35.16 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 109.977 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 51.0 Cg_endo -75.84 -160.65 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.177 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.6 ttt -119.95 43.75 0.59 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 111.075 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.8 Cg_endo -76.23 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.533 1.28 . . . . 0.0 109.626 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.33 10.26 3.25 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 34.7 m -72.85 -159.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.351 -1.088 . . . . 0.0 110.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.41 158.23 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 110.514 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -110.59 165.9 11.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 109.228 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 6.1 p -159.35 133.33 7.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.099 . . . . 0.0 110.769 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CB ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -62.4 120.92 11.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.484 -0.76 . . . . 0.0 110.3 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -70.31 -6.2 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 19.4 tt0 -54.11 -65.58 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.35 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -131.6 23.86 4.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 83.2 28.52 36.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.512 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.39 165.11 25.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.183 -1.186 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 35.5 mt-10 -119.24 135.54 54.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.598 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 49.3 t -154.3 175.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 42.8 p -122.39 166.66 14.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.9 p-10 -66.57 -7.37 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.288 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -22.43 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.7 m -84.24 13.89 4.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 4.8 m-85 -100.42 97.82 7.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.017 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.9 Cg_endo -71.3 -92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.896 1.472 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -128.95 64.86 0.6 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 63' ' ' PHE . 12.0 mt -42.92 161.78 0.18 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -1.096 . . . . 0.0 110.174 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.6 Cg_endo -71.95 162.91 40.46 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.075 1.566 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -42.29 150.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.59 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 42.98 38.35 1.4 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.881 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.85 110.35 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 110.175 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 12' ' ' LYS . 2.3 tp10 -70.48 99.76 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.357 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD23 HD11 ' A' ' 66' ' ' LEU . 6.5 mp -114.6 158.09 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -140.14 116.86 10.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 110.434 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 6.8 tp -70.64 149.12 47.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -153.51 155.3 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.091 -1.005 . . . . 0.0 110.007 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.536 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 19.2 p -135.88 172.46 12.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.08 -31.77 31.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.865 . . . . 0.0 110.291 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.92 17.47 41.04 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' CA ' ' OE1' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -149.97 149.38 30.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -1.21 . . . . 0.0 110.574 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.26 134.84 22.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.508 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . 7.1 t-105 -103.16 133.25 48.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -83.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -169.82 158.11 30.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 34.7 t80 -75.9 92.09 3.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 110.13 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -87.52 145.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 86' ' ' SER . 5.0 p -103.56 106.34 16.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.232 -179.896 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.178 0.513 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 1' ' ' MET . 6.1 p 175.89 46.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 110.223 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 2' ' ' CYS . . . 56.99 61.7 2.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.47 101.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.098 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.42 -165.13 0.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.5 mtt180 -108.03 67.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 109.904 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 68.91 148.27 0.12 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.801 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.8 Cg_endo -72.58 133.85 21.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.977 1.514 . . . . 0.0 110.586 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.69 -171.91 3.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 50.6 t -149.16 149.45 31.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.001 -1.062 . . . . 0.0 110.505 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 24' ' ' VAL . 6.2 m -148.26 134.71 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 mmtp -97.28 95.15 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD23 ' CE2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -74.25 89.45 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.984 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.8 tpt180 -89.39 151.72 21.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.963 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.05 131.31 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 110.576 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -24.47 62.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.117 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' HB2' ' OE2' ' A' ' 79' ' ' GLU . 3.6 t-160 -86.72 16.08 5.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -135.1 -161.28 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.43 29.79 5.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.296 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 174.84 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 110.666 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.37 164.37 30.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -102.5 79.66 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -61.92 87.84 0.04 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.54 HG13 ' CD2' ' A' ' 32' ' ' LEU . 8.6 p -103.37 140.59 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.616 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.15 39.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.761 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 32' ' ' LEU . . . -173.99 148.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 11.0 mmt180 -62.97 -48.16 80.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -84.57 89.19 7.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 110.104 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 28' ' ' SER . 6.6 p -42.64 -31.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.08 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.14 -36.09 78.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 109.907 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 2.7 tp10 -62.41 -51.41 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.778 . . . . 0.0 110.019 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' CD2' HG13 ' A' ' 24' ' ' VAL . 43.7 mt -53.41 -39.26 64.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 63' ' ' PHE . 4.5 mt -57.26 -69.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 110.148 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -60.14 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.849 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 14.0 mtpt -46.97 -27.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.486 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -69.98 -56.09 8.53 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.6 -15.18 25.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.196 . . . . 0.0 109.937 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.5 t -87.97 -55.48 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.733 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.64 70.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.521 ' CE2' HD23 ' A' ' 13' ' ' LEU . 3.2 m-30 -95.79 -21.99 17.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.382 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.26 84.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.516 -0.74 . . . . 0.0 110.732 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.15 98.47 38.8 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 110.159 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 52.6 Cg_endo -74.37 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.958 1.504 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 19.4 ttm -124.05 43.86 0.91 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.081 -1.012 . . . . 0.0 111.262 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 44' ' ' MET . 51.7 Cg_endo -77.43 2.28 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.533 1.281 . . . . 0.0 109.984 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.0 12.35 5.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.538 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 49.1 m -74.18 -161.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -1.11 . . . . 0.0 110.42 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER 178.61 150.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' VAL . 5.1 mp -115.81 115.15 25.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 56' ' ' THR . 99.9 m -92.46 -171.13 2.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 111.058 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.481 HD12 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -121.72 126.85 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.647 -0.658 . . . . 0.0 109.729 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -15.45 63.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 110.816 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -44.9 -68.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.995 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 54' ' ' ASP . 26.3 t70 -143.07 40.09 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.467 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.526 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 72.23 38.5 58.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' CYS . 0.3 OUTLIER -80.47 160.03 25.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -1.193 . . . . 0.0 109.834 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -114.49 128.77 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 110.383 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.555 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 3.1 t -147.93 -171.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 p -145.41 165.51 28.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.049 . . . . 0.0 110.251 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.462 ' HB3' HD23 ' A' ' 49' ' ' LEU . 4.7 p-10 -79.23 8.65 5.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -124.92 5.52 8.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 110.354 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t -119.78 -36.56 3.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' CD1' HD21 ' A' ' 66' ' ' LEU . 4.8 m-85 -40.86 100.58 0.22 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.6 Cg_endo -76.67 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.039 1.547 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -110.47 67.68 0.22 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 63' ' ' PHE . 3.6 mp -41.95 146.13 0.66 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 110.425 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.65 158.08 43.77 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.116 1.587 . . . . 0.0 110.281 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 12.4 p30 -44.27 147.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 109.89 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.7 OUTLIER 43.88 36.4 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.684 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.98 119.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -82.49 101.51 10.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.479 ' CD2' ' CE2' ' A' ' 63' ' ' PHE . 1.2 mp -110.24 152.76 25.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.9 OUTLIER -131.02 104.83 7.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.59 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD12 ' HG ' ' A' ' 42' ' ' LEU . 10.2 tp -60.5 126.66 28.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -139.16 158.57 43.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.982 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.538 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 49.8 p -134.24 176.39 8.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.16 -32.51 36.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.85 20.95 29.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' C ' HD13 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -145.3 148.62 33.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.538 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.76 138.0 24.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.451 -0.781 . . . . 0.0 109.855 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.455 ' HB2' ' CD2' ' A' ' 73' ' ' LEU . 5.5 t-105 -107.89 123.94 49.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.991 -1.068 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -67.33 -62.47 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 153.69 6.07 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -88.98 166.04 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -1.089 . . . . 0.0 110.171 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 m -86.62 174.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.341 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.38 47.05 1.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.303 -179.857 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.265 0.555 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.1 t -43.42 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -163.86 47.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.16 62.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.18 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 27' ' ' ARG . 76.0 mt -111.2 128.46 55.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 15.4 mmt180 -105.65 40.84 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER 166.16 119.39 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.574 -0.704 . . . . 0.0 110.022 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.46 130.79 16.59 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.871 1.459 . . . . 0.0 110.566 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 4.3 ttpt -79.98 155.13 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.85 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ASP . 7.4 t -129.52 153.46 47.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.622 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.472 ' CG2' HG13 ' A' ' 24' ' ' VAL . 10.6 m -148.66 135.0 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.08 96.21 10.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 110.355 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -76.33 81.58 3.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.92 . . . . 0.0 110.024 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 5.3 tpt180 -80.59 158.72 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 18' ' ' SER . . . -140.26 112.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.5 -30.38 71.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.857 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 17' ' ' HIS . 52.1 t60 -82.19 8.1 11.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 19' ' ' ALA . 28.6 t -121.2 -160.59 0.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -119.23 19.51 12.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 175.84 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.108 -0.995 . . . . 0.0 110.781 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.97 168.8 18.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.552 -0.718 . . . . 0.0 109.883 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -122.52 99.85 6.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.323 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.41 92.58 0.27 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 32' ' ' LEU . 4.1 p -97.39 146.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 0.0 110.354 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' N ' HD22 ' A' ' 32' ' ' LEU . . . -134.92 144.88 47.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.37 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -170.51 123.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.5 mtt180 -42.29 -29.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -100.67 95.64 6.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.277 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 30' ' ' GLN . 21.1 p -44.98 -33.27 1.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.449 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 8.5 mp0 -62.55 -20.64 64.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.73 -48.3 16.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.934 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 ' CG2' ' A' ' 24' ' ' VAL . 22.3 mt -58.98 -38.86 80.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' CD2' ' CD1' ' A' ' 66' ' ' LEU . 52.8 mt -66.36 -63.63 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.687 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -52.78 -65.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.804 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -50.61 -24.21 3.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.607 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.7 -52.55 11.93 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -63.28 -16.11 59.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -1.203 . . . . 0.0 110.056 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 99.3 t -78.16 -59.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.008 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -35.1 79.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.942 . . . . 0.0 109.982 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.7 m-30 -84.87 -14.72 46.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 58.2 mm-40 53.1 78.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.398 -0.814 . . . . 0.0 110.554 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -116.82 97.63 50.77 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.9 Cg_endo -72.15 161.47 44.52 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.693 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.552 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.24 -48.23 13.26 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 0.0 110.654 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 44' ' ' MET . 48.0 Cg_endo -76.6 150.26 31.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.759 1.399 . . . . 0.0 110.649 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 44.34 51.38 7.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.528 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -165.74 164.79 18.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -1.122 . . . . 0.0 110.25 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -177.63 146.52 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.01 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 60' ' ' ASP . 2.2 mt -114.65 169.12 9.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' THR . 3.6 p -151.98 161.92 41.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.945 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -92.47 115.97 28.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.65 -0.656 . . . . 0.0 109.955 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 7.5 t80 -64.22 -15.43 59.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.409 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -48.77 -51.69 27.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.47 20.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 82.57 22.26 58.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.8 174.34 2.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.127 -1.22 . . . . 0.0 109.672 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 4.9 mm-40 -126.17 137.05 53.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.513 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.545 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 90.5 t -156.64 173.96 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.193 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 22.7 p -121.87 159.9 25.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.896 . . . . 0.0 110.023 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.517 ' N ' HD13 ' A' ' 49' ' ' LEU . 7.7 p-10 -64.57 -7.79 11.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.637 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -15.38 14.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.02 -1.05 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.2 m -88.34 -40.63 13.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.045 . . . . 0.0 110.45 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' THR . 47.8 m-85 -39.77 99.75 0.2 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.462 -0.774 . . . . 0.0 110.357 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.8 Cg_endo -76.74 -87.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.071 1.563 . . . . 0.0 110.406 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -117.63 67.31 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 ' CD1' ' A' ' 63' ' ' PHE . 1.6 mt -43.03 143.23 1.31 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.957 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.32 167.36 27.12 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.019 1.537 . . . . 0.0 110.47 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ASP . 4.2 t-20 -52.1 152.91 2.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 110.457 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER 42.49 38.92 1.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.809 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 11' ' ' VAL . . . -54.33 116.9 2.88 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' O ' HD11 ' A' ' 72' ' ' LEU . 1.5 mt-10 -89.12 108.06 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.438 HD11 ' O ' ' A' ' 71' ' ' GLU . 4.6 mp -117.08 159.75 22.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 110.004 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -134.7 139.97 45.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.646 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 12.2 tp -79.99 144.73 33.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 3.1 tt -154.02 159.96 41.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 79' ' ' GLU . 21.9 p -152.17 167.81 27.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -45.89 -29.89 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.147 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.81 22.45 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -155.81 152.69 28.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.613 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.44 ' HA ' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.789 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.507 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 9.5 t-105 -107.8 135.28 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.008 -1.058 . . . . 0.0 110.786 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -78.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.336 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.483 ' O ' ' CZ2' ' A' ' 81' ' ' TRP . . . 174.22 177.92 43.74 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -83.9 131.48 34.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -1.142 . . . . 0.0 110.271 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -84.55 136.44 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 110.385 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.2 t -111.25 95.89 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.083 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.261 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' O ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.274 0.559 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 t -161.13 127.0 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.27 86.68 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 110.102 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.82 98.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.122 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.9 166.39 12.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 110.334 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -82.17 59.89 4.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.318 -0.864 . . . . 0.0 109.439 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 74.93 159.04 0.16 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.69 -0.631 . . . . 0.0 109.799 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 7' ' ' GLN . 43.9 Cg_endo -71.15 134.14 24.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.924 1.487 . . . . 0.0 110.814 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 152.5 22.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.969 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 69' ' ' ASP . 39.2 m -121.75 153.67 37.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 110.383 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.499 ' CG2' HG11 ' A' ' 24' ' ' VAL . 11.3 m -147.2 132.77 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -97.46 99.59 11.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.919 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.573 HD22 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -81.52 95.04 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.639 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.7 tpt180 -91.61 157.59 16.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.572 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.78 120.06 10.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -64.86 -17.44 64.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.893 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -79.69 -0.54 34.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -134.18 -159.17 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.858 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.16 34.2 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.435 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 6.7 p -177.18 -162.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 110.706 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -140.21 -169.15 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.522 -0.736 . . . . 0.0 110.038 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t80 -130.41 81.29 2.0 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 110.28 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.27 85.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG13 ' CD2' ' A' ' 32' ' ' LEU . 2.1 p -107.21 146.6 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -1.14 . . . . 0.0 110.117 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -124.13 163.63 21.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.002 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . 179.45 135.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -0.863 . . . . 0.0 110.202 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -52.39 -61.69 2.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' CYS . 70.7 m -75.22 93.87 2.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.868 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 28' ' ' SER . 21.3 p -40.98 -30.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -38.49 58.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -68.07 -43.16 79.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.751 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 24' ' ' VAL . 17.0 mt -53.75 -46.81 71.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.563 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 66' ' ' LEU . 27.8 mt -66.87 -67.18 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 109.898 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -43.73 -68.31 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.61 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 5.6 mtpp -46.83 -27.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.87 -55.64 16.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.22 -13.77 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.179 . . . . 0.0 109.714 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 78.4 t -87.27 -52.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.77 . . . . 0.0 109.997 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -63.83 -29.25 70.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.573 ' CD2' HD22 ' A' ' 13' ' ' LEU . 4.4 m-30 -99.24 -18.86 17.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 109.503 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER 60.34 85.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 110.699 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.521 ' CD2' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -124.89 92.4 47.74 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.07 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 48.3 Cg_endo -73.51 -160.5 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.009 1.531 . . . . 0.0 110.153 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.565 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 3.7 ttt -120.78 43.35 0.61 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.117 -0.99 . . . . 0.0 111.426 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 44' ' ' MET . 53.2 Cg_endo -77.25 -0.48 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.537 1.282 . . . . 0.0 109.844 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.98 6.09 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.516 ' CB ' ' HA ' ' A' ' 76' ' ' THR . 39.4 m -73.05 -161.82 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -1.102 . . . . 0.0 110.512 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.1 OUTLIER 176.41 167.62 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.49 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 60' ' ' ASP . 0.6 OUTLIER -120.57 170.25 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 109.556 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 56' ' ' THR . 74.1 m -148.36 -178.99 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.477 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -116.1 120.08 37.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.973 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -5.98 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 110.538 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -50.05 -62.59 1.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.471 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -147.53 20.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 110.724 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 96.33 44.56 2.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -94.88 167.57 11.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 109.985 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.489 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 9.5 mm-40 -122.03 136.81 54.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 11.7 t -151.73 179.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 18.4 p -129.91 164.76 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 49' ' ' LEU . 17.5 p-10 -73.96 1.2 11.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.44 -23.95 7.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 37.4 t -79.96 -41.24 26.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.401 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 58' ' ' VAL . 12.6 m-85 -40.49 99.78 0.21 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.488 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.9 Cg_endo -80.59 -87.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 110.595 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.8 67.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 63' ' ' PHE . 3.3 mp -44.38 148.16 0.9 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.305 -1.115 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.81 157.58 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.935 1.492 . . . . 0.0 109.976 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.98 146.46 0.81 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.038 -1.039 . . . . 0.0 110.067 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.9 m-20 45.58 36.47 2.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.709 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.58 116.45 0.86 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.85 95.45 9.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.0 mp -103.92 162.8 12.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -136.43 106.5 6.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.551 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.521 HD12 ' CD2' ' A' ' 42' ' ' LEU . 17.1 tp -55.3 148.35 14.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.65 156.57 32.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 21.5 p -138.83 165.74 26.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 110.359 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 76' ' ' THR . . . -43.76 -32.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.98 27.79 7.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -154.73 155.87 35.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 110.587 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.539 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.1 141.07 16.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.847 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.488 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.1 t-105 -110.69 130.1 55.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.0 110.338 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -72.54 -61.79 1.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.93 . . . . 0.0 110.099 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.7 162.7 10.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 26.3 t80 -86.02 48.44 1.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -1.055 . . . . 0.0 110.218 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.22 -172.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 110.016 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -147.18 66.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.245 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.291 0.567 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.26 61.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 4' ' ' VAL . . . -141.3 79.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.209 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 3' ' ' ALA . 4.2 t 40.74 79.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.57 138.43 31.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 2.2 mmm180 -111.67 45.54 1.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 167.79 113.83 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 110.332 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.4 Cg_endo -73.77 126.3 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 110.314 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -79.61 152.57 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 0.0 110.034 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -124.36 151.01 44.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.504 ' CG2' HG12 ' A' ' 24' ' ' VAL . 22.8 m -148.02 141.03 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.73 102.61 15.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.3 tp -78.63 89.52 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.1 tpt180 -91.49 154.68 18.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -140.34 113.1 8.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.036 -1.04 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 HD12 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -58.09 -20.8 42.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -81.5 -0.18 40.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -127.1 -160.91 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.98 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.76 28.54 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.347 -0.845 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -179.39 -159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.603 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.38 -176.03 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 110.033 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -133.83 91.13 2.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.97 95.02 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.504 HG12 ' CG2' ' A' ' 11' ' ' VAL . 4.2 p -101.56 147.14 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -1.083 . . . . 0.0 110.3 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.476 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -128.09 147.74 50.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 110.35 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 32' ' ' LEU . . . -169.79 150.84 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 mmt180 -62.0 -55.94 24.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 7.8 p -83.49 96.97 8.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.2 p -41.29 -29.65 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' SER . 24.8 mm100 -60.34 -23.55 64.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.076 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.12 -46.78 40.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 26' ' ' ALA . 24.3 mt -59.7 -38.25 81.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.976 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.416 HD23 HD12 ' A' ' 66' ' ' LEU . 18.4 mt -67.16 -54.98 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.859 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -65.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.764 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -49.9 -29.37 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.43 -53.04 23.09 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.6 t -57.53 -17.0 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.554 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.24 -56.3 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.985 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -62.92 -33.54 75.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 4.7 m-30 -94.13 -13.25 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.88 84.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.698 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 HD22 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -127.34 96.78 32.76 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.0 -1.062 . . . . 0.0 110.257 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 47' ' ' SER . 43.7 Cg_endo -71.84 127.53 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.086 1.572 . . . . 0.0 110.332 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.521 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -41.44 -53.22 7.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.403 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 50.9 Cg_endo -77.81 164.14 28.09 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.025 1.539 . . . . 0.0 110.618 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 43.38 30.8 1.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -163.49 -177.64 5.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -1.177 . . . . 0.0 110.214 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 175.99 153.74 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.182 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 74' ' ' LEU . 1.1 mt -122.84 160.08 26.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.647 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 56' ' ' THR . 63.7 m -147.78 139.18 23.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 110.348 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.533 HD11 ' CG2' ' A' ' 58' ' ' VAL . 0.3 OUTLIER -67.32 120.3 13.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.487 -0.758 . . . . 0.0 110.463 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 21.5 t80 -69.54 -12.58 61.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.765 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.06 -41.14 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 110.319 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.58 40.2 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.182 -0.948 . . . . 0.0 110.645 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.509 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 57.38 29.75 60.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.53 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -74.2 161.08 30.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.249 . . . . 0.0 109.7 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.6 pt-20 -114.75 133.0 56.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.048 -1.032 . . . . 0.0 110.599 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.602 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 81.3 t -156.67 173.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 24.2 p -122.58 158.81 29.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 6.1 p-10 -63.16 -16.19 59.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 110.405 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -1.49 31.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.0 t -101.06 -41.46 6.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.602 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 35.2 m-85 -39.61 99.27 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.726 . . . . 0.0 110.246 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.5 Cg_endo -73.65 -55.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.008 1.531 . . . . 0.0 110.462 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.6 68.51 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 1.5 mp -48.09 160.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.126 . . . . 0.0 109.879 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.12 165.6 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -44.64 150.38 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.248 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.0 m-20 47.43 35.74 4.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -52.22 125.84 17.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.753 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 69' ' ' ASP . 31.5 mp0 -96.25 110.24 22.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.163 -0.96 . . . . 0.0 110.914 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.51 HD11 ' CD2' ' A' ' 66' ' ' LEU . 2.7 mm? -114.48 141.26 47.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 0.0 109.788 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -115.9 149.25 38.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 0.0 110.416 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.54 ' CG ' HD22 ' A' ' 42' ' ' LEU . 10.7 tp -86.98 147.1 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.824 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.3 tt -158.99 157.06 30.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.488 ' CG2' ' C ' ' A' ' 75' ' ' LEU . 11.8 p -152.29 173.21 15.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.59 -36.14 6.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -87.36 23.24 12.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.4 mt-10 -157.65 150.71 23.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.093 -1.239 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.512 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.53 133.17 20.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.509 ' NE1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -96.88 125.52 41.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.248 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.418 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 26.4 m80 -67.8 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 110.166 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.5 128.65 1.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 85' ' ' VAL . 59.0 t80 -59.93 132.62 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 11.7 m -80.19 166.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 86' ' ' SER . 9.6 p -99.6 61.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.185 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.173 0.511 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 65.7 m -52.57 146.28 10.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.14 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.84 51.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 27' ' ' ARG . 3.7 t -104.45 45.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD12 ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER 52.38 46.59 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.847 . . . . 0.0 110.302 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.1 mmt-85 43.19 47.71 5.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.988 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 68.53 163.22 0.14 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.334 -0.854 . . . . 0.0 110.268 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.0 Cg_endo -71.65 137.53 30.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.864 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 169.24 16.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.745 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' C ' ' CG1' ' A' ' 11' ' ' VAL . 26.5 m -141.38 152.32 44.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' CG2' HG11 ' A' ' 24' ' ' VAL . 3.6 m -148.07 142.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 55.2 mmtt -98.33 92.4 5.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.566 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -72.61 84.31 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 110.382 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 4.0 tpt180 -81.59 159.82 23.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.825 . . . . 0.0 109.693 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB3' ' CE2' ' A' ' 40' ' ' PHE . . . -141.31 126.64 18.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 110.589 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -68.57 -24.51 64.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.951 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -79.93 5.98 12.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -150.81 148.88 29.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 110.019 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.42 54.94 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 110.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.2 p -173.65 -172.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.25 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.473 -0.767 . . . . 0.0 109.931 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 24' ' ' VAL . 14.2 t80 -147.71 79.0 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.0 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -62.49 81.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 32' ' ' LEU . 4.8 p -93.83 144.99 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -1.102 . . . . 0.0 110.728 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -123.68 154.42 39.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 110.059 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -177.12 130.05 0.17 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 ttp180 -45.51 -57.15 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.2 p -82.26 97.18 8.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.5 p -41.83 -29.42 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' OE1' ' SG ' ' A' ' 29' ' ' CYS . 1.4 mp0 -56.69 -24.02 46.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -46.2 42.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.373 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 24' ' ' VAL . 20.4 mt -61.68 -39.46 91.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 29.1 mt -63.03 -58.78 6.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.053 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 4.4 mmt180 -59.42 -71.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 0.0 109.86 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' ARG . 32.6 mtpt -42.96 -34.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.776 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -63.96 -54.66 29.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.0 t -61.5 -13.5 21.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.15 -1.206 . . . . 0.0 109.872 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.6 -49.98 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.0 109.687 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -25.51 63.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.534 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -99.63 -18.96 17.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.797 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 60.57 83.23 0.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.4 OUTLIER -125.06 102.85 30.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.99 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.9 Cg_endo -71.54 156.14 58.37 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.938 1.494 . . . . 0.0 110.531 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -74.5 -48.54 5.3 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.976 . . . . 0.0 110.234 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 44' ' ' MET . 51.1 Cg_endo -79.99 133.49 10.07 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.015 1.534 . . . . 0.0 110.391 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.1 44.35 95.9 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -166.98 174.94 7.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -1.152 . . . . 0.0 109.993 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.2 147.05 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.893 -1.129 . . . . 0.0 110.948 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mp -110.09 175.76 5.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.36 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.9 p -159.07 146.6 17.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 0.0 110.673 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -71.55 111.51 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 110.121 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.452 ' CD1' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -68.97 -14.54 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -53.05 -44.51 67.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.285 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t70 -136.47 -33.78 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 131.3 38.59 0.27 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.514 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.3 171.5 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.102 . . . . 0.0 110.018 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.7 mm-40 -121.24 135.94 55.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 109.73 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 82.5 t -155.38 168.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.601 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.416 ' N ' ' CG1' ' A' ' 58' ' ' VAL . 55.0 p -110.14 159.46 17.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 110.12 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.47 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.8 p-10 -67.06 -8.01 27.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 110.433 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.32 -17.1 14.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.6 m -84.58 -41.61 16.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 58' ' ' VAL . 18.6 m-85 -40.0 100.18 0.21 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.401 -0.812 . . . . 0.0 110.57 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -75.84 -89.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.07 1.563 . . . . 0.0 110.36 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -125.98 65.83 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 17.5 mt -42.76 163.37 0.15 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -73.0 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.214 1.639 . . . . 0.0 109.921 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -74.44 150.28 40.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.126 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 70' ' ' ALA . 38.7 m-20 42.75 37.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.86 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.03 100.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.63 . . . . 0.0 110.253 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.7 tt0 -71.35 106.07 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.367 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 72' ' ' LEU . 6.0 mp -111.37 166.42 11.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -142.39 138.33 31.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -80.89 146.23 30.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.82 159.45 36.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.092 -1.005 . . . . 0.0 109.899 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 75' ' ' LEU . 5.2 p -150.98 174.08 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.41 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.931 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.28 18.47 57.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -151.49 161.22 43.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -1.145 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.13 142.64 17.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.827 . . . . 0.0 110.166 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.7 t-105 -116.26 133.12 56.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.125 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.28 -80.23 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -168.36 154.19 23.85 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.5 96.02 9.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.14 . . . . 0.0 110.28 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -91.62 151.52 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m -99.44 74.57 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 t0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.238 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.266 0.555 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.5 OUTLIER 59.55 -168.54 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 44.1 61.19 2.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.96 128.12 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.62 -177.61 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.471 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.0 mmt180 -121.94 73.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.1 tt0 69.57 144.14 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.272 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.3 Cg_endo -73.3 123.58 8.84 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.129 1.594 . . . . 0.0 110.953 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 1.9 ttpm? -80.92 155.87 26.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.743 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' ASP . 25.0 t -125.38 151.84 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' VAL . 8.9 m -144.53 149.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 3.5 mmtt -99.31 101.24 12.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -79.27 75.28 5.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.431 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.8 tpt180 -83.73 157.31 22.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.83 122.4 20.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.049 -1.032 . . . . 0.0 110.661 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.36 -30.6 66.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.475 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 61.0 t-80 -79.89 5.76 12.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 110.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -127.18 -163.79 1.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.961 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.14 33.05 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -171.88 -162.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.822 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.95 -164.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.769 . . . . 0.0 109.853 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -156.08 89.56 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.447 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.56 96.1 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 32' ' ' LEU . 2.3 p -105.74 151.83 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 110.43 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -134.06 161.81 33.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.059 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -178.52 141.91 0.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 0.0 110.478 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.38 -65.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.99 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.3 OUTLIER -79.72 95.03 5.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.846 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.463 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 29.5 p -41.44 -28.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.808 . . . . 0.0 110.423 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 13.0 tt0 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 1.2 tp10 -74.41 -46.13 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.385 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 24' ' ' VAL . 22.0 mt -60.97 -36.89 80.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD21 ' CD1' ' A' ' 66' ' ' LEU . 63.8 mt -66.37 -59.89 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.838 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -70.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 24.0 mtpp -45.48 -32.03 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.598 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.27 58.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.3 t -65.76 -15.78 63.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.696 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 82.5 t -80.53 -46.5 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -32.57 64.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.671 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CD2' HD22 ' A' ' 74' ' ' LEU . 2.0 m-30 -90.6 -10.55 42.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.77 82.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.322 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.3 OUTLIER -124.63 111.26 27.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 110.153 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 47' ' ' SER . 46.7 Cg_endo -73.04 162.34 41.15 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.015 1.534 . . . . 0.0 110.301 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.524 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 2.1 ttp -76.36 -54.31 1.93 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 48.8 Cg_endo -77.61 153.39 30.26 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.901 1.474 . . . . 0.0 110.44 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.32 38.93 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -155.05 172.32 18.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 110.196 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 178.95 140.03 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 60' ' ' ASP . 2.0 mp -112.1 118.73 36.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.374 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 56' ' ' THR . 71.6 m -103.34 155.11 18.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.056 -1.028 . . . . 0.0 110.753 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -83.27 124.09 30.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.014 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -73.93 1.24 11.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.741 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.414 ' HB2' HD21 ' A' ' 51' ' ' LEU . 1.1 tp10 -59.73 -54.97 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.35 21.19 1.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.507 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 87.63 35.9 9.0 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 50' ' ' CYS . 0.2 OUTLIER -82.11 163.15 22.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -1.175 . . . . 0.0 110.013 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 14.7 pt-20 -116.04 134.81 54.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 21.2 t -153.09 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 62' ' ' CYS . 44.5 p -131.48 161.44 32.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.003 -1.061 . . . . 0.0 109.99 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.504 ' N ' HD11 ' A' ' 49' ' ' LEU . 5.7 p-10 -72.61 -0.75 13.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 110.579 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -113.0 -11.52 13.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.379 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 3.3 t -98.39 -38.2 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.48 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 66' ' ' LEU . 6.9 m-85 -39.99 99.48 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.2 Cg_endo -81.35 -67.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.935 1.492 . . . . 0.0 110.349 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -147.97 64.78 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.615 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 4.7 mt -42.31 163.45 0.13 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 43.5 Cg_endo -71.24 161.98 44.01 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.209 1.636 . . . . 0.0 110.2 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.45 153.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 4.8 m-20 45.02 37.22 2.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -49.54 112.83 0.7 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.406 -0.808 . . . . 0.0 109.864 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' C ' HD11 ' A' ' 72' ' ' LEU . 4.6 mt-10 -82.07 111.64 18.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 72' ' ' LEU . 4.7 mp -109.22 148.32 31.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.752 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 1.1 tp -132.18 126.03 32.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.943 -1.098 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.488 HD22 ' CD2' ' A' ' 40' ' ' PHE . 9.0 tp -67.74 131.24 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 109.929 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 1.3 tt -147.77 159.48 43.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 109.656 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.3 p -146.79 -178.03 5.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.94 73.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.14 11.13 58.82 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER -141.96 154.16 44.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -1.184 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.59 141.61 23.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -114.51 129.53 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.351 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -66.81 -69.92 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.235 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.507 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 131.81 2.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.39 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -1.182 . . . . 0.0 110.477 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 85' ' ' VAL . 31.6 m -96.0 127.92 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -130.94 50.83 2.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.244 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t 60.27 72.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.333 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.4 64.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.242 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.65 137.84 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 109.992 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.85 -165.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.454 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 3.7 mmt180 -136.2 81.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 67.82 143.7 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.451 -0.781 . . . . 0.0 109.632 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.3 Cg_endo -72.0 125.52 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.981 1.517 . . . . 0.0 110.97 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -85.89 153.35 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' ASP . 13.5 t -127.61 158.83 36.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.381 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.498 HG23 ' CG1' ' A' ' 24' ' ' VAL . 5.4 m -149.02 135.87 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -92.89 96.47 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -75.84 82.42 2.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.546 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.5 tpt180 -81.01 160.53 24.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 14' ' ' ARG . . . -142.39 132.31 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 110.519 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.497 ' CD1' HD23 ' A' ' 73' ' ' LEU . 4.6 mt -74.55 -20.86 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 109.941 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.529 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 21.4 t60 -79.96 3.34 20.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.899 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 165.48 31.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.96 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 53.2 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -174.98 -172.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 111.09 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -145.62 -162.11 1.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.501 -0.749 . . . . 0.0 109.919 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 9.0 t80 -144.86 87.23 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 110.491 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.07 83.47 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.55 ' CG1' HD22 ' A' ' 32' ' ' LEU . 7.5 p -95.1 152.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -1.158 . . . . 0.0 110.239 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' N ' HD23 ' A' ' 32' ' ' LEU . . . -132.57 164.29 26.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB1' ' HG ' ' A' ' 32' ' ' LEU . . . 177.92 133.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mtm180 -50.14 -33.41 18.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' GLN . 3.2 m -107.35 93.74 4.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.898 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 13.9 p -38.77 -28.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.581 -0.699 . . . . 0.0 110.466 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.12 -33.88 72.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 3.5 tt0 -68.13 -31.33 70.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.55 HD22 ' CG1' ' A' ' 24' ' ' VAL . 30.0 mt -76.38 -34.34 58.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.94 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 79.9 mt -66.91 -61.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -53.25 -53.8 45.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtpm? -56.78 -28.25 60.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.341 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -65.46 -51.98 43.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.9 t -67.09 -18.07 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -1.228 . . . . 0.0 109.84 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.9 t -81.11 -53.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.891 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -66.79 -42.03 86.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.535 ' CD2' HD21 ' A' ' 13' ' ' LEU . 2.5 m-30 -84.95 -13.22 51.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.558 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.77 80.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.437 -0.789 . . . . 0.0 110.281 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 0.5 OUTLIER -111.5 105.13 56.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo -71.64 168.86 22.5 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.048 1.552 . . . . 0.0 110.495 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -88.57 -44.98 0.46 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.816 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.3 Cg_endo -80.02 120.06 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.683 1.36 . . . . 0.0 110.668 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.11 28.58 55.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -144.58 174.11 11.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -1.207 . . . . 0.0 110.505 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.57 142.55 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.925 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 74' ' ' LEU . 3.5 mt -108.72 162.49 14.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.594 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.3 p -149.78 162.59 39.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.614 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' CB ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.36 115.7 27.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -70.19 -5.96 31.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.376 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.64 -54.26 47.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.5 8.56 3.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 91.5 29.0 12.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -74.66 176.65 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 109.888 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 12.2 mt-10 -126.83 137.06 53.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 110.733 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 63' ' ' PHE . 49.0 t -155.77 174.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 43.3 p -122.92 165.22 17.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 110.261 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 p-10 -69.79 -4.1 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.892 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.87 -8.12 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.315 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.7 m -105.07 18.69 21.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.197 -0.939 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 10.9 m-85 -100.87 98.58 8.68 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -72.98 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -127.45 66.54 0.56 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 16.1 mt -41.44 162.98 0.12 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.311 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.1 Cg_endo -70.75 154.89 63.57 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.232 1.649 . . . . 0.0 109.854 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.3 t-20 -41.91 143.99 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 10' ' ' CYS . 2.6 m-20 54.38 36.18 24.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.713 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.81 111.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.586 -0.696 . . . . 0.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 98.23 5.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 66' ' ' LEU . 1.4 mp -108.34 156.03 19.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.911 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.497 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -139.11 123.99 18.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.53 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 11.5 tp -67.77 138.45 56.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 110.184 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 0.7 OUTLIER -148.76 157.67 43.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.47 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -148.02 176.8 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.25 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.46 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.42 15.03 52.87 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 2.4 mt-10 -143.42 145.88 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -1.13 . . . . 0.0 110.513 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.509 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.77 157.77 43.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.822 . . . . 0.0 109.812 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.519 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.7 t-105 -129.73 126.69 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.459 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.54 -59.28 3.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.391 -0.818 . . . . 0.0 110.11 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.46 161.34 8.69 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.449 ' O ' HG22 ' A' ' 85' ' ' VAL . 45.6 t80 -76.03 146.46 39.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 110.144 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 84' ' ' TYR . 6.1 t -142.31 166.05 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.7 t -146.69 51.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.271 0.558 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.06 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -170.05 59.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.36 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -144.23 152.71 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.033 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.338 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -108.9 44.72 1.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 110.033 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 4.9 pt20 -178.14 113.37 0.23 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.36 -0.838 . . . . 0.0 109.812 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -73.16 125.73 10.54 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.945 1.497 . . . . 0.0 110.794 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -80.92 171.4 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.917 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ASP . 44.5 m -138.68 151.16 46.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.464 HG21 HG13 ' A' ' 24' ' ' VAL . 5.5 m -146.32 129.51 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 13.7 mmmt -85.65 96.69 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 87.21 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 110.698 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 3.6 tpt180 -81.99 154.83 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.705 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -143.43 117.23 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 HD13 HD22 ' A' ' 73' ' ' LEU . 1.5 mt -60.81 -27.44 68.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.201 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -83.1 10.77 7.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.13 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 8.0 m -128.19 -161.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.82 14.17 15.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.399 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 -155.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -130.36 176.0 8.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 110.301 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 24' ' ' VAL . 19.2 t80 -120.19 84.93 2.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -59.82 85.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.551 ' CG2' ' CD2' ' A' ' 32' ' ' LEU . 7.0 p -96.3 148.4 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -1.096 . . . . 0.0 110.41 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -130.25 151.09 51.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -171.93 142.35 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 110.468 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -47.03 -66.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 110.008 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.9 OUTLIER -81.59 96.24 7.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 24.7 p -41.94 -31.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -29.24 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 4.0 tp10 -72.79 -35.43 67.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.501 -0.749 . . . . 0.0 109.817 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.551 ' CD2' ' CG2' ' A' ' 24' ' ' VAL . 18.1 mt -69.1 -32.84 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD22 ' CB ' ' A' ' 63' ' ' PHE . 42.3 mt -67.98 -53.41 26.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.0 mmt180 -61.29 -61.8 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.826 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 11.2 mtpt -53.79 -27.95 32.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.61 -44.07 95.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 20.7 t -73.81 -20.65 60.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -1.199 . . . . 0.0 110.169 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 55.0 t -70.94 -49.3 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.469 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -75.72 -26.92 57.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 74' ' ' LEU . 2.5 m-30 -92.76 -3.72 54.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 78.3 mm-40 46.32 72.18 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -115.45 105.34 52.31 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 110.466 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 47' ' ' SER . 40.9 Cg_endo -71.46 157.84 55.44 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.862 1.454 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.615 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 21.1 ttt -87.22 -39.28 0.51 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 111.929 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.2 Cg_endo -77.27 -52.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.275 1.145 . . . . 0.0 111.336 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.03 64.25 0.54 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -175.74 -178.11 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -1.121 . . . . 0.0 110.67 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -178.01 137.04 0.18 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 3.4 mt -109.63 163.88 13.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.719 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' THR . 7.2 p -154.97 136.95 14.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.947 . . . . 0.0 110.368 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -66.3 112.22 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.75 -17.84 38.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.274 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.67 -53.54 30.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.178 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.13 23.17 2.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.54 26.38 71.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -67.8 165.43 17.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -1.221 . . . . 0.0 109.791 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 11.4 pm0 -113.88 135.56 53.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.003 -1.061 . . . . 0.0 110.96 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 63' ' ' PHE . 98.7 t -157.53 173.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.685 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 58.0 p -128.45 158.83 37.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 52.3 p30 -62.2 -11.47 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.7 t0 -107.63 4.45 25.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 37.7 t -112.21 -40.24 4.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.176 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 58' ' ' VAL . 44.6 m-85 -40.04 99.95 0.21 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -74.41 -90.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.005 1.529 . . . . 0.0 110.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.73 66.27 0.57 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 63' ' ' PHE . 40.2 mt -44.62 163.73 0.18 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.31 -1.112 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.26 -174.34 1.76 Allowed 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.173 1.617 . . . . 0.0 109.847 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 69' ' ' ASP . 33.6 p30 -63.79 154.05 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 110.039 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.5 m-20 42.65 38.79 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.855 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.34 112.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.493 -0.755 . . . . 0.0 109.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.76 103.59 11.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.502 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.467 HD13 ' CD1' ' A' ' 66' ' ' LEU . 8.7 mp -114.86 156.63 24.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.32 -0.863 . . . . 0.0 110.106 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -133.21 125.89 30.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.476 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 12.3 tp -71.79 133.66 45.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.465 -0.772 . . . . 0.0 109.949 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 1.5 tt -147.47 160.82 42.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.134 -0.979 . . . . 0.0 109.547 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.479 ' N ' HD22 ' A' ' 75' ' ' LEU . 4.6 p -148.83 173.11 13.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 109.96 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.47 -24.34 7.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.959 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.98 16.52 60.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -150.72 156.59 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -1.081 . . . . 0.0 110.242 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.27 153.84 39.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.224 -0.923 . . . . 0.0 110.401 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.475 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.3 t-105 -130.9 116.95 18.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.347 -0.845 . . . . 0.0 110.254 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -63.47 -72.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.058 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.42 167.01 19.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 12.9 t80 -88.31 108.71 19.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -1.186 . . . . 0.0 110.349 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 ' O ' HG21 ' A' ' 85' ' ' VAL . 35.8 m -80.2 144.99 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 60.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.158 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 24.5 mtt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.233 0.539 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 173.67 -170.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.6 87.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.339 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 4' ' ' VAL . 7.1 p -168.88 74.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.07 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.9 144.62 30.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.526 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 5.1 mmm-85 -122.32 45.92 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.388 -0.82 . . . . 0.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.9 pt20 174.26 99.35 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 43.9 Cg_endo -71.88 124.15 9.91 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.98 1.516 . . . . 0.0 110.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 158.71 23.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.699 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.8 t -127.85 151.64 48.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 HD21 ' A' ' 32' ' ' LEU . 3.0 m -140.06 152.7 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.977 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -110.32 99.28 8.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 HD23 ' CA ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -82.23 88.79 6.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.975 . . . . 0.0 110.689 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.537 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 2.4 tpt180 -95.4 157.31 15.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.03 139.27 44.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 81' ' ' TRP . 1.6 mt -76.26 -21.14 56.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -79.38 -2.04 39.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -155.79 138.13 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.94 53.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.19 167.36 29.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 110.606 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.88 162.32 40.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.512 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.514 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 8.4 t80 -115.66 87.74 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.93 95.57 0.28 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 32' ' ' LEU . 6.0 p -108.68 154.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -1.193 . . . . 0.0 110.903 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . . . -124.8 166.44 16.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.63 147.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.5 mtm180 -66.86 -53.99 26.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 110.033 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' CYS . 73.9 m -83.82 97.14 9.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' SER . 7.2 p -41.65 -30.55 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.105 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -54.87 -27.49 43.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.17 -44.03 39.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 24' ' ' VAL . 11.5 mt -57.34 -42.36 81.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 63' ' ' PHE . 68.2 mt -67.21 -59.83 3.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -54.03 -70.48 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.795 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 27.8 mtpt -47.29 -24.59 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.472 ' CA ' HD23 ' A' ' 13' ' ' LEU . . . -73.48 -53.44 7.5 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.3 t -66.64 -11.87 55.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -1.107 . . . . 0.0 109.748 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 97.5 t -82.5 -69.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.967 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -51.77 -31.89 28.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.685 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.9 m-85 -89.82 -17.95 27.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.58 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 5.5 mt-30 56.56 80.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -118.2 105.33 46.93 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 110.175 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo -71.1 155.85 60.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.968 1.51 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.538 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -65.53 -54.67 29.03 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.094 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 52.8 Cg_endo -78.02 165.93 25.56 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.978 1.515 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 41.95 34.76 1.44 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -154.41 171.23 19.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.931 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER 179.01 146.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 110.595 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mt -116.35 170.7 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.257 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.2 p -160.21 131.24 5.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.85 -1.156 . . . . 0.0 111.137 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -53.63 133.4 41.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.772 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 25.1 t80 -92.45 -13.26 30.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 110.37 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -53.7 -24.86 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 1.6 t0 -156.46 -43.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.652 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.53 54.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.486 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.59 160.88 14.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.964 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -111.16 130.74 55.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 0.0 110.278 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 51' ' ' LEU . 52.3 t -148.8 172.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.483 ' HA ' HD12 ' A' ' 49' ' ' LEU . 35.3 p -115.16 158.44 22.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p-10 -70.47 -13.36 62.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -102.44 6.24 40.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.3 t -112.33 -36.99 5.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 66' ' ' LEU . 25.6 m-85 -40.59 100.62 0.22 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.461 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -75.38 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.105 1.582 . . . . 0.0 110.275 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.32 69.29 0.52 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 63' ' ' PHE . 17.7 mt -50.37 161.76 0.58 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.209 -1.171 . . . . 0.0 110.051 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.59 167.27 26.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -45.75 153.02 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 110.103 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 27.1 m-20 43.89 37.37 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.2 117.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.761 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -82.88 107.69 15.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 110.501 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 HD22 ' CE2' ' A' ' 63' ' ' PHE . 1.3 mp -118.25 137.64 52.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.805 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -115.87 131.7 56.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.926 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.518 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 11.7 tp -77.12 139.74 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -155.07 163.71 39.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.2 p -147.79 168.25 22.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.09 -25.44 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.74 15.42 61.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 0.4 OUTLIER -151.96 151.65 31.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 110.344 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.91 144.26 30.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.103 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . 9.6 t-105 -110.95 135.87 50.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -79.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 166.95 147.17 5.14 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -81.64 146.25 30.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.16 177.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -113.35 79.99 1.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 86' ' ' SER . 1.7 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.252 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' ALA . 1.9 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.266 0.555 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -57.83 86.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.224 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -164.21 81.89 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.113 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.41 59.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER 58.48 106.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 44.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.878 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -179.41 113.13 0.21 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.879 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -72.49 123.06 8.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.824 1.434 . . . . 0.0 110.183 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.69 139.91 37.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.7 t -108.1 149.06 28.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.12 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 24' ' ' VAL . 30.2 m -143.95 126.13 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -83.51 97.4 8.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -78.04 79.35 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HA ' ' CB ' ' A' ' 21' ' ' LYS . 5.1 tpt180 -80.56 160.36 25.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.835 . . . . 0.0 109.705 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.93 116.93 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.041 -1.037 . . . . 0.0 110.709 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' CD1' HD23 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -69.28 -19.77 63.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.79 2.05 24.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.9 -161.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.38 39.86 3.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.9 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.9 p -173.41 -161.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 13.7 ptpt -150.61 -162.03 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 0.0 109.981 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -151.89 90.61 1.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.08 89.89 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG11 ' CD2' ' A' ' 32' ' ' LEU . 3.7 p -97.97 144.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -1.205 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' C ' HD13 ' A' ' 32' ' ' LEU . . . -128.21 148.32 50.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.488 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . . . -172.2 154.09 3.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mtm180 -63.04 -59.3 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.456 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -84.92 96.2 9.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -42.32 -34.14 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.42 -30.87 42.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.404 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -74.19 -32.87 63.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.503 -0.748 . . . . 0.0 109.779 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' CD2' HG11 ' A' ' 24' ' ' VAL . 14.8 mt -75.8 -37.52 59.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.11 -60.65 2.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.93 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -58.58 7.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.765 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -51.33 -32.93 27.09 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.405 -0.81 . . . . 0.0 109.355 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.17 -51.94 53.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -61.36 -19.38 61.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.178 . . . . 0.0 109.864 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 89.1 t -78.96 -48.08 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -76.43 -33.14 58.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.058 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -89.7 -12.45 39.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -0.882 . . . . 0.0 109.616 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 82.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 110.424 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.547 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.31 108.76 37.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.374 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.2 Cg_endo -73.07 170.49 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.533 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -79.33 -50.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 44' ' ' MET . 48.3 Cg_endo -76.54 158.26 36.17 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.766 1.403 . . . . 0.0 110.462 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 76' ' ' THR . . . 44.13 36.09 3.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -137.26 169.12 18.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.8 116.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 110.318 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.2 mt -99.62 111.26 23.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.3 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 73' ' ' LEU . 26.4 p -96.33 168.51 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.947 . . . . 0.0 110.768 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.43 116.66 31.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.552 -0.718 . . . . 0.0 110.173 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' CB ' ' OE1' ' A' ' 71' ' ' GLU . 15.3 t80 -62.26 -14.41 38.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -56.49 15.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.28 42.98 1.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.495 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.44 33.9 78.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -76.81 164.22 26.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.103 -1.233 . . . . 0.0 109.619 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 58' ' ' VAL . 16.9 pt-20 -116.94 131.89 56.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.97 -1.081 . . . . 0.0 110.241 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 25.9 t -151.04 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.478 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 19.3 p -130.71 165.09 23.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.471 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 10.7 p-10 -70.95 -11.86 61.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.603 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.24 -2.42 20.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.052 -1.03 . . . . 0.0 110.524 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 47.9 t -103.01 -39.55 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.636 ' CE1' ' CG1' ' A' ' 58' ' ' VAL . 16.4 m-85 -40.46 100.0 0.21 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 110.59 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.5 Cg_endo -81.9 -79.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.027 1.541 . . . . 0.0 110.491 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.79 70.91 0.51 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.566 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 5.5 mt -51.93 161.55 0.92 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.334 -1.098 . . . . 0.0 110.473 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.438 ' HD2' HD21 ' A' ' 66' ' ' LEU . 44.6 Cg_endo -73.42 178.85 6.13 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.19 1.626 . . . . 0.0 109.996 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 69' ' ' ASP . 28.5 t-20 -59.82 150.27 28.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.205 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 44.35 39.03 2.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 109.723 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.81 109.62 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.564 -0.71 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -78.7 95.29 5.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -103.96 152.92 21.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -132.65 124.76 28.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.446 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.547 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 11.6 tp -72.67 121.84 20.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.539 -0.726 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 76' ' ' THR . 0.3 OUTLIER -138.69 157.45 46.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 10.6 p -135.68 179.86 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.56 63.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.75 17.35 50.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -147.23 162.64 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -1.186 . . . . 0.0 110.514 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.418 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -154.71 141.61 19.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.466 ' CE2' ' HA2' ' A' ' 83' ' ' GLY . 2.8 t-105 -115.7 125.44 52.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.449 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 3.7 t60 -62.18 -60.14 4.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 81' ' ' TRP . . . 130.67 143.52 5.33 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -62.41 115.92 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.851 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.8 146.68 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 110.306 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.12 86.29 2.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.148 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.5 139.7 28.89 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.905 1.476 . . . . 0.0 110.44 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 2.0 ttpt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.1 t -118.05 148.55 42.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.545 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 11' ' ' VAL . 22.4 m -142.37 127.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.922 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 4.0 mmpt? -82.7 107.54 15.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.976 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -88.46 86.2 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.383 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.724 ' HG3' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -86.94 157.46 19.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.42 128.87 30.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.048 -1.032 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt -72.54 -26.87 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.808 . . . . 0.0 109.716 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 48.7 t-80 -85.14 13.52 6.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.408 -0.807 . . . . 0.0 109.995 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 -160.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.377 -0.827 . . . . 0.0 109.998 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . -129.54 35.88 4.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 4.8 p 174.69 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -168.07 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.0 109.9 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 2.1 t80 -143.96 90.81 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HE2' ' A' ' 12' ' ' LYS . . . -64.61 91.72 0.11 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.863 HG13 HD23 ' A' ' 32' ' ' LEU . 3.1 p -99.41 134.51 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -1.154 . . . . 0.0 110.126 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.736 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.46 149.51 40.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -168.48 145.08 3.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -59.03 -58.56 8.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.066 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 m -80.27 98.07 7.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -0.864 . . . . 0.0 109.93 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.056 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -40.56 -29.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -0.787 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' SER . 31.9 tt0 -60.14 -28.98 68.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.4 -45.01 66.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.802 . . . . 0.0 109.845 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.056 HD12 ' HA ' ' A' ' 29' ' ' CYS . 4.8 mt -57.8 -43.43 85.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 110.001 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 63' ' ' PHE . 2.6 mt -61.85 -65.92 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' NH1' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -43.61 -69.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -47.24 -27.36 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.49 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.42 -55.37 12.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.57 -11.64 17.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 0.0 110.032 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 34' ' ' ARG . 74.7 t -85.33 -71.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -23.51 5.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.347 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 m-85 -102.99 -16.57 15.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 54.01 85.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.86 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -129.08 99.95 21.21 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.558 . . . . 0.0 110.171 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.14 0.495 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 172.75 148.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 74' ' ' LEU . 2.1 mt -118.22 168.85 10.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.1 p -154.97 139.65 17.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 110.848 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -68.08 127.01 31.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 110.292 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -80.85 1.3 31.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' HD23 ' A' ' 51' ' ' LEU . 3.0 tt0 -59.35 -46.38 88.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.0 15.52 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.552 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 94.02 28.97 10.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.06 164.64 25.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -1.222 . . . . 0.0 109.402 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.557 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.2 mt-10 -121.46 130.67 53.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.929 -1.107 . . . . 0.0 110.497 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.912 HG11 ' CE1' ' A' ' 63' ' ' PHE . 57.3 t -153.1 173.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 36.9 p -123.35 164.95 17.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 33' ' ' LEU . 3.0 p30 -67.61 -12.17 59.81 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.325 -0.859 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -105.35 -5.41 20.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.3 t -107.42 17.2 23.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.168 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.912 ' CE1' HG11 ' A' ' 58' ' ' VAL . 6.6 m-85 -100.99 96.54 5.8 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.392 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.5 Cg_endo -72.13 -91.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.782 1.411 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -112.48 68.63 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.832 HD22 ' HB1' ' A' ' 70' ' ' ALA . 1.5 mt -42.84 152.76 0.35 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 0.0 110.343 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.44 164.51 32.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.986 1.519 . . . . 0.0 110.132 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -49.13 148.94 2.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER 43.12 37.33 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.721 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.832 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -42.86 127.6 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 110.035 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 108.72 19.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 72' ' ' LEU . 1.2 mp -117.85 145.41 44.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.724 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -128.58 137.25 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.455 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.86 HD11 HD23 ' A' ' 42' ' ' LEU . 9.9 tp -77.4 138.94 39.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.881 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.6 tt -156.0 162.33 40.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.642 ' N ' HD23 ' A' ' 75' ' ' LEU . 71.2 p -153.99 171.92 18.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.718 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.57 -25.48 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 23.35 34.13 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 17' ' ' HIS . 2.2 mt-10 -156.36 162.66 40.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -1.165 . . . . 0.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.608 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.16 151.31 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.647 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.456 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 7.5 t-105 -124.23 126.32 45.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.878 . . . . 0.0 109.791 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.82 -71.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 163.65 175.85 34.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 5.5 t80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.4 -1.059 . . . . 0.0 110.104 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.2 Cg_endo -72.69 120.82 6.91 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.937 1.493 . . . . 0.0 111.107 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -84.36 -166.02 1.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.684 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.8 t -153.23 154.53 34.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.981 HG22 HD22 ' A' ' 32' ' ' LEU . 32.8 m -147.04 146.26 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -107.01 96.76 6.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.742 HD23 ' CG ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -77.82 90.98 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.7 tpt180 -91.73 152.8 20.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.015 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -137.94 131.81 31.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.1 -28.15 64.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.782 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -79.83 3.05 20.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.983 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 t -123.97 -163.04 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 110.048 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.83 33.2 5.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 110.107 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 172.95 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.747 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.04 166.7 23.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.752 . . . . 0.0 109.87 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 6.3 t80 -112.48 97.74 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 110.459 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.404 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -71.81 98.5 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -115.5 150.75 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -1.175 . . . . 0.0 110.569 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -125.65 167.0 15.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 110.229 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -179.75 150.1 0.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.642 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mmm180 -62.79 -57.33 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.11 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.8 m -82.99 95.99 8.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.368 -0.833 . . . . 0.0 110.01 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.978 ' HA ' HD12 ' A' ' 32' ' ' LEU . 28.2 p -41.61 -28.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -55.55 -38.59 69.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.837 . . . . 0.0 109.741 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.6 tp10 -63.46 -43.95 95.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.025 HD23 HG13 ' A' ' 24' ' ' VAL . 8.4 mt -55.24 -47.62 75.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.87 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 63' ' ' PHE . 15.8 mt -63.29 -64.48 0.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.882 . . . . 0.0 109.938 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 tpp85 -47.75 -68.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.907 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -44.93 -30.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.541 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.02 -55.36 24.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.4 t -60.17 -14.36 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.865 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 34' ' ' ARG . 57.4 t -84.83 -60.35 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.377 -0.827 . . . . 0.0 110.28 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -25.32 68.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 110.339 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.742 ' CG ' HD23 ' A' ' 13' ' ' LEU . 3.1 m-85 -101.45 -17.49 16.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.86 84.22 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -123.94 105.72 31.95 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.874 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.808 0 O-C-N 124.008 1.531 . . . . 0.0 110.71 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.3 mtt85 -179.25 117.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 74' ' ' LEU . 13.0 mt -89.57 101.45 14.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.34 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' THR . 94.3 m -89.61 178.88 6.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 111.006 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.4 131.11 55.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.445 -0.784 . . . . 0.0 110.081 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.559 ' CD1' HD13 ' A' ' 73' ' ' LEU . 2.1 t80 -80.74 2.55 25.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.792 . . . . 0.0 110.495 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 4.5 tt0 -66.28 -59.5 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -141.54 22.39 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.333 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.544 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 83.68 48.79 5.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.33 166.2 12.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -1.183 . . . . 0.0 109.715 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -118.98 126.84 52.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.058 . . . . 0.0 110.544 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 10.3 t -144.67 179.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.626 ' H ' HG12 ' A' ' 58' ' ' VAL . 20.4 p -138.88 158.5 44.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.553 ' HB3' HD12 ' A' ' 49' ' ' LEU . 4.1 p30 -61.96 -11.49 13.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 110.26 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -106.67 -5.74 18.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 t -98.18 -48.62 5.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.441 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.169 ' CE1' HD21 ' A' ' 66' ' ' LEU . 10.1 m-85 -41.17 100.53 0.22 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 110.493 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.7 Cg_endo -79.47 -48.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.036 1.545 . . . . 0.0 110.431 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.86 69.55 0.18 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.169 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.7 mt -48.33 161.39 0.38 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 44.0 Cg_endo -72.13 -167.31 0.31 Allowed 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 124.097 1.578 . . . . 0.0 110.116 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 44.9 t30 -70.02 144.57 52.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' CYS . 54.6 t0 56.88 33.98 24.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.982 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -45.46 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.57 -0.706 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' LEU . 1.2 tt0 -78.16 111.02 13.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 71' ' ' GLU . 7.4 mp -115.06 162.79 16.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 109.99 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.89 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -136.98 122.11 19.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.416 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 49' ' ' LEU . 8.5 tp -68.3 115.55 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.803 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -132.63 159.03 40.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 7.6 p -149.05 171.49 16.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 110.158 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.34 -25.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.848 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.25 14.73 62.9 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' OE1' ' CB ' ' A' ' 16' ' ' LEU . 2.9 mt-10 -153.6 144.42 22.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.73 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -135.68 131.13 35.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.485 ' CZ2' ' O ' ' A' ' 83' ' ' GLY . 5.7 t-105 -101.85 130.68 48.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -43.75 18.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 110.429 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 131.7 -172.34 20.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 26.8 t80 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.139 . . . . 0.0 110.27 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.7 Cg_endo -74.37 133.52 17.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.882 1.464 . . . . 0.0 110.495 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.49 166.29 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' C ' HG13 ' A' ' 11' ' ' VAL . 27.8 m -139.19 155.32 47.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 HD22 ' A' ' 32' ' ' LEU . 22.3 m -150.32 131.71 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.2 mmtt -89.3 85.34 6.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.938 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.491 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.1 tp -65.29 85.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.842 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.972 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.0 tpt180 -82.52 153.05 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 109.42 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.0 133.02 37.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.411 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 2.8 mt -80.81 -16.58 53.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.518 ' CE1' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -82.34 -0.87 47.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 110.133 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -129.98 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.78 34.85 5.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.93 -160.63 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -138.29 -160.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.243 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.6 t80 -149.59 84.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -67.26 93.58 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.905 HG13 HD23 ' A' ' 32' ' ' LEU . 1.3 p -107.59 151.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -1.106 . . . . 0.0 110.171 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.449 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -125.33 153.05 43.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.51 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.974 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -167.09 132.93 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.2 mmt180 -48.42 -62.29 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.107 -0.996 . . . . 0.0 110.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -76.07 96.48 3.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.017 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -42.07 -33.32 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -32.06 58.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.536 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -72.4 -39.23 68.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.83 . . . . 0.0 109.404 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.012 HD22 HG22 ' A' ' 11' ' ' VAL . 15.9 mt -56.25 -45.36 80.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.764 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 63' ' ' PHE . 23.6 mt -65.87 -64.69 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -46.33 -70.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.937 . . . . 0.0 109.827 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 9.0 mtpt -48.95 -22.97 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.979 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.37 -45.71 45.84 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 15.5 t -76.06 -15.71 60.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -1.129 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 34' ' ' ARG . 18.8 t -79.47 -50.17 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.795 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.11 -39.36 78.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-30 -83.24 -15.22 51.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 57.41 80.3 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -120.62 110.23 35.61 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.361 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 124.039 1.547 . . . . 0.0 110.335 179.883 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 175.99 141.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.093 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 2.5 mt -109.13 166.71 10.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.976 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.4 m -150.14 169.17 21.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 110.41 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.6 129.33 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.404 -0.81 . . . . 0.0 110.16 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -80.57 -8.68 59.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 51' ' ' LEU . 7.5 tt0 -58.29 -48.62 79.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.9 10.87 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 88.08 46.33 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.19 171.89 9.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -1.208 . . . . 0.0 109.709 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.1 pt-20 -118.43 129.02 55.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.058 -1.026 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.4 t -152.71 176.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 7.3 p -126.37 172.52 10.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 110.214 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 18.7 p-10 -81.61 -4.39 55.99 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.238 -0.913 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.64 0.85 14.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.125 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.9 t -107.43 -40.15 5.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.074 ' CD1' HD11 ' A' ' 66' ' ' LEU . 4.8 m-85 -42.26 101.64 0.25 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 43.6 Cg_endo -72.41 -63.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.057 1.556 . . . . 0.0 111.063 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.68 62.47 0.34 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.074 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.3 mt -44.86 164.46 0.18 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -1.187 . . . . 0.0 110.071 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_endo -69.53 -168.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.16 1.61 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 69' ' ' ASP . 59.7 t30 -68.53 152.33 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.17 -0.956 . . . . 0.0 110.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 10' ' ' CYS . 1.1 m-20 44.04 37.26 1.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.461 -0.774 . . . . 0.0 110.13 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -48.76 106.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.0 109.492 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 27.6 mt-10 -72.97 105.62 4.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.917 . . . . 0.0 110.837 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.652 HD11 HD13 ' A' ' 66' ' ' LEU . 3.2 mp -100.94 169.85 8.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.972 HD12 ' HG3' ' A' ' 14' ' ' ARG . 2.5 tp -143.05 137.45 29.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.911 -1.118 . . . . 0.0 110.916 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.776 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -85.61 130.1 34.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.82 . . . . 0.0 109.687 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.671 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.2 tt -146.41 158.07 43.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.987 -1.07 . . . . 0.0 109.924 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -150.67 171.06 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.67 -29.87 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.054 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.16 14.9 59.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -147.75 159.68 43.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 110.49 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.671 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.91 139.71 13.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.448 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 8.0 t-105 -111.56 133.72 53.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.22 -59.52 2.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.06 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 141.12 163.29 9.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 t80 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 179.887 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 1.8 pt20 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.7 Cg_endo -73.22 138.54 27.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.844 1.444 . . . . 0.0 110.659 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.12 138.9 31.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASP . 98.2 m -115.18 149.42 37.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.424 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.693 HG22 HD22 ' A' ' 32' ' ' LEU . 10.9 m -143.28 146.87 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 10.5 mmtp -105.12 92.18 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.47 97.85 2.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.757 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.734 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.7 tpt180 -94.95 155.74 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.78 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -139.87 121.48 15.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.849 -1.157 . . . . 0.0 110.821 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.01 HD12 HD21 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -65.32 -21.34 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.158 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' CG ' ' OE2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -79.53 0.83 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.5 -162.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.0 27.88 7.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 7.7 p -170.76 -161.55 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.627 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -169.11 2.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.511 -0.743 . . . . 0.0 109.707 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.7 t80 -135.81 85.89 2.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -64.86 94.49 0.17 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.011 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -110.58 140.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -1.095 . . . . 0.0 110.424 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -109.65 162.42 14.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.306 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.895 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 178.38 134.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.88 -58.39 8.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 t -80.26 98.83 7.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.941 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.107 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.7 p -41.85 -28.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.397 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 29.3 mt-30 -57.85 -29.62 65.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -41.42 64.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.825 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.107 HD12 ' HA ' ' A' ' 29' ' ' CYS . 7.3 mt -58.14 -43.08 87.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.776 . . . . 0.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 63' ' ' PHE . 14.9 mt -65.6 -66.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.84 -69.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.782 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -47.71 -25.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.43 -0.794 . . . . 0.0 109.504 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.78 -51.81 28.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.2 t -66.5 -14.12 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.101 -1.235 . . . . 0.0 109.816 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 34' ' ' ARG . 48.3 t -84.99 -56.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -64.38 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.994 -1.066 . . . . 0.0 110.106 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.78 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 3.3 m-85 -103.17 -13.61 16.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 80.7 mm-40 56.46 88.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.117 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.71 93.4 44.48 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.187 -0.946 . . . . 0.0 109.879 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 O-C-N 124.02 1.537 . . . . 0.0 110.038 -179.815 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 1.2 mtt180 175.99 158.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.215 -0.928 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 74' ' ' LEU . 2.0 mp -115.09 168.06 10.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.909 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' THR . 54.2 m -153.11 147.13 25.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 110.379 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -69.69 127.18 32.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.804 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -74.56 0.64 14.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.425 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -61.23 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.08 -1.013 . . . . 0.0 110.2 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.61 22.79 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.55 45.09 38.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.564 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.7 167.9 14.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 109.612 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.8 pt-20 -113.12 131.69 55.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.933 -1.104 . . . . 0.0 111.175 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.899 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.4 t -157.02 173.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.563 -0.711 . . . . 0.0 109.52 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 ' N ' HG12 ' A' ' 58' ' ' VAL . 39.9 p -131.83 160.41 35.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.057 -1.027 . . . . 0.0 110.605 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 33' ' ' LEU . 2.5 p30 -62.18 -10.96 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.02 -7.29 20.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 110.55 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -98.05 -42.31 7.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 0.0 110.411 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.899 ' CE1' HG11 ' A' ' 58' ' ' VAL . 45.8 m-85 -41.7 101.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 110.63 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -76.14 -87.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.93 74.11 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.881 HD11 ' CD1' ' A' ' 63' ' ' PHE . 58.7 mt -58.58 160.18 10.71 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.175 -1.191 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.34 -161.36 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 109.799 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.33 150.47 36.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 10' ' ' CYS . 17.0 m-20 47.52 37.29 6.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -44.06 96.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 109.928 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -62.46 98.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.718 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.664 HD21 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -111.87 161.66 16.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 110.17 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.81 133.13 31.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 110.434 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.117 HD11 HD23 ' A' ' 42' ' ' LEU . 9.8 tp -86.86 143.34 27.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.998 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -151.88 158.55 43.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.644 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 70.4 p -139.7 168.76 19.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.38 -22.24 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.07 21.76 40.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 75' ' ' LEU . 3.5 mt-10 -160.59 141.3 11.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 110.594 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -135.26 146.96 49.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.818 . . . . 0.0 109.834 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.56 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.5 t-105 -116.29 130.26 56.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 110.291 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.68 -75.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -178.26 166.15 35.96 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.342 -1.093 . . . . 0.0 110.168 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tt0 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.2 Cg_endo -71.66 132.79 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.999 1.526 . . . . 0.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -83.13 148.11 27.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.81 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 t -116.77 144.7 44.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 32' ' ' LEU . 3.8 m -139.44 144.54 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.7 mmmm -99.0 91.3 4.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.976 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.85 87.44 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.576 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.717 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -90.86 159.4 16.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.735 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -149.61 130.67 14.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.05 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -84.41 -14.54 49.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.891 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.96 -4.0 53.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 110.022 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -143.93 25.42 1.6 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 0.0 110.413 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 29.4 53.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 120.966 0.412 . . . . 0.0 111.6 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -163.53 172.78 13.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.985 -1.072 . . . . 0.0 110.603 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.04 165.53 28.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.997 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -143.33 99.15 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -68.47 95.85 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.02 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -101.01 141.72 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.158 . . . . 0.0 110.451 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -121.34 146.14 47.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.336 -0.853 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.871 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.77 140.1 6.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -52.23 -59.36 4.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.308 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -83.42 97.13 8.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.156 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 10.9 p -41.72 -29.62 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 28' ' ' SER . 4.3 mm-40 -57.89 -24.69 58.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.8 mt-10 -72.61 -55.35 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 110.052 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.02 HD22 HG13 ' A' ' 24' ' ' VAL . 37.3 mt -56.54 -35.19 67.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 0.0 110.068 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.693 HD21 HD11 ' A' ' 66' ' ' LEU . 52.8 mt -65.48 -65.85 0.62 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.33 -0.856 . . . . 0.0 110.152 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -57.75 -68.69 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 109.97 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 20.5 mtmt -42.84 -37.39 1.8 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.399 -0.813 . . . . 0.0 109.908 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.63 -48.43 84.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.1 t -63.18 -19.4 64.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.237 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 52.1 t -77.24 -41.95 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 39' ' ' ARG . 1.8 tmt_? -81.05 -28.82 35.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.761 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 1.9 m-30 -92.58 -8.15 45.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 74.2 mm-40 49.19 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.799 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -131.04 95.63 24.66 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.093 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.4 Cg_endo . . . . . 0 C--N 1.306 -1.696 0 O-C-N 124.063 1.559 . . . . 0.0 110.321 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.553 ' OG ' HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.204 0.525 . . . . 0.0 110.287 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.839 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -178.75 143.2 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 60' ' ' ASP . 1.4 mt -111.97 164.9 12.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.869 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' THR . 3.5 p -155.09 149.08 25.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 110.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -76.09 105.12 6.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.826 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 85.8 t80 -56.27 -22.35 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.359 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -51.63 -52.42 47.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.987 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -128.22 0.25 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 86.9 30.23 21.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.54 167.28 21.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.15 . . . . 0.0 109.857 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.616 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.8 pt-20 -115.45 133.23 56.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.932 -1.105 . . . . 0.0 109.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.934 HG11 ' CE1' ' A' ' 63' ' ' PHE . 59.1 t -155.52 173.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 110.508 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 30.5 p -119.01 159.6 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 49' ' ' LEU . 44.8 p30 -70.12 -2.72 13.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.95 -23.14 10.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.588 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 m -80.19 -37.6 32.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 110.221 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.152 ' CE2' HD21 ' A' ' 72' ' ' LEU . 20.8 m-85 -39.07 99.14 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.531 -0.73 . . . . 0.0 110.53 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 50.5 Cg_endo -76.93 -39.41 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.989 1.521 . . . . 0.0 110.415 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . 178.51 66.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.883 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.8 mp -42.5 161.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.272 -1.134 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 44.7 Cg_endo -72.85 -174.13 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.071 1.564 . . . . 0.0 110.259 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.5 t30 -58.41 152.64 17.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.108 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLU . 8.5 m-20 42.85 37.86 1.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 0.0 109.924 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -42.24 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -69.49 96.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.777 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.152 HD21 ' CE2' ' A' ' 63' ' ' PHE . 4.8 tp -106.48 153.16 22.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -133.68 140.02 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 110.61 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.799 HD11 HD23 ' A' ' 42' ' ' LEU . 11.8 tp -80.35 132.66 35.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.509 -0.744 . . . . 0.0 109.9 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.839 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.8 tt -145.67 159.03 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.838 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 69.1 p -149.76 -159.96 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.29 73.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.431 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.38 18.01 40.04 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -145.77 148.18 32.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 0.0 110.457 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -149.9 139.8 21.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t-105 -117.0 128.86 55.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -76.73 -61.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.81 147.0 4.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.283 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.7 Cg_endo -72.59 125.15 10.37 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.734 1.386 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.97 137.16 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 110.234 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.529 ' C ' HG13 ' A' ' 11' ' ' VAL . 35.3 m -108.19 157.85 17.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.071 HG22 HD13 ' A' ' 32' ' ' LEU . 34.9 m -152.46 137.85 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.9 . . . . 0.0 109.976 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -96.32 107.7 20.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.272 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.605 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -84.53 83.2 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.591 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -80.26 157.24 26.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.352 -0.843 . . . . 0.0 109.877 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.25 123.0 14.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.552 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HD21 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -74.48 -20.44 60.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 110.16 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -79.48 -1.5 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.88 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -128.42 -160.76 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 0.0 109.951 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.45 38.82 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.48 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.62 -159.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.048 -1.032 . . . . 0.0 110.69 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.69 -161.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 19.1 t80 -145.6 98.05 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.19 101.27 1.03 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD22 ' A' ' 32' ' ' LEU . 2.9 p -116.26 149.07 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -1.149 . . . . 0.0 110.291 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.95 159.28 41.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.004 . . . . 0.0 110.262 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.84 132.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 25.1 mmm-85 -46.21 -56.15 6.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 110.212 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -82.47 97.94 8.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.036 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 28.2 p -40.26 -27.56 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 21.7 mp0 -62.27 -28.55 69.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 tt0 -66.38 -44.62 82.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 110.249 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.071 HD13 HG22 ' A' ' 11' ' ' VAL . 38.2 mt -67.13 -35.65 80.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 87.4 mt -65.23 -60.75 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tpt180 -55.23 -69.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 26.0 mtpp -46.08 -29.62 1.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -60.57 -52.37 52.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.7 t -67.13 -16.24 64.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -1.181 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 54.1 t -81.73 -52.57 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -66.94 -39.7 87.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.743 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.605 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.9 m-30 -83.28 -19.55 36.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.853 . . . . 0.0 109.783 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 44.7 mm-40 60.34 77.74 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.475 -0.766 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.064 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -121.33 97.52 47.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 123.946 1.498 . . . . 0.0 109.714 179.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.722 ' HB3' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.089 0.471 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 176.23 154.23 0.2 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.113 -0.992 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -111.76 165.83 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 109.414 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.5 p -156.97 133.69 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.58 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.697 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -63.3 126.43 27.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.404 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 84.6 t80 -77.13 2.02 16.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.939 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -50.82 50.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.433 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.08 54.77 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.543 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 51.98 40.81 51.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.37 159.03 18.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.048 -1.266 . . . . 0.0 109.495 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.609 ' C ' HG23 ' A' ' 58' ' ' VAL . 7.3 mp0 -117.34 136.75 52.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 110.468 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.839 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.1 t -156.8 175.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.589 ' N ' HG12 ' A' ' 58' ' ' VAL . 72.2 p -130.83 160.39 34.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.58 -30.53 71.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.37 -0.831 . . . . 0.0 110.471 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.4 22.39 6.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 110.346 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 32.0 t -130.84 -35.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.198 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.141 ' CD1' HD11 ' A' ' 66' ' ' LEU . 34.2 m-85 -44.16 104.22 0.37 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.209 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.4 Cg_endo -72.96 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.009 1.531 . . . . 0.0 110.344 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.12 64.53 0.59 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.141 HD11 ' CD1' ' A' ' 63' ' ' PHE . 52.2 mt -43.71 162.81 0.18 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.303 -1.116 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ASN . 44.3 Cg_endo -72.51 164.44 35.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.169 1.615 . . . . 0.0 110.134 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.8 p-10 -44.49 151.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.945 . . . . 0.0 109.978 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.9 m-20 45.64 37.72 3.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.861 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -40.7 107.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.649 . . . . 0.0 110.186 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 72' ' ' LEU . 12.3 tt0 -83.25 97.87 9.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 110.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.818 HD21 ' CD1' ' A' ' 66' ' ' LEU . 9.0 mp -105.06 159.07 16.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.892 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.761 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -129.53 113.36 14.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.394 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.064 HD11 HD23 ' A' ' 42' ' ' LEU . 12.8 tp -67.89 133.47 49.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -145.98 157.7 43.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.117 -0.989 . . . . 0.0 109.493 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 47' ' ' SER . 39.6 p -132.6 -174.98 3.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.0 -12.13 46.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.92 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.3 25.17 27.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -156.37 163.14 39.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -1.153 . . . . 0.0 110.813 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.676 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.63 139.02 14.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.563 ' CE3' HD11 ' A' ' 16' ' ' LEU . 8.3 t-105 -103.94 137.01 42.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.756 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -69.41 -79.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.324 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . -160.64 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 18.5 t80 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.162 -1.199 . . . . 0.0 110.179 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.1 Cg_endo -71.58 127.11 12.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.943 1.496 . . . . 0.0 110.403 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -79.94 153.12 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 24.9 m -121.48 140.5 52.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 HD22 ' A' ' 32' ' ' LEU . 5.2 m -134.38 136.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.937 . . . . 0.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.18 92.33 5.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.541 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -73.55 94.11 2.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.59 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.912 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -88.96 158.14 18.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.442 -0.786 . . . . 0.0 109.64 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -138.51 135.8 35.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.651 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.7 -24.22 56.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.224 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 7.99 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.0 t -138.26 -164.88 1.7 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.133 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.07 24.25 8.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -161.14 -163.43 1.02 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 0.0 110.592 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -140.44 -162.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.494 -0.754 . . . . 0.0 110.177 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 6.9 t80 -138.47 79.54 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -63.94 84.3 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 32' ' ' LEU . 1.4 p -104.57 141.3 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.138 . . . . 0.0 110.122 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.33 146.97 43.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.448 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.876 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -160.96 144.16 13.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mmt180 -57.9 -61.87 2.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.095 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 1.5 t -77.97 96.89 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.955 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.0 p -42.57 -31.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 mm-40 -52.39 -30.93 31.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.106 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 9.5 mt-10 -72.31 -46.01 57.5 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.604 0.716 . . . . 0.0 109.422 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 29' ' ' CYS . 12.1 mt -56.26 -43.82 79.11 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.75 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 34' ' ' ARG . 70.5 mt -67.09 -69.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.691 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -45.76 -70.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.546 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 31' ' ' GLU . 1.9 mtmp? -46.13 -26.36 0.75 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.166 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.28 -46.01 66.72 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 42' ' ' LEU . 41.0 t -74.24 -16.51 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -1.153 . . . . 0.0 109.78 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 34' ' ' ARG . 20.1 t -84.23 -47.6 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.776 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -35.84 78.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-85 -91.14 -13.51 32.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.57 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 1.7 mt-30 56.44 83.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 110.764 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -118.17 113.62 37.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.016 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.7 Cg_endo . . . . . 0 C--N 1.306 -1.658 0 O-C-N 124.015 1.534 . . . . 0.0 110.726 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.116 0.484 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 172.84 150.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 110.154 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 74' ' ' LEU . 1.7 mt -115.39 168.56 9.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.0 p -157.02 146.38 20.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -70.92 118.83 14.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.713 ' HD1' HD13 ' A' ' 73' ' ' LEU . 63.1 t80 -76.34 -21.23 56.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.381 -0.824 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' TYR . 2.9 tp10 -43.38 -45.94 6.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 110.352 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -137.13 -49.53 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.383 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.24 49.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.71 164.98 12.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -1.149 . . . . 0.0 109.916 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.587 ' C ' HG23 ' A' ' 58' ' ' VAL . 5.5 pt-20 -118.18 131.42 56.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.042 -1.037 . . . . 0.0 110.543 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.6 t -154.64 170.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.523 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -119.44 157.65 27.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 11.3 p-10 -62.44 -16.62 56.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 110.596 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -102.17 6.23 40.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.47 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.5 m -112.19 -34.62 5.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.832 ' CE1' HG11 ' A' ' 58' ' ' VAL . 13.6 m-85 -45.57 104.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 110.399 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.8 Cg_endo -76.52 -86.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.071 1.564 . . . . 0.0 110.338 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.74 64.22 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 63' ' ' PHE . 94.5 mt -45.18 160.84 0.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.289 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.39 178.36 6.24 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -56.76 152.01 13.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 0.0 110.218 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' CYS . 6.1 m-20 44.36 38.85 2.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.797 . . . . 0.0 109.782 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.42 105.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' LEU . 18.4 mt-10 -73.18 103.02 3.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.642 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 66' ' ' LEU . 7.0 mp -113.19 159.74 18.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 109.623 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.912 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -140.09 132.91 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.032 -1.043 . . . . 0.0 110.475 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD11 HD23 ' A' ' 42' ' ' LEU . 11.1 tp -72.29 135.27 45.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.786 . . . . 0.0 109.889 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -146.04 155.33 42.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 10.9 p -146.33 178.29 8.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.57 70.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.09 7.95 53.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 160.02 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.219 -1.165 . . . . 0.0 110.54 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.609 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.01 140.69 12.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.437 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.6 t-105 -111.61 131.41 55.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.122 -0.986 . . . . 0.0 110.32 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -83.37 -61.69 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 150.53 159.62 8.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD1' ' CE2' ' A' ' 52' ' ' TYR . 2.5 t80 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.62 133.52 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.803 1.423 . . . . 0.0 110.575 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -81.59 -179.59 7.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 69' ' ' ASP . 23.5 t -150.54 148.68 28.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.41 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 32' ' ' LEU . 6.3 m -144.86 136.49 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 23.6 mmtt -95.83 94.51 7.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.064 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -72.24 89.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.593 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.908 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -86.7 150.85 23.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 17' ' ' HIS . . . -135.36 137.63 42.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.69 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 73' ' ' LEU . 1.2 mt -75.18 -22.79 57.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.903 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.747 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 28.5 p80 -84.34 6.93 21.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -161.38 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.058 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.56 27.02 6.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.38 -161.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -134.38 -176.26 4.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.82 . . . . 0.0 110.194 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -120.79 99.32 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.58 85.59 0.35 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.991 HG13 HD22 ' A' ' 32' ' ' LEU . 3.5 p -104.14 136.87 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 146.08 47.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.32 133.44 4.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.099 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -50.43 -30.55 12.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 110.458 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 31' ' ' GLU . 1.4 p -104.25 94.53 5.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 26.9 p -41.88 -31.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -30.9 71.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.928 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 68.1 tt0 -68.94 -32.06 71.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 HG13 ' A' ' 24' ' ' VAL . 16.5 mt -77.44 -31.47 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 94.1 mt -66.15 -57.74 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -59.0 -55.86 29.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 29.7 mtpp -55.02 -27.19 42.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.633 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.52 -51.55 30.71 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 29.1 t -65.67 -14.37 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -1.163 . . . . 0.0 109.604 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.69 -45.71 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -24.1 60.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-30 -102.6 -16.54 16.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.507 -0.746 . . . . 0.0 109.64 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER 61.99 88.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.055 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -133.82 97.44 15.49 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.939 . . . . 0.0 110.034 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--N 1.304 -1.777 0 O-C-N 123.912 1.48 . . . . 0.0 110.264 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 76' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.151 0.501 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 176.05 154.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 110.922 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -114.9 116.77 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 56' ' ' THR . 29.0 m -94.41 -179.2 4.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.72 122.94 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 110.247 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -68.72 -7.61 35.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.17 -46.34 90.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 33.35 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 110.503 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 69.22 33.31 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.58 165.75 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -1.191 . . . . 0.0 109.834 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' C ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -119.54 128.45 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.39 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.986 HG11 ' CE1' ' A' ' 63' ' ' PHE . 14.3 t -150.08 -179.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.633 ' H ' HG12 ' A' ' 58' ' ' VAL . 22.9 p -131.4 159.82 36.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.002 . . . . 0.0 110.39 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.654 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.3 p30 -73.61 0.15 13.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.291 -0.881 . . . . 0.0 110.44 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -115.11 -1.29 13.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 110.515 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.6 t -108.07 -36.08 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.923 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.081 ' CE1' HD21 ' A' ' 66' ' ' LEU . 19.8 m-85 -39.62 99.29 0.19 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.436 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.5 Cg_endo -77.7 -33.28 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.044 1.55 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.84 68.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.081 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.1 mp -50.0 163.61 0.41 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.242 -1.152 . . . . 0.0 110.075 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 42.2 Cg_endo -69.43 178.67 4.14 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.109 1.584 . . . . 0.0 110.172 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.72 150.03 20.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.2 m-20 48.84 35.88 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.455 -0.778 . . . . 0.0 110.198 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -50.2 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.74 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 mm-40 -72.58 96.93 2.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -96.4 164.8 12.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HG3' ' A' ' 14' ' ' ARG . 1.4 tp -134.96 118.7 17.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.966 -1.084 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.055 HD11 HD23 ' A' ' 42' ' ' LEU . 15.4 tp -69.43 127.47 33.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -140.46 158.45 43.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 47' ' ' SER . 32.1 p -141.92 174.23 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.99 19.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.43 23.47 21.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.31 149.0 25.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 110.593 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -144.25 158.62 43.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 0.0 109.696 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.575 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -125.48 122.57 37.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.312 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.26 -82.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 0.0 110.115 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 55' ' ' GLY . . . -175.75 172.93 45.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 67.8 t80 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.317 -1.107 . . . . 0.0 110.087 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.7 Cg_endo -75.17 132.05 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.974 1.513 . . . . 0.0 110.789 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.39 159.81 25.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 69' ' ' ASP . 42.8 t -135.15 149.6 50.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.7 m -146.95 134.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.323 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 69' ' ' ASP . 37.6 mmtt -86.27 89.33 7.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -70.79 79.96 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.998 . . . . 0.0 110.201 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.837 ' CG ' HD12 ' A' ' 73' ' ' LEU . 6.5 tpt180 -83.8 159.12 21.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -150.8 122.44 8.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.278 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.895 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -76.79 -8.66 57.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 6.5 t-80 -94.54 10.44 34.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.512 ' O ' ' C ' ' A' ' 19' ' ' ALA . 4.5 m -149.49 30.28 0.75 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.514 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 27.28 49.86 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.095 0.474 . . . . 0.0 111.744 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -174.06 -176.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -145.03 -171.67 3.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 110.0 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 10.5 t80 -153.21 84.54 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.8 94.65 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.979 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -102.89 151.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -1.104 . . . . 0.0 110.769 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.43 151.86 51.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.441 -0.787 . . . . 0.0 110.012 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.875 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.8 136.0 0.89 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.71 -61.43 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.063 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 29' ' ' CYS . 17.7 m -78.3 96.71 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' C ' ' O ' ' A' ' 28' ' ' SER . 25.8 p -41.29 -28.73 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.524 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' SER . 6.9 tt0 -59.56 -25.6 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 110.192 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -70.53 -52.12 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HG13 ' A' ' 24' ' ' VAL . 32.1 mt -60.46 -34.61 74.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.867 . . . . 0.0 110.207 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 63' ' ' PHE . 11.0 mt -67.54 -64.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.066 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.69 -64.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' CB ' ' NZ ' ' A' ' 35' ' ' LYS . 7.6 mtmp? -49.45 -28.92 5.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.7 -48.78 78.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -71.42 -14.56 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.0 109.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.509 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 94.4 t -79.69 -49.43 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.929 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -28.9 62.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.019 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.8 m-30 -93.51 -11.56 31.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 30.4 mm-40 51.16 83.89 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.962 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -128.37 109.12 19.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.953 . . . . 0.0 110.779 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 47' ' ' SER . 47.4 Cg_endo . . . . . 0 C--N 1.305 -1.76 0 O-C-N 123.929 1.489 . . . . 0.0 110.205 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.279 0.561 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -179.87 140.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.733 . . . . 0.0 109.892 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 4.4 mt -109.26 165.81 11.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.059 -1.026 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 73' ' ' LEU . 4.7 p -154.46 157.38 38.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.431 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -85.97 124.44 32.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.706 ' HD2' HD13 ' A' ' 73' ' ' LEU . 35.7 t80 -73.44 -14.3 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.25 -57.06 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.84 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.99 5.09 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.473 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 95.46 32.88 6.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.8 176.78 8.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -1.231 . . . . 0.0 109.706 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.605 ' C ' HG23 ' A' ' 58' ' ' VAL . 40.4 mt-10 -125.29 138.11 54.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.03 . . . . 0.0 110.775 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.1 t -156.46 173.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 58' ' ' VAL . 29.9 p -121.52 158.37 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.511 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.1 p-10 -66.07 -7.81 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -108.62 -18.09 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.5 t -84.05 -39.34 19.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 58' ' ' VAL . 24.9 m-85 -42.32 101.6 0.25 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.1 Cg_endo -79.18 -90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.048 1.552 . . . . 0.0 110.666 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.98 66.37 0.3 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.99 HD22 ' HB1' ' A' ' 70' ' ' ALA . 3.6 mt -43.94 149.92 0.63 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.403 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -161.06 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.976 1.514 . . . . 0.0 110.115 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ASP . 31.6 p-10 -77.2 150.93 35.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . 5.8 t0 42.08 37.05 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.74 . . . . 0.0 110.016 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.99 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -46.43 120.27 2.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 3.4 mp0 -83.2 106.94 15.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.943 . . . . 0.0 110.85 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 3.2 mp -110.92 154.59 23.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.895 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -138.73 127.99 24.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.014 -1.054 . . . . 0.0 110.662 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.705 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -74.08 134.82 42.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 110.24 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.787 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.9 OUTLIER -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.628 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 79' ' ' GLU . 4.4 p -147.51 169.66 19.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.072 . . . . 0.0 109.843 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.14 -33.67 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.3 17.97 39.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -1.193 . . . . 0.0 110.544 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.787 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.19 172.39 13.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.223 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.553 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.7 t-105 -141.24 122.88 15.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -70.15 -79.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.485 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . 179.09 171.87 42.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.218 -1.166 . . . . 0.0 110.239 -179.947 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.1 Cg_endo -72.87 125.53 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.835 1.439 . . . . 0.0 110.537 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 160.2 24.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 69' ' ' ASP . 37.3 m -130.76 152.96 49.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.038 HG22 HD22 ' A' ' 32' ' ' LEU . 9.2 m -141.55 125.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . 10.0 mmtt -87.95 85.45 7.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.6 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -74.81 81.41 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.607 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.642 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -79.72 160.47 26.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.815 . . . . 0.0 109.325 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -135.06 124.24 24.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.773 -1.204 . . . . 0.0 110.679 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 81' ' ' TRP . 2.2 mt -75.72 -20.88 58.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -79.41 2.88 20.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.884 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -140.66 -175.12 4.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.873 . . . . 0.0 109.783 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.04 33.42 4.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.267 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.04 -167.91 2.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.62 -164.88 1.97 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.911 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 8.5 t80 -144.58 77.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.44 92.54 0.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.986 HG13 HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -116.96 151.58 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -128.25 173.79 9.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.386 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.1 126.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.035 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.94 -55.98 3.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -81.42 97.82 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.729 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.4 p -41.6 -30.79 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -0.824 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.23 -34.95 59.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 1.6 mp0 -67.11 -46.46 74.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.689 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG22 ' A' ' 11' ' ' VAL . 18.0 mt -54.42 -42.46 70.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -63.17 -70.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.11 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -59.64 2.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -49.45 -26.6 3.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -70.39 -58.08 6.26 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 44.6 t -64.85 -13.65 56.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' GLN . 31.1 t -85.76 -72.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 109.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.13 -29.82 1.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 13' ' ' LEU . 4.5 m-30 -96.69 -17.94 20.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.567 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.4 mt-30 57.11 84.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.744 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -124.08 101.57 35.16 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 109.977 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.177 -179.781 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 34.7 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.275 0.559 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.41 158.23 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 110.514 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -110.59 165.9 11.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 109.228 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 73' ' ' LEU . 6.1 p -159.35 133.33 7.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.099 . . . . 0.0 110.769 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -62.4 120.92 11.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.484 -0.76 . . . . 0.0 110.3 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -70.31 -6.2 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 19.4 tt0 -54.11 -65.58 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.35 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -131.6 23.86 4.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 83.2 28.52 36.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.39 165.11 25.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.183 -1.186 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' C ' HG23 ' A' ' 58' ' ' VAL . 35.5 mt-10 -119.24 135.54 54.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.3 t -154.3 175.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 42.8 p -122.39 166.66 14.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.9 p-10 -66.57 -7.37 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.288 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -22.43 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.7 m -84.24 13.89 4.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.955 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -100.42 97.82 7.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.017 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.9 Cg_endo -71.3 -92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.896 1.472 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -128.95 64.86 0.6 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' PHE . 12.0 mt -42.92 161.78 0.18 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -1.096 . . . . 0.0 110.174 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.6 Cg_endo -71.95 162.91 40.46 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.075 1.566 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' ASP . 8.9 p-10 -42.29 150.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.59 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 42.98 38.35 1.4 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.881 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.85 110.35 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 110.175 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 12' ' ' LYS . 2.3 tp10 -70.48 99.76 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.357 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 66' ' ' LEU . 6.5 mp -114.6 158.09 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -140.14 116.86 10.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 110.434 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.955 HD11 HD23 ' A' ' 42' ' ' LEU . 6.8 tp -70.64 149.12 47.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -153.51 155.3 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.091 -1.005 . . . . 0.0 110.007 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 19.2 p -135.88 172.46 12.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.08 -31.77 31.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.865 . . . . 0.0 110.291 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.92 17.47 41.04 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' CA ' ' OE1' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -149.97 149.38 30.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -1.21 . . . . 0.0 110.574 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.753 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.26 134.84 22.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.861 ' HB2' HD12 ' A' ' 16' ' ' LEU . 7.1 t-105 -103.16 133.25 48.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -83.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -169.82 158.11 30.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 34.7 t80 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 7' ' ' GLN . 45.8 Cg_endo -72.58 133.85 21.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.977 1.514 . . . . 0.0 110.586 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -171.91 3.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 50.6 t -149.16 149.45 31.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.001 -1.062 . . . . 0.0 110.505 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.2 m -148.26 134.71 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 mmtp -97.28 95.15 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -74.25 89.45 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.984 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.626 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -89.39 151.72 21.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.963 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.05 131.31 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 110.576 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -70.73 -24.47 62.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.416 ' HB2' ' OE2' ' A' ' 79' ' ' GLU . 3.6 t-160 -86.72 16.08 5.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -135.1 -161.28 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.43 29.79 5.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.296 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 174.84 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 110.666 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.37 164.37 30.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 15.0 t80 -102.5 79.66 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -61.92 87.84 0.04 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.038 HG13 HD22 ' A' ' 32' ' ' LEU . 8.6 p -103.37 140.59 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.616 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.15 39.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.761 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.79 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -173.99 148.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 11.0 mmt180 -62.97 -48.16 80.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -84.57 89.19 7.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 110.104 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 28' ' ' SER . 6.6 p -42.64 -31.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.08 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.14 -36.09 78.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 109.907 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 2.7 tp10 -62.41 -51.41 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.778 . . . . 0.0 110.019 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG13 ' A' ' 24' ' ' VAL . 43.7 mt -53.41 -39.26 64.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 63' ' ' PHE . 4.5 mt -57.26 -69.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 110.148 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.735 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.27 -60.14 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.849 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 14.0 mtpt -46.97 -27.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.486 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -69.98 -56.09 8.53 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.6 -15.18 25.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.196 . . . . 0.0 109.937 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 34' ' ' ARG . 24.5 t -87.97 -55.48 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.733 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.64 70.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 3.2 m-30 -95.79 -21.99 17.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.382 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.26 84.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.516 -0.74 . . . . 0.0 110.732 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.025 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.15 98.47 38.8 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 110.159 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--N 1.306 -1.694 0 O-C-N 123.958 1.504 . . . . 0.0 109.774 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' HD11 ' A' ' 42' ' ' LEU . 49.1 m . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.362 0.601 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER 178.61 150.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 60' ' ' ASP . 5.1 mp -115.81 115.15 25.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 56' ' ' THR . 99.9 m -92.46 -171.13 2.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 111.058 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD12 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -121.72 126.85 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.647 -0.658 . . . . 0.0 109.729 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.31 -15.45 63.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 110.816 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -44.9 -68.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.995 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 54' ' ' ASP . 26.3 t70 -143.07 40.09 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.467 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.549 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 72.23 38.5 58.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -80.47 160.03 25.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -1.193 . . . . 0.0 109.834 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -114.49 128.77 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 110.383 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.045 HG11 ' CE1' ' A' ' 63' ' ' PHE . 3.1 t -147.93 -171.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.743 ' H ' HG12 ' A' ' 58' ' ' VAL . 53.9 p -145.41 165.51 28.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.049 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.653 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.7 p-10 -79.23 8.65 5.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -124.92 5.52 8.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 110.354 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t -119.78 -36.56 3.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.045 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -40.86 100.58 0.22 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.6 Cg_endo -76.67 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.039 1.547 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -110.47 67.68 0.22 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.6 mp -41.95 146.13 0.66 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 110.425 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.65 158.08 43.77 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.116 1.587 . . . . 0.0 110.281 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 12.4 p30 -44.27 147.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 109.89 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.7 OUTLIER 43.88 36.4 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.684 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.98 119.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -82.49 101.51 10.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.741 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 1.2 mp -110.24 152.76 25.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -131.02 104.83 7.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.59 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.025 HD11 HD23 ' A' ' 42' ' ' LEU . 10.2 tp -60.5 126.66 28.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -139.16 158.57 43.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.982 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 49.8 p -134.24 176.39 8.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.16 -32.51 36.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.85 20.95 29.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -145.3 148.62 33.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.721 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.76 138.0 24.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.451 -0.781 . . . . 0.0 109.855 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.467 ' HB2' ' CD2' ' A' ' 73' ' ' LEU . 5.5 t-105 -107.89 123.94 49.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.991 -1.068 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -67.33 -62.47 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 153.69 6.07 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 14.1 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.348 -1.089 . . . . 0.0 110.171 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.46 130.79 16.59 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.871 1.459 . . . . 0.0 110.566 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 4.3 ttpt -79.98 155.13 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.85 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' VAL . 7.4 t -129.52 153.46 47.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.622 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.619 HG22 HD13 ' A' ' 32' ' ' LEU . 10.6 m -148.66 135.0 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.08 96.21 10.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 110.355 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -76.33 81.58 3.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.92 . . . . 0.0 110.024 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.718 ' CG ' HD12 ' A' ' 73' ' ' LEU . 5.3 tpt180 -80.59 158.72 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -140.26 112.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -62.5 -30.38 71.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.857 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.572 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 52.1 t60 -82.19 8.1 11.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 28.6 t -121.2 -160.59 0.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -119.23 19.51 12.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 175.84 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.108 -0.995 . . . . 0.0 110.781 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.97 168.8 18.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.552 -0.718 . . . . 0.0 109.883 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -122.52 99.85 6.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.323 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.41 92.58 0.27 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.998 HG13 HD22 ' A' ' 32' ' ' LEU . 4.1 p -97.39 146.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 0.0 110.354 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.596 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -134.92 144.88 47.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.37 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -170.51 123.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.5 mtt180 -42.29 -29.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -100.67 95.64 6.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.277 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 30' ' ' GLN . 21.1 p -44.98 -33.27 1.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.449 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 8.5 mp0 -62.55 -20.64 64.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.73 -48.3 16.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.934 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.998 HD22 HG13 ' A' ' 24' ' ' VAL . 22.3 mt -58.98 -38.86 80.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.022 HD21 ' CD1' ' A' ' 66' ' ' LEU . 52.8 mt -66.36 -63.63 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.687 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.4 mmm-85 -52.78 -65.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.804 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 28.0 mtpt -50.61 -24.21 3.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.607 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.7 -52.55 11.93 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -63.28 -16.11 59.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -1.203 . . . . 0.0 110.056 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 34' ' ' ARG . 99.3 t -78.16 -59.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.008 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -35.1 79.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.942 . . . . 0.0 109.982 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.7 m-30 -84.87 -14.72 46.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 58.2 mm-40 53.1 78.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.398 -0.814 . . . . 0.0 110.554 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -116.82 97.63 50.77 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.9 Cg_endo . . . . . 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.693 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -177.63 146.52 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.01 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.715 ' CD2' HD12 ' A' ' 74' ' ' LEU . 2.2 mt -114.65 169.12 9.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 3.6 p -151.98 161.92 41.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.945 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.752 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -92.47 115.97 28.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.65 -0.656 . . . . 0.0 109.955 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.47 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 7.5 t80 -64.22 -15.43 59.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.409 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -48.77 -51.69 27.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.47 20.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 82.57 22.26 58.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.8 174.34 2.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.127 -1.22 . . . . 0.0 109.672 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 4.9 mm-40 -126.17 137.05 53.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.513 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 51' ' ' LEU . 90.5 t -156.64 173.96 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.193 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -121.87 159.9 25.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.896 . . . . 0.0 110.023 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.57 -7.79 11.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.637 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -15.38 14.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.02 -1.05 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.2 m -88.34 -40.63 13.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.045 . . . . 0.0 110.45 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.602 ' CE1' HD21 ' A' ' 72' ' ' LEU . 47.8 m-85 -39.77 99.75 0.2 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.462 -0.774 . . . . 0.0 110.357 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.8 Cg_endo -76.74 -87.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.071 1.563 . . . . 0.0 110.406 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -117.63 67.31 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.022 ' CD1' HD21 ' A' ' 33' ' ' LEU . 1.6 mt -43.03 143.23 1.31 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.957 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 44.1 Cg_endo -72.32 167.36 27.12 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.019 1.537 . . . . 0.0 110.47 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ASP . 4.2 t-20 -52.1 152.91 2.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 110.457 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER 42.49 38.92 1.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.809 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.994 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -54.33 116.9 2.88 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mt-10 -89.12 108.06 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.6 mp -117.08 159.75 22.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 110.004 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.718 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -134.7 139.97 45.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.646 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.036 HD11 HD23 ' A' ' 42' ' ' LEU . 12.2 tp -79.99 144.73 33.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 75' ' ' LEU . 3.1 tt -154.02 159.96 41.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 21.9 p -152.17 167.81 27.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -45.89 -29.89 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.147 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.81 22.45 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -155.81 152.69 28.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.613 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.573 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.789 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.523 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 9.5 t-105 -107.8 135.28 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.008 -1.058 . . . . 0.0 110.786 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -78.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.336 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.483 ' O ' ' CZ2' ' A' ' 81' ' ' TRP . . . 174.22 177.92 43.74 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 61.2 t80 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.258 -1.142 . . . . 0.0 110.271 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 7' ' ' GLN . 43.9 Cg_endo -71.15 134.14 24.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.924 1.487 . . . . 0.0 110.814 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 152.5 22.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.969 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 69' ' ' ASP . 39.2 m -121.75 153.67 37.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 110.383 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.831 HG22 HD22 ' A' ' 32' ' ' LEU . 11.3 m -147.2 132.77 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -97.46 99.59 11.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.919 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -81.52 95.04 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.639 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 4.7 tpt180 -91.61 157.59 16.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.572 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.78 120.06 10.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -64.86 -17.44 64.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.893 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -79.69 -0.54 34.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -134.18 -159.17 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.858 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.16 34.2 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.435 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 6.7 p -177.18 -162.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 110.706 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -140.21 -169.15 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.522 -0.736 . . . . 0.0 110.038 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 3.7 t80 -130.41 81.29 2.0 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 110.28 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.27 85.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HD23 ' A' ' 32' ' ' LEU . 2.1 p -107.21 146.6 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -1.14 . . . . 0.0 110.117 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.68 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -124.13 163.63 21.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.002 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.912 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 179.45 135.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -0.863 . . . . 0.0 110.202 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -52.39 -61.69 2.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' CYS . 70.7 m -75.22 93.87 2.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.868 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.752 ' HA ' HD12 ' A' ' 32' ' ' LEU . 21.3 p -40.98 -30.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -38.49 58.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -68.07 -43.16 79.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.751 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.082 HD23 HG13 ' A' ' 24' ' ' VAL . 17.0 mt -53.75 -46.81 71.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.563 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.659 HD11 HD11 ' A' ' 66' ' ' LEU . 27.8 mt -66.87 -67.18 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 109.898 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -43.73 -68.31 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.61 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 5.6 mtpp -46.83 -27.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.87 -55.64 16.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.22 -13.77 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.179 . . . . 0.0 109.714 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.27 -52.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.77 . . . . 0.0 109.997 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -63.83 -29.25 70.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.4 m-30 -99.24 -18.86 17.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 109.503 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER 60.34 85.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 110.699 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.717 ' CG ' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -124.89 92.4 47.74 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.07 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 124.009 1.531 . . . . 0.0 110.153 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 76' ' ' THR . 39.4 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.1 OUTLIER 176.41 167.62 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.49 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 60' ' ' ASP . 0.6 OUTLIER -120.57 170.25 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 109.556 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 56' ' ' THR . 74.1 m -148.36 -178.99 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.477 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -116.1 120.08 37.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.973 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -5.98 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 110.538 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -50.05 -62.59 1.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.471 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -147.53 20.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 110.724 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.546 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 96.33 44.56 2.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -94.88 167.57 11.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 109.985 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.526 ' C ' HG23 ' A' ' 58' ' ' VAL . 9.5 mm-40 -122.03 136.81 54.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.888 HG11 ' CE1' ' A' ' 63' ' ' PHE . 11.7 t -151.73 179.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.621 ' H ' HG12 ' A' ' 58' ' ' VAL . 18.4 p -129.91 164.76 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.553 ' N ' HD13 ' A' ' 49' ' ' LEU . 17.5 p-10 -73.96 1.2 11.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.44 -23.95 7.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 37.4 t -79.96 -41.24 26.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.401 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.933 ' HB3' HD11 ' A' ' 66' ' ' LEU . 12.6 m-85 -40.49 99.78 0.21 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.488 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.9 Cg_endo -80.59 -87.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 110.595 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.8 67.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.933 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.3 mp -44.38 148.16 0.9 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.305 -1.115 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.81 157.58 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.935 1.492 . . . . 0.0 109.976 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.98 146.46 0.81 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.038 -1.039 . . . . 0.0 110.067 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.9 m-20 45.58 36.47 2.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.709 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -42.58 116.45 0.86 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.85 95.45 9.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.0 mp -103.92 162.8 12.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.744 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -136.43 106.5 6.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.551 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 42' ' ' LEU . 17.1 tp -55.3 148.35 14.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.719 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.65 156.57 32.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 47' ' ' SER . 21.5 p -138.83 165.74 26.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 110.359 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 76' ' ' THR . . . -43.76 -32.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.98 27.79 7.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -154.73 155.87 35.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 110.587 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.719 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.1 141.07 16.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.847 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.488 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.1 t-105 -110.69 130.1 55.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.0 110.338 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -72.54 -61.79 1.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.93 . . . . 0.0 110.099 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.7 162.7 10.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 26.3 t80 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.407 -1.055 . . . . 0.0 110.218 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 120.707 0.289 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.4 Cg_endo -73.77 126.3 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 110.314 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -79.61 152.57 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 0.0 110.034 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.896 ' SG ' ' HB2' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -124.36 151.01 44.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.597 HG22 HD13 ' A' ' 32' ' ' LEU . 22.8 m -148.02 141.03 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.73 102.61 15.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.3 tp -78.63 89.52 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.607 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -91.49 154.68 18.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -140.34 113.1 8.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.036 -1.04 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -58.09 -20.8 42.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -81.5 -0.18 40.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -127.1 -160.91 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.98 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.76 28.54 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.347 -0.845 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -179.39 -159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.603 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.38 -176.03 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 110.033 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.7 t80 -133.83 91.13 2.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.97 95.02 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.868 HG13 HD22 ' A' ' 32' ' ' LEU . 4.2 p -101.56 147.14 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -1.083 . . . . 0.0 110.3 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.896 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . . . -128.09 147.74 50.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 110.35 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -169.79 150.84 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 mmt180 -62.0 -55.94 24.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 7.8 p -83.49 96.97 8.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.2 p -41.29 -29.65 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.566 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.8 mm100 -60.34 -23.55 64.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.076 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -74.12 -46.78 40.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HG13 ' A' ' 24' ' ' VAL . 24.3 mt -59.7 -38.25 81.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.976 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 30' ' ' GLN . 18.4 mt -67.16 -54.98 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.859 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -58.74 -65.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.764 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 19.5 mtpp -49.9 -29.37 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.402 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -68.43 -53.04 23.09 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.6 t -57.53 -17.0 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.554 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 34' ' ' ARG . 47.6 t -84.24 -56.3 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.985 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -62.92 -33.54 75.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.7 m-30 -94.13 -13.25 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.88 84.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.698 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -127.34 96.78 32.76 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.0 -1.062 . . . . 0.0 110.257 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 47' ' ' SER . 43.7 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 124.086 1.572 . . . . 0.0 110.332 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.197 0.523 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 175.99 153.74 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.182 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.578 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.1 mt -122.84 160.08 26.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.647 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 56' ' ' THR . 63.7 m -147.78 139.18 23.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 110.348 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -67.32 120.3 13.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.487 -0.758 . . . . 0.0 110.463 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 21.5 t80 -69.54 -12.58 61.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.765 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.06 -41.14 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 110.319 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.58 40.2 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.182 -0.948 . . . . 0.0 110.645 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 57.38 29.75 60.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -74.2 161.08 30.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.249 . . . . 0.0 109.7 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.6 pt-20 -114.75 133.0 56.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.048 -1.032 . . . . 0.0 110.599 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.77 HG11 ' CE1' ' A' ' 63' ' ' PHE . 81.3 t -156.67 173.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.588 ' N ' HG12 ' A' ' 58' ' ' VAL . 24.2 p -122.58 158.81 29.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.1 p-10 -63.16 -16.19 59.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 110.405 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -1.49 31.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.0 t -101.06 -41.46 6.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.875 ' CD1' HD21 ' A' ' 66' ' ' LEU . 35.2 m-85 -39.61 99.27 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.726 . . . . 0.0 110.246 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.5 Cg_endo -73.65 -55.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.008 1.531 . . . . 0.0 110.462 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.6 68.51 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.875 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.5 mp -48.09 160.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.126 . . . . 0.0 109.879 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.12 165.6 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -44.64 150.38 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.248 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.0 m-20 47.43 35.74 4.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -52.22 125.84 17.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.753 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.595 ' C ' HD22 ' A' ' 72' ' ' LEU . 31.5 mp0 -96.25 110.24 22.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.163 -0.96 . . . . 0.0 110.914 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.758 HD21 HD22 ' A' ' 66' ' ' LEU . 2.7 mm? -114.48 141.26 47.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 0.0 109.788 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -115.9 149.25 38.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 0.0 110.416 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.8 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.7 tp -86.98 147.1 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.824 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.3 tt -158.99 157.06 30.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.8 p -152.29 173.21 15.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.59 -36.14 6.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -87.36 23.24 12.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.4 mt-10 -157.65 150.71 23.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.093 -1.239 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.53 133.17 20.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.518 ' NE1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -96.88 125.52 41.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.248 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.418 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 26.4 m80 -67.8 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 110.166 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.5 128.65 1.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.979 179.753 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 120.72 0.295 . . . . 0.0 110.268 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.0 Cg_endo -71.65 137.53 30.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.864 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 169.24 16.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.745 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.445 ' C ' HG13 ' A' ' 11' ' ' VAL . 26.5 m -141.38 152.32 44.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.6 m -148.07 142.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 55.2 mmtt -98.33 92.4 5.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -72.61 84.31 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 110.382 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.729 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -81.59 159.82 23.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.825 . . . . 0.0 109.693 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -141.31 126.64 18.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 110.589 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -68.57 -24.51 64.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.951 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -79.93 5.98 12.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -150.81 148.88 29.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 110.019 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.42 54.94 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 110.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.2 p -173.65 -172.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.25 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.473 -0.767 . . . . 0.0 109.931 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 24' ' ' VAL . 14.2 t80 -147.71 79.0 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.0 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -62.49 81.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.015 HG13 HD22 ' A' ' 32' ' ' LEU . 4.8 p -93.83 144.99 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -1.102 . . . . 0.0 110.728 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -123.68 154.42 39.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 110.059 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -177.12 130.05 0.17 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 ttp180 -45.51 -57.15 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.2 p -82.26 97.18 8.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 31.5 p -41.83 -29.42 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' OE1' ' SG ' ' A' ' 29' ' ' CYS . 1.4 mp0 -56.69 -24.02 46.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -46.2 42.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.373 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.015 HD22 HG13 ' A' ' 24' ' ' VAL . 20.4 mt -61.68 -39.46 91.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.515 HD13 ' HB2' ' A' ' 63' ' ' PHE . 29.1 mt -63.03 -58.78 6.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.053 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 4.4 mmt180 -59.42 -71.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 0.0 109.86 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' ARG . 32.6 mtpt -42.96 -34.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.776 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -63.96 -54.66 29.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.0 t -61.5 -13.5 21.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.15 -1.206 . . . . 0.0 109.872 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.6 -49.98 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.0 109.687 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -25.51 63.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.534 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.1 m-30 -99.63 -18.96 17.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.797 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 60.57 83.23 0.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.739 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -125.06 102.85 30.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.99 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.9 Cg_endo . . . . . 0 C--N 1.303 -1.831 0 O-C-N 123.938 1.494 . . . . 0.0 110.531 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.019 0.438 . . . . 0.0 109.993 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.2 147.05 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.893 -1.129 . . . . 0.0 110.948 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 59' ' ' THR . 1.1 mp -110.09 175.76 5.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.36 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HD23 ' A' ' 73' ' ' LEU . 1.9 p -159.07 146.6 17.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 0.0 110.673 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -71.55 111.51 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 110.121 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.751 ' CD1' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -68.97 -14.54 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -53.05 -44.51 67.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.285 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t70 -136.47 -33.78 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.468 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 131.3 38.59 0.27 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.523 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.3 171.5 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.102 . . . . 0.0 110.018 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.558 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.7 mm-40 -121.24 135.94 55.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 109.73 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.5 t -155.38 168.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.601 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 49' ' ' LEU . 55.0 p -110.14 159.46 17.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 110.12 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.8 p-10 -67.06 -8.01 27.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 110.433 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.32 -17.1 14.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.6 m -84.58 -41.61 16.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.718 ' CE1' HG11 ' A' ' 58' ' ' VAL . 18.6 m-85 -40.0 100.18 0.21 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.401 -0.812 . . . . 0.0 110.57 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -75.84 -89.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.07 1.563 . . . . 0.0 110.36 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -125.98 65.83 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 17.5 mt -42.76 163.37 0.15 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -73.0 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.214 1.639 . . . . 0.0 109.921 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -74.44 150.28 40.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.126 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 70' ' ' ALA . 38.7 m-20 42.75 37.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.86 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -41.03 100.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.63 . . . . 0.0 110.253 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.7 tt0 -71.35 106.07 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.367 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 71' ' ' GLU . 6.0 mp -111.37 166.42 11.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -142.39 138.33 31.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.739 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -80.89 146.23 30.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.82 159.45 36.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.092 -1.005 . . . . 0.0 109.899 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.2 p -150.98 174.08 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.41 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.931 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.28 18.47 57.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -151.49 161.22 43.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -1.145 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.13 142.64 17.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.827 . . . . 0.0 110.166 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.7 t-105 -116.26 133.12 56.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.125 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.28 -80.23 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -168.36 154.19 23.85 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.14 . . . . 0.0 110.28 -179.798 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.809 0.337 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.3 Cg_endo -73.3 123.58 8.84 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.129 1.594 . . . . 0.0 110.953 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 1.9 ttpm? -80.92 155.87 26.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.743 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' ASP . 25.0 t -125.38 151.84 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 24' ' ' VAL . 8.9 m -144.53 149.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -99.31 101.24 12.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -79.27 75.28 5.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.431 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.844 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.8 tpt180 -83.73 157.31 22.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 18' ' ' SER . . . -135.83 122.4 20.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.049 -1.032 . . . . 0.0 110.661 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.011 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.36 -30.6 66.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CA ' ' OE2' ' A' ' 79' ' ' GLU . 61.0 t-80 -79.89 5.76 12.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 110.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 58.0 m -127.18 -163.79 1.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.961 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.14 33.05 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -171.88 -162.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.822 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.95 -164.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.769 . . . . 0.0 109.853 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.0 t80 -156.08 89.56 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.447 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.56 96.1 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 32' ' ' LEU . 2.3 p -105.74 151.83 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 110.43 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.06 161.81 33.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.059 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -178.52 141.91 0.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 0.0 110.478 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.38 -65.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.99 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.3 OUTLIER -79.72 95.03 5.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.846 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 29.5 p -41.44 -28.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.808 . . . . 0.0 110.423 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 13.0 tt0 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 1.2 tp10 -74.41 -46.13 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.385 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 24' ' ' VAL . 22.0 mt -60.97 -36.89 80.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 66' ' ' LEU . 63.8 mt -66.37 -59.89 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.838 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -70.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 24.0 mtpp -45.48 -32.03 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.598 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -61.6 -51.27 58.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.3 t -65.76 -15.78 63.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.696 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 82.5 t -80.53 -46.5 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -32.57 64.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.671 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.516 ' CD2' HD22 ' A' ' 74' ' ' LEU . 2.0 m-30 -90.6 -10.55 42.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.77 82.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.322 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.63 111.26 27.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 110.153 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 47' ' ' SER . 46.7 Cg_endo . . . . . 0 C--N 1.304 -1.779 0 O-C-N 124.015 1.534 . . . . 0.0 110.301 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.143 0.497 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.914 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 178.95 140.03 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 60' ' ' ASP . 2.0 mp -112.1 118.73 36.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.374 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 75' ' ' LEU . 71.6 m -103.34 155.11 18.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.056 -1.028 . . . . 0.0 110.753 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -83.27 124.09 30.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.014 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 73' ' ' LEU . 6.5 t80 -73.93 1.24 11.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.741 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' HD23 ' A' ' 51' ' ' LEU . 1.1 tp10 -59.73 -54.97 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.35 21.19 1.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 87.63 35.9 9.0 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.11 163.15 22.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -1.175 . . . . 0.0 110.013 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' C ' HG23 ' A' ' 58' ' ' VAL . 14.7 pt-20 -116.04 134.81 54.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.054 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.2 t -153.09 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.589 ' H ' HG12 ' A' ' 58' ' ' VAL . 44.5 p -131.48 161.44 32.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.003 -1.061 . . . . 0.0 109.99 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.7 p-10 -72.61 -0.75 13.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 110.579 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -113.0 -11.52 13.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.379 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 3.3 t -98.39 -38.2 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.48 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.105 ' CE1' HD21 ' A' ' 66' ' ' LEU . 6.9 m-85 -39.99 99.48 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.2 Cg_endo -81.35 -67.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.935 1.492 . . . . 0.0 110.349 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -147.97 64.78 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.105 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.7 mt -42.31 163.45 0.13 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 43.5 Cg_endo -71.24 161.98 44.01 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.209 1.636 . . . . 0.0 110.2 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.45 153.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 4.8 m-20 45.02 37.22 2.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -49.54 112.83 0.7 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.406 -0.808 . . . . 0.0 109.864 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 111.64 18.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.574 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 mp -109.22 148.32 31.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.752 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 16' ' ' LEU . 1.1 tp -132.18 126.03 32.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.943 -1.098 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.8 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -67.74 131.24 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 109.929 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.914 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.3 tt -147.77 159.48 43.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 109.656 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.3 p -146.79 -178.03 5.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.94 73.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.14 11.13 58.82 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' OE2' ' CA ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER -141.96 154.16 44.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -1.184 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.576 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -150.59 141.61 23.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -114.51 129.53 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.351 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -66.81 -69.92 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.235 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 131.81 2.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.4 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.191 -1.182 . . . . 0.0 110.477 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.3 Cg_endo -72.0 125.52 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.981 1.517 . . . . 0.0 110.97 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -85.89 153.35 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' ASP . 13.5 t -127.61 158.83 36.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.381 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG2' HG12 ' A' ' 24' ' ' VAL . 5.4 m -149.02 135.87 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -92.89 96.47 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -75.84 82.42 2.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.877 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.5 tpt180 -81.01 160.53 24.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.39 132.31 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 110.519 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.559 HD12 HD21 ' A' ' 73' ' ' LEU . 4.6 mt -74.55 -20.86 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 109.941 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.529 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 21.4 t60 -79.96 3.34 20.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.899 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 165.48 31.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.96 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 53.2 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -174.98 -172.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 111.09 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -145.62 -162.11 1.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.501 -0.749 . . . . 0.0 109.919 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 9.0 t80 -144.86 87.23 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 110.491 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.07 83.47 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.04 HG13 HD22 ' A' ' 32' ' ' LEU . 7.5 p -95.1 152.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -1.158 . . . . 0.0 110.239 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.7 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.57 164.29 26.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.92 133.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mtm180 -50.14 -33.41 18.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' GLN . 3.2 m -107.35 93.74 4.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.898 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 13.9 p -38.77 -28.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.581 -0.699 . . . . 0.0 110.466 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.12 -33.88 72.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.5 tt0 -68.13 -31.33 70.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HG13 ' A' ' 24' ' ' VAL . 30.0 mt -76.38 -34.34 58.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.94 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 63' ' ' PHE . 79.9 mt -66.91 -61.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 tpt180 -53.25 -53.8 45.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtpm? -56.78 -28.25 60.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.341 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -65.46 -51.98 43.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.9 t -67.09 -18.07 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -1.228 . . . . 0.0 109.84 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 34' ' ' ARG . 77.9 t -81.11 -53.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.891 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -66.79 -42.03 86.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.5 m-30 -84.95 -13.22 51.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.558 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.77 80.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.437 -0.789 . . . . 0.0 110.281 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -111.5 105.13 56.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 124.048 1.552 . . . . 0.0 110.495 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.211 0.529 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.57 142.55 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.925 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.604 HD21 HD12 ' A' ' 74' ' ' LEU . 3.5 mt -108.72 162.49 14.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.594 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.3 p -149.78 162.59 39.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.614 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.36 115.7 27.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -70.19 -5.96 31.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.376 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.64 -54.26 47.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.5 8.56 3.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 91.5 29.0 12.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.544 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -74.66 176.65 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 109.888 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' HG23 ' A' ' 58' ' ' VAL . 12.2 mt-10 -126.83 137.06 53.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 110.733 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.0 t -155.77 174.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.578 ' N ' HG12 ' A' ' 58' ' ' VAL . 43.3 p -122.92 165.22 17.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 110.261 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 p-10 -69.79 -4.1 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.892 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.87 -8.12 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.315 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.7 m -105.07 18.69 21.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.197 -0.939 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.877 ' CD1' HD11 ' A' ' 66' ' ' LEU . 10.9 m-85 -100.87 98.58 8.68 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -72.98 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -127.45 66.54 0.56 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.877 HD11 ' CD1' ' A' ' 63' ' ' PHE . 16.1 mt -41.44 162.98 0.12 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.311 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.1 Cg_endo -70.75 154.89 63.57 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.232 1.649 . . . . 0.0 109.854 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.3 t-20 -41.91 143.99 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 10' ' ' CYS . 2.6 m-20 54.38 36.18 24.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.713 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.81 111.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.586 -0.696 . . . . 0.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 98.23 5.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 mp -108.34 156.03 19.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.911 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.877 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -139.11 123.99 18.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.834 HD11 HD23 ' A' ' 42' ' ' LEU . 11.5 tp -67.77 138.45 56.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 110.184 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.7 OUTLIER -148.76 157.67 43.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.47 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -148.02 176.8 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.25 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.46 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.42 15.03 52.87 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 2.4 mt-10 -143.42 145.88 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -1.13 . . . . 0.0 110.513 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.722 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.77 157.77 43.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.822 . . . . 0.0 109.812 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.536 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.7 t-105 -129.73 126.69 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.459 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -59.28 3.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.391 -0.818 . . . . 0.0 110.11 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.46 161.34 8.69 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 45.6 t80 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 110.144 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 4.9 pt20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -73.16 125.73 10.54 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.945 1.497 . . . . 0.0 110.794 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -80.92 171.4 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.917 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ASP . 44.5 m -138.68 151.16 46.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' VAL . 5.5 m -146.32 129.51 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 13.7 mmmt -85.65 96.69 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -75.76 87.21 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 110.698 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.884 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -81.99 154.83 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.705 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -143.43 117.23 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.818 HD12 HD21 ' A' ' 73' ' ' LEU . 1.5 mt -60.81 -27.44 68.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.201 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -83.1 10.77 7.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.13 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -128.19 -161.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.82 14.17 15.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.399 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 -155.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -130.36 176.0 8.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 110.301 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 24' ' ' VAL . 19.2 t80 -120.19 84.93 2.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.82 85.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 32' ' ' LEU . 7.0 p -96.3 148.4 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -1.096 . . . . 0.0 110.41 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.574 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -130.25 151.09 51.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.854 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.93 142.35 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 110.468 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -47.03 -66.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 110.008 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.9 OUTLIER -81.59 96.24 7.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 24.7 p -41.94 -31.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.707 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -54.79 -29.24 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 4.0 tp10 -72.79 -35.43 67.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.501 -0.749 . . . . 0.0 109.817 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 24' ' ' VAL . 18.1 mt -69.1 -32.84 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.718 HD22 ' CB ' ' A' ' 63' ' ' PHE . 42.3 mt -67.98 -53.41 26.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.0 mmt180 -61.29 -61.8 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.826 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 11.2 mtpt -53.79 -27.95 32.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.61 -44.07 95.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 20.7 t -73.81 -20.65 60.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -1.199 . . . . 0.0 110.169 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 34' ' ' ARG . 55.0 t -70.94 -49.3 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -75.72 -26.92 57.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 74' ' ' LEU . 2.5 m-30 -92.76 -3.72 54.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 78.3 mm-40 46.32 72.18 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -115.45 105.34 52.31 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 110.466 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 47' ' ' SER . 40.9 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.862 1.454 . . . . 0.0 110.281 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.45 0.643 . . . . 0.0 110.67 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.892 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -178.01 137.04 0.18 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.672 HD21 HD12 ' A' ' 74' ' ' LEU . 3.4 mt -109.63 163.88 13.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.719 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 73' ' ' LEU . 7.2 p -154.97 136.95 14.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.947 . . . . 0.0 110.368 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.3 112.22 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.75 -17.84 38.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.274 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.67 -53.54 30.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.178 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.13 23.17 2.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.54 26.38 71.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.562 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -67.8 165.43 17.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -1.221 . . . . 0.0 109.791 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 11.4 pm0 -113.88 135.56 53.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.003 -1.061 . . . . 0.0 110.96 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 ' CE1' ' A' ' 63' ' ' PHE . 98.7 t -157.53 173.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.685 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' VAL . 58.0 p -128.45 158.83 37.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 52.3 p30 -62.2 -11.47 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.7 t0 -107.63 4.45 25.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 37.7 t -112.21 -40.24 4.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.176 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CD1' HD11 ' A' ' 66' ' ' LEU . 44.6 m-85 -40.04 99.95 0.21 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -74.41 -90.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.005 1.529 . . . . 0.0 110.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.73 66.27 0.57 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.2 mt -44.62 163.73 0.18 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.31 -1.112 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.26 -174.34 1.76 Allowed 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.173 1.617 . . . . 0.0 109.847 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 69' ' ' ASP . 33.6 p30 -63.79 154.05 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 110.039 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.5 m-20 42.65 38.79 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.855 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.34 112.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.493 -0.755 . . . . 0.0 109.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 72' ' ' LEU . 4.2 mm-40 -81.76 103.59 11.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 66' ' ' LEU . 8.7 mp -114.86 156.63 24.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.32 -0.863 . . . . 0.0 110.106 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -133.21 125.89 30.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.476 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.823 ' CG ' HD23 ' A' ' 42' ' ' LEU . 12.3 tp -71.79 133.66 45.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.465 -0.772 . . . . 0.0 109.949 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.5 tt -147.47 160.82 42.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.134 -0.979 . . . . 0.0 109.547 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 75' ' ' LEU . 4.6 p -148.83 173.11 13.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 109.96 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.47 -24.34 7.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.959 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.98 16.52 60.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -150.72 156.59 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -1.081 . . . . 0.0 110.242 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.27 153.84 39.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.224 -0.923 . . . . 0.0 110.401 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.494 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.3 t-105 -130.9 116.95 18.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.347 -0.845 . . . . 0.0 110.254 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -63.47 -72.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.058 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.42 167.01 19.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 12.9 t80 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.183 -1.186 . . . . 0.0 110.349 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 43.9 Cg_endo -71.88 124.15 9.91 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.98 1.516 . . . . 0.0 110.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 158.71 23.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.699 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.8 t -127.85 151.64 48.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.0 m -140.06 152.7 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.977 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HE3' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mmtt -110.32 99.28 8.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -82.23 88.79 6.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.975 . . . . 0.0 110.689 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 2.4 tpt180 -95.4 157.31 15.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.03 139.27 44.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD21 ' A' ' 73' ' ' LEU . 1.6 mt -76.26 -21.14 56.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -79.38 -2.04 39.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -155.79 138.13 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.94 53.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.19 167.36 29.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 110.606 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.88 162.32 40.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.512 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 8.4 t80 -115.66 87.74 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.93 95.57 0.28 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HD23 ' A' ' 32' ' ' LEU . 6.0 p -108.68 154.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -1.193 . . . . 0.0 110.903 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -124.8 166.44 16.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.63 147.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.5 mtm180 -66.86 -53.99 26.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 110.033 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' CYS . 73.9 m -83.82 97.14 9.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.913 ' HA ' HD12 ' A' ' 32' ' ' LEU . 7.2 p -41.65 -30.55 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.105 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -54.87 -27.49 43.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.17 -44.03 39.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.978 HD23 HG13 ' A' ' 24' ' ' VAL . 11.5 mt -57.34 -42.36 81.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 63' ' ' PHE . 68.2 mt -67.21 -59.83 3.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.652 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.1 mpp_? -54.03 -70.48 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 27.8 mtpt -47.29 -24.59 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -73.48 -53.44 7.5 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.3 t -66.64 -11.87 55.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -1.107 . . . . 0.0 109.748 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 34' ' ' ARG . 97.5 t -82.5 -69.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.967 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -51.77 -31.89 28.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.685 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-85 -89.82 -17.95 27.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.58 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 5.5 mt-30 56.56 80.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.998 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -118.2 105.33 46.93 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 110.175 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 123.968 1.51 . . . . 0.0 110.212 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.173 0.511 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER 179.01 146.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 110.595 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mt -116.35 170.7 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.257 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.2 p -160.21 131.24 5.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.85 -1.156 . . . . 0.0 111.137 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -53.63 133.4 41.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.772 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 25.1 t80 -92.45 -13.26 30.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 110.37 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -53.7 -24.86 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 1.6 t0 -156.46 -43.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.652 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.53 54.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.59 160.88 14.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.964 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.3 pp20? -111.16 130.74 55.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.3 t -148.8 172.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.573 ' N ' HG12 ' A' ' 58' ' ' VAL . 35.3 p -115.16 158.44 22.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p-10 -70.47 -13.36 62.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -102.44 6.24 40.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 42.3 t -112.33 -36.99 5.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.686 ' CD1' HD11 ' A' ' 66' ' ' LEU . 25.6 m-85 -40.59 100.62 0.22 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.461 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -75.38 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.105 1.582 . . . . 0.0 110.275 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.32 69.29 0.52 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 63' ' ' PHE . 17.7 mt -50.37 161.76 0.58 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.209 -1.171 . . . . 0.0 110.051 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.59 167.27 26.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -45.75 153.02 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 110.103 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 27.1 m-20 43.89 37.37 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.2 117.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.761 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -82.88 107.69 15.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 110.501 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 63' ' ' PHE . 1.3 mp -118.25 137.64 52.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.805 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.68 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -115.87 131.7 56.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.926 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.998 HD11 HD23 ' A' ' 42' ' ' LEU . 11.7 tp -77.12 139.74 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -155.07 163.71 39.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.67 ' N ' HD23 ' A' ' 75' ' ' LEU . 20.2 p -147.79 168.25 22.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.09 -25.44 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.74 15.42 61.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 0.4 OUTLIER -151.96 151.65 31.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 110.344 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.782 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.91 144.26 30.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.103 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.495 ' HB2' HD12 ' A' ' 16' ' ' LEU . 9.6 t-105 -110.95 135.87 50.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -79.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 166.95 147.17 5.14 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -72.49 123.06 8.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.824 1.434 . . . . 0.0 110.183 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.69 139.91 37.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.7 t -108.1 149.06 28.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.12 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 24' ' ' VAL . 30.2 m -143.95 126.13 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -83.51 97.4 8.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -78.04 79.35 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.554 ' HG3' HD12 ' A' ' 73' ' ' LEU . 5.1 tpt180 -80.56 160.36 25.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.835 . . . . 0.0 109.705 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.93 116.93 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.041 -1.037 . . . . 0.0 110.709 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.92 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -69.28 -19.77 63.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 2.05 24.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.9 -161.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.38 39.86 3.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.9 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.9 p -173.41 -161.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 13.7 ptpt -150.61 -162.03 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 0.0 109.981 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -151.89 90.61 1.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.08 89.89 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.027 ' CG1' HD22 ' A' ' 32' ' ' LEU . 3.7 p -97.97 144.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -1.205 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -128.21 148.32 50.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -172.2 154.09 3.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mtm180 -63.04 -59.3 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.456 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -84.92 96.2 9.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -42.32 -34.14 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.42 -30.87 42.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.404 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -74.19 -32.87 63.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.503 -0.748 . . . . 0.0 109.779 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.027 HD22 ' CG1' ' A' ' 24' ' ' VAL . 14.8 mt -75.8 -37.52 59.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.11 -60.65 2.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.93 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -55.39 -58.58 7.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.765 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -51.33 -32.93 27.09 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.405 -0.81 . . . . 0.0 109.355 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.17 -51.94 53.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -61.36 -19.38 61.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.178 . . . . 0.0 109.864 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ARG . 89.1 t -78.96 -48.08 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -76.43 -33.14 58.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.058 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -89.7 -12.45 39.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -0.882 . . . . 0.0 109.616 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.04 82.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 110.424 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.93 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.31 108.76 37.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.374 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.2 Cg_endo . . . . . 0 C--N 1.305 -1.711 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.53 ' OG ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.168 0.509 . . . . 0.0 110.15 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.8 116.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 110.318 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.85 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.2 mt -99.62 111.26 23.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.3 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 73' ' ' LEU . 26.4 p -96.33 168.51 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.947 . . . . 0.0 110.768 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -98.43 116.66 31.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.552 -0.718 . . . . 0.0 110.173 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' CB ' ' OE1' ' A' ' 71' ' ' GLU . 15.3 t80 -62.26 -14.41 38.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -56.49 15.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.28 42.98 1.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.495 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.44 33.9 78.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -76.81 164.22 26.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.103 -1.233 . . . . 0.0 109.619 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.534 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.9 pt-20 -116.94 131.89 56.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.97 -1.081 . . . . 0.0 110.241 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.003 HG11 ' CE1' ' A' ' 63' ' ' PHE . 25.9 t -151.04 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.478 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.564 ' N ' HG12 ' A' ' 58' ' ' VAL . 19.3 p -130.71 165.09 23.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.471 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 10.7 p-10 -70.95 -11.86 61.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.603 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.24 -2.42 20.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.052 -1.03 . . . . 0.0 110.524 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 47.9 t -103.01 -39.55 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE1' HG11 ' A' ' 58' ' ' VAL . 16.4 m-85 -40.46 100.0 0.21 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 110.59 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.5 Cg_endo -81.9 -79.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.027 1.541 . . . . 0.0 110.491 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.79 70.91 0.51 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.997 HD11 ' CD1' ' A' ' 63' ' ' PHE . 5.5 mt -51.93 161.55 0.92 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.334 -1.098 . . . . 0.0 110.473 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.42 178.85 6.13 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.19 1.626 . . . . 0.0 109.996 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 69' ' ' ASP . 28.5 t-20 -59.82 150.27 28.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.205 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 44.35 39.03 2.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 109.723 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -40.81 109.62 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.564 -0.71 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -78.7 95.29 5.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 3.0 mp -103.96 152.92 21.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.92 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -132.65 124.76 28.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.446 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.93 HD11 HD23 ' A' ' 42' ' ' LEU . 11.6 tp -72.67 121.84 20.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.539 -0.726 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.715 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -138.69 157.45 46.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.516 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 10.6 p -135.68 179.86 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.56 63.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.75 17.35 50.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -147.23 162.64 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -1.186 . . . . 0.0 110.514 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -154.71 141.61 19.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' A' ' 82' ' ' HIS . 2.8 t-105 -115.7 125.44 52.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.449 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 3.7 t60 -62.18 -60.14 4.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' HA2' ' CE2' ' A' ' 81' ' ' TRP . . . 130.67 143.52 5.33 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.851 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 29.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.246 0.546 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 0.5 OUTLIER 66.02 -172.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 179.87 63.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 4' ' ' VAL . 3.7 m -64.13 150.15 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.22 98.29 8.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 2.8 mmt180 -87.47 48.29 1.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.817 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 6.3 pt20 172.73 113.57 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.038 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.5 139.7 28.89 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.905 1.476 . . . . 0.0 110.44 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 2.0 ttpt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.1 t -118.05 148.55 42.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.545 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 11' ' ' VAL . 22.4 m -142.37 127.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.922 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 4.0 mmpt? -82.7 107.54 15.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.976 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -88.46 86.2 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.383 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.724 ' HG3' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -86.94 157.46 19.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.42 128.87 30.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.048 -1.032 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt -72.54 -26.87 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.808 . . . . 0.0 109.716 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 48.7 t-80 -85.14 13.52 6.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.408 -0.807 . . . . 0.0 109.995 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 -160.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.377 -0.827 . . . . 0.0 109.998 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . -129.54 35.88 4.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 4.8 p 174.69 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -168.07 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.0 109.9 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 2.1 t80 -143.96 90.81 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HE2' ' A' ' 12' ' ' LYS . . . -64.61 91.72 0.11 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.863 HG13 HD23 ' A' ' 32' ' ' LEU . 3.1 p -99.41 134.51 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -1.154 . . . . 0.0 110.126 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.736 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.46 149.51 40.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -168.48 145.08 3.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -59.03 -58.56 8.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.066 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 m -80.27 98.07 7.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -0.864 . . . . 0.0 109.93 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.056 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -40.56 -29.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -0.787 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' SER . 31.9 tt0 -60.14 -28.98 68.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.4 -45.01 66.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.802 . . . . 0.0 109.845 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.056 HD12 ' HA ' ' A' ' 29' ' ' CYS . 4.8 mt -57.8 -43.43 85.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 110.001 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 63' ' ' PHE . 2.6 mt -61.85 -65.92 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' NH1' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -43.61 -69.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -47.24 -27.36 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.49 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.42 -55.37 12.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.57 -11.64 17.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 0.0 110.032 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 34' ' ' ARG . 74.7 t -85.33 -71.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -23.51 5.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.347 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 m-85 -102.99 -16.57 15.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 54.01 85.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.86 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -129.08 99.95 21.21 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo -73.45 154.05 50.31 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.558 . . . . 0.0 110.171 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.553 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.89 -51.29 65.32 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.457 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 44' ' ' MET . 47.2 Cg_endo -76.61 157.03 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.886 1.466 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 44.06 44.71 7.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -167.98 178.0 5.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.136 . . . . 0.0 110.007 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 172.75 148.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 74' ' ' LEU . 2.1 mt -118.22 168.85 10.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.1 p -154.97 139.65 17.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 110.848 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -68.08 127.01 31.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 110.292 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -80.85 1.3 31.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' HD23 ' A' ' 51' ' ' LEU . 3.0 tt0 -59.35 -46.38 88.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.0 15.52 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.552 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 94.02 28.97 10.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.06 164.64 25.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -1.222 . . . . 0.0 109.402 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.557 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.2 mt-10 -121.46 130.67 53.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.929 -1.107 . . . . 0.0 110.497 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.912 HG11 ' CE1' ' A' ' 63' ' ' PHE . 57.3 t -153.1 173.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 36.9 p -123.35 164.95 17.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 33' ' ' LEU . 3.0 p30 -67.61 -12.17 59.81 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.325 -0.859 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -105.35 -5.41 20.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.3 t -107.42 17.2 23.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.168 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.912 ' CE1' HG11 ' A' ' 58' ' ' VAL . 6.6 m-85 -100.99 96.54 5.8 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.392 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.5 Cg_endo -72.13 -91.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.782 1.411 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -112.48 68.63 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.832 HD22 ' HB1' ' A' ' 70' ' ' ALA . 1.5 mt -42.84 152.76 0.35 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 0.0 110.343 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.44 164.51 32.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.986 1.519 . . . . 0.0 110.132 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -49.13 148.94 2.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER 43.12 37.33 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.721 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.832 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -42.86 127.6 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 110.035 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 108.72 19.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 72' ' ' LEU . 1.2 mp -117.85 145.41 44.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.724 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -128.58 137.25 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.455 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.86 HD11 HD23 ' A' ' 42' ' ' LEU . 9.9 tp -77.4 138.94 39.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.881 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.6 tt -156.0 162.33 40.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.642 ' N ' HD23 ' A' ' 75' ' ' LEU . 71.2 p -153.99 171.92 18.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.718 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.57 -25.48 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 23.35 34.13 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 17' ' ' HIS . 2.2 mt-10 -156.36 162.66 40.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -1.165 . . . . 0.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.608 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.16 151.31 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.647 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.456 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 7.5 t-105 -124.23 126.32 45.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.878 . . . . 0.0 109.791 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.82 -71.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 163.65 175.85 34.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 5.5 t80 -114.2 53.21 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.4 -1.059 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 86' ' ' SER . 2.9 t -120.56 179.1 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 0.0 110.3 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.579 ' H ' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -114.17 59.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.329 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.202 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 1.9 ttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.364 0.602 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 171.25 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.034 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.9 78.81 0.84 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.3 126.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.168 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -132.54 135.86 46.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 15.2 mmt-85 -100.43 46.51 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 10.1 pt20 178.4 114.68 0.18 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.888 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.2 Cg_endo -72.69 120.82 6.91 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.937 1.493 . . . . 0.0 111.107 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -84.36 -166.02 1.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.684 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.8 t -153.23 154.53 34.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.981 HG22 HD22 ' A' ' 32' ' ' LEU . 32.8 m -147.04 146.26 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -107.01 96.76 6.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.742 HD23 ' CG ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -77.82 90.98 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.7 tpt180 -91.73 152.8 20.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.015 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -137.94 131.81 31.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.1 -28.15 64.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.782 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -79.83 3.05 20.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.983 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 t -123.97 -163.04 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 110.048 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.83 33.2 5.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 110.107 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 172.95 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.747 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.04 166.7 23.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.752 . . . . 0.0 109.87 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 6.3 t80 -112.48 97.74 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 110.459 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.404 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -71.81 98.5 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -115.5 150.75 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -1.175 . . . . 0.0 110.569 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -125.65 167.0 15.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 110.229 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -179.75 150.1 0.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.642 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mmm180 -62.79 -57.33 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.11 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.8 m -82.99 95.99 8.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.368 -0.833 . . . . 0.0 110.01 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.978 ' HA ' HD12 ' A' ' 32' ' ' LEU . 28.2 p -41.61 -28.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -55.55 -38.59 69.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.837 . . . . 0.0 109.741 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.6 tp10 -63.46 -43.95 95.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.025 HD23 HG13 ' A' ' 24' ' ' VAL . 8.4 mt -55.24 -47.62 75.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.87 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 63' ' ' PHE . 15.8 mt -63.29 -64.48 0.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.882 . . . . 0.0 109.938 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 tpp85 -47.75 -68.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.907 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -44.93 -30.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.541 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.02 -55.36 24.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.4 t -60.17 -14.36 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.865 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 34' ' ' ARG . 57.4 t -84.83 -60.35 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.377 -0.827 . . . . 0.0 110.28 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -25.32 68.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 110.339 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.742 ' CG ' HD23 ' A' ' 13' ' ' LEU . 3.1 m-85 -101.45 -17.49 16.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.86 84.22 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -123.94 105.72 31.95 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.874 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo -73.52 145.05 37.02 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.008 1.531 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.54 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -56.43 -50.49 87.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 110.116 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' MET . 49.1 Cg_endo -79.54 158.0 25.34 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.1 1.579 . . . . 0.0 110.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 44.34 51.81 7.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -172.38 174.99 3.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.136 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.3 mtt85 -179.25 117.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 74' ' ' LEU . 13.0 mt -89.57 101.45 14.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.34 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' THR . 94.3 m -89.61 178.88 6.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 111.006 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.4 131.11 55.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.445 -0.784 . . . . 0.0 110.081 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.559 ' CD1' HD13 ' A' ' 73' ' ' LEU . 2.1 t80 -80.74 2.55 25.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.792 . . . . 0.0 110.495 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 4.5 tt0 -66.28 -59.5 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -141.54 22.39 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.333 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.544 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 83.68 48.79 5.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.33 166.2 12.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -1.183 . . . . 0.0 109.715 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -118.98 126.84 52.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.058 . . . . 0.0 110.544 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 10.3 t -144.67 179.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.626 ' H ' HG12 ' A' ' 58' ' ' VAL . 20.4 p -138.88 158.5 44.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.553 ' HB3' HD12 ' A' ' 49' ' ' LEU . 4.1 p30 -61.96 -11.49 13.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 110.26 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -106.67 -5.74 18.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 t -98.18 -48.62 5.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.441 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.169 ' CE1' HD21 ' A' ' 66' ' ' LEU . 10.1 m-85 -41.17 100.53 0.22 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 110.493 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.7 Cg_endo -79.47 -48.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.036 1.545 . . . . 0.0 110.431 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.86 69.55 0.18 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.169 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.7 mt -48.33 161.39 0.38 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 44.0 Cg_endo -72.13 -167.31 0.31 Allowed 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 124.097 1.578 . . . . 0.0 110.116 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 44.9 t30 -70.02 144.57 52.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' CYS . 54.6 t0 56.88 33.98 24.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.982 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -45.46 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.57 -0.706 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' LEU . 1.2 tt0 -78.16 111.02 13.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 71' ' ' GLU . 7.4 mp -115.06 162.79 16.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 109.99 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.89 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -136.98 122.11 19.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.416 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 49' ' ' LEU . 8.5 tp -68.3 115.55 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.803 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -132.63 159.03 40.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 7.6 p -149.05 171.49 16.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 110.158 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.34 -25.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.848 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.25 14.73 62.9 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' OE1' ' CB ' ' A' ' 16' ' ' LEU . 2.9 mt-10 -153.6 144.42 22.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.73 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -135.68 131.13 35.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.485 ' CZ2' ' O ' ' A' ' 83' ' ' GLY . 5.7 t-105 -101.85 130.68 48.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -43.75 18.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 110.429 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 131.7 -172.34 20.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 26.8 t80 -118.7 62.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.139 . . . . 0.0 110.27 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.32 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 110.424 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.7 m -112.85 56.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 0.0 110.05 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.215 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.9 mtt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.286 0.565 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 169.98 149.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.37 56.21 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.3 151.51 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 83.0 mt -71.34 114.13 9.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.922 . . . . 0.0 110.436 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 6.8 mtt-85 -94.04 40.37 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.945 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 3.2 pt20 171.58 132.74 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.013 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.7 Cg_endo -74.37 133.52 17.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.882 1.464 . . . . 0.0 110.495 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.49 166.29 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' C ' HG13 ' A' ' 11' ' ' VAL . 27.8 m -139.19 155.32 47.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 HD22 ' A' ' 32' ' ' LEU . 22.3 m -150.32 131.71 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.2 mmtt -89.3 85.34 6.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.938 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.491 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.1 tp -65.29 85.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.842 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.972 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.0 tpt180 -82.52 153.05 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 109.42 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.0 133.02 37.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.411 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 2.8 mt -80.81 -16.58 53.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.518 ' CE1' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -82.34 -0.87 47.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 110.133 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -129.98 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.78 34.85 5.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.93 -160.63 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -138.29 -160.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.243 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.6 t80 -149.59 84.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -67.26 93.58 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.905 HG13 HD23 ' A' ' 32' ' ' LEU . 1.3 p -107.59 151.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -1.106 . . . . 0.0 110.171 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.449 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -125.33 153.05 43.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.51 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.974 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -167.09 132.93 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.2 mmt180 -48.42 -62.29 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.107 -0.996 . . . . 0.0 110.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -76.07 96.48 3.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.017 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -42.07 -33.32 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -32.06 58.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.536 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -72.4 -39.23 68.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.83 . . . . 0.0 109.404 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.012 HD22 HG22 ' A' ' 11' ' ' VAL . 15.9 mt -56.25 -45.36 80.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.764 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 63' ' ' PHE . 23.6 mt -65.87 -64.69 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -46.33 -70.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.937 . . . . 0.0 109.827 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 9.0 mtpt -48.95 -22.97 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.979 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.37 -45.71 45.84 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 15.5 t -76.06 -15.71 60.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -1.129 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 34' ' ' ARG . 18.8 t -79.47 -50.17 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.795 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.11 -39.36 78.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-30 -83.24 -15.22 51.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 57.41 80.3 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -120.62 110.23 35.61 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.361 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.07 167.28 27.58 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.039 1.547 . . . . 0.0 110.335 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.28 -48.53 0.59 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.557 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.6 Cg_endo -80.97 136.04 10.22 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.813 1.428 . . . . 0.0 110.741 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.48 76.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -141.61 178.23 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -1.16 . . . . 0.0 110.05 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 175.99 141.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.093 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 2.5 mt -109.13 166.71 10.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.976 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.4 m -150.14 169.17 21.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 110.41 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.6 129.33 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.404 -0.81 . . . . 0.0 110.16 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -80.57 -8.68 59.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 51' ' ' LEU . 7.5 tt0 -58.29 -48.62 79.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.9 10.87 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 88.08 46.33 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.19 171.89 9.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -1.208 . . . . 0.0 109.709 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.1 pt-20 -118.43 129.02 55.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.058 -1.026 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.4 t -152.71 176.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 7.3 p -126.37 172.52 10.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 110.214 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 18.7 p-10 -81.61 -4.39 55.99 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.238 -0.913 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.64 0.85 14.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.125 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.9 t -107.43 -40.15 5.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.074 ' CD1' HD11 ' A' ' 66' ' ' LEU . 4.8 m-85 -42.26 101.64 0.25 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 43.6 Cg_endo -72.41 -63.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.057 1.556 . . . . 0.0 111.063 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.68 62.47 0.34 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.074 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.3 mt -44.86 164.46 0.18 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -1.187 . . . . 0.0 110.071 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_endo -69.53 -168.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.16 1.61 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 69' ' ' ASP . 59.7 t30 -68.53 152.33 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.17 -0.956 . . . . 0.0 110.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 10' ' ' CYS . 1.1 m-20 44.04 37.26 1.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.461 -0.774 . . . . 0.0 110.13 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -48.76 106.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.0 109.492 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 27.6 mt-10 -72.97 105.62 4.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.917 . . . . 0.0 110.837 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.652 HD11 HD13 ' A' ' 66' ' ' LEU . 3.2 mp -100.94 169.85 8.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.972 HD12 ' HG3' ' A' ' 14' ' ' ARG . 2.5 tp -143.05 137.45 29.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.911 -1.118 . . . . 0.0 110.916 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.776 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -85.61 130.1 34.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.82 . . . . 0.0 109.687 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.671 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.2 tt -146.41 158.07 43.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.987 -1.07 . . . . 0.0 109.924 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -150.67 171.06 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.67 -29.87 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.054 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.16 14.9 59.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -147.75 159.68 43.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 110.49 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.671 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.91 139.71 13.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.448 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 8.0 t-105 -111.56 133.72 53.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.22 -59.52 2.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.06 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 141.12 163.29 9.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.58 88.89 6.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.46 -169.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m 50.92 53.42 13.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 110.183 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.255 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 146.34 15.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 110.339 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.98 70.12 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 110.186 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -93.74 112.18 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -162.4 119.72 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 6.1 mmt-85 -94.45 41.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 1.8 pt20 173.52 120.99 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.51 -0.744 . . . . 0.0 109.996 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.7 Cg_endo -73.22 138.54 27.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.844 1.444 . . . . 0.0 110.659 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.12 138.9 31.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASP . 98.2 m -115.18 149.42 37.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.424 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.693 HG22 HD22 ' A' ' 32' ' ' LEU . 10.9 m -143.28 146.87 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 10.5 mmtp -105.12 92.18 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.47 97.85 2.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.757 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.734 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.7 tpt180 -94.95 155.74 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.78 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -139.87 121.48 15.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.849 -1.157 . . . . 0.0 110.821 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.01 HD12 HD21 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -65.32 -21.34 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.158 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' CG ' ' OE2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -79.53 0.83 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.5 -162.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.0 27.88 7.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 7.7 p -170.76 -161.55 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.627 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -169.11 2.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.511 -0.743 . . . . 0.0 109.707 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.7 t80 -135.81 85.89 2.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -64.86 94.49 0.17 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.011 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -110.58 140.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -1.095 . . . . 0.0 110.424 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -109.65 162.42 14.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.306 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.895 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 178.38 134.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.88 -58.39 8.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 t -80.26 98.83 7.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.941 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.107 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.7 p -41.85 -28.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.397 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 29.3 mt-30 -57.85 -29.62 65.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -41.42 64.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.825 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.107 HD12 ' HA ' ' A' ' 29' ' ' CYS . 7.3 mt -58.14 -43.08 87.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.776 . . . . 0.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 63' ' ' PHE . 14.9 mt -65.6 -66.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.84 -69.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.782 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -47.71 -25.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.43 -0.794 . . . . 0.0 109.504 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.78 -51.81 28.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.2 t -66.5 -14.12 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.101 -1.235 . . . . 0.0 109.816 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 34' ' ' ARG . 48.3 t -84.99 -56.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -64.38 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.994 -1.066 . . . . 0.0 110.106 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.78 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 3.3 m-85 -103.17 -13.61 16.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 80.7 mm-40 56.46 88.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.117 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.71 93.4 44.48 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.187 -0.946 . . . . 0.0 109.879 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 49.7 Cg_endo -73.0 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.02 1.537 . . . . 0.0 110.038 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 38.4 ttp -120.72 43.82 0.65 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.069 -1.019 . . . . 0.0 111.222 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' MET . 52.6 Cg_endo -77.08 -2.36 12.59 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.49 1.258 . . . . 0.0 109.791 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.14 2.66 10.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -61.07 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -1.127 . . . . 0.0 110.353 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 1.2 mtt180 175.99 158.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.215 -0.928 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 74' ' ' LEU . 2.0 mp -115.09 168.06 10.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.909 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' THR . 54.2 m -153.11 147.13 25.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 110.379 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -69.69 127.18 32.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.804 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -74.56 0.64 14.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.425 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -61.23 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.08 -1.013 . . . . 0.0 110.2 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.61 22.79 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.55 45.09 38.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.564 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.7 167.9 14.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 109.612 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.8 pt-20 -113.12 131.69 55.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.933 -1.104 . . . . 0.0 111.175 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.899 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.4 t -157.02 173.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.563 -0.711 . . . . 0.0 109.52 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' N ' HG12 ' A' ' 58' ' ' VAL . 39.9 p -131.83 160.41 35.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.057 -1.027 . . . . 0.0 110.605 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 33' ' ' LEU . 2.5 p30 -62.18 -10.96 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.02 -7.29 20.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 110.55 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -98.05 -42.31 7.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 0.0 110.411 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.899 ' CE1' HG11 ' A' ' 58' ' ' VAL . 45.8 m-85 -41.7 101.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 110.63 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -76.14 -87.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.93 74.11 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.881 HD11 ' CD1' ' A' ' 63' ' ' PHE . 58.7 mt -58.58 160.18 10.71 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.175 -1.191 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.34 -161.36 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 109.799 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.33 150.47 36.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 10' ' ' CYS . 17.0 m-20 47.52 37.29 6.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -44.06 96.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 109.928 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -62.46 98.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.718 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.664 HD21 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -111.87 161.66 16.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 110.17 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.81 133.13 31.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 110.434 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.117 HD11 HD23 ' A' ' 42' ' ' LEU . 9.8 tp -86.86 143.34 27.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.998 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -151.88 158.55 43.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.644 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 70.4 p -139.7 168.76 19.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.38 -22.24 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.07 21.76 40.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 75' ' ' LEU . 3.5 mt-10 -160.59 141.3 11.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 110.594 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -135.26 146.96 49.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.818 . . . . 0.0 109.834 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.56 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.5 t-105 -116.29 130.26 56.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 110.291 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.68 -75.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -178.26 166.15 35.96 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 85' ' ' VAL . 5.0 t80 -118.16 142.82 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -1.093 . . . . 0.0 110.168 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 33.2 m -80.33 167.04 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 t -99.44 63.26 1.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.128 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.262 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.7 tpt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.221 0.534 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER 170.92 175.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.264 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 2' ' ' CYS . . . 67.31 83.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 4' ' ' VAL . 5.5 p -137.29 79.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -109.7 93.78 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 110.316 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -84.67 44.98 1.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tt0 179.39 105.32 0.16 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.587 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.2 Cg_endo -71.66 132.79 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.999 1.526 . . . . 0.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -83.13 148.11 27.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.81 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 t -116.77 144.7 44.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 32' ' ' LEU . 3.8 m -139.44 144.54 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.7 mmmm -99.0 91.3 4.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.976 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.85 87.44 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.576 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.717 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -90.86 159.4 16.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.735 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -149.61 130.67 14.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.05 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -84.41 -14.54 49.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.891 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.96 -4.0 53.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 110.022 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -143.93 25.42 1.6 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 0.0 110.413 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 29.4 53.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 120.966 0.412 . . . . 0.0 111.6 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -163.53 172.78 13.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.985 -1.072 . . . . 0.0 110.603 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.04 165.53 28.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.997 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -143.33 99.15 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -68.47 95.85 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.02 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -101.01 141.72 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.158 . . . . 0.0 110.451 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -121.34 146.14 47.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.336 -0.853 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.871 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.77 140.1 6.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -52.23 -59.36 4.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.308 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -83.42 97.13 8.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.156 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 10.9 p -41.72 -29.62 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 28' ' ' SER . 4.3 mm-40 -57.89 -24.69 58.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.8 mt-10 -72.61 -55.35 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 110.052 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.02 HD22 HG13 ' A' ' 24' ' ' VAL . 37.3 mt -56.54 -35.19 67.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 0.0 110.068 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.693 HD21 HD11 ' A' ' 66' ' ' LEU . 52.8 mt -65.48 -65.85 0.62 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.33 -0.856 . . . . 0.0 110.152 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -57.75 -68.69 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 109.97 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 20.5 mtmt -42.84 -37.39 1.8 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.399 -0.813 . . . . 0.0 109.908 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.63 -48.43 84.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.1 t -63.18 -19.4 64.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.237 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 52.1 t -77.24 -41.95 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 39' ' ' ARG . 1.8 tmt_? -81.05 -28.82 35.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.761 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 1.9 m-30 -92.58 -8.15 45.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 74.2 mm-40 49.19 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.799 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -131.04 95.63 24.66 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.093 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.4 Cg_endo -73.23 144.55 37.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.063 1.559 . . . . 0.0 110.321 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.542 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -51.7 -49.43 83.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.569 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 44' ' ' MET . 50.2 Cg_endo -79.05 159.36 27.05 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.903 1.475 . . . . 0.0 110.66 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 43.63 45.88 7.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.553 ' OG ' HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -171.55 171.4 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -1.189 . . . . 0.0 110.287 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.839 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -178.75 143.2 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 60' ' ' ASP . 1.4 mt -111.97 164.9 12.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.869 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' THR . 3.5 p -155.09 149.08 25.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 110.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -76.09 105.12 6.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.826 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 85.8 t80 -56.27 -22.35 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.359 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -51.63 -52.42 47.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.987 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -128.22 0.25 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 86.9 30.23 21.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.54 167.28 21.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.15 . . . . 0.0 109.857 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.616 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.8 pt-20 -115.45 133.23 56.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.932 -1.105 . . . . 0.0 109.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.934 HG11 ' CE1' ' A' ' 63' ' ' PHE . 59.1 t -155.52 173.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 110.508 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 30.5 p -119.01 159.6 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 49' ' ' LEU . 44.8 p30 -70.12 -2.72 13.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.95 -23.14 10.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.588 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 m -80.19 -37.6 32.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 110.221 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.152 ' CE2' HD21 ' A' ' 72' ' ' LEU . 20.8 m-85 -39.07 99.14 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.531 -0.73 . . . . 0.0 110.53 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 50.5 Cg_endo -76.93 -39.41 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.989 1.521 . . . . 0.0 110.415 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . 178.51 66.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.883 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.8 mp -42.5 161.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.272 -1.134 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 44.7 Cg_endo -72.85 -174.13 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.071 1.564 . . . . 0.0 110.259 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.5 t30 -58.41 152.64 17.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.108 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLU . 8.5 m-20 42.85 37.86 1.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 0.0 109.924 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -42.24 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -69.49 96.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.777 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.152 HD21 ' CE2' ' A' ' 63' ' ' PHE . 4.8 tp -106.48 153.16 22.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -133.68 140.02 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 110.61 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.799 HD11 HD23 ' A' ' 42' ' ' LEU . 11.8 tp -80.35 132.66 35.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.509 -0.744 . . . . 0.0 109.9 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.839 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.8 tt -145.67 159.03 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.838 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 69.1 p -149.76 -159.96 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.29 73.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.431 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.38 18.01 40.04 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -145.77 148.18 32.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 0.0 110.457 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -149.9 139.8 21.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t-105 -117.0 128.86 55.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -76.73 -61.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.81 147.0 4.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.05 144.69 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.283 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 85' ' ' VAL . 35.3 m -83.56 143.14 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 110.331 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 46.3 p -108.56 53.07 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 86' ' ' SER . 13.5 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.245 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 1.8 tpp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.307 0.575 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.564 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.3 OUTLIER 171.26 148.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 43.23 49.68 5.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 4' ' ' VAL . 3.1 p -161.85 75.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 mt -142.38 158.87 43.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -125.11 42.09 3.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 167.39 124.56 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.7 Cg_endo -72.59 125.15 10.37 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.734 1.386 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.97 137.16 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 110.234 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.529 ' C ' HG13 ' A' ' 11' ' ' VAL . 35.3 m -108.19 157.85 17.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.071 HG22 HD13 ' A' ' 32' ' ' LEU . 34.9 m -152.46 137.85 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.9 . . . . 0.0 109.976 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -96.32 107.7 20.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.272 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.605 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -84.53 83.2 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.591 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -80.26 157.24 26.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.352 -0.843 . . . . 0.0 109.877 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.25 123.0 14.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.552 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HD21 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -74.48 -20.44 60.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 110.16 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -79.48 -1.5 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.88 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -128.42 -160.76 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 0.0 109.951 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.45 38.82 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.48 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.62 -159.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.048 -1.032 . . . . 0.0 110.69 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.69 -161.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 19.1 t80 -145.6 98.05 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.19 101.27 1.03 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD22 ' A' ' 32' ' ' LEU . 2.9 p -116.26 149.07 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -1.149 . . . . 0.0 110.291 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.95 159.28 41.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.004 . . . . 0.0 110.262 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.84 132.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 25.1 mmm-85 -46.21 -56.15 6.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 110.212 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -82.47 97.94 8.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.036 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 28.2 p -40.26 -27.56 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 21.7 mp0 -62.27 -28.55 69.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 tt0 -66.38 -44.62 82.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 110.249 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.071 HD13 HG22 ' A' ' 11' ' ' VAL . 38.2 mt -67.13 -35.65 80.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 87.4 mt -65.23 -60.75 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tpt180 -55.23 -69.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 26.0 mtpp -46.08 -29.62 1.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -60.57 -52.37 52.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.7 t -67.13 -16.24 64.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -1.181 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 54.1 t -81.73 -52.57 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -66.94 -39.7 87.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.743 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.605 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.9 m-30 -83.28 -19.55 36.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.853 . . . . 0.0 109.783 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 44.7 mm-40 60.34 77.74 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.475 -0.766 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.064 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -121.33 97.52 47.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 50.5 Cg_endo -75.16 -162.67 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.946 1.498 . . . . 0.0 109.714 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 1.2 ptt? -123.62 45.53 1.2 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.008 -1.058 . . . . 0.0 111.393 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 44' ' ' MET . 50.7 Cg_endo -76.29 -1.38 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.66 1.347 . . . . 0.0 109.764 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.09 5.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.722 ' HB3' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER -63.15 -161.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -1.077 . . . . 0.0 110.232 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 176.23 154.23 0.2 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.113 -0.992 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -111.76 165.83 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 109.414 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.5 p -156.97 133.69 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.58 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.697 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -63.3 126.43 27.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.404 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 84.6 t80 -77.13 2.02 16.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.939 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -50.82 50.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.433 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.08 54.77 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 51.98 40.81 51.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.37 159.03 18.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.048 -1.266 . . . . 0.0 109.495 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.609 ' C ' HG23 ' A' ' 58' ' ' VAL . 7.3 mp0 -117.34 136.75 52.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 110.468 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.839 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.1 t -156.8 175.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.589 ' N ' HG12 ' A' ' 58' ' ' VAL . 72.2 p -130.83 160.39 34.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.58 -30.53 71.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.37 -0.831 . . . . 0.0 110.471 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.4 22.39 6.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 110.346 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 32.0 t -130.84 -35.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.198 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.141 ' CD1' HD11 ' A' ' 66' ' ' LEU . 34.2 m-85 -44.16 104.22 0.37 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.209 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.4 Cg_endo -72.96 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.009 1.531 . . . . 0.0 110.344 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.12 64.53 0.59 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.141 HD11 ' CD1' ' A' ' 63' ' ' PHE . 52.2 mt -43.71 162.81 0.18 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.303 -1.116 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ASN . 44.3 Cg_endo -72.51 164.44 35.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.169 1.615 . . . . 0.0 110.134 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.8 p-10 -44.49 151.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.945 . . . . 0.0 109.978 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.9 m-20 45.64 37.72 3.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.861 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -40.7 107.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.649 . . . . 0.0 110.186 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 72' ' ' LEU . 12.3 tt0 -83.25 97.87 9.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 110.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.818 HD21 ' CD1' ' A' ' 66' ' ' LEU . 9.0 mp -105.06 159.07 16.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.892 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.761 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -129.53 113.36 14.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.394 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.064 HD11 HD23 ' A' ' 42' ' ' LEU . 12.8 tp -67.89 133.47 49.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -145.98 157.7 43.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.117 -0.989 . . . . 0.0 109.493 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 47' ' ' SER . 39.6 p -132.6 -174.98 3.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.0 -12.13 46.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.92 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.3 25.17 27.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -156.37 163.14 39.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -1.153 . . . . 0.0 110.813 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.676 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.63 139.02 14.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.563 ' CE3' HD11 ' A' ' 16' ' ' LEU . 8.3 t-105 -103.94 137.01 42.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.756 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -69.41 -79.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.324 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . -160.64 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 18.5 t80 174.88 84.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.162 -1.199 . . . . 0.0 110.179 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 85' ' ' VAL . 23.3 m -92.17 -179.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.18 -0.95 . . . . 0.0 110.136 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.59 62.01 7.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.139 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.278 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 1.3 mtp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.176 0.512 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 24.4 p -179.58 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.274 -0.891 . . . . 0.0 110.338 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 177.86 62.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 t -103.88 157.4 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 5' ' ' LEU . 6.8 mt -132.62 176.45 8.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 19.4 mmt180 -84.64 58.79 5.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.555 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.1 mp0 70.29 158.27 0.16 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.622 -0.674 . . . . 0.0 109.991 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.1 Cg_endo -71.58 127.11 12.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.943 1.496 . . . . 0.0 110.403 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -79.94 153.12 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 24.9 m -121.48 140.5 52.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 HD22 ' A' ' 32' ' ' LEU . 5.2 m -134.38 136.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.937 . . . . 0.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.18 92.33 5.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.541 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -73.55 94.11 2.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.59 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.912 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -88.96 158.14 18.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.442 -0.786 . . . . 0.0 109.64 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -138.51 135.8 35.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.651 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.7 -24.22 56.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.224 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 7.99 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.0 t -138.26 -164.88 1.7 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.133 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.07 24.25 8.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -161.14 -163.43 1.02 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 0.0 110.592 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -140.44 -162.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.494 -0.754 . . . . 0.0 110.177 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 6.9 t80 -138.47 79.54 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -63.94 84.3 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 32' ' ' LEU . 1.4 p -104.57 141.3 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.138 . . . . 0.0 110.122 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.33 146.97 43.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.448 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.876 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -160.96 144.16 13.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mmt180 -57.9 -61.87 2.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.095 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 1.5 t -77.97 96.89 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.955 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.0 p -42.57 -31.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 mm-40 -52.39 -30.93 31.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.106 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 9.5 mt-10 -72.31 -46.01 57.5 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.604 0.716 . . . . 0.0 109.422 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 29' ' ' CYS . 12.1 mt -56.26 -43.82 79.11 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.75 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 34' ' ' ARG . 70.5 mt -67.09 -69.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.691 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -45.76 -70.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.546 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 31' ' ' GLU . 1.9 mtmp? -46.13 -26.36 0.75 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.166 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.28 -46.01 66.72 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 42' ' ' LEU . 41.0 t -74.24 -16.51 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -1.153 . . . . 0.0 109.78 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 34' ' ' ARG . 20.1 t -84.23 -47.6 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.776 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -35.84 78.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-85 -91.14 -13.51 32.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.57 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 1.7 mt-30 56.44 83.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 110.764 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -118.17 113.62 37.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.016 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.7 Cg_endo -72.57 173.51 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.015 1.534 . . . . 0.0 110.726 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 1.2 ttm -90.69 -44.42 0.39 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.354 -0.841 . . . . 0.0 111.173 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' MET . 47.3 Cg_endo -80.84 140.32 12.77 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.655 1.345 . . . . 0.0 110.367 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.91 36.56 60.48 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -142.71 164.42 30.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -1.004 . . . . 0.0 110.128 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 172.84 150.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 110.154 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 74' ' ' LEU . 1.7 mt -115.39 168.56 9.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.0 p -157.02 146.38 20.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -70.92 118.83 14.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.713 ' HD1' HD13 ' A' ' 73' ' ' LEU . 63.1 t80 -76.34 -21.23 56.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.381 -0.824 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' TYR . 2.9 tp10 -43.38 -45.94 6.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 110.352 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -137.13 -49.53 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.383 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.24 49.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.71 164.98 12.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -1.149 . . . . 0.0 109.916 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.587 ' C ' HG23 ' A' ' 58' ' ' VAL . 5.5 pt-20 -118.18 131.42 56.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.042 -1.037 . . . . 0.0 110.543 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.6 t -154.64 170.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.523 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -119.44 157.65 27.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 11.3 p-10 -62.44 -16.62 56.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 110.596 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -102.17 6.23 40.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.47 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.5 m -112.19 -34.62 5.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.832 ' CE1' HG11 ' A' ' 58' ' ' VAL . 13.6 m-85 -45.57 104.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 110.399 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.8 Cg_endo -76.52 -86.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.071 1.564 . . . . 0.0 110.338 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.74 64.22 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 63' ' ' PHE . 94.5 mt -45.18 160.84 0.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.289 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.39 178.36 6.24 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -56.76 152.01 13.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 0.0 110.218 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' CYS . 6.1 m-20 44.36 38.85 2.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.797 . . . . 0.0 109.782 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.42 105.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' LEU . 18.4 mt-10 -73.18 103.02 3.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.642 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 66' ' ' LEU . 7.0 mp -113.19 159.74 18.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 109.623 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.912 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -140.09 132.91 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.032 -1.043 . . . . 0.0 110.475 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD11 HD23 ' A' ' 42' ' ' LEU . 11.1 tp -72.29 135.27 45.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.786 . . . . 0.0 109.889 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -146.04 155.33 42.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 10.9 p -146.33 178.29 8.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.57 70.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.09 7.95 53.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 160.02 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.219 -1.165 . . . . 0.0 110.54 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.609 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.01 140.69 12.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.437 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.6 t-105 -111.61 131.41 55.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.122 -0.986 . . . . 0.0 110.32 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -83.37 -61.69 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 150.53 159.62 8.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD1' ' CE2' ' A' ' 52' ' ' TYR . 2.5 t80 -86.62 94.34 9.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 163.51 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.6 p -104.75 60.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.228 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.308 0.575 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p -42.95 134.75 3.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.254 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.46 51.91 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 7' ' ' GLN . 25.8 m -82.38 53.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 46.76 41.56 10.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 5' ' ' LEU . 5.7 mmm-85 39.84 52.31 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.501 ' H ' HG23 ' A' ' 4' ' ' VAL . 21.5 mt-30 58.06 163.83 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 109.674 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.62 133.52 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.803 1.423 . . . . 0.0 110.575 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -81.59 -179.59 7.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 69' ' ' ASP . 23.5 t -150.54 148.68 28.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.41 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 32' ' ' LEU . 6.3 m -144.86 136.49 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 23.6 mmtt -95.83 94.51 7.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.064 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -72.24 89.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.593 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.908 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -86.7 150.85 23.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 17' ' ' HIS . . . -135.36 137.63 42.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.69 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 73' ' ' LEU . 1.2 mt -75.18 -22.79 57.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.903 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.747 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 28.5 p80 -84.34 6.93 21.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -161.38 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.058 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.56 27.02 6.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.38 -161.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -134.38 -176.26 4.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.82 . . . . 0.0 110.194 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -120.79 99.32 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.58 85.59 0.35 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.991 HG13 HD22 ' A' ' 32' ' ' LEU . 3.5 p -104.14 136.87 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 146.08 47.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.32 133.44 4.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.099 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -50.43 -30.55 12.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 110.458 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 31' ' ' GLU . 1.4 p -104.25 94.53 5.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 26.9 p -41.88 -31.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -30.9 71.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.928 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 68.1 tt0 -68.94 -32.06 71.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 HG13 ' A' ' 24' ' ' VAL . 16.5 mt -77.44 -31.47 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 94.1 mt -66.15 -57.74 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -59.0 -55.86 29.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 29.7 mtpp -55.02 -27.19 42.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.633 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.52 -51.55 30.71 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 29.1 t -65.67 -14.37 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -1.163 . . . . 0.0 109.604 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.69 -45.71 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -24.1 60.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-30 -102.6 -16.54 16.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.507 -0.746 . . . . 0.0 109.64 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER 61.99 88.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.055 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -133.82 97.44 15.49 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.939 . . . . 0.0 110.034 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.461 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 49.6 Cg_endo -74.86 -162.84 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.912 1.48 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 ttm -121.35 44.51 0.77 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 44' ' ' MET . 49.9 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.503 1.265 . . . . 0.0 109.836 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.9 -2.09 5.94 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 76' ' ' THR . 48.9 m -63.56 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -1.09 . . . . 0.0 110.148 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 176.05 154.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 110.922 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -114.9 116.77 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 56' ' ' THR . 29.0 m -94.41 -179.2 4.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.72 122.94 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 110.247 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -68.72 -7.61 35.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.17 -46.34 90.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 33.35 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 110.503 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 69.22 33.31 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.58 165.75 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -1.191 . . . . 0.0 109.834 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' C ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -119.54 128.45 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.39 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.986 HG11 ' CE1' ' A' ' 63' ' ' PHE . 14.3 t -150.08 -179.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.633 ' H ' HG12 ' A' ' 58' ' ' VAL . 22.9 p -131.4 159.82 36.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.002 . . . . 0.0 110.39 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.654 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.3 p30 -73.61 0.15 13.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.291 -0.881 . . . . 0.0 110.44 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -115.11 -1.29 13.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 110.515 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.6 t -108.07 -36.08 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.923 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.081 ' CE1' HD21 ' A' ' 66' ' ' LEU . 19.8 m-85 -39.62 99.29 0.19 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.436 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.5 Cg_endo -77.7 -33.28 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.044 1.55 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.84 68.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.081 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.1 mp -50.0 163.61 0.41 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.242 -1.152 . . . . 0.0 110.075 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 42.2 Cg_endo -69.43 178.67 4.14 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.109 1.584 . . . . 0.0 110.172 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.72 150.03 20.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.2 m-20 48.84 35.88 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.455 -0.778 . . . . 0.0 110.198 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -50.2 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.74 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 mm-40 -72.58 96.93 2.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -96.4 164.8 12.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HG3' ' A' ' 14' ' ' ARG . 1.4 tp -134.96 118.7 17.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.966 -1.084 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.055 HD11 HD23 ' A' ' 42' ' ' LEU . 15.4 tp -69.43 127.47 33.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -140.46 158.45 43.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 47' ' ' SER . 32.1 p -141.92 174.23 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.99 19.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.43 23.47 21.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.31 149.0 25.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 110.593 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -144.25 158.62 43.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 0.0 109.696 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.575 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -125.48 122.57 37.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.312 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.26 -82.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 0.0 110.115 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 55' ' ' GLY . . . -175.75 172.93 45.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -113.63 67.54 0.67 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -1.107 . . . . 0.0 110.087 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -80.02 169.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.937 . . . . 0.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ASP . 2.9 p -151.92 67.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 86' ' ' SER . 18.6 t0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.246 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.278 0.561 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.63 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 0.5 OUTLIER -45.54 139.04 4.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 173.63 101.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 32.8 t -118.05 162.43 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER 63.98 93.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 110.46 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 1.9 mmt180 -84.44 45.43 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.91 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 170.85 124.22 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 0.0 110.047 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.7 Cg_endo -75.17 132.05 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.974 1.513 . . . . 0.0 110.789 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.39 159.81 25.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 69' ' ' ASP . 42.8 t -135.15 149.6 50.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.7 m -146.95 134.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.323 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 69' ' ' ASP . 37.6 mmtt -86.27 89.33 7.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -70.79 79.96 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.998 . . . . 0.0 110.201 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.837 ' CG ' HD12 ' A' ' 73' ' ' LEU . 6.5 tpt180 -83.8 159.12 21.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -150.8 122.44 8.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.278 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.895 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -76.79 -8.66 57.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 6.5 t-80 -94.54 10.44 34.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.512 ' O ' ' C ' ' A' ' 19' ' ' ALA . 4.5 m -149.49 30.28 0.75 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.514 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 27.28 49.86 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.095 0.474 . . . . 0.0 111.744 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -174.06 -176.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -145.03 -171.67 3.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 110.0 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 10.5 t80 -153.21 84.54 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.8 94.65 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.979 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -102.89 151.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -1.104 . . . . 0.0 110.769 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.43 151.86 51.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.441 -0.787 . . . . 0.0 110.012 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.875 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.8 136.0 0.89 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.71 -61.43 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.063 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 29' ' ' CYS . 17.7 m -78.3 96.71 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' C ' ' O ' ' A' ' 28' ' ' SER . 25.8 p -41.29 -28.73 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.524 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' SER . 6.9 tt0 -59.56 -25.6 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 110.192 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -70.53 -52.12 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HG13 ' A' ' 24' ' ' VAL . 32.1 mt -60.46 -34.61 74.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.867 . . . . 0.0 110.207 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 63' ' ' PHE . 11.0 mt -67.54 -64.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.066 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.69 -64.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' CB ' ' NZ ' ' A' ' 35' ' ' LYS . 7.6 mtmp? -49.45 -28.92 5.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.7 -48.78 78.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -71.42 -14.56 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.0 109.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.509 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 94.4 t -79.69 -49.43 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.929 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -28.9 62.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.019 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.8 m-30 -93.51 -11.56 31.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 30.4 mm-40 51.16 83.89 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.962 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -128.37 109.12 19.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.953 . . . . 0.0 110.779 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 47' ' ' SER . 47.4 Cg_endo -77.24 167.8 24.14 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.929 1.489 . . . . 0.0 110.205 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -87.42 -45.37 0.51 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.5 Cg_endo -80.39 127.38 6.57 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.824 1.434 . . . . 0.0 110.699 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.23 -40.77 3.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -84.98 -177.31 6.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.42 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -179.87 140.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.733 . . . . 0.0 109.892 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 4.4 mt -109.26 165.81 11.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.059 -1.026 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 73' ' ' LEU . 4.7 p -154.46 157.38 38.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.431 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -85.97 124.44 32.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.706 ' HD2' HD13 ' A' ' 73' ' ' LEU . 35.7 t80 -73.44 -14.3 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.25 -57.06 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.84 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.99 5.09 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.473 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 95.46 32.88 6.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.8 176.78 8.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -1.231 . . . . 0.0 109.706 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.605 ' C ' HG23 ' A' ' 58' ' ' VAL . 40.4 mt-10 -125.29 138.11 54.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.03 . . . . 0.0 110.775 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.1 t -156.46 173.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 58' ' ' VAL . 29.9 p -121.52 158.37 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.511 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.1 p-10 -66.07 -7.81 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -108.62 -18.09 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.5 t -84.05 -39.34 19.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 58' ' ' VAL . 24.9 m-85 -42.32 101.6 0.25 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.1 Cg_endo -79.18 -90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.048 1.552 . . . . 0.0 110.666 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.98 66.37 0.3 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.99 HD22 ' HB1' ' A' ' 70' ' ' ALA . 3.6 mt -43.94 149.92 0.63 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.403 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -161.06 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.976 1.514 . . . . 0.0 110.115 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ASP . 31.6 p-10 -77.2 150.93 35.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . 5.8 t0 42.08 37.05 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.74 . . . . 0.0 110.016 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.99 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -46.43 120.27 2.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 3.4 mp0 -83.2 106.94 15.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.943 . . . . 0.0 110.85 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 3.2 mp -110.92 154.59 23.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.895 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -138.73 127.99 24.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.014 -1.054 . . . . 0.0 110.662 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.705 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -74.08 134.82 42.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 110.24 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.787 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.9 OUTLIER -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.628 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 79' ' ' GLU . 4.4 p -147.51 169.66 19.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.072 . . . . 0.0 109.843 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.14 -33.67 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.3 17.97 39.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -1.193 . . . . 0.0 110.544 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.787 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.19 172.39 13.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.223 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.553 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.7 t-105 -141.24 122.88 15.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -70.15 -79.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.485 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . 179.09 171.87 42.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -98.17 118.44 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -1.166 . . . . 0.0 110.239 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.21 156.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.939 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.82 80.14 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.125 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.257 0.551 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 1' ' ' MET . 25.3 p -179.66 163.29 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 110.131 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 42.75 48.39 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.207 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 4' ' ' VAL . 4.1 p -97.01 139.68 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 110.364 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.24 118.54 14.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.855 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 1.7 mmm180 -101.02 44.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 0.6 OUTLIER 174.68 116.1 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.279 -0.888 . . . . 0.0 110.205 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.1 Cg_endo -72.87 125.53 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.835 1.439 . . . . 0.0 110.537 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 160.2 24.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 69' ' ' ASP . 37.3 m -130.76 152.96 49.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.038 HG22 HD22 ' A' ' 32' ' ' LEU . 9.2 m -141.55 125.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . 10.0 mmtt -87.95 85.45 7.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.6 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -74.81 81.41 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.607 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.642 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -79.72 160.47 26.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.815 . . . . 0.0 109.325 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -135.06 124.24 24.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.773 -1.204 . . . . 0.0 110.679 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 81' ' ' TRP . 2.2 mt -75.72 -20.88 58.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -79.41 2.88 20.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.884 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -140.66 -175.12 4.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.873 . . . . 0.0 109.783 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.04 33.42 4.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.267 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.04 -167.91 2.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.62 -164.88 1.97 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.911 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 8.5 t80 -144.58 77.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.44 92.54 0.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.986 HG13 HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -116.96 151.58 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -128.25 173.79 9.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.386 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.1 126.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.035 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.94 -55.98 3.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -81.42 97.82 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.729 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.4 p -41.6 -30.79 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -0.824 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.23 -34.95 59.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 1.6 mp0 -67.11 -46.46 74.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.689 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG22 ' A' ' 11' ' ' VAL . 18.0 mt -54.42 -42.46 70.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -63.17 -70.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.11 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -59.64 2.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -49.45 -26.6 3.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -70.39 -58.08 6.26 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 44.6 t -64.85 -13.65 56.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' GLN . 31.1 t -85.76 -72.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 109.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.13 -29.82 1.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 13' ' ' LEU . 4.5 m-30 -96.69 -17.94 20.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.567 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.4 mt-30 57.11 84.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.744 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -124.08 101.57 35.16 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 109.977 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 51.0 Cg_endo -75.84 -160.65 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.177 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.6 ttt -119.95 43.75 0.59 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 111.075 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.8 Cg_endo -76.23 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.533 1.28 . . . . 0.0 109.626 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.33 10.26 3.25 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 34.7 m -72.85 -159.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.351 -1.088 . . . . 0.0 110.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.41 158.23 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 110.514 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -110.59 165.9 11.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 109.228 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 73' ' ' LEU . 6.1 p -159.35 133.33 7.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.099 . . . . 0.0 110.769 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -62.4 120.92 11.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.484 -0.76 . . . . 0.0 110.3 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -70.31 -6.2 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 19.4 tt0 -54.11 -65.58 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.35 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -131.6 23.86 4.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 83.2 28.52 36.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.39 165.11 25.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.183 -1.186 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' C ' HG23 ' A' ' 58' ' ' VAL . 35.5 mt-10 -119.24 135.54 54.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.3 t -154.3 175.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 42.8 p -122.39 166.66 14.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.9 p-10 -66.57 -7.37 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.288 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -22.43 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.7 m -84.24 13.89 4.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.955 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -100.42 97.82 7.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.017 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.9 Cg_endo -71.3 -92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.896 1.472 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -128.95 64.86 0.6 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' PHE . 12.0 mt -42.92 161.78 0.18 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -1.096 . . . . 0.0 110.174 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.6 Cg_endo -71.95 162.91 40.46 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.075 1.566 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' ASP . 8.9 p-10 -42.29 150.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.59 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 42.98 38.35 1.4 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.881 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.85 110.35 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 110.175 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 12' ' ' LYS . 2.3 tp10 -70.48 99.76 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.357 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 66' ' ' LEU . 6.5 mp -114.6 158.09 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -140.14 116.86 10.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 110.434 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.955 HD11 HD23 ' A' ' 42' ' ' LEU . 6.8 tp -70.64 149.12 47.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -153.51 155.3 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.091 -1.005 . . . . 0.0 110.007 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 19.2 p -135.88 172.46 12.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.08 -31.77 31.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.865 . . . . 0.0 110.291 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.92 17.47 41.04 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' CA ' ' OE1' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -149.97 149.38 30.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -1.21 . . . . 0.0 110.574 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.753 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.26 134.84 22.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.861 ' HB2' HD12 ' A' ' 16' ' ' LEU . 7.1 t-105 -103.16 133.25 48.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -83.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -169.82 158.11 30.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 34.7 t80 -75.9 92.09 3.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 110.13 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -87.52 145.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 86' ' ' SER . 5.0 p -103.56 106.34 16.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.232 -179.896 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.178 0.513 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 6.1 p 175.89 46.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 110.223 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 2' ' ' CYS . . . 56.99 61.7 2.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 4' ' ' VAL . 4.7 p -56.47 101.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 27' ' ' ARG . 1.1 mt -111.42 -165.13 0.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.5 mtt180 -108.03 67.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 109.904 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 68.91 148.27 0.12 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.801 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 7' ' ' GLN . 45.8 Cg_endo -72.58 133.85 21.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.977 1.514 . . . . 0.0 110.586 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -171.91 3.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 50.6 t -149.16 149.45 31.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.001 -1.062 . . . . 0.0 110.505 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.2 m -148.26 134.71 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 mmtp -97.28 95.15 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -74.25 89.45 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.984 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.626 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -89.39 151.72 21.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.963 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.05 131.31 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 110.576 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -70.73 -24.47 62.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.416 ' HB2' ' OE2' ' A' ' 79' ' ' GLU . 3.6 t-160 -86.72 16.08 5.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -135.1 -161.28 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.43 29.79 5.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.296 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 174.84 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 110.666 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.37 164.37 30.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 15.0 t80 -102.5 79.66 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -61.92 87.84 0.04 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.038 HG13 HD22 ' A' ' 32' ' ' LEU . 8.6 p -103.37 140.59 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.616 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.15 39.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.761 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.79 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -173.99 148.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 11.0 mmt180 -62.97 -48.16 80.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -84.57 89.19 7.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 110.104 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 28' ' ' SER . 6.6 p -42.64 -31.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.08 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.14 -36.09 78.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 109.907 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 2.7 tp10 -62.41 -51.41 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.778 . . . . 0.0 110.019 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG13 ' A' ' 24' ' ' VAL . 43.7 mt -53.41 -39.26 64.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 63' ' ' PHE . 4.5 mt -57.26 -69.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 110.148 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.735 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.27 -60.14 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.849 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 14.0 mtpt -46.97 -27.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.486 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -69.98 -56.09 8.53 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.6 -15.18 25.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.196 . . . . 0.0 109.937 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 34' ' ' ARG . 24.5 t -87.97 -55.48 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.733 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.64 70.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 3.2 m-30 -95.79 -21.99 17.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.382 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.26 84.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.516 -0.74 . . . . 0.0 110.732 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.025 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.15 98.47 38.8 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 110.159 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 52.6 Cg_endo -74.37 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.958 1.504 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 19.4 ttm -124.05 43.86 0.91 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.081 -1.012 . . . . 0.0 111.262 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 44' ' ' MET . 51.7 Cg_endo -77.43 2.28 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.533 1.281 . . . . 0.0 109.984 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.0 12.35 5.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' HD11 ' A' ' 42' ' ' LEU . 49.1 m -74.18 -161.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -1.11 . . . . 0.0 110.42 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER 178.61 150.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 60' ' ' ASP . 5.1 mp -115.81 115.15 25.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 56' ' ' THR . 99.9 m -92.46 -171.13 2.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 111.058 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD12 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -121.72 126.85 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.647 -0.658 . . . . 0.0 109.729 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.31 -15.45 63.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 110.816 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -44.9 -68.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.995 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 54' ' ' ASP . 26.3 t70 -143.07 40.09 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.467 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.549 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 72.23 38.5 58.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -80.47 160.03 25.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -1.193 . . . . 0.0 109.834 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -114.49 128.77 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 110.383 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.045 HG11 ' CE1' ' A' ' 63' ' ' PHE . 3.1 t -147.93 -171.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.743 ' H ' HG12 ' A' ' 58' ' ' VAL . 53.9 p -145.41 165.51 28.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.049 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.653 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.7 p-10 -79.23 8.65 5.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -124.92 5.52 8.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 110.354 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t -119.78 -36.56 3.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.045 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -40.86 100.58 0.22 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.6 Cg_endo -76.67 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.039 1.547 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -110.47 67.68 0.22 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.6 mp -41.95 146.13 0.66 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 110.425 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.65 158.08 43.77 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.116 1.587 . . . . 0.0 110.281 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 12.4 p30 -44.27 147.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 109.89 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.7 OUTLIER 43.88 36.4 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.684 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.98 119.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -82.49 101.51 10.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.741 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 1.2 mp -110.24 152.76 25.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -131.02 104.83 7.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.59 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.025 HD11 HD23 ' A' ' 42' ' ' LEU . 10.2 tp -60.5 126.66 28.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -139.16 158.57 43.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.982 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 49.8 p -134.24 176.39 8.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.16 -32.51 36.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.85 20.95 29.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -145.3 148.62 33.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.721 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.76 138.0 24.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.451 -0.781 . . . . 0.0 109.855 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.467 ' HB2' ' CD2' ' A' ' 73' ' ' LEU . 5.5 t-105 -107.89 123.94 49.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.991 -1.068 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -67.33 -62.47 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 153.69 6.07 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 14.1 t80 -88.98 166.04 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -1.089 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 m -86.62 174.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.341 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.38 47.05 1.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.303 -179.857 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.265 0.555 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.1 t -43.42 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -163.86 47.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.2 p -157.16 62.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.18 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 27' ' ' ARG . 76.0 mt -111.2 128.46 55.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 15.4 mmt180 -105.65 40.84 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER 166.16 119.39 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.574 -0.704 . . . . 0.0 110.022 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.46 130.79 16.59 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.871 1.459 . . . . 0.0 110.566 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 4.3 ttpt -79.98 155.13 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.85 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' VAL . 7.4 t -129.52 153.46 47.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.622 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.619 HG22 HD13 ' A' ' 32' ' ' LEU . 10.6 m -148.66 135.0 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.08 96.21 10.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 110.355 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -76.33 81.58 3.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.92 . . . . 0.0 110.024 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.718 ' CG ' HD12 ' A' ' 73' ' ' LEU . 5.3 tpt180 -80.59 158.72 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -140.26 112.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -62.5 -30.38 71.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.857 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.572 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 52.1 t60 -82.19 8.1 11.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 28.6 t -121.2 -160.59 0.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -119.23 19.51 12.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 175.84 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.108 -0.995 . . . . 0.0 110.781 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.97 168.8 18.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.552 -0.718 . . . . 0.0 109.883 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -122.52 99.85 6.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.323 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.41 92.58 0.27 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.998 HG13 HD22 ' A' ' 32' ' ' LEU . 4.1 p -97.39 146.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 0.0 110.354 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.596 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -134.92 144.88 47.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.37 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -170.51 123.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.5 mtt180 -42.29 -29.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -100.67 95.64 6.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.277 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 30' ' ' GLN . 21.1 p -44.98 -33.27 1.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.449 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 8.5 mp0 -62.55 -20.64 64.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.73 -48.3 16.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.934 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.998 HD22 HG13 ' A' ' 24' ' ' VAL . 22.3 mt -58.98 -38.86 80.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.022 HD21 ' CD1' ' A' ' 66' ' ' LEU . 52.8 mt -66.36 -63.63 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.687 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.4 mmm-85 -52.78 -65.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.804 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 28.0 mtpt -50.61 -24.21 3.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.607 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.7 -52.55 11.93 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -63.28 -16.11 59.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -1.203 . . . . 0.0 110.056 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 34' ' ' ARG . 99.3 t -78.16 -59.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.008 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -35.1 79.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.942 . . . . 0.0 109.982 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.7 m-30 -84.87 -14.72 46.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 58.2 mm-40 53.1 78.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.398 -0.814 . . . . 0.0 110.554 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -116.82 97.63 50.77 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.9 Cg_endo -72.15 161.47 44.52 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.693 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.24 -48.23 13.26 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 0.0 110.654 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 44' ' ' MET . 48.0 Cg_endo -76.6 150.26 31.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.759 1.399 . . . . 0.0 110.649 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 44.34 51.38 7.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -165.74 164.79 18.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -1.122 . . . . 0.0 110.25 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -177.63 146.52 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.01 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.715 ' CD2' HD12 ' A' ' 74' ' ' LEU . 2.2 mt -114.65 169.12 9.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 3.6 p -151.98 161.92 41.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.945 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.752 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -92.47 115.97 28.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.65 -0.656 . . . . 0.0 109.955 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.47 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 7.5 t80 -64.22 -15.43 59.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.409 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -48.77 -51.69 27.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.47 20.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 82.57 22.26 58.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.8 174.34 2.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.127 -1.22 . . . . 0.0 109.672 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 4.9 mm-40 -126.17 137.05 53.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.513 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 51' ' ' LEU . 90.5 t -156.64 173.96 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.193 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -121.87 159.9 25.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.896 . . . . 0.0 110.023 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.57 -7.79 11.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.637 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -15.38 14.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.02 -1.05 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.2 m -88.34 -40.63 13.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.045 . . . . 0.0 110.45 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.602 ' CE1' HD21 ' A' ' 72' ' ' LEU . 47.8 m-85 -39.77 99.75 0.2 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.462 -0.774 . . . . 0.0 110.357 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.8 Cg_endo -76.74 -87.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.071 1.563 . . . . 0.0 110.406 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -117.63 67.31 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.022 ' CD1' HD21 ' A' ' 33' ' ' LEU . 1.6 mt -43.03 143.23 1.31 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.957 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 44.1 Cg_endo -72.32 167.36 27.12 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.019 1.537 . . . . 0.0 110.47 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ASP . 4.2 t-20 -52.1 152.91 2.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 110.457 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER 42.49 38.92 1.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.809 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.994 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -54.33 116.9 2.88 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mt-10 -89.12 108.06 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.6 mp -117.08 159.75 22.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 110.004 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.718 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -134.7 139.97 45.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.646 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.036 HD11 HD23 ' A' ' 42' ' ' LEU . 12.2 tp -79.99 144.73 33.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 75' ' ' LEU . 3.1 tt -154.02 159.96 41.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 21.9 p -152.17 167.81 27.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -45.89 -29.89 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.147 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.81 22.45 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -155.81 152.69 28.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.613 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.573 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.789 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.523 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 9.5 t-105 -107.8 135.28 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.008 -1.058 . . . . 0.0 110.786 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -78.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.336 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.483 ' O ' ' CZ2' ' A' ' 81' ' ' TRP . . . 174.22 177.92 43.74 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -83.9 131.48 34.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -1.142 . . . . 0.0 110.271 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 85' ' ' VAL . 10.5 m -84.55 136.44 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 110.385 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.2 t -111.25 95.89 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.083 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.261 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.274 0.559 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 t -161.13 127.0 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.27 86.68 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 110.102 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 4' ' ' VAL . 5.6 p -147.82 98.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.122 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.9 166.39 12.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 110.334 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -82.17 59.89 4.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.318 -0.864 . . . . 0.0 109.439 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 74.93 159.04 0.16 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.69 -0.631 . . . . 0.0 109.799 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 7' ' ' GLN . 43.9 Cg_endo -71.15 134.14 24.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.924 1.487 . . . . 0.0 110.814 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 152.5 22.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.969 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 69' ' ' ASP . 39.2 m -121.75 153.67 37.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 110.383 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.831 HG22 HD22 ' A' ' 32' ' ' LEU . 11.3 m -147.2 132.77 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -97.46 99.59 11.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.919 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -81.52 95.04 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.639 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 4.7 tpt180 -91.61 157.59 16.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.572 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.78 120.06 10.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -64.86 -17.44 64.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.893 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -79.69 -0.54 34.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -134.18 -159.17 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.858 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.16 34.2 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.435 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 6.7 p -177.18 -162.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 110.706 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -140.21 -169.15 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.522 -0.736 . . . . 0.0 110.038 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 3.7 t80 -130.41 81.29 2.0 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 110.28 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.27 85.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HD23 ' A' ' 32' ' ' LEU . 2.1 p -107.21 146.6 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -1.14 . . . . 0.0 110.117 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.68 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -124.13 163.63 21.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.002 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.912 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 179.45 135.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -0.863 . . . . 0.0 110.202 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -52.39 -61.69 2.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' CYS . 70.7 m -75.22 93.87 2.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.868 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.752 ' HA ' HD12 ' A' ' 32' ' ' LEU . 21.3 p -40.98 -30.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -38.49 58.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -68.07 -43.16 79.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.751 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.082 HD23 HG13 ' A' ' 24' ' ' VAL . 17.0 mt -53.75 -46.81 71.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.563 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.659 HD11 HD11 ' A' ' 66' ' ' LEU . 27.8 mt -66.87 -67.18 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 109.898 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -43.73 -68.31 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.61 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 5.6 mtpp -46.83 -27.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.87 -55.64 16.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.22 -13.77 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.179 . . . . 0.0 109.714 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.27 -52.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.77 . . . . 0.0 109.997 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -63.83 -29.25 70.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.4 m-30 -99.24 -18.86 17.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 109.503 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER 60.34 85.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 110.699 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.717 ' CG ' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -124.89 92.4 47.74 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.07 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 48.3 Cg_endo -73.51 -160.5 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.009 1.531 . . . . 0.0 110.153 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 3.7 ttt -120.78 43.35 0.61 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.117 -0.99 . . . . 0.0 111.426 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 44' ' ' MET . 53.2 Cg_endo -77.25 -0.48 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.537 1.282 . . . . 0.0 109.844 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.98 6.09 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 76' ' ' THR . 39.4 m -73.05 -161.82 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -1.102 . . . . 0.0 110.512 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.1 OUTLIER 176.41 167.62 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.49 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 60' ' ' ASP . 0.6 OUTLIER -120.57 170.25 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 109.556 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 56' ' ' THR . 74.1 m -148.36 -178.99 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.477 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -116.1 120.08 37.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.973 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -5.98 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 110.538 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -50.05 -62.59 1.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.471 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -147.53 20.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 110.724 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.546 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 96.33 44.56 2.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -94.88 167.57 11.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 109.985 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.526 ' C ' HG23 ' A' ' 58' ' ' VAL . 9.5 mm-40 -122.03 136.81 54.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.888 HG11 ' CE1' ' A' ' 63' ' ' PHE . 11.7 t -151.73 179.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.621 ' H ' HG12 ' A' ' 58' ' ' VAL . 18.4 p -129.91 164.76 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.553 ' N ' HD13 ' A' ' 49' ' ' LEU . 17.5 p-10 -73.96 1.2 11.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.44 -23.95 7.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 37.4 t -79.96 -41.24 26.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.401 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.933 ' HB3' HD11 ' A' ' 66' ' ' LEU . 12.6 m-85 -40.49 99.78 0.21 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.488 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.9 Cg_endo -80.59 -87.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 110.595 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.8 67.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.933 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.3 mp -44.38 148.16 0.9 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.305 -1.115 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.81 157.58 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.935 1.492 . . . . 0.0 109.976 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.98 146.46 0.81 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.038 -1.039 . . . . 0.0 110.067 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.9 m-20 45.58 36.47 2.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.709 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -42.58 116.45 0.86 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.85 95.45 9.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.0 mp -103.92 162.8 12.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.744 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -136.43 106.5 6.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.551 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 42' ' ' LEU . 17.1 tp -55.3 148.35 14.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.719 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.65 156.57 32.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 47' ' ' SER . 21.5 p -138.83 165.74 26.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 110.359 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 76' ' ' THR . . . -43.76 -32.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.98 27.79 7.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -154.73 155.87 35.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 110.587 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.719 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.1 141.07 16.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.847 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.488 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.1 t-105 -110.69 130.1 55.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.0 110.338 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -72.54 -61.79 1.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.93 . . . . 0.0 110.099 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.7 162.7 10.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 26.3 t80 -86.02 48.44 1.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -1.055 . . . . 0.0 110.218 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG12 ' H ' ' A' ' 86' ' ' SER . 2.5 t -106.22 -172.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 110.016 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.696 ' H ' HG12 ' A' ' 85' ' ' VAL . 2.8 m -147.18 66.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.208 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.245 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.291 0.567 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.26 61.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 4' ' ' VAL . . . -141.3 79.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.209 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 3' ' ' ALA . 4.2 t 40.74 79.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.57 138.43 31.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 2.2 mmm180 -111.67 45.54 1.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 167.79 113.83 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 110.332 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.4 Cg_endo -73.77 126.3 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 110.314 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -79.61 152.57 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 0.0 110.034 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.896 ' SG ' ' HB2' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -124.36 151.01 44.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.597 HG22 HD13 ' A' ' 32' ' ' LEU . 22.8 m -148.02 141.03 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.73 102.61 15.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.3 tp -78.63 89.52 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.607 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -91.49 154.68 18.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -140.34 113.1 8.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.036 -1.04 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -58.09 -20.8 42.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -81.5 -0.18 40.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -127.1 -160.91 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.98 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.76 28.54 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.347 -0.845 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -179.39 -159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.603 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.38 -176.03 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 110.033 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.7 t80 -133.83 91.13 2.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.97 95.02 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.868 HG13 HD22 ' A' ' 32' ' ' LEU . 4.2 p -101.56 147.14 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -1.083 . . . . 0.0 110.3 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.896 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . . . -128.09 147.74 50.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 110.35 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -169.79 150.84 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 mmt180 -62.0 -55.94 24.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 7.8 p -83.49 96.97 8.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.2 p -41.29 -29.65 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.566 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.8 mm100 -60.34 -23.55 64.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.076 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -74.12 -46.78 40.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HG13 ' A' ' 24' ' ' VAL . 24.3 mt -59.7 -38.25 81.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.976 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 30' ' ' GLN . 18.4 mt -67.16 -54.98 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.859 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -58.74 -65.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.764 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 19.5 mtpp -49.9 -29.37 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -68.43 -53.04 23.09 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.6 t -57.53 -17.0 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.554 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 34' ' ' ARG . 47.6 t -84.24 -56.3 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.985 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -62.92 -33.54 75.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.7 m-30 -94.13 -13.25 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.88 84.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.698 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -127.34 96.78 32.76 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.0 -1.062 . . . . 0.0 110.257 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 47' ' ' SER . 43.7 Cg_endo -71.84 127.53 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.086 1.572 . . . . 0.0 110.332 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.532 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -41.44 -53.22 7.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.403 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 50.9 Cg_endo -77.81 164.14 28.09 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.025 1.539 . . . . 0.0 110.618 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 43.38 30.8 1.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -163.49 -177.64 5.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -1.177 . . . . 0.0 110.214 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 175.99 153.74 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.182 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.578 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.1 mt -122.84 160.08 26.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.647 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 56' ' ' THR . 63.7 m -147.78 139.18 23.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 110.348 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -67.32 120.3 13.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.487 -0.758 . . . . 0.0 110.463 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 21.5 t80 -69.54 -12.58 61.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.765 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.06 -41.14 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 110.319 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.58 40.2 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.182 -0.948 . . . . 0.0 110.645 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 57.38 29.75 60.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -74.2 161.08 30.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.249 . . . . 0.0 109.7 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.6 pt-20 -114.75 133.0 56.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.048 -1.032 . . . . 0.0 110.599 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.77 HG11 ' CE1' ' A' ' 63' ' ' PHE . 81.3 t -156.67 173.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.588 ' N ' HG12 ' A' ' 58' ' ' VAL . 24.2 p -122.58 158.81 29.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.1 p-10 -63.16 -16.19 59.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 110.405 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -1.49 31.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.0 t -101.06 -41.46 6.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.875 ' CD1' HD21 ' A' ' 66' ' ' LEU . 35.2 m-85 -39.61 99.27 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.726 . . . . 0.0 110.246 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.5 Cg_endo -73.65 -55.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.008 1.531 . . . . 0.0 110.462 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.6 68.51 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.875 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.5 mp -48.09 160.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.126 . . . . 0.0 109.879 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.12 165.6 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -44.64 150.38 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.248 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.0 m-20 47.43 35.74 4.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -52.22 125.84 17.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.753 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.595 ' C ' HD22 ' A' ' 72' ' ' LEU . 31.5 mp0 -96.25 110.24 22.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.163 -0.96 . . . . 0.0 110.914 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.758 HD21 HD22 ' A' ' 66' ' ' LEU . 2.7 mm? -114.48 141.26 47.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 0.0 109.788 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -115.9 149.25 38.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 0.0 110.416 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.8 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.7 tp -86.98 147.1 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.824 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.3 tt -158.99 157.06 30.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.8 p -152.29 173.21 15.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.59 -36.14 6.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -87.36 23.24 12.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.4 mt-10 -157.65 150.71 23.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.093 -1.239 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.53 133.17 20.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.518 ' NE1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -96.88 125.52 41.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.248 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.418 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 26.4 m80 -67.8 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 110.166 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.5 128.65 1.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 85' ' ' VAL . 59.0 t80 -59.93 132.62 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 11.7 m -80.19 166.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 86' ' ' SER . 9.6 p -99.6 61.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.185 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.173 0.511 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 65.7 m -52.57 146.28 10.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.14 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.84 51.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.45 45.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.6 OUTLIER 52.38 46.59 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.847 . . . . 0.0 110.302 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.1 mmt-85 43.19 47.71 5.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.988 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 68.53 163.22 0.14 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.334 -0.854 . . . . 0.0 110.268 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.0 Cg_endo -71.65 137.53 30.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.864 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 169.24 16.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.745 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.445 ' C ' HG13 ' A' ' 11' ' ' VAL . 26.5 m -141.38 152.32 44.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.6 m -148.07 142.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 55.2 mmtt -98.33 92.4 5.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.566 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -72.61 84.31 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 110.382 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.729 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -81.59 159.82 23.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.825 . . . . 0.0 109.693 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -141.31 126.64 18.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 110.589 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -68.57 -24.51 64.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.951 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -79.93 5.98 12.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -150.81 148.88 29.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 110.019 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.42 54.94 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 110.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.2 p -173.65 -172.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.25 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.473 -0.767 . . . . 0.0 109.931 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 24' ' ' VAL . 14.2 t80 -147.71 79.0 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.0 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -62.49 81.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.015 HG13 HD22 ' A' ' 32' ' ' LEU . 4.8 p -93.83 144.99 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -1.102 . . . . 0.0 110.728 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -123.68 154.42 39.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 110.059 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -177.12 130.05 0.17 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' O ' HD13 ' A' ' 5' ' ' LEU . 4.6 ttp180 -45.51 -57.15 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.2 p -82.26 97.18 8.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 31.5 p -41.83 -29.42 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' OE1' ' SG ' ' A' ' 29' ' ' CYS . 1.4 mp0 -56.69 -24.02 46.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -46.2 42.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.373 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.015 HD22 HG13 ' A' ' 24' ' ' VAL . 20.4 mt -61.68 -39.46 91.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.515 HD13 ' HB2' ' A' ' 63' ' ' PHE . 29.1 mt -63.03 -58.78 6.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.053 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 4.4 mmt180 -59.42 -71.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 0.0 109.86 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' ARG . 32.6 mtpt -42.96 -34.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.776 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -63.96 -54.66 29.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.0 t -61.5 -13.5 21.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.15 -1.206 . . . . 0.0 109.872 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.6 -49.98 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.0 109.687 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -25.51 63.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.534 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.1 m-30 -99.63 -18.96 17.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.797 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 60.57 83.23 0.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.739 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -125.06 102.85 30.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.99 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.9 Cg_endo -71.54 156.14 58.37 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.938 1.494 . . . . 0.0 110.531 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -74.5 -48.54 5.3 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.976 . . . . 0.0 110.234 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 44' ' ' MET . 51.1 Cg_endo -79.99 133.49 10.07 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.015 1.534 . . . . 0.0 110.391 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.1 44.35 95.9 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -166.98 174.94 7.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -1.152 . . . . 0.0 109.993 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.2 147.05 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.893 -1.129 . . . . 0.0 110.948 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 59' ' ' THR . 1.1 mp -110.09 175.76 5.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.36 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HD23 ' A' ' 73' ' ' LEU . 1.9 p -159.07 146.6 17.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 0.0 110.673 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -71.55 111.51 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 110.121 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.751 ' CD1' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -68.97 -14.54 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -53.05 -44.51 67.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.285 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t70 -136.47 -33.78 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.468 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 131.3 38.59 0.27 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.523 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.3 171.5 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.102 . . . . 0.0 110.018 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.558 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.7 mm-40 -121.24 135.94 55.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 109.73 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.5 t -155.38 168.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.601 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 49' ' ' LEU . 55.0 p -110.14 159.46 17.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 110.12 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.8 p-10 -67.06 -8.01 27.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 110.433 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.32 -17.1 14.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.6 m -84.58 -41.61 16.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.718 ' CE1' HG11 ' A' ' 58' ' ' VAL . 18.6 m-85 -40.0 100.18 0.21 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.401 -0.812 . . . . 0.0 110.57 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -75.84 -89.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.07 1.563 . . . . 0.0 110.36 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -125.98 65.83 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 17.5 mt -42.76 163.37 0.15 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -73.0 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.214 1.639 . . . . 0.0 109.921 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -74.44 150.28 40.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.126 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 70' ' ' ALA . 38.7 m-20 42.75 37.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.86 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -41.03 100.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.63 . . . . 0.0 110.253 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.7 tt0 -71.35 106.07 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.367 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 71' ' ' GLU . 6.0 mp -111.37 166.42 11.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -142.39 138.33 31.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.739 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -80.89 146.23 30.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.82 159.45 36.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.092 -1.005 . . . . 0.0 109.899 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.2 p -150.98 174.08 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.41 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.931 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.28 18.47 57.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -151.49 161.22 43.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -1.145 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.13 142.64 17.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.827 . . . . 0.0 110.166 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.7 t-105 -116.26 133.12 56.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.125 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.28 -80.23 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -168.36 154.19 23.85 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.5 96.02 9.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.14 . . . . 0.0 110.28 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 85' ' ' VAL . 19.6 m -91.62 151.52 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m -99.44 74.57 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 t0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.238 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.266 0.555 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.5 OUTLIER 59.55 -168.54 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 44.1 61.19 2.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.96 128.12 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.62 -177.61 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.471 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.0 mmt180 -121.94 73.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.1 tt0 69.57 144.14 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.272 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.3 Cg_endo -73.3 123.58 8.84 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.129 1.594 . . . . 0.0 110.953 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 1.9 ttpm? -80.92 155.87 26.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.743 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' ASP . 25.0 t -125.38 151.84 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 24' ' ' VAL . 8.9 m -144.53 149.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -99.31 101.24 12.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -79.27 75.28 5.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.431 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.844 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.8 tpt180 -83.73 157.31 22.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 18' ' ' SER . . . -135.83 122.4 20.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.049 -1.032 . . . . 0.0 110.661 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.011 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.36 -30.6 66.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CA ' ' OE2' ' A' ' 79' ' ' GLU . 61.0 t-80 -79.89 5.76 12.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 110.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 58.0 m -127.18 -163.79 1.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.961 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.14 33.05 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -171.88 -162.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.822 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.95 -164.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.769 . . . . 0.0 109.853 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.0 t80 -156.08 89.56 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.447 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.56 96.1 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 32' ' ' LEU . 2.3 p -105.74 151.83 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 110.43 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.06 161.81 33.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.059 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -178.52 141.91 0.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 0.0 110.478 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.38 -65.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.99 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.3 OUTLIER -79.72 95.03 5.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.846 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 29.5 p -41.44 -28.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.808 . . . . 0.0 110.423 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 13.0 tt0 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 1.2 tp10 -74.41 -46.13 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.385 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 24' ' ' VAL . 22.0 mt -60.97 -36.89 80.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 66' ' ' LEU . 63.8 mt -66.37 -59.89 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.838 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -70.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 24.0 mtpp -45.48 -32.03 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.598 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -61.6 -51.27 58.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.3 t -65.76 -15.78 63.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.696 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 82.5 t -80.53 -46.5 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -32.57 64.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.671 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.516 ' CD2' HD22 ' A' ' 74' ' ' LEU . 2.0 m-30 -90.6 -10.55 42.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.77 82.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.322 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.63 111.26 27.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 110.153 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 47' ' ' SER . 46.7 Cg_endo -73.04 162.34 41.15 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.015 1.534 . . . . 0.0 110.301 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.536 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 2.1 ttp -76.36 -54.31 1.93 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 48.8 Cg_endo -77.61 153.39 30.26 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.901 1.474 . . . . 0.0 110.44 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.32 38.93 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -155.05 172.32 18.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 110.196 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.914 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 178.95 140.03 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 60' ' ' ASP . 2.0 mp -112.1 118.73 36.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.374 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 75' ' ' LEU . 71.6 m -103.34 155.11 18.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.056 -1.028 . . . . 0.0 110.753 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -83.27 124.09 30.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.014 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 73' ' ' LEU . 6.5 t80 -73.93 1.24 11.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.741 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' HD23 ' A' ' 51' ' ' LEU . 1.1 tp10 -59.73 -54.97 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.35 21.19 1.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 87.63 35.9 9.0 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.11 163.15 22.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -1.175 . . . . 0.0 110.013 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' C ' HG23 ' A' ' 58' ' ' VAL . 14.7 pt-20 -116.04 134.81 54.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.054 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.2 t -153.09 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.589 ' H ' HG12 ' A' ' 58' ' ' VAL . 44.5 p -131.48 161.44 32.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.003 -1.061 . . . . 0.0 109.99 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.7 p-10 -72.61 -0.75 13.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 110.579 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -113.0 -11.52 13.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.379 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 3.3 t -98.39 -38.2 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.48 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.105 ' CE1' HD21 ' A' ' 66' ' ' LEU . 6.9 m-85 -39.99 99.48 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.2 Cg_endo -81.35 -67.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.935 1.492 . . . . 0.0 110.349 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -147.97 64.78 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.105 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.7 mt -42.31 163.45 0.13 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 43.5 Cg_endo -71.24 161.98 44.01 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.209 1.636 . . . . 0.0 110.2 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.45 153.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 4.8 m-20 45.02 37.22 2.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -49.54 112.83 0.7 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.406 -0.808 . . . . 0.0 109.864 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 111.64 18.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.574 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 mp -109.22 148.32 31.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.752 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 16' ' ' LEU . 1.1 tp -132.18 126.03 32.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.943 -1.098 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.8 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -67.74 131.24 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 109.929 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.914 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.3 tt -147.77 159.48 43.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 109.656 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.3 p -146.79 -178.03 5.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.94 73.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.14 11.13 58.82 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' OE2' ' CA ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER -141.96 154.16 44.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -1.184 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.576 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -150.59 141.61 23.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -114.51 129.53 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.351 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -66.81 -69.92 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.235 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 131.81 2.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.39 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -1.182 . . . . 0.0 110.477 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 85' ' ' VAL . 31.6 m -96.0 127.92 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -130.94 50.83 2.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.244 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t 60.27 72.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.333 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.4 64.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.242 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.65 137.84 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 109.992 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.85 -165.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.454 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 3.7 mmt180 -136.2 81.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 67.82 143.7 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.451 -0.781 . . . . 0.0 109.632 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.3 Cg_endo -72.0 125.52 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.981 1.517 . . . . 0.0 110.97 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -85.89 153.35 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' ASP . 13.5 t -127.61 158.83 36.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.381 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG2' HG12 ' A' ' 24' ' ' VAL . 5.4 m -149.02 135.87 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -92.89 96.47 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -75.84 82.42 2.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.877 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.5 tpt180 -81.01 160.53 24.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.39 132.31 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 110.519 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.559 HD12 HD21 ' A' ' 73' ' ' LEU . 4.6 mt -74.55 -20.86 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 109.941 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.529 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 21.4 t60 -79.96 3.34 20.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.899 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 165.48 31.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.96 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 53.2 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -174.98 -172.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 111.09 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -145.62 -162.11 1.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.501 -0.749 . . . . 0.0 109.919 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 9.0 t80 -144.86 87.23 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 110.491 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.07 83.47 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.04 HG13 HD22 ' A' ' 32' ' ' LEU . 7.5 p -95.1 152.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -1.158 . . . . 0.0 110.239 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.7 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.57 164.29 26.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.92 133.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mtm180 -50.14 -33.41 18.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' GLN . 3.2 m -107.35 93.74 4.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.898 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 13.9 p -38.77 -28.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.581 -0.699 . . . . 0.0 110.466 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.12 -33.88 72.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.5 tt0 -68.13 -31.33 70.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HG13 ' A' ' 24' ' ' VAL . 30.0 mt -76.38 -34.34 58.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.94 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 63' ' ' PHE . 79.9 mt -66.91 -61.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 tpt180 -53.25 -53.8 45.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtpm? -56.78 -28.25 60.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.341 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -65.46 -51.98 43.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.9 t -67.09 -18.07 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -1.228 . . . . 0.0 109.84 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 34' ' ' ARG . 77.9 t -81.11 -53.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.891 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -66.79 -42.03 86.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.5 m-30 -84.95 -13.22 51.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.558 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.77 80.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.437 -0.789 . . . . 0.0 110.281 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -111.5 105.13 56.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo -71.64 168.86 22.5 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.048 1.552 . . . . 0.0 110.495 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -88.57 -44.98 0.46 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.816 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.3 Cg_endo -80.02 120.06 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.683 1.36 . . . . 0.0 110.668 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.11 28.58 55.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -144.58 174.11 11.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -1.207 . . . . 0.0 110.505 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.57 142.55 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.925 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.604 HD21 HD12 ' A' ' 74' ' ' LEU . 3.5 mt -108.72 162.49 14.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.594 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.3 p -149.78 162.59 39.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.614 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.36 115.7 27.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -70.19 -5.96 31.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.376 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.64 -54.26 47.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.5 8.56 3.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 91.5 29.0 12.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.544 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -74.66 176.65 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 109.888 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' HG23 ' A' ' 58' ' ' VAL . 12.2 mt-10 -126.83 137.06 53.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 110.733 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.0 t -155.77 174.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.578 ' N ' HG12 ' A' ' 58' ' ' VAL . 43.3 p -122.92 165.22 17.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 110.261 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 p-10 -69.79 -4.1 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.892 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.87 -8.12 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.315 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.7 m -105.07 18.69 21.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.197 -0.939 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.877 ' CD1' HD11 ' A' ' 66' ' ' LEU . 10.9 m-85 -100.87 98.58 8.68 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -72.98 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -127.45 66.54 0.56 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.877 HD11 ' CD1' ' A' ' 63' ' ' PHE . 16.1 mt -41.44 162.98 0.12 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.311 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.1 Cg_endo -70.75 154.89 63.57 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.232 1.649 . . . . 0.0 109.854 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.3 t-20 -41.91 143.99 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 10' ' ' CYS . 2.6 m-20 54.38 36.18 24.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.713 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.81 111.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.586 -0.696 . . . . 0.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 98.23 5.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 mp -108.34 156.03 19.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.911 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.877 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -139.11 123.99 18.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.834 HD11 HD23 ' A' ' 42' ' ' LEU . 11.5 tp -67.77 138.45 56.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 110.184 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.7 OUTLIER -148.76 157.67 43.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.47 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -148.02 176.8 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.25 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.46 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.42 15.03 52.87 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 2.4 mt-10 -143.42 145.88 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -1.13 . . . . 0.0 110.513 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.722 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.77 157.77 43.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.822 . . . . 0.0 109.812 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.536 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.7 t-105 -129.73 126.69 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.459 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -59.28 3.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.391 -0.818 . . . . 0.0 110.11 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.46 161.34 8.69 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -76.03 146.46 39.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 110.144 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.31 166.05 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.7 t -146.69 51.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.271 0.558 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.06 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -170.05 59.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.36 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -144.23 152.71 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.033 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.338 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -108.9 44.72 1.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 110.033 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 4.9 pt20 -178.14 113.37 0.23 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.36 -0.838 . . . . 0.0 109.812 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -73.16 125.73 10.54 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.945 1.497 . . . . 0.0 110.794 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -80.92 171.4 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.917 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ASP . 44.5 m -138.68 151.16 46.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' VAL . 5.5 m -146.32 129.51 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 13.7 mmmt -85.65 96.69 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -75.76 87.21 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 110.698 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.884 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -81.99 154.83 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.705 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -143.43 117.23 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.818 HD12 HD21 ' A' ' 73' ' ' LEU . 1.5 mt -60.81 -27.44 68.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.201 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -83.1 10.77 7.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.13 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -128.19 -161.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.82 14.17 15.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.399 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 -155.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -130.36 176.0 8.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 110.301 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 24' ' ' VAL . 19.2 t80 -120.19 84.93 2.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.82 85.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 32' ' ' LEU . 7.0 p -96.3 148.4 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -1.096 . . . . 0.0 110.41 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.574 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -130.25 151.09 51.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.854 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.93 142.35 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 110.468 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -47.03 -66.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 110.008 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.9 OUTLIER -81.59 96.24 7.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 24.7 p -41.94 -31.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.707 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -54.79 -29.24 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 4.0 tp10 -72.79 -35.43 67.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.501 -0.749 . . . . 0.0 109.817 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 24' ' ' VAL . 18.1 mt -69.1 -32.84 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.718 HD22 ' CB ' ' A' ' 63' ' ' PHE . 42.3 mt -67.98 -53.41 26.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.0 mmt180 -61.29 -61.8 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.826 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 11.2 mtpt -53.79 -27.95 32.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.61 -44.07 95.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 20.7 t -73.81 -20.65 60.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -1.199 . . . . 0.0 110.169 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 34' ' ' ARG . 55.0 t -70.94 -49.3 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -75.72 -26.92 57.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 74' ' ' LEU . 2.5 m-30 -92.76 -3.72 54.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 78.3 mm-40 46.32 72.18 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -115.45 105.34 52.31 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 110.466 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 47' ' ' SER . 40.9 Cg_endo -71.46 157.84 55.44 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.862 1.454 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.615 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 21.1 ttt -87.22 -39.28 0.51 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 111.929 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.2 Cg_endo -77.27 -52.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.275 1.145 . . . . 0.0 111.336 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -101.03 64.25 0.54 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -175.74 -178.11 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -1.121 . . . . 0.0 110.67 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.892 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -178.01 137.04 0.18 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.672 HD21 HD12 ' A' ' 74' ' ' LEU . 3.4 mt -109.63 163.88 13.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.719 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 73' ' ' LEU . 7.2 p -154.97 136.95 14.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.947 . . . . 0.0 110.368 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.3 112.22 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.75 -17.84 38.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.274 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.67 -53.54 30.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.178 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.13 23.17 2.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.54 26.38 71.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.562 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -67.8 165.43 17.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -1.221 . . . . 0.0 109.791 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 11.4 pm0 -113.88 135.56 53.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.003 -1.061 . . . . 0.0 110.96 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 ' CE1' ' A' ' 63' ' ' PHE . 98.7 t -157.53 173.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.685 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' VAL . 58.0 p -128.45 158.83 37.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 52.3 p30 -62.2 -11.47 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.7 t0 -107.63 4.45 25.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 37.7 t -112.21 -40.24 4.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.176 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CD1' HD11 ' A' ' 66' ' ' LEU . 44.6 m-85 -40.04 99.95 0.21 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -74.41 -90.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.005 1.529 . . . . 0.0 110.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.73 66.27 0.57 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.2 mt -44.62 163.73 0.18 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.31 -1.112 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.26 -174.34 1.76 Allowed 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.173 1.617 . . . . 0.0 109.847 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 69' ' ' ASP . 33.6 p30 -63.79 154.05 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 110.039 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.5 m-20 42.65 38.79 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.855 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.34 112.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.493 -0.755 . . . . 0.0 109.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 72' ' ' LEU . 4.2 mm-40 -81.76 103.59 11.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 66' ' ' LEU . 8.7 mp -114.86 156.63 24.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.32 -0.863 . . . . 0.0 110.106 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -133.21 125.89 30.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.476 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.823 ' CG ' HD23 ' A' ' 42' ' ' LEU . 12.3 tp -71.79 133.66 45.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.465 -0.772 . . . . 0.0 109.949 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.5 tt -147.47 160.82 42.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.134 -0.979 . . . . 0.0 109.547 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 75' ' ' LEU . 4.6 p -148.83 173.11 13.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 109.96 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.47 -24.34 7.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.959 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.98 16.52 60.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -150.72 156.59 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -1.081 . . . . 0.0 110.242 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.27 153.84 39.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.224 -0.923 . . . . 0.0 110.401 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.494 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.3 t-105 -130.9 116.95 18.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.347 -0.845 . . . . 0.0 110.254 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -63.47 -72.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.058 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.42 167.01 19.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 12.9 t80 -88.31 108.71 19.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -1.186 . . . . 0.0 110.349 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.2 144.99 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 110.169 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 60.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.158 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 24.5 mtt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.233 0.539 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 173.67 -170.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.6 87.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.339 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.1 p -168.88 74.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.07 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 5' ' ' LEU . 13.8 mt -101.9 144.62 30.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.526 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 5.1 mmm-85 -122.32 45.92 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.388 -0.82 . . . . 0.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.9 pt20 174.26 99.35 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 43.9 Cg_endo -71.88 124.15 9.91 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.98 1.516 . . . . 0.0 110.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 158.71 23.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.699 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.8 t -127.85 151.64 48.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.0 m -140.06 152.7 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.977 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HE3' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mmtt -110.32 99.28 8.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -82.23 88.79 6.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.975 . . . . 0.0 110.689 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 2.4 tpt180 -95.4 157.31 15.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.03 139.27 44.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD21 ' A' ' 73' ' ' LEU . 1.6 mt -76.26 -21.14 56.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -79.38 -2.04 39.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -155.79 138.13 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.94 53.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.19 167.36 29.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 110.606 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.88 162.32 40.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.512 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 8.4 t80 -115.66 87.74 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.93 95.57 0.28 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HD23 ' A' ' 32' ' ' LEU . 6.0 p -108.68 154.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -1.193 . . . . 0.0 110.903 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -124.8 166.44 16.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.63 147.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.5 mtm180 -66.86 -53.99 26.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 110.033 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' CYS . 73.9 m -83.82 97.14 9.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.913 ' HA ' HD12 ' A' ' 32' ' ' LEU . 7.2 p -41.65 -30.55 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.105 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -54.87 -27.49 43.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.17 -44.03 39.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.978 HD23 HG13 ' A' ' 24' ' ' VAL . 11.5 mt -57.34 -42.36 81.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 63' ' ' PHE . 68.2 mt -67.21 -59.83 3.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.652 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.1 mpp_? -54.03 -70.48 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 27.8 mtpt -47.29 -24.59 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -73.48 -53.44 7.5 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.3 t -66.64 -11.87 55.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -1.107 . . . . 0.0 109.748 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 34' ' ' ARG . 97.5 t -82.5 -69.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.967 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -51.77 -31.89 28.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.685 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-85 -89.82 -17.95 27.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.58 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 5.5 mt-30 56.56 80.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.998 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -118.2 105.33 46.93 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 110.175 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo -71.1 155.85 60.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.968 1.51 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.545 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -65.53 -54.67 29.03 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.094 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 52.8 Cg_endo -78.02 165.93 25.56 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.978 1.515 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 41.95 34.76 1.44 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -154.41 171.23 19.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.931 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER 179.01 146.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 110.595 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mt -116.35 170.7 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.257 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.2 p -160.21 131.24 5.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.85 -1.156 . . . . 0.0 111.137 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -53.63 133.4 41.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.772 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 25.1 t80 -92.45 -13.26 30.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 110.37 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -53.7 -24.86 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 1.6 t0 -156.46 -43.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.652 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.53 54.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.59 160.88 14.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.964 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.3 pp20? -111.16 130.74 55.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.3 t -148.8 172.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.573 ' N ' HG12 ' A' ' 58' ' ' VAL . 35.3 p -115.16 158.44 22.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p-10 -70.47 -13.36 62.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -102.44 6.24 40.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 42.3 t -112.33 -36.99 5.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.686 ' CD1' HD11 ' A' ' 66' ' ' LEU . 25.6 m-85 -40.59 100.62 0.22 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.461 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -75.38 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.105 1.582 . . . . 0.0 110.275 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.32 69.29 0.52 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 63' ' ' PHE . 17.7 mt -50.37 161.76 0.58 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.209 -1.171 . . . . 0.0 110.051 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.59 167.27 26.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -45.75 153.02 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 110.103 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 27.1 m-20 43.89 37.37 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.2 117.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.761 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -82.88 107.69 15.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 110.501 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 63' ' ' PHE . 1.3 mp -118.25 137.64 52.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.805 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -115.87 131.7 56.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.926 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.998 HD11 HD23 ' A' ' 42' ' ' LEU . 11.7 tp -77.12 139.74 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -155.07 163.71 39.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.67 ' N ' HD23 ' A' ' 75' ' ' LEU . 20.2 p -147.79 168.25 22.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.09 -25.44 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.74 15.42 61.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 0.4 OUTLIER -151.96 151.65 31.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 110.344 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.782 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.91 144.26 30.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.103 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.495 ' HB2' HD12 ' A' ' 16' ' ' LEU . 9.6 t-105 -110.95 135.87 50.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -79.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 166.95 147.17 5.14 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -81.64 146.25 30.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.16 177.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -113.35 79.99 1.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 86' ' ' SER . 1.7 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.252 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' ALA . 1.9 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.266 0.555 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -57.83 86.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.224 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -164.21 81.89 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.113 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 4' ' ' VAL . 27.2 m -71.41 59.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.442 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.48 106.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 44.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.878 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -179.41 113.13 0.21 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.879 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -72.49 123.06 8.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.824 1.434 . . . . 0.0 110.183 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.69 139.91 37.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.7 t -108.1 149.06 28.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.12 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 24' ' ' VAL . 30.2 m -143.95 126.13 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -83.51 97.4 8.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -78.04 79.35 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.554 ' HG3' HD12 ' A' ' 73' ' ' LEU . 5.1 tpt180 -80.56 160.36 25.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.835 . . . . 0.0 109.705 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.93 116.93 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.041 -1.037 . . . . 0.0 110.709 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.92 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -69.28 -19.77 63.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 2.05 24.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.9 -161.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.38 39.86 3.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.9 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.9 p -173.41 -161.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 13.7 ptpt -150.61 -162.03 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 0.0 109.981 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -151.89 90.61 1.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.08 89.89 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.027 ' CG1' HD22 ' A' ' 32' ' ' LEU . 3.7 p -97.97 144.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -1.205 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -128.21 148.32 50.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -172.2 154.09 3.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mtm180 -63.04 -59.3 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.456 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -84.92 96.2 9.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -42.32 -34.14 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.42 -30.87 42.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.404 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -74.19 -32.87 63.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.503 -0.748 . . . . 0.0 109.779 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.027 HD22 ' CG1' ' A' ' 24' ' ' VAL . 14.8 mt -75.8 -37.52 59.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.11 -60.65 2.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.93 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -55.39 -58.58 7.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.765 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -51.33 -32.93 27.09 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.405 -0.81 . . . . 0.0 109.355 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.17 -51.94 53.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -61.36 -19.38 61.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.178 . . . . 0.0 109.864 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ARG . 89.1 t -78.96 -48.08 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -76.43 -33.14 58.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.058 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -89.7 -12.45 39.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -0.882 . . . . 0.0 109.616 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.04 82.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 110.424 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.93 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.31 108.76 37.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.374 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.2 Cg_endo -73.07 170.49 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.55 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -79.33 -50.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 44' ' ' MET . 48.3 Cg_endo -76.54 158.26 36.17 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.766 1.403 . . . . 0.0 110.462 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 77' ' ' ALA . . . 44.13 36.09 3.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.53 ' OG ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -137.26 169.12 18.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.8 116.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 110.318 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.85 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.2 mt -99.62 111.26 23.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.3 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 73' ' ' LEU . 26.4 p -96.33 168.51 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.947 . . . . 0.0 110.768 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -98.43 116.66 31.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.552 -0.718 . . . . 0.0 110.173 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' CB ' ' OE1' ' A' ' 71' ' ' GLU . 15.3 t80 -62.26 -14.41 38.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -56.49 15.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.28 42.98 1.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.495 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.44 33.9 78.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -76.81 164.22 26.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.103 -1.233 . . . . 0.0 109.619 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.534 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.9 pt-20 -116.94 131.89 56.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.97 -1.081 . . . . 0.0 110.241 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.003 HG11 ' CE1' ' A' ' 63' ' ' PHE . 25.9 t -151.04 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.478 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.564 ' N ' HG12 ' A' ' 58' ' ' VAL . 19.3 p -130.71 165.09 23.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.471 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 10.7 p-10 -70.95 -11.86 61.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.603 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.24 -2.42 20.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.052 -1.03 . . . . 0.0 110.524 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 47.9 t -103.01 -39.55 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE1' HG11 ' A' ' 58' ' ' VAL . 16.4 m-85 -40.46 100.0 0.21 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 110.59 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.5 Cg_endo -81.9 -79.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.027 1.541 . . . . 0.0 110.491 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.79 70.91 0.51 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.997 HD11 ' CD1' ' A' ' 63' ' ' PHE . 5.5 mt -51.93 161.55 0.92 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.334 -1.098 . . . . 0.0 110.473 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.42 178.85 6.13 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.19 1.626 . . . . 0.0 109.996 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 69' ' ' ASP . 28.5 t-20 -59.82 150.27 28.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.205 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 44.35 39.03 2.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 109.723 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -40.81 109.62 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.564 -0.71 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -78.7 95.29 5.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 3.0 mp -103.96 152.92 21.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.92 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -132.65 124.76 28.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.446 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.93 HD11 HD23 ' A' ' 42' ' ' LEU . 11.6 tp -72.67 121.84 20.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.539 -0.726 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.715 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -138.69 157.45 46.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.516 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 10.6 p -135.68 179.86 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . . . -58.64 -26.56 63.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.338 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.75 17.35 50.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -147.23 162.64 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -1.186 . . . . 0.0 110.514 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -154.71 141.61 19.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' A' ' 82' ' ' HIS . 2.8 t-105 -115.7 125.44 52.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.449 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 3.7 t60 -62.18 -60.14 4.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' HA2' ' CE2' ' A' ' 81' ' ' TRP . . . 130.67 143.52 5.33 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -62.41 115.92 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.851 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 85' ' ' VAL . 35.4 m -83.8 146.68 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 110.306 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.12 86.29 2.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.148 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.5 139.7 28.89 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.905 1.476 . . . . 0.0 110.44 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 2.0 ttpt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.1 t -118.05 148.55 42.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.545 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 11' ' ' VAL . 22.4 m -142.37 127.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.922 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 4.0 mmpt? -82.7 107.54 15.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.976 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -88.46 86.2 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.383 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.724 ' HG3' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -86.94 157.46 19.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.42 128.87 30.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.048 -1.032 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt -72.54 -26.87 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.808 . . . . 0.0 109.716 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 36.5 t60 -85.14 13.52 6.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.408 -0.807 . . . . 0.0 109.995 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 -160.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.377 -0.827 . . . . 0.0 109.998 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . -129.54 35.88 4.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 4.8 p 174.69 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -168.07 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.0 109.9 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 2.1 t80 -143.96 90.81 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HE2' ' A' ' 12' ' ' LYS . . . -64.61 91.72 0.11 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.863 HG13 HD23 ' A' ' 32' ' ' LEU . 3.1 p -99.41 134.51 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -1.154 . . . . 0.0 110.126 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.736 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.46 149.51 40.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -168.48 145.08 3.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -59.03 -58.56 8.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.066 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 m -80.27 98.07 7.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -0.864 . . . . 0.0 109.93 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.056 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -40.56 -29.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -0.787 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' SER . 31.9 tt0 -60.14 -28.98 68.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.4 -45.01 66.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.802 . . . . 0.0 109.845 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.056 HD12 ' HA ' ' A' ' 29' ' ' CYS . 4.8 mt -57.8 -43.43 85.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 110.001 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 63' ' ' PHE . 2.6 mt -61.85 -65.92 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' NH1' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -43.61 -69.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -47.24 -27.36 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.49 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.42 -55.37 12.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.57 -11.64 17.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 0.0 110.032 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 34' ' ' ARG . 74.7 t -85.33 -71.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -23.51 5.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.347 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 m-85 -102.99 -16.57 15.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 54.01 85.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.86 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -129.08 99.95 21.21 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.558 . . . . 0.0 110.171 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.14 0.495 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 172.75 148.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 74' ' ' LEU . 2.1 mt -118.22 168.85 10.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.1 p -154.97 139.65 17.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 110.848 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -68.08 127.01 31.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 110.292 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -80.85 1.3 31.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' HD23 ' A' ' 51' ' ' LEU . 3.0 tt0 -59.35 -46.38 88.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.0 15.52 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.552 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 94.02 28.97 10.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.06 164.64 25.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -1.222 . . . . 0.0 109.402 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.557 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.2 mt-10 -121.46 130.67 53.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.929 -1.107 . . . . 0.0 110.497 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.912 HG11 ' CE1' ' A' ' 63' ' ' PHE . 57.3 t -153.1 173.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 36.9 p -123.35 164.95 17.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 33' ' ' LEU . 3.0 p30 -67.61 -12.17 59.81 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.325 -0.859 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -105.35 -5.41 20.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.3 t -107.42 17.2 23.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.168 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.912 ' CE1' HG11 ' A' ' 58' ' ' VAL . 6.6 m-85 -100.99 96.54 5.8 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.392 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.5 Cg_endo -72.13 -91.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.782 1.411 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -112.48 68.63 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.832 HD22 ' HB1' ' A' ' 70' ' ' ALA . 1.5 mt -42.84 152.76 0.35 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 0.0 110.343 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.44 164.51 32.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.986 1.519 . . . . 0.0 110.132 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -49.13 148.94 2.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER 43.12 37.33 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.721 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.832 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -42.86 127.6 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 110.035 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 108.72 19.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 72' ' ' LEU . 1.2 mp -117.85 145.41 44.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.724 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -128.58 137.25 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.455 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.86 HD11 HD23 ' A' ' 42' ' ' LEU . 9.9 tp -77.4 138.94 39.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.881 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.6 tt -156.0 162.33 40.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.642 ' N ' HD23 ' A' ' 75' ' ' LEU . 71.2 p -153.99 171.92 18.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.718 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.57 -25.48 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 23.35 34.13 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 17' ' ' HIS . 2.2 mt-10 -156.36 162.66 40.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -1.165 . . . . 0.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.608 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.16 151.31 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.647 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.456 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 7.5 t-105 -124.23 126.32 45.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.878 . . . . 0.0 109.791 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -66.82 -71.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 163.65 175.85 34.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 5.5 t80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.4 -1.059 . . . . 0.0 110.104 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.2 Cg_endo -72.69 120.82 6.91 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.937 1.493 . . . . 0.0 111.107 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -84.36 -166.02 1.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.684 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.8 t -153.23 154.53 34.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.981 HG22 HD22 ' A' ' 32' ' ' LEU . 32.8 m -147.04 146.26 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -107.01 96.76 6.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.742 HD23 ' CG ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -77.82 90.98 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.7 tpt180 -91.73 152.8 20.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.015 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -137.94 131.81 31.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.1 -28.15 64.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.782 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -79.83 3.05 20.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.983 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 t -123.97 -163.04 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 110.048 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.83 33.2 5.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 110.107 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 172.95 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.747 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.04 166.7 23.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.752 . . . . 0.0 109.87 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 6.3 t80 -112.48 97.74 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 110.459 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.404 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -71.81 98.5 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -115.5 150.75 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -1.175 . . . . 0.0 110.569 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -125.65 167.0 15.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 110.229 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -179.75 150.1 0.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.642 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mmm180 -62.79 -57.33 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.11 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.8 m -82.99 95.99 8.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.368 -0.833 . . . . 0.0 110.01 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.978 ' HA ' HD12 ' A' ' 32' ' ' LEU . 28.2 p -41.61 -28.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -55.55 -38.59 69.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.837 . . . . 0.0 109.741 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.6 tp10 -63.46 -43.95 95.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.025 HD23 HG13 ' A' ' 24' ' ' VAL . 8.4 mt -55.24 -47.62 75.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.87 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 63' ' ' PHE . 15.8 mt -63.29 -64.48 0.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.882 . . . . 0.0 109.938 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 tpp85 -47.75 -68.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.907 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -44.93 -30.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.541 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.02 -55.36 24.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.4 t -60.17 -14.36 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.865 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 34' ' ' ARG . 57.4 t -84.83 -60.35 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.377 -0.827 . . . . 0.0 110.28 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -25.32 68.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 110.339 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.742 ' CG ' HD23 ' A' ' 13' ' ' LEU . 3.1 m-85 -101.45 -17.49 16.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.86 84.22 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -123.94 105.72 31.95 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.874 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.808 0 O-C-N 124.008 1.531 . . . . 0.0 110.71 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.3 mtt85 -179.25 117.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 74' ' ' LEU . 13.0 mt -89.57 101.45 14.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.34 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' THR . 94.3 m -89.61 178.88 6.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 111.006 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.4 131.11 55.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.445 -0.784 . . . . 0.0 110.081 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.559 ' CD1' HD13 ' A' ' 73' ' ' LEU . 2.1 t80 -80.74 2.55 25.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.792 . . . . 0.0 110.495 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 4.5 tt0 -66.28 -59.5 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -141.54 22.39 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.333 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.544 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 83.68 48.79 5.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.33 166.2 12.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -1.183 . . . . 0.0 109.715 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -118.98 126.84 52.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.058 . . . . 0.0 110.544 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 10.3 t -144.67 179.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.626 ' H ' HG12 ' A' ' 58' ' ' VAL . 20.4 p -138.88 158.5 44.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.553 ' HB3' HD12 ' A' ' 49' ' ' LEU . 4.1 p30 -61.96 -11.49 13.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 110.26 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -106.67 -5.74 18.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 t -98.18 -48.62 5.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.441 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.169 ' CE1' HD21 ' A' ' 66' ' ' LEU . 10.1 m-85 -41.17 100.53 0.22 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 110.493 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.7 Cg_endo -79.47 -48.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.036 1.545 . . . . 0.0 110.431 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.86 69.55 0.18 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.169 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.7 mt -48.33 161.39 0.38 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 44.0 Cg_endo -72.13 -167.31 0.31 Allowed 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 124.097 1.578 . . . . 0.0 110.116 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 44.9 t30 -70.02 144.57 52.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' CYS . 54.6 t0 56.88 33.98 24.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.982 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -45.46 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.57 -0.706 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' LEU . 1.2 tt0 -78.16 111.02 13.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 71' ' ' GLU . 7.4 mp -115.06 162.79 16.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 109.99 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.89 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -136.98 122.11 19.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.416 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 49' ' ' LEU . 8.5 tp -68.3 115.55 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.803 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -132.63 159.03 40.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 7.6 p -149.05 171.49 16.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 110.158 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.34 -25.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.848 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.25 14.73 62.9 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' OE1' ' CB ' ' A' ' 16' ' ' LEU . 2.9 mt-10 -153.6 144.42 22.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.73 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -135.68 131.13 35.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.485 ' CZ2' ' O ' ' A' ' 83' ' ' GLY . 5.7 t-105 -101.85 130.68 48.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -43.75 18.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 110.429 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 131.7 -172.34 20.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 26.8 t80 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.139 . . . . 0.0 110.27 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.7 Cg_endo -74.37 133.52 17.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.882 1.464 . . . . 0.0 110.495 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.49 166.29 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' C ' HG13 ' A' ' 11' ' ' VAL . 27.8 m -139.19 155.32 47.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 HD22 ' A' ' 32' ' ' LEU . 22.3 m -150.32 131.71 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.2 mmtt -89.3 85.34 6.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.938 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.491 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.1 tp -65.29 85.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.842 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.972 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.0 tpt180 -82.52 153.05 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 109.42 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.0 133.02 37.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.411 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 2.8 mt -80.81 -16.58 53.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.518 ' CE1' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -82.34 -0.87 47.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 110.133 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -129.98 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.78 34.85 5.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.93 -160.63 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -138.29 -160.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.243 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.6 t80 -149.59 84.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -67.26 93.58 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.905 HG13 HD23 ' A' ' 32' ' ' LEU . 1.3 p -107.59 151.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -1.106 . . . . 0.0 110.171 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.449 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -125.33 153.05 43.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.51 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.974 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -167.09 132.93 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.2 mmt180 -48.42 -62.29 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.107 -0.996 . . . . 0.0 110.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -76.07 96.48 3.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.017 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -42.07 -33.32 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -32.06 58.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.536 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -72.4 -39.23 68.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.83 . . . . 0.0 109.404 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.012 HD22 HG22 ' A' ' 11' ' ' VAL . 15.9 mt -56.25 -45.36 80.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.764 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 63' ' ' PHE . 23.6 mt -65.87 -64.69 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -46.33 -70.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.937 . . . . 0.0 109.827 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 9.0 mtpt -48.95 -22.97 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.979 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.37 -45.71 45.84 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 15.5 t -76.06 -15.71 60.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -1.129 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 34' ' ' ARG . 18.8 t -79.47 -50.17 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.795 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.11 -39.36 78.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-30 -83.24 -15.22 51.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 57.41 80.3 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -120.62 110.23 35.61 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.361 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 124.039 1.547 . . . . 0.0 110.335 179.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 175.99 141.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.093 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 2.5 mt -109.13 166.71 10.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.976 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.4 m -150.14 169.17 21.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 110.41 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.6 129.33 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.404 -0.81 . . . . 0.0 110.16 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -80.57 -8.68 59.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 51' ' ' LEU . 7.5 tt0 -58.29 -48.62 79.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.9 10.87 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 88.08 46.33 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.19 171.89 9.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -1.208 . . . . 0.0 109.709 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.1 pt-20 -118.43 129.02 55.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.058 -1.026 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.4 t -152.71 176.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 7.3 p -126.37 172.52 10.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 110.214 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 18.7 p-10 -81.61 -4.39 55.99 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.238 -0.913 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.64 0.85 14.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.125 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.9 t -107.43 -40.15 5.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.074 ' CD1' HD11 ' A' ' 66' ' ' LEU . 4.8 m-85 -42.26 101.64 0.25 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 43.6 Cg_endo -72.41 -63.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.057 1.556 . . . . 0.0 111.063 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.68 62.47 0.34 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.074 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.3 mt -44.86 164.46 0.18 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -1.187 . . . . 0.0 110.071 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_endo -69.53 -168.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.16 1.61 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 69' ' ' ASP . 59.7 t30 -68.53 152.33 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.17 -0.956 . . . . 0.0 110.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 10' ' ' CYS . 1.1 m-20 44.04 37.26 1.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.461 -0.774 . . . . 0.0 110.13 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -48.76 106.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.0 109.492 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 27.6 mt-10 -72.97 105.62 4.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.917 . . . . 0.0 110.837 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.652 HD11 HD13 ' A' ' 66' ' ' LEU . 3.2 mp -100.94 169.85 8.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.972 HD12 ' HG3' ' A' ' 14' ' ' ARG . 2.5 tp -143.05 137.45 29.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.911 -1.118 . . . . 0.0 110.916 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.776 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -85.61 130.1 34.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.82 . . . . 0.0 109.687 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.671 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.2 tt -146.41 158.07 43.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.987 -1.07 . . . . 0.0 109.924 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -150.67 171.06 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.67 -29.87 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.054 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.16 14.9 59.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -147.75 159.68 43.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 110.49 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.671 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.91 139.71 13.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.448 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 8.0 t-105 -111.56 133.72 53.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.22 -59.52 2.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.06 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 141.12 163.29 9.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 t80 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 179.887 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 1.8 pt20 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.7 Cg_endo -73.22 138.54 27.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.844 1.444 . . . . 0.0 110.659 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.12 138.9 31.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASP . 98.2 m -115.18 149.42 37.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.424 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.693 HG22 HD22 ' A' ' 32' ' ' LEU . 10.9 m -143.28 146.87 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 10.5 mmtp -105.12 92.18 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.47 97.85 2.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.757 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.734 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.7 tpt180 -94.95 155.74 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.78 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -139.87 121.48 15.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.849 -1.157 . . . . 0.0 110.821 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.01 HD12 HD21 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -65.32 -21.34 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.158 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' CG ' ' OE2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -79.53 0.83 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.5 -162.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.0 27.88 7.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 7.7 p -170.76 -161.55 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.627 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -169.11 2.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.511 -0.743 . . . . 0.0 109.707 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.7 t80 -135.81 85.89 2.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -64.86 94.49 0.17 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.011 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -110.58 140.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -1.095 . . . . 0.0 110.424 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -109.65 162.42 14.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.306 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.895 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 178.38 134.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.88 -58.39 8.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 t -80.26 98.83 7.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.941 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.107 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.7 p -41.85 -28.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.397 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 29.3 mt-30 -57.85 -29.62 65.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -41.42 64.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.825 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.107 HD12 ' HA ' ' A' ' 29' ' ' CYS . 7.3 mt -58.14 -43.08 87.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.776 . . . . 0.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 63' ' ' PHE . 14.9 mt -65.6 -66.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.84 -69.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.782 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -47.71 -25.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.43 -0.794 . . . . 0.0 109.504 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.78 -51.81 28.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.2 t -66.5 -14.12 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.101 -1.235 . . . . 0.0 109.816 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 34' ' ' ARG . 48.3 t -84.99 -56.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -64.38 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.994 -1.066 . . . . 0.0 110.106 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.78 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 3.3 m-85 -103.17 -13.61 16.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 80.7 mm-40 56.46 88.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.117 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.71 93.4 44.48 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.187 -0.946 . . . . 0.0 109.879 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 O-C-N 124.02 1.537 . . . . 0.0 110.038 -179.815 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 1.2 mtt180 175.99 158.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.215 -0.928 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 74' ' ' LEU . 2.0 mp -115.09 168.06 10.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.909 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' THR . 54.2 m -153.11 147.13 25.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 110.379 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -69.69 127.18 32.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.804 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -74.56 0.64 14.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.425 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -61.23 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.08 -1.013 . . . . 0.0 110.2 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.61 22.79 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.55 45.09 38.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.564 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.7 167.9 14.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 109.612 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.8 pt-20 -113.12 131.69 55.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.933 -1.104 . . . . 0.0 111.175 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.899 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.4 t -157.02 173.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.563 -0.711 . . . . 0.0 109.52 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 ' N ' HG12 ' A' ' 58' ' ' VAL . 39.9 p -131.83 160.41 35.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.057 -1.027 . . . . 0.0 110.605 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 33' ' ' LEU . 2.5 p30 -62.18 -10.96 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.02 -7.29 20.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 110.55 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -98.05 -42.31 7.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 0.0 110.411 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.899 ' CE1' HG11 ' A' ' 58' ' ' VAL . 45.8 m-85 -41.7 101.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 110.63 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -76.14 -87.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.93 74.11 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.881 HD11 ' CD1' ' A' ' 63' ' ' PHE . 58.7 mt -58.58 160.18 10.71 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.175 -1.191 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.34 -161.36 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 109.799 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.33 150.47 36.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 10' ' ' CYS . 17.0 m-20 47.52 37.29 6.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -44.06 96.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 109.928 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -62.46 98.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.718 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.664 HD21 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -111.87 161.66 16.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 110.17 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.81 133.13 31.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 110.434 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.117 HD11 HD23 ' A' ' 42' ' ' LEU . 9.8 tp -86.86 143.34 27.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.998 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -151.88 158.55 43.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.644 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 70.4 p -139.7 168.76 19.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.38 -22.24 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.07 21.76 40.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 75' ' ' LEU . 3.5 mt-10 -160.59 141.3 11.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 110.594 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -135.26 146.96 49.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.818 . . . . 0.0 109.834 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.56 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.5 t-105 -116.29 130.26 56.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 110.291 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.68 -75.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -178.26 166.15 35.96 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.342 -1.093 . . . . 0.0 110.168 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tt0 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.2 Cg_endo -71.66 132.79 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.999 1.526 . . . . 0.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -83.13 148.11 27.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.81 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 t -116.77 144.7 44.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 32' ' ' LEU . 3.8 m -139.44 144.54 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.7 mmmm -99.0 91.3 4.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.976 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.85 87.44 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.576 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.717 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -90.86 159.4 16.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.735 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -149.61 130.67 14.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.05 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -84.41 -14.54 49.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.891 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.96 -4.0 53.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 110.022 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -143.93 25.42 1.6 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 0.0 110.413 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 29.4 53.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 120.966 0.412 . . . . 0.0 111.6 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -163.53 172.78 13.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.985 -1.072 . . . . 0.0 110.603 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.04 165.53 28.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.997 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -143.33 99.15 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -68.47 95.85 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.02 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -101.01 141.72 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.158 . . . . 0.0 110.451 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -121.34 146.14 47.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.336 -0.853 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.871 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.77 140.1 6.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -52.23 -59.36 4.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.308 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -83.42 97.13 8.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.156 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 10.9 p -41.72 -29.62 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 28' ' ' SER . 4.3 mm-40 -57.89 -24.69 58.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.8 mt-10 -72.61 -55.35 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 110.052 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.02 HD22 HG13 ' A' ' 24' ' ' VAL . 37.3 mt -56.54 -35.19 67.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 0.0 110.068 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.693 HD21 HD11 ' A' ' 66' ' ' LEU . 52.8 mt -65.48 -65.85 0.62 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.33 -0.856 . . . . 0.0 110.152 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -57.75 -68.69 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 109.97 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 20.5 mtmt -42.84 -37.39 1.8 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.399 -0.813 . . . . 0.0 109.908 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.63 -48.43 84.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.1 t -63.18 -19.4 64.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.237 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 52.1 t -77.24 -41.95 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 39' ' ' ARG . 1.8 tmt_? -81.05 -28.82 35.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.761 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 1.9 m-30 -92.58 -8.15 45.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 74.2 mm-40 49.19 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.799 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -131.04 95.63 24.66 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.093 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.4 Cg_endo . . . . . 0 C--N 1.306 -1.696 0 O-C-N 124.063 1.559 . . . . 0.0 110.321 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.553 ' OG ' HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.204 0.525 . . . . 0.0 110.287 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.839 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -178.75 143.2 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 60' ' ' ASP . 1.4 mt -111.97 164.9 12.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.869 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' THR . 3.5 p -155.09 149.08 25.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 110.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -76.09 105.12 6.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.826 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 85.8 t80 -56.27 -22.35 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.359 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -51.63 -52.42 47.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.987 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -128.22 0.25 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 86.9 30.23 21.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.54 167.28 21.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.15 . . . . 0.0 109.857 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.616 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.8 pt-20 -115.45 133.23 56.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.932 -1.105 . . . . 0.0 109.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.934 HG11 ' CE1' ' A' ' 63' ' ' PHE . 59.1 t -155.52 173.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 110.508 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 30.5 p -119.01 159.6 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 49' ' ' LEU . 44.8 p30 -70.12 -2.72 13.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.95 -23.14 10.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.588 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 m -80.19 -37.6 32.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 110.221 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.152 ' CE2' HD21 ' A' ' 72' ' ' LEU . 20.8 m-85 -39.07 99.14 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.531 -0.73 . . . . 0.0 110.53 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 50.5 Cg_endo -76.93 -39.41 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.989 1.521 . . . . 0.0 110.415 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . 178.51 66.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.883 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.8 mp -42.5 161.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.272 -1.134 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 44.7 Cg_endo -72.85 -174.13 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.071 1.564 . . . . 0.0 110.259 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -58.41 152.64 17.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.108 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLU . 8.5 m-20 42.85 37.86 1.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 0.0 109.924 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -42.24 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -69.49 96.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.777 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.152 HD21 ' CE2' ' A' ' 63' ' ' PHE . 4.8 tp -106.48 153.16 22.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -133.68 140.02 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 110.61 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.799 HD11 HD23 ' A' ' 42' ' ' LEU . 11.8 tp -80.35 132.66 35.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.509 -0.744 . . . . 0.0 109.9 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.839 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.8 tt -145.67 159.03 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.838 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 69.1 p -149.76 -159.96 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.29 73.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.431 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.38 18.01 40.04 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -145.77 148.18 32.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 0.0 110.457 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -149.9 139.8 21.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t-105 -117.0 128.86 55.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -76.73 -61.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.81 147.0 4.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.283 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.7 Cg_endo -72.59 125.15 10.37 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.734 1.386 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.97 137.16 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 110.234 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.529 ' C ' HG13 ' A' ' 11' ' ' VAL . 35.3 m -108.19 157.85 17.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.071 HG22 HD13 ' A' ' 32' ' ' LEU . 34.9 m -152.46 137.85 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.9 . . . . 0.0 109.976 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -96.32 107.7 20.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.272 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.605 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -84.53 83.2 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.591 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -80.26 157.24 26.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.352 -0.843 . . . . 0.0 109.877 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.25 123.0 14.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.552 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HD21 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -74.48 -20.44 60.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 110.16 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.48 -1.5 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.88 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -128.42 -160.76 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 0.0 109.951 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.45 38.82 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.48 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.62 -159.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.048 -1.032 . . . . 0.0 110.69 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.69 -161.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 19.1 t80 -145.6 98.05 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.19 101.27 1.03 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD22 ' A' ' 32' ' ' LEU . 2.9 p -116.26 149.07 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -1.149 . . . . 0.0 110.291 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.95 159.28 41.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.004 . . . . 0.0 110.262 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.84 132.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 25.1 mmm-85 -46.21 -56.15 6.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 110.212 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -82.47 97.94 8.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.036 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 28.2 p -40.26 -27.56 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 21.7 mp0 -62.27 -28.55 69.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 tt0 -66.38 -44.62 82.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 110.249 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.071 HD13 HG22 ' A' ' 11' ' ' VAL . 38.2 mt -67.13 -35.65 80.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 87.4 mt -65.23 -60.75 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tpt180 -55.23 -69.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 26.0 mtpp -46.08 -29.62 1.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -60.57 -52.37 52.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.7 t -67.13 -16.24 64.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -1.181 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 54.1 t -81.73 -52.57 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -66.94 -39.7 87.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.743 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.605 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.9 m-30 -83.28 -19.55 36.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.853 . . . . 0.0 109.783 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 44.7 mm-40 60.34 77.74 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.475 -0.766 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.064 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -121.33 97.52 47.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 123.946 1.498 . . . . 0.0 109.714 179.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.722 ' HB3' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.089 0.471 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 176.23 154.23 0.2 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.113 -0.992 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -111.76 165.83 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 109.414 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.5 p -156.97 133.69 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.58 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.697 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -63.3 126.43 27.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.404 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 84.6 t80 -77.13 2.02 16.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.939 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -50.82 50.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.433 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.08 54.77 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.543 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 51.98 40.81 51.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.37 159.03 18.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.048 -1.266 . . . . 0.0 109.495 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.609 ' C ' HG23 ' A' ' 58' ' ' VAL . 7.3 mp0 -117.34 136.75 52.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 110.468 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.839 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.1 t -156.8 175.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.589 ' N ' HG12 ' A' ' 58' ' ' VAL . 72.2 p -130.83 160.39 34.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.58 -30.53 71.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.37 -0.831 . . . . 0.0 110.471 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.4 22.39 6.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 110.346 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 32.0 t -130.84 -35.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.198 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.141 ' CD1' HD11 ' A' ' 66' ' ' LEU . 34.2 m-85 -44.16 104.22 0.37 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.209 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.4 Cg_endo -72.96 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.009 1.531 . . . . 0.0 110.344 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.12 64.53 0.59 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.141 HD11 ' CD1' ' A' ' 63' ' ' PHE . 52.2 mt -43.71 162.81 0.18 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.303 -1.116 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ASN . 44.3 Cg_endo -72.51 164.44 35.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.169 1.615 . . . . 0.0 110.134 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' PRO . 8.8 p30 -44.49 151.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.945 . . . . 0.0 109.978 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.9 m-20 45.64 37.72 3.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.861 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -40.7 107.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.649 . . . . 0.0 110.186 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 72' ' ' LEU . 12.3 tt0 -83.25 97.87 9.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 110.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.818 HD21 ' CD1' ' A' ' 66' ' ' LEU . 9.0 mp -105.06 159.07 16.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.892 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.761 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -129.53 113.36 14.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.394 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.064 HD11 HD23 ' A' ' 42' ' ' LEU . 12.8 tp -67.89 133.47 49.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -145.98 157.7 43.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.117 -0.989 . . . . 0.0 109.493 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 47' ' ' SER . 39.6 p -132.6 -174.98 3.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.0 -12.13 46.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.92 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.3 25.17 27.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -156.37 163.14 39.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -1.153 . . . . 0.0 110.813 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.676 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.63 139.02 14.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.563 ' CE3' HD11 ' A' ' 16' ' ' LEU . 8.3 t-105 -103.94 137.01 42.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.756 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -69.41 -79.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.324 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . -160.64 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 18.5 t80 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.162 -1.199 . . . . 0.0 110.179 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.1 Cg_endo -71.58 127.11 12.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.943 1.496 . . . . 0.0 110.403 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -79.94 153.12 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 24.9 m -121.48 140.5 52.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 HD22 ' A' ' 32' ' ' LEU . 5.2 m -134.38 136.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.937 . . . . 0.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.18 92.33 5.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.541 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -73.55 94.11 2.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.59 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.912 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -88.96 158.14 18.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.442 -0.786 . . . . 0.0 109.64 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -138.51 135.8 35.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.651 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.7 -24.22 56.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.224 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 7.99 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.0 t -138.26 -164.88 1.7 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.133 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.07 24.25 8.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -161.14 -163.43 1.02 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 0.0 110.592 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -140.44 -162.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.494 -0.754 . . . . 0.0 110.177 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 6.9 t80 -138.47 79.54 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -63.94 84.3 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 32' ' ' LEU . 1.4 p -104.57 141.3 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.138 . . . . 0.0 110.122 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.33 146.97 43.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.448 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.876 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -160.96 144.16 13.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mmt180 -57.9 -61.87 2.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.095 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 1.5 t -77.97 96.89 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.955 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.0 p -42.57 -31.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 mm-40 -52.39 -30.93 31.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.106 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 9.5 mt-10 -72.31 -46.01 57.5 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.604 0.716 . . . . 0.0 109.422 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 29' ' ' CYS . 12.1 mt -56.26 -43.82 79.11 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.75 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 34' ' ' ARG . 70.5 mt -67.09 -69.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.691 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -45.76 -70.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.546 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 31' ' ' GLU . 1.9 mtmp? -46.13 -26.36 0.75 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.166 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.28 -46.01 66.72 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 42' ' ' LEU . 41.0 t -74.24 -16.51 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -1.153 . . . . 0.0 109.78 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 34' ' ' ARG . 20.1 t -84.23 -47.6 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.776 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -35.84 78.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-85 -91.14 -13.51 32.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.57 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 1.7 mt-30 56.44 83.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 110.764 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -118.17 113.62 37.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.016 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.7 Cg_endo . . . . . 0 C--N 1.306 -1.658 0 O-C-N 124.015 1.534 . . . . 0.0 110.726 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.116 0.484 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 172.84 150.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 110.154 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 74' ' ' LEU . 1.7 mt -115.39 168.56 9.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.0 p -157.02 146.38 20.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -70.92 118.83 14.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.713 ' HD1' HD13 ' A' ' 73' ' ' LEU . 63.1 t80 -76.34 -21.23 56.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.381 -0.824 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' TYR . 2.9 tp10 -43.38 -45.94 6.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 110.352 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -137.13 -49.53 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.383 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.24 49.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.71 164.98 12.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -1.149 . . . . 0.0 109.916 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.587 ' C ' HG23 ' A' ' 58' ' ' VAL . 5.5 pt-20 -118.18 131.42 56.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.042 -1.037 . . . . 0.0 110.543 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.6 t -154.64 170.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.523 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -119.44 157.65 27.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 11.3 p-10 -62.44 -16.62 56.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 110.596 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -102.17 6.23 40.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.47 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.5 m -112.19 -34.62 5.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.832 ' CE1' HG11 ' A' ' 58' ' ' VAL . 13.6 m-85 -45.57 104.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 110.399 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.8 Cg_endo -76.52 -86.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.071 1.564 . . . . 0.0 110.338 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.74 64.22 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 63' ' ' PHE . 94.5 mt -45.18 160.84 0.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.289 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.39 178.36 6.24 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -56.76 152.01 13.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 0.0 110.218 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' CYS . 6.1 m-20 44.36 38.85 2.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.797 . . . . 0.0 109.782 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.42 105.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' LEU . 18.4 mt-10 -73.18 103.02 3.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.642 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 66' ' ' LEU . 7.0 mp -113.19 159.74 18.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 109.623 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.912 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -140.09 132.91 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.032 -1.043 . . . . 0.0 110.475 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD11 HD23 ' A' ' 42' ' ' LEU . 11.1 tp -72.29 135.27 45.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.786 . . . . 0.0 109.889 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -146.04 155.33 42.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 10.9 p -146.33 178.29 8.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.57 70.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.09 7.95 53.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 160.02 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.219 -1.165 . . . . 0.0 110.54 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.609 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.01 140.69 12.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.437 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.6 t-105 -111.61 131.41 55.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.122 -0.986 . . . . 0.0 110.32 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -83.37 -61.69 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 150.53 159.62 8.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD1' ' CE2' ' A' ' 52' ' ' TYR . 2.5 t80 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.62 133.52 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.803 1.423 . . . . 0.0 110.575 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -81.59 -179.59 7.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 69' ' ' ASP . 23.5 t -150.54 148.68 28.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.41 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 32' ' ' LEU . 6.3 m -144.86 136.49 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 23.6 mmtt -95.83 94.51 7.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.064 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -72.24 89.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.593 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.908 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -86.7 150.85 23.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 17' ' ' HIS . . . -135.36 137.63 42.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.69 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 73' ' ' LEU . 1.2 mt -75.18 -22.79 57.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.903 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.747 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 28.5 p80 -84.34 6.93 21.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -161.38 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.058 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.56 27.02 6.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.38 -161.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -134.38 -176.26 4.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.82 . . . . 0.0 110.194 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -120.79 99.32 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.58 85.59 0.35 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.991 HG13 HD22 ' A' ' 32' ' ' LEU . 3.5 p -104.14 136.87 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 146.08 47.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.32 133.44 4.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.099 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -50.43 -30.55 12.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 110.458 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 31' ' ' GLU . 1.4 p -104.25 94.53 5.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 26.9 p -41.88 -31.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -30.9 71.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.928 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 68.1 tt0 -68.94 -32.06 71.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 HG13 ' A' ' 24' ' ' VAL . 16.5 mt -77.44 -31.47 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 94.1 mt -66.15 -57.74 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -59.0 -55.86 29.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 29.7 mtpp -55.02 -27.19 42.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.633 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.52 -51.55 30.71 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 29.1 t -65.67 -14.37 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -1.163 . . . . 0.0 109.604 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.69 -45.71 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -24.1 60.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-30 -102.6 -16.54 16.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.507 -0.746 . . . . 0.0 109.64 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 61.99 88.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.055 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -133.82 97.44 15.49 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.939 . . . . 0.0 110.034 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--N 1.304 -1.777 0 O-C-N 123.912 1.48 . . . . 0.0 110.264 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 76' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.151 0.501 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 176.05 154.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 110.922 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -114.9 116.77 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 56' ' ' THR . 29.0 m -94.41 -179.2 4.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.72 122.94 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 110.247 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -68.72 -7.61 35.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.17 -46.34 90.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 33.35 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 110.503 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 69.22 33.31 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.58 165.75 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -1.191 . . . . 0.0 109.834 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' C ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -119.54 128.45 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.39 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.986 HG11 ' CE1' ' A' ' 63' ' ' PHE . 14.3 t -150.08 -179.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.633 ' H ' HG12 ' A' ' 58' ' ' VAL . 22.9 p -131.4 159.82 36.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.002 . . . . 0.0 110.39 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.654 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.3 p30 -73.61 0.15 13.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.291 -0.881 . . . . 0.0 110.44 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -115.11 -1.29 13.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 110.515 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.6 t -108.07 -36.08 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.923 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.081 ' CE1' HD21 ' A' ' 66' ' ' LEU . 19.8 m-85 -39.62 99.29 0.19 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.436 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.5 Cg_endo -77.7 -33.28 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.044 1.55 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.84 68.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.081 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.1 mp -50.0 163.61 0.41 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.242 -1.152 . . . . 0.0 110.075 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 42.2 Cg_endo -69.43 178.67 4.14 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.109 1.584 . . . . 0.0 110.172 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.72 150.03 20.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.2 m-20 48.84 35.88 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.455 -0.778 . . . . 0.0 110.198 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -50.2 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.74 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 mm-40 -72.58 96.93 2.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -96.4 164.8 12.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HG3' ' A' ' 14' ' ' ARG . 1.4 tp -134.96 118.7 17.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.966 -1.084 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.055 HD11 HD23 ' A' ' 42' ' ' LEU . 15.4 tp -69.43 127.47 33.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -140.46 158.45 43.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 47' ' ' SER . 32.1 p -141.92 174.23 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.99 19.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.43 23.47 21.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.31 149.0 25.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 110.593 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -144.25 158.62 43.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 0.0 109.696 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.575 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -125.48 122.57 37.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.312 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.26 -82.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 0.0 110.115 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 55' ' ' GLY . . . -175.75 172.93 45.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 67.8 t80 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.317 -1.107 . . . . 0.0 110.087 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.7 Cg_endo -75.17 132.05 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.974 1.513 . . . . 0.0 110.789 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.39 159.81 25.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 69' ' ' ASP . 42.8 t -135.15 149.6 50.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.7 m -146.95 134.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.323 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 69' ' ' ASP . 37.6 mmtt -86.27 89.33 7.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -70.79 79.96 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.998 . . . . 0.0 110.201 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.837 ' CG ' HD12 ' A' ' 73' ' ' LEU . 6.5 tpt180 -83.8 159.12 21.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -150.8 122.44 8.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.278 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.895 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -76.79 -8.66 57.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 6.5 t-80 -94.54 10.44 34.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.512 ' O ' ' C ' ' A' ' 19' ' ' ALA . 4.5 m -149.49 30.28 0.75 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.514 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 27.28 49.86 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.095 0.474 . . . . 0.0 111.744 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -174.06 -176.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -145.03 -171.67 3.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 110.0 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 10.5 t80 -153.21 84.54 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.8 94.65 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.979 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -102.89 151.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -1.104 . . . . 0.0 110.769 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.43 151.86 51.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.441 -0.787 . . . . 0.0 110.012 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.875 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.8 136.0 0.89 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.71 -61.43 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.063 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 29' ' ' CYS . 17.7 m -78.3 96.71 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' C ' ' O ' ' A' ' 28' ' ' SER . 25.8 p -41.29 -28.73 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.524 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' SER . 6.9 tt0 -59.56 -25.6 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 110.192 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -70.53 -52.12 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HG13 ' A' ' 24' ' ' VAL . 32.1 mt -60.46 -34.61 74.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.867 . . . . 0.0 110.207 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 63' ' ' PHE . 11.0 mt -67.54 -64.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.066 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.69 -64.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' CB ' ' NZ ' ' A' ' 35' ' ' LYS . 7.6 mtmp? -49.45 -28.92 5.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.7 -48.78 78.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -71.42 -14.56 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.0 109.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.509 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 94.4 t -79.69 -49.43 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.929 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -28.9 62.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.019 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.8 m-30 -93.51 -11.56 31.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 30.4 mm-40 51.16 83.89 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.962 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -128.37 109.12 19.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.953 . . . . 0.0 110.779 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 47' ' ' SER . 47.4 Cg_endo . . . . . 0 C--N 1.305 -1.76 0 O-C-N 123.929 1.489 . . . . 0.0 110.205 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.279 0.561 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -179.87 140.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.733 . . . . 0.0 109.892 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 4.4 mt -109.26 165.81 11.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.059 -1.026 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 73' ' ' LEU . 4.7 p -154.46 157.38 38.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.431 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -85.97 124.44 32.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.706 ' HD2' HD13 ' A' ' 73' ' ' LEU . 35.7 t80 -73.44 -14.3 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.25 -57.06 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.84 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.99 5.09 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.473 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 95.46 32.88 6.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.8 176.78 8.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -1.231 . . . . 0.0 109.706 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.605 ' C ' HG23 ' A' ' 58' ' ' VAL . 40.4 mt-10 -125.29 138.11 54.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.03 . . . . 0.0 110.775 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.1 t -156.46 173.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 58' ' ' VAL . 29.9 p -121.52 158.37 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.511 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.1 p-10 -66.07 -7.81 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -108.62 -18.09 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.5 t -84.05 -39.34 19.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 58' ' ' VAL . 24.9 m-85 -42.32 101.6 0.25 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.1 Cg_endo -79.18 -90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.048 1.552 . . . . 0.0 110.666 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.98 66.37 0.3 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.99 HD22 ' HB1' ' A' ' 70' ' ' ALA . 3.6 mt -43.94 149.92 0.63 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.403 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -161.06 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.976 1.514 . . . . 0.0 110.115 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ASP . 31.6 p-10 -77.2 150.93 35.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . 5.8 t0 42.08 37.05 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.74 . . . . 0.0 110.016 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.99 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -46.43 120.27 2.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 3.4 mp0 -83.2 106.94 15.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.943 . . . . 0.0 110.85 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 3.2 mp -110.92 154.59 23.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.895 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -138.73 127.99 24.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.014 -1.054 . . . . 0.0 110.662 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.705 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -74.08 134.82 42.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 110.24 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.787 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.9 OUTLIER -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.628 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 79' ' ' GLU . 4.4 p -147.51 169.66 19.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.072 . . . . 0.0 109.843 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.14 -33.67 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.3 17.97 39.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -1.193 . . . . 0.0 110.544 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.787 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.19 172.39 13.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.223 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.553 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.7 t-105 -141.24 122.88 15.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -70.15 -79.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.485 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . 179.09 171.87 42.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.218 -1.166 . . . . 0.0 110.239 -179.947 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.1 Cg_endo -72.87 125.53 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.835 1.439 . . . . 0.0 110.537 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 160.2 24.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 69' ' ' ASP . 37.3 m -130.76 152.96 49.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.038 HG22 HD22 ' A' ' 32' ' ' LEU . 9.2 m -141.55 125.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . 10.0 mmtt -87.95 85.45 7.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.6 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -74.81 81.41 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.607 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.642 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -79.72 160.47 26.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.815 . . . . 0.0 109.325 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -135.06 124.24 24.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.773 -1.204 . . . . 0.0 110.679 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 81' ' ' TRP . 2.2 mt -75.72 -20.88 58.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -79.41 2.88 20.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.884 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -140.66 -175.12 4.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.873 . . . . 0.0 109.783 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.04 33.42 4.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.267 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.04 -167.91 2.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.62 -164.88 1.97 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.911 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 8.5 t80 -144.58 77.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.44 92.54 0.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.986 HG13 HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -116.96 151.58 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -128.25 173.79 9.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.386 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.1 126.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.035 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.94 -55.98 3.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -81.42 97.82 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.729 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.4 p -41.6 -30.79 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -0.824 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.23 -34.95 59.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 1.6 mp0 -67.11 -46.46 74.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.689 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG22 ' A' ' 11' ' ' VAL . 18.0 mt -54.42 -42.46 70.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -63.17 -70.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.11 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -59.64 2.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -49.45 -26.6 3.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -70.39 -58.08 6.26 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 44.6 t -64.85 -13.65 56.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' GLN . 31.1 t -85.76 -72.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 109.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.13 -29.82 1.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 13' ' ' LEU . 4.5 m-30 -96.69 -17.94 20.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.567 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.4 mt-30 57.11 84.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.744 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -124.08 101.57 35.16 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 109.977 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.177 -179.781 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 34.7 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.275 0.559 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.41 158.23 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 110.514 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -110.59 165.9 11.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 109.228 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 73' ' ' LEU . 6.1 p -159.35 133.33 7.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.099 . . . . 0.0 110.769 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -62.4 120.92 11.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.484 -0.76 . . . . 0.0 110.3 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -70.31 -6.2 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 19.4 tt0 -54.11 -65.58 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.35 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -131.6 23.86 4.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 83.2 28.52 36.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.39 165.11 25.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.183 -1.186 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' C ' HG23 ' A' ' 58' ' ' VAL . 35.5 mt-10 -119.24 135.54 54.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.3 t -154.3 175.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 42.8 p -122.39 166.66 14.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.9 p-10 -66.57 -7.37 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.288 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -22.43 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.7 m -84.24 13.89 4.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.955 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -100.42 97.82 7.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.017 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.9 Cg_endo -71.3 -92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.896 1.472 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -128.95 64.86 0.6 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' PHE . 12.0 mt -42.92 161.78 0.18 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -1.096 . . . . 0.0 110.174 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.6 Cg_endo -71.95 162.91 40.46 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.075 1.566 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -42.29 150.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.59 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 42.98 38.35 1.4 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.881 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.85 110.35 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 110.175 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 12' ' ' LYS . 2.3 tp10 -70.48 99.76 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.357 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 66' ' ' LEU . 6.5 mp -114.6 158.09 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -140.14 116.86 10.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 110.434 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.955 HD11 HD23 ' A' ' 42' ' ' LEU . 6.8 tp -70.64 149.12 47.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -153.51 155.3 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.091 -1.005 . . . . 0.0 110.007 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 19.2 p -135.88 172.46 12.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.08 -31.77 31.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.865 . . . . 0.0 110.291 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.92 17.47 41.04 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' CA ' ' OE1' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -149.97 149.38 30.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -1.21 . . . . 0.0 110.574 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.753 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.26 134.84 22.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.861 ' HB2' HD12 ' A' ' 16' ' ' LEU . 7.1 t-105 -103.16 133.25 48.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -83.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -169.82 158.11 30.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 34.7 t80 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 7' ' ' GLN . 45.8 Cg_endo -72.58 133.85 21.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.977 1.514 . . . . 0.0 110.586 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -171.91 3.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 50.6 t -149.16 149.45 31.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.001 -1.062 . . . . 0.0 110.505 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.2 m -148.26 134.71 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 mmtp -97.28 95.15 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -74.25 89.45 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.984 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.626 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -89.39 151.72 21.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.963 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.05 131.31 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 110.576 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -70.73 -24.47 62.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.416 ' HB2' ' OE2' ' A' ' 79' ' ' GLU . 3.6 t-160 -86.72 16.08 5.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -135.1 -161.28 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.43 29.79 5.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.296 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 174.84 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 110.666 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.37 164.37 30.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 15.0 t80 -102.5 79.66 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -61.92 87.84 0.04 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.038 HG13 HD22 ' A' ' 32' ' ' LEU . 8.6 p -103.37 140.59 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.616 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.15 39.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.761 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.79 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -173.99 148.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 11.0 mmt180 -62.97 -48.16 80.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -84.57 89.19 7.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 110.104 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 28' ' ' SER . 6.6 p -42.64 -31.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.08 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.14 -36.09 78.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 109.907 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 2.7 tp10 -62.41 -51.41 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.778 . . . . 0.0 110.019 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG13 ' A' ' 24' ' ' VAL . 43.7 mt -53.41 -39.26 64.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 63' ' ' PHE . 4.5 mt -57.26 -69.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 110.148 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.735 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.27 -60.14 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.849 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 14.0 mtpt -46.97 -27.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.486 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -69.98 -56.09 8.53 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.6 -15.18 25.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.196 . . . . 0.0 109.937 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 34' ' ' ARG . 24.5 t -87.97 -55.48 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.733 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.64 70.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 3.2 m-30 -95.79 -21.99 17.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.382 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.26 84.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.516 -0.74 . . . . 0.0 110.732 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.025 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.15 98.47 38.8 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 110.159 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--N 1.306 -1.694 0 O-C-N 123.958 1.504 . . . . 0.0 109.774 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' HD11 ' A' ' 42' ' ' LEU . 49.1 m . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.362 0.601 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER 178.61 150.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 60' ' ' ASP . 5.1 mp -115.81 115.15 25.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 56' ' ' THR . 99.9 m -92.46 -171.13 2.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 111.058 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD12 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -121.72 126.85 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.647 -0.658 . . . . 0.0 109.729 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.31 -15.45 63.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 110.816 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -44.9 -68.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.995 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 54' ' ' ASP . 26.3 t70 -143.07 40.09 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.467 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.549 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 72.23 38.5 58.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -80.47 160.03 25.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -1.193 . . . . 0.0 109.834 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -114.49 128.77 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 110.383 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.045 HG11 ' CE1' ' A' ' 63' ' ' PHE . 3.1 t -147.93 -171.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.743 ' H ' HG12 ' A' ' 58' ' ' VAL . 53.9 p -145.41 165.51 28.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.049 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.653 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.7 p-10 -79.23 8.65 5.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -124.92 5.52 8.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 110.354 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t -119.78 -36.56 3.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.045 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -40.86 100.58 0.22 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.6 Cg_endo -76.67 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.039 1.547 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -110.47 67.68 0.22 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.6 mp -41.95 146.13 0.66 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 110.425 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.65 158.08 43.77 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.116 1.587 . . . . 0.0 110.281 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 12.4 p30 -44.27 147.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 109.89 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.7 OUTLIER 43.88 36.4 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.684 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.98 119.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -82.49 101.51 10.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.741 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 1.2 mp -110.24 152.76 25.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -131.02 104.83 7.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.59 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.025 HD11 HD23 ' A' ' 42' ' ' LEU . 10.2 tp -60.5 126.66 28.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -139.16 158.57 43.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.982 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 49.8 p -134.24 176.39 8.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.16 -32.51 36.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.85 20.95 29.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -145.3 148.62 33.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.721 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.76 138.0 24.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.451 -0.781 . . . . 0.0 109.855 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.467 ' HB2' ' CD2' ' A' ' 73' ' ' LEU . 5.5 t-105 -107.89 123.94 49.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.991 -1.068 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -67.33 -62.47 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 153.69 6.07 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 14.1 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.348 -1.089 . . . . 0.0 110.171 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.46 130.79 16.59 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.871 1.459 . . . . 0.0 110.566 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 4.3 ttpt -79.98 155.13 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.85 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' VAL . 7.4 t -129.52 153.46 47.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.622 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.619 HG22 HD13 ' A' ' 32' ' ' LEU . 10.6 m -148.66 135.0 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.08 96.21 10.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 110.355 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -76.33 81.58 3.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.92 . . . . 0.0 110.024 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.718 ' CG ' HD12 ' A' ' 73' ' ' LEU . 5.3 tpt180 -80.59 158.72 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -140.26 112.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -62.5 -30.38 71.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.857 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.572 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 52.1 t60 -82.19 8.1 11.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 28.6 t -121.2 -160.59 0.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -119.23 19.51 12.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 175.84 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.108 -0.995 . . . . 0.0 110.781 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.97 168.8 18.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.552 -0.718 . . . . 0.0 109.883 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -122.52 99.85 6.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.323 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.41 92.58 0.27 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.998 HG13 HD22 ' A' ' 32' ' ' LEU . 4.1 p -97.39 146.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 0.0 110.354 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.596 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -134.92 144.88 47.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.37 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -170.51 123.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.5 mtt180 -42.29 -29.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -100.67 95.64 6.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.277 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 30' ' ' GLN . 21.1 p -44.98 -33.27 1.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.449 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 8.5 mp0 -62.55 -20.64 64.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.73 -48.3 16.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.934 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.998 HD22 HG13 ' A' ' 24' ' ' VAL . 22.3 mt -58.98 -38.86 80.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.022 HD21 ' CD1' ' A' ' 66' ' ' LEU . 52.8 mt -66.36 -63.63 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.687 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.4 mmm-85 -52.78 -65.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.804 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 28.0 mtpt -50.61 -24.21 3.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.607 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.7 -52.55 11.93 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -63.28 -16.11 59.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -1.203 . . . . 0.0 110.056 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 34' ' ' ARG . 99.3 t -78.16 -59.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.008 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -35.1 79.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.942 . . . . 0.0 109.982 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.7 m-30 -84.87 -14.72 46.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 58.2 mm-40 53.1 78.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.398 -0.814 . . . . 0.0 110.554 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -116.82 97.63 50.77 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.9 Cg_endo . . . . . 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.693 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -177.63 146.52 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.01 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.715 ' CD2' HD12 ' A' ' 74' ' ' LEU . 2.2 mt -114.65 169.12 9.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 3.6 p -151.98 161.92 41.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.945 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.752 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -92.47 115.97 28.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.65 -0.656 . . . . 0.0 109.955 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.47 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 7.5 t80 -64.22 -15.43 59.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.409 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -48.77 -51.69 27.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.47 20.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 82.57 22.26 58.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.8 174.34 2.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.127 -1.22 . . . . 0.0 109.672 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 4.9 mm-40 -126.17 137.05 53.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.513 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 51' ' ' LEU . 90.5 t -156.64 173.96 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.193 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -121.87 159.9 25.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.896 . . . . 0.0 110.023 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.57 -7.79 11.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.637 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -15.38 14.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.02 -1.05 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.2 m -88.34 -40.63 13.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.045 . . . . 0.0 110.45 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.602 ' CE1' HD21 ' A' ' 72' ' ' LEU . 47.8 m-85 -39.77 99.75 0.2 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.462 -0.774 . . . . 0.0 110.357 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.8 Cg_endo -76.74 -87.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.071 1.563 . . . . 0.0 110.406 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -117.63 67.31 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.022 ' CD1' HD21 ' A' ' 33' ' ' LEU . 1.6 mt -43.03 143.23 1.31 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.957 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 44.1 Cg_endo -72.32 167.36 27.12 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.019 1.537 . . . . 0.0 110.47 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ASP . 4.2 t-20 -52.1 152.91 2.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 110.457 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER 42.49 38.92 1.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.809 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.994 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -54.33 116.9 2.88 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mt-10 -89.12 108.06 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.6 mp -117.08 159.75 22.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 110.004 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.718 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -134.7 139.97 45.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.646 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.036 HD11 HD23 ' A' ' 42' ' ' LEU . 12.2 tp -79.99 144.73 33.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 75' ' ' LEU . 3.1 tt -154.02 159.96 41.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 21.9 p -152.17 167.81 27.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -45.89 -29.89 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.147 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.81 22.45 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -155.81 152.69 28.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.613 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.573 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.789 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.523 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 9.5 t-105 -107.8 135.28 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.008 -1.058 . . . . 0.0 110.786 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -78.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.336 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.483 ' O ' ' CZ2' ' A' ' 81' ' ' TRP . . . 174.22 177.92 43.74 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 61.2 t80 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.258 -1.142 . . . . 0.0 110.271 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 7' ' ' GLN . 43.9 Cg_endo -71.15 134.14 24.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.924 1.487 . . . . 0.0 110.814 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 152.5 22.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.969 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 69' ' ' ASP . 39.2 m -121.75 153.67 37.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 110.383 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.831 HG22 HD22 ' A' ' 32' ' ' LEU . 11.3 m -147.2 132.77 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -97.46 99.59 11.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.919 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -81.52 95.04 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.639 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 4.7 tpt180 -91.61 157.59 16.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.572 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.78 120.06 10.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -64.86 -17.44 64.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.893 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -79.69 -0.54 34.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -134.18 -159.17 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.858 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.16 34.2 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.435 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 6.7 p -177.18 -162.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 110.706 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -140.21 -169.15 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.522 -0.736 . . . . 0.0 110.038 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 3.7 t80 -130.41 81.29 2.0 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 110.28 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.27 85.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HD23 ' A' ' 32' ' ' LEU . 2.1 p -107.21 146.6 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -1.14 . . . . 0.0 110.117 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.68 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -124.13 163.63 21.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.002 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.912 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 179.45 135.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -0.863 . . . . 0.0 110.202 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -52.39 -61.69 2.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' CYS . 70.7 m -75.22 93.87 2.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.868 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.752 ' HA ' HD12 ' A' ' 32' ' ' LEU . 21.3 p -40.98 -30.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -38.49 58.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -68.07 -43.16 79.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.751 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.082 HD23 HG13 ' A' ' 24' ' ' VAL . 17.0 mt -53.75 -46.81 71.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.563 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.659 HD11 HD11 ' A' ' 66' ' ' LEU . 27.8 mt -66.87 -67.18 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 109.898 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -43.73 -68.31 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.61 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 5.6 mtpp -46.83 -27.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.87 -55.64 16.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.22 -13.77 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.179 . . . . 0.0 109.714 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 78.4 t -87.27 -52.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.77 . . . . 0.0 109.997 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -63.83 -29.25 70.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.4 m-30 -99.24 -18.86 17.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 109.503 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER 60.34 85.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 110.699 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.717 ' CG ' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -124.89 92.4 47.74 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.07 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 124.009 1.531 . . . . 0.0 110.153 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 76' ' ' THR . 39.4 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.1 OUTLIER 176.41 167.62 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.49 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 60' ' ' ASP . 0.6 OUTLIER -120.57 170.25 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 109.556 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 56' ' ' THR . 74.1 m -148.36 -178.99 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.477 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -116.1 120.08 37.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.973 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -5.98 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 110.538 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -50.05 -62.59 1.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.471 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -147.53 20.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 110.724 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.546 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 96.33 44.56 2.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -94.88 167.57 11.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 109.985 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.526 ' C ' HG23 ' A' ' 58' ' ' VAL . 9.5 mm-40 -122.03 136.81 54.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.888 HG11 ' CE1' ' A' ' 63' ' ' PHE . 11.7 t -151.73 179.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.621 ' H ' HG12 ' A' ' 58' ' ' VAL . 18.4 p -129.91 164.76 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.553 ' N ' HD13 ' A' ' 49' ' ' LEU . 17.5 p-10 -73.96 1.2 11.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.44 -23.95 7.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 37.4 t -79.96 -41.24 26.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.401 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.933 ' HB3' HD11 ' A' ' 66' ' ' LEU . 12.6 m-85 -40.49 99.78 0.21 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.488 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.9 Cg_endo -80.59 -87.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 110.595 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.8 67.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.933 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.3 mp -44.38 148.16 0.9 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.305 -1.115 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.81 157.58 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.935 1.492 . . . . 0.0 109.976 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.98 146.46 0.81 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.038 -1.039 . . . . 0.0 110.067 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.9 m-20 45.58 36.47 2.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.709 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -42.58 116.45 0.86 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.85 95.45 9.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.0 mp -103.92 162.8 12.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.744 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -136.43 106.5 6.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.551 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 42' ' ' LEU . 17.1 tp -55.3 148.35 14.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.719 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.65 156.57 32.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 47' ' ' SER . 21.5 p -138.83 165.74 26.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 110.359 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 76' ' ' THR . . . -43.76 -32.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.98 27.79 7.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -154.73 155.87 35.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 110.587 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.719 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.1 141.07 16.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.847 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.488 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.1 t-105 -110.69 130.1 55.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.0 110.338 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -72.54 -61.79 1.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.93 . . . . 0.0 110.099 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.7 162.7 10.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 26.3 t80 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.407 -1.055 . . . . 0.0 110.218 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 120.707 0.289 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.4 Cg_endo -73.77 126.3 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 110.314 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -79.61 152.57 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 0.0 110.034 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.896 ' SG ' ' HB2' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -124.36 151.01 44.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.597 HG22 HD13 ' A' ' 32' ' ' LEU . 22.8 m -148.02 141.03 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.73 102.61 15.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.3 tp -78.63 89.52 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.607 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -91.49 154.68 18.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -140.34 113.1 8.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.036 -1.04 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -58.09 -20.8 42.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -81.5 -0.18 40.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -127.1 -160.91 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.98 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.76 28.54 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.347 -0.845 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -179.39 -159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.603 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.38 -176.03 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 110.033 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.7 t80 -133.83 91.13 2.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.97 95.02 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.868 HG13 HD22 ' A' ' 32' ' ' LEU . 4.2 p -101.56 147.14 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -1.083 . . . . 0.0 110.3 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.896 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . . . -128.09 147.74 50.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 110.35 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -169.79 150.84 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 mmt180 -62.0 -55.94 24.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 7.8 p -83.49 96.97 8.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.2 p -41.29 -29.65 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.566 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.8 mm100 -60.34 -23.55 64.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.076 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -74.12 -46.78 40.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HG13 ' A' ' 24' ' ' VAL . 24.3 mt -59.7 -38.25 81.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.976 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 30' ' ' GLN . 18.4 mt -67.16 -54.98 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.859 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -58.74 -65.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.764 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 19.5 mtpp -49.9 -29.37 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.402 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -68.43 -53.04 23.09 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.6 t -57.53 -17.0 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.554 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 34' ' ' ARG . 47.6 t -84.24 -56.3 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.985 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -62.92 -33.54 75.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.7 m-30 -94.13 -13.25 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.88 84.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.698 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -127.34 96.78 32.76 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.0 -1.062 . . . . 0.0 110.257 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 47' ' ' SER . 43.7 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 124.086 1.572 . . . . 0.0 110.332 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.197 0.523 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 175.99 153.74 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.182 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.578 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.1 mt -122.84 160.08 26.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.647 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 56' ' ' THR . 63.7 m -147.78 139.18 23.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 110.348 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -67.32 120.3 13.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.487 -0.758 . . . . 0.0 110.463 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 21.5 t80 -69.54 -12.58 61.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.765 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.06 -41.14 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 110.319 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.58 40.2 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.182 -0.948 . . . . 0.0 110.645 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 57.38 29.75 60.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -74.2 161.08 30.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.249 . . . . 0.0 109.7 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.6 pt-20 -114.75 133.0 56.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.048 -1.032 . . . . 0.0 110.599 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.77 HG11 ' CE1' ' A' ' 63' ' ' PHE . 81.3 t -156.67 173.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.588 ' N ' HG12 ' A' ' 58' ' ' VAL . 24.2 p -122.58 158.81 29.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.1 p-10 -63.16 -16.19 59.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 110.405 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -1.49 31.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.0 t -101.06 -41.46 6.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.875 ' CD1' HD21 ' A' ' 66' ' ' LEU . 35.2 m-85 -39.61 99.27 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.726 . . . . 0.0 110.246 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.5 Cg_endo -73.65 -55.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.008 1.531 . . . . 0.0 110.462 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.6 68.51 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.875 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.5 mp -48.09 160.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.126 . . . . 0.0 109.879 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.12 165.6 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -44.64 150.38 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.248 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.0 m-20 47.43 35.74 4.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -52.22 125.84 17.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.753 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.595 ' C ' HD22 ' A' ' 72' ' ' LEU . 31.5 mp0 -96.25 110.24 22.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.163 -0.96 . . . . 0.0 110.914 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.758 HD21 HD22 ' A' ' 66' ' ' LEU . 2.7 mm? -114.48 141.26 47.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 0.0 109.788 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -115.9 149.25 38.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 0.0 110.416 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.8 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.7 tp -86.98 147.1 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.824 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.3 tt -158.99 157.06 30.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.8 p -152.29 173.21 15.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.59 -36.14 6.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -87.36 23.24 12.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.4 mt-10 -157.65 150.71 23.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.093 -1.239 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.53 133.17 20.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.518 ' NE1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -96.88 125.52 41.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.248 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.418 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 26.4 m80 -67.8 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 110.166 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.5 128.65 1.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.979 179.753 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 120.72 0.295 . . . . 0.0 110.268 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.0 Cg_endo -71.65 137.53 30.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.864 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 169.24 16.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.745 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.445 ' C ' HG13 ' A' ' 11' ' ' VAL . 26.5 m -141.38 152.32 44.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.6 m -148.07 142.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 55.2 mmtt -98.33 92.4 5.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -72.61 84.31 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 110.382 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.729 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -81.59 159.82 23.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.825 . . . . 0.0 109.693 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -141.31 126.64 18.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 110.589 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -68.57 -24.51 64.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.951 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -79.93 5.98 12.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -150.81 148.88 29.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 110.019 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.42 54.94 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 110.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.2 p -173.65 -172.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.25 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.473 -0.767 . . . . 0.0 109.931 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 24' ' ' VAL . 14.2 t80 -147.71 79.0 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.0 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -62.49 81.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.015 HG13 HD22 ' A' ' 32' ' ' LEU . 4.8 p -93.83 144.99 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -1.102 . . . . 0.0 110.728 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -123.68 154.42 39.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 110.059 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -177.12 130.05 0.17 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 ttp180 -45.51 -57.15 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.2 p -82.26 97.18 8.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 31.5 p -41.83 -29.42 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' OE1' ' SG ' ' A' ' 29' ' ' CYS . 1.4 mp0 -56.69 -24.02 46.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -46.2 42.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.373 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.015 HD22 HG13 ' A' ' 24' ' ' VAL . 20.4 mt -61.68 -39.46 91.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.515 HD13 ' HB2' ' A' ' 63' ' ' PHE . 29.1 mt -63.03 -58.78 6.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.053 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 4.4 mmt180 -59.42 -71.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 0.0 109.86 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' ARG . 32.6 mtpt -42.96 -34.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.776 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -63.96 -54.66 29.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.0 t -61.5 -13.5 21.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.15 -1.206 . . . . 0.0 109.872 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.6 -49.98 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.0 109.687 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -25.51 63.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.534 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.1 m-30 -99.63 -18.96 17.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.797 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 60.57 83.23 0.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.739 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -125.06 102.85 30.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.99 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.9 Cg_endo . . . . . 0 C--N 1.303 -1.831 0 O-C-N 123.938 1.494 . . . . 0.0 110.531 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.019 0.438 . . . . 0.0 109.993 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.2 147.05 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.893 -1.129 . . . . 0.0 110.948 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 59' ' ' THR . 1.1 mp -110.09 175.76 5.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.36 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HD23 ' A' ' 73' ' ' LEU . 1.9 p -159.07 146.6 17.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 0.0 110.673 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -71.55 111.51 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 110.121 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.751 ' CD1' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -68.97 -14.54 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -53.05 -44.51 67.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.285 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t70 -136.47 -33.78 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.468 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 131.3 38.59 0.27 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.523 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.3 171.5 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.102 . . . . 0.0 110.018 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.558 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.7 mm-40 -121.24 135.94 55.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 109.73 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.5 t -155.38 168.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.601 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 49' ' ' LEU . 55.0 p -110.14 159.46 17.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 110.12 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.8 p-10 -67.06 -8.01 27.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 110.433 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.32 -17.1 14.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.6 m -84.58 -41.61 16.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.718 ' CE1' HG11 ' A' ' 58' ' ' VAL . 18.6 m-85 -40.0 100.18 0.21 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.401 -0.812 . . . . 0.0 110.57 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -75.84 -89.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.07 1.563 . . . . 0.0 110.36 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -125.98 65.83 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 17.5 mt -42.76 163.37 0.15 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -73.0 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.214 1.639 . . . . 0.0 109.921 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -74.44 150.28 40.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.126 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 70' ' ' ALA . 38.7 m-20 42.75 37.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.86 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -41.03 100.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.63 . . . . 0.0 110.253 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.7 tt0 -71.35 106.07 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.367 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 71' ' ' GLU . 6.0 mp -111.37 166.42 11.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -142.39 138.33 31.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.739 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -80.89 146.23 30.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.82 159.45 36.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.092 -1.005 . . . . 0.0 109.899 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.2 p -150.98 174.08 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.41 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.931 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.28 18.47 57.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -151.49 161.22 43.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -1.145 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.13 142.64 17.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.827 . . . . 0.0 110.166 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.7 t-105 -116.26 133.12 56.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.125 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.28 -80.23 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -168.36 154.19 23.85 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.14 . . . . 0.0 110.28 -179.798 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.809 0.337 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.3 Cg_endo -73.3 123.58 8.84 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.129 1.594 . . . . 0.0 110.953 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 1.9 ttpm? -80.92 155.87 26.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.743 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' ASP . 25.0 t -125.38 151.84 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 24' ' ' VAL . 8.9 m -144.53 149.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -99.31 101.24 12.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -79.27 75.28 5.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.431 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.844 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.8 tpt180 -83.73 157.31 22.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 18' ' ' SER . . . -135.83 122.4 20.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.049 -1.032 . . . . 0.0 110.661 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.011 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.36 -30.6 66.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CA ' ' OE2' ' A' ' 79' ' ' GLU . 61.0 t-80 -79.89 5.76 12.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 110.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 58.0 m -127.18 -163.79 1.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.961 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.14 33.05 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -171.88 -162.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.822 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.95 -164.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.769 . . . . 0.0 109.853 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.0 t80 -156.08 89.56 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.447 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.56 96.1 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 32' ' ' LEU . 2.3 p -105.74 151.83 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 110.43 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.06 161.81 33.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.059 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -178.52 141.91 0.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 0.0 110.478 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.38 -65.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.99 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.3 OUTLIER -79.72 95.03 5.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.846 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 29.5 p -41.44 -28.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.808 . . . . 0.0 110.423 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 13.0 tt0 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 1.2 tp10 -74.41 -46.13 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.385 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 24' ' ' VAL . 22.0 mt -60.97 -36.89 80.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 66' ' ' LEU . 63.8 mt -66.37 -59.89 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.838 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -70.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 24.0 mtpp -45.48 -32.03 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.598 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -61.6 -51.27 58.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.3 t -65.76 -15.78 63.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.696 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 82.5 t -80.53 -46.5 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -32.57 64.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.671 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.516 ' CD2' HD22 ' A' ' 74' ' ' LEU . 2.0 m-30 -90.6 -10.55 42.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.77 82.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.322 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.63 111.26 27.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 110.153 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 47' ' ' SER . 46.7 Cg_endo . . . . . 0 C--N 1.304 -1.779 0 O-C-N 124.015 1.534 . . . . 0.0 110.301 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.143 0.497 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.914 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 178.95 140.03 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 60' ' ' ASP . 2.0 mp -112.1 118.73 36.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.374 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 75' ' ' LEU . 71.6 m -103.34 155.11 18.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.056 -1.028 . . . . 0.0 110.753 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -83.27 124.09 30.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.014 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 73' ' ' LEU . 6.5 t80 -73.93 1.24 11.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.741 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' HD23 ' A' ' 51' ' ' LEU . 1.1 tp10 -59.73 -54.97 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.35 21.19 1.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 87.63 35.9 9.0 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.11 163.15 22.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -1.175 . . . . 0.0 110.013 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' C ' HG23 ' A' ' 58' ' ' VAL . 14.7 pt-20 -116.04 134.81 54.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.054 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.2 t -153.09 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.589 ' H ' HG12 ' A' ' 58' ' ' VAL . 44.5 p -131.48 161.44 32.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.003 -1.061 . . . . 0.0 109.99 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.7 p-10 -72.61 -0.75 13.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 110.579 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -113.0 -11.52 13.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.379 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 3.3 t -98.39 -38.2 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.48 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.105 ' CE1' HD21 ' A' ' 66' ' ' LEU . 6.9 m-85 -39.99 99.48 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.2 Cg_endo -81.35 -67.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.935 1.492 . . . . 0.0 110.349 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -147.97 64.78 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.105 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.7 mt -42.31 163.45 0.13 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 43.5 Cg_endo -71.24 161.98 44.01 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.209 1.636 . . . . 0.0 110.2 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.45 153.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 4.8 m-20 45.02 37.22 2.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -49.54 112.83 0.7 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.406 -0.808 . . . . 0.0 109.864 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 111.64 18.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.574 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 mp -109.22 148.32 31.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.752 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 16' ' ' LEU . 1.1 tp -132.18 126.03 32.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.943 -1.098 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.8 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -67.74 131.24 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 109.929 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.914 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.3 tt -147.77 159.48 43.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 109.656 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.3 p -146.79 -178.03 5.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.94 73.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.14 11.13 58.82 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' OE2' ' CA ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER -141.96 154.16 44.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -1.184 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.576 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -150.59 141.61 23.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -114.51 129.53 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.351 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -66.81 -69.92 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.235 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 131.81 2.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.4 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.191 -1.182 . . . . 0.0 110.477 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.3 Cg_endo -72.0 125.52 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.981 1.517 . . . . 0.0 110.97 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -85.89 153.35 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' ASP . 13.5 t -127.61 158.83 36.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.381 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG2' HG12 ' A' ' 24' ' ' VAL . 5.4 m -149.02 135.87 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -92.89 96.47 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -75.84 82.42 2.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.877 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.5 tpt180 -81.01 160.53 24.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.39 132.31 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 110.519 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.559 HD12 HD21 ' A' ' 73' ' ' LEU . 4.6 mt -74.55 -20.86 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 109.941 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.529 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 21.4 t60 -79.96 3.34 20.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.899 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 165.48 31.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.96 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 53.2 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -174.98 -172.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 111.09 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -145.62 -162.11 1.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.501 -0.749 . . . . 0.0 109.919 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 9.0 t80 -144.86 87.23 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 110.491 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.07 83.47 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.04 HG13 HD22 ' A' ' 32' ' ' LEU . 7.5 p -95.1 152.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -1.158 . . . . 0.0 110.239 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.7 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.57 164.29 26.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.92 133.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mtm180 -50.14 -33.41 18.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' GLN . 3.2 m -107.35 93.74 4.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.898 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 13.9 p -38.77 -28.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.581 -0.699 . . . . 0.0 110.466 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.12 -33.88 72.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.5 tt0 -68.13 -31.33 70.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HG13 ' A' ' 24' ' ' VAL . 30.0 mt -76.38 -34.34 58.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.94 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 63' ' ' PHE . 79.9 mt -66.91 -61.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 tpt180 -53.25 -53.8 45.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtpm? -56.78 -28.25 60.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.341 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -65.46 -51.98 43.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.9 t -67.09 -18.07 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -1.228 . . . . 0.0 109.84 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 34' ' ' ARG . 77.9 t -81.11 -53.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.891 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -66.79 -42.03 86.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.5 m-30 -84.95 -13.22 51.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.558 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.77 80.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.437 -0.789 . . . . 0.0 110.281 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -111.5 105.13 56.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 124.048 1.552 . . . . 0.0 110.495 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.211 0.529 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.57 142.55 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.925 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.604 HD21 HD12 ' A' ' 74' ' ' LEU . 3.5 mt -108.72 162.49 14.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.594 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.3 p -149.78 162.59 39.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.614 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.36 115.7 27.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -70.19 -5.96 31.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.376 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.64 -54.26 47.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.5 8.56 3.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 91.5 29.0 12.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.544 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -74.66 176.65 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 109.888 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' HG23 ' A' ' 58' ' ' VAL . 12.2 mt-10 -126.83 137.06 53.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 110.733 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.0 t -155.77 174.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.578 ' N ' HG12 ' A' ' 58' ' ' VAL . 43.3 p -122.92 165.22 17.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 110.261 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 p-10 -69.79 -4.1 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.892 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.87 -8.12 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.315 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.7 m -105.07 18.69 21.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.197 -0.939 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.877 ' CD1' HD11 ' A' ' 66' ' ' LEU . 10.9 m-85 -100.87 98.58 8.68 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -72.98 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -127.45 66.54 0.56 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.877 HD11 ' CD1' ' A' ' 63' ' ' PHE . 16.1 mt -41.44 162.98 0.12 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.311 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.1 Cg_endo -70.75 154.89 63.57 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.232 1.649 . . . . 0.0 109.854 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.3 t-20 -41.91 143.99 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 10' ' ' CYS . 2.6 m-20 54.38 36.18 24.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.713 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.81 111.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.586 -0.696 . . . . 0.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 98.23 5.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 mp -108.34 156.03 19.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.911 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.877 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -139.11 123.99 18.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.834 HD11 HD23 ' A' ' 42' ' ' LEU . 11.5 tp -67.77 138.45 56.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 110.184 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.7 OUTLIER -148.76 157.67 43.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.47 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -148.02 176.8 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.25 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.46 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.42 15.03 52.87 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 2.4 mt-10 -143.42 145.88 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -1.13 . . . . 0.0 110.513 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.722 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.77 157.77 43.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.822 . . . . 0.0 109.812 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.536 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.7 t-105 -129.73 126.69 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.459 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.54 -59.28 3.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.391 -0.818 . . . . 0.0 110.11 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.46 161.34 8.69 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 45.6 t80 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 110.144 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 4.9 pt20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -73.16 125.73 10.54 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.945 1.497 . . . . 0.0 110.794 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -80.92 171.4 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.917 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ASP . 44.5 m -138.68 151.16 46.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' VAL . 5.5 m -146.32 129.51 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 13.7 mmmt -85.65 96.69 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -75.76 87.21 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 110.698 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.884 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -81.99 154.83 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.705 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -143.43 117.23 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.818 HD12 HD21 ' A' ' 73' ' ' LEU . 1.5 mt -60.81 -27.44 68.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.201 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -83.1 10.77 7.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.13 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -128.19 -161.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.82 14.17 15.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.399 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 -155.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -130.36 176.0 8.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 110.301 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 24' ' ' VAL . 19.2 t80 -120.19 84.93 2.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.82 85.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 32' ' ' LEU . 7.0 p -96.3 148.4 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -1.096 . . . . 0.0 110.41 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.574 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -130.25 151.09 51.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.854 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.93 142.35 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 110.468 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -47.03 -66.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 110.008 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.9 OUTLIER -81.59 96.24 7.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 24.7 p -41.94 -31.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.707 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -54.79 -29.24 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 4.0 tp10 -72.79 -35.43 67.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.501 -0.749 . . . . 0.0 109.817 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 24' ' ' VAL . 18.1 mt -69.1 -32.84 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.718 HD22 ' CB ' ' A' ' 63' ' ' PHE . 42.3 mt -67.98 -53.41 26.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.0 mmt180 -61.29 -61.8 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.826 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 11.2 mtpt -53.79 -27.95 32.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.61 -44.07 95.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 20.7 t -73.81 -20.65 60.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -1.199 . . . . 0.0 110.169 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 34' ' ' ARG . 55.0 t -70.94 -49.3 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -75.72 -26.92 57.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 74' ' ' LEU . 2.5 m-30 -92.76 -3.72 54.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 78.3 mm-40 46.32 72.18 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -115.45 105.34 52.31 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 110.466 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 47' ' ' SER . 40.9 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.862 1.454 . . . . 0.0 110.281 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.45 0.643 . . . . 0.0 110.67 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.892 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -178.01 137.04 0.18 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.672 HD21 HD12 ' A' ' 74' ' ' LEU . 3.4 mt -109.63 163.88 13.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.719 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 73' ' ' LEU . 7.2 p -154.97 136.95 14.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.947 . . . . 0.0 110.368 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.3 112.22 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.75 -17.84 38.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.274 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.67 -53.54 30.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.178 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.13 23.17 2.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.54 26.38 71.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.562 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -67.8 165.43 17.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -1.221 . . . . 0.0 109.791 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 11.4 pm0 -113.88 135.56 53.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.003 -1.061 . . . . 0.0 110.96 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 ' CE1' ' A' ' 63' ' ' PHE . 98.7 t -157.53 173.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.685 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' VAL . 58.0 p -128.45 158.83 37.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 52.3 p30 -62.2 -11.47 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.7 t0 -107.63 4.45 25.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 37.7 t -112.21 -40.24 4.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.176 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CD1' HD11 ' A' ' 66' ' ' LEU . 44.6 m-85 -40.04 99.95 0.21 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -74.41 -90.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.005 1.529 . . . . 0.0 110.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.73 66.27 0.57 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.2 mt -44.62 163.73 0.18 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.31 -1.112 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.26 -174.34 1.76 Allowed 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.173 1.617 . . . . 0.0 109.847 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 69' ' ' ASP . 33.6 p30 -63.79 154.05 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 110.039 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.5 m-20 42.65 38.79 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.855 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.34 112.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.493 -0.755 . . . . 0.0 109.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 72' ' ' LEU . 4.2 mm-40 -81.76 103.59 11.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 66' ' ' LEU . 8.7 mp -114.86 156.63 24.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.32 -0.863 . . . . 0.0 110.106 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -133.21 125.89 30.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.476 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.823 ' CG ' HD23 ' A' ' 42' ' ' LEU . 12.3 tp -71.79 133.66 45.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.465 -0.772 . . . . 0.0 109.949 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.5 tt -147.47 160.82 42.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.134 -0.979 . . . . 0.0 109.547 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 75' ' ' LEU . 4.6 p -148.83 173.11 13.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 109.96 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.47 -24.34 7.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.959 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.98 16.52 60.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -150.72 156.59 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -1.081 . . . . 0.0 110.242 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.27 153.84 39.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.224 -0.923 . . . . 0.0 110.401 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.494 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.3 t-105 -130.9 116.95 18.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.347 -0.845 . . . . 0.0 110.254 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -63.47 -72.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.058 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.42 167.01 19.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 12.9 t80 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.183 -1.186 . . . . 0.0 110.349 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 43.9 Cg_endo -71.88 124.15 9.91 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.98 1.516 . . . . 0.0 110.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 158.71 23.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.699 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.8 t -127.85 151.64 48.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.0 m -140.06 152.7 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.977 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HE3' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mmtt -110.32 99.28 8.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -82.23 88.79 6.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.975 . . . . 0.0 110.689 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 2.4 tpt180 -95.4 157.31 15.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.03 139.27 44.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD21 ' A' ' 73' ' ' LEU . 1.6 mt -76.26 -21.14 56.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -79.38 -2.04 39.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -155.79 138.13 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.94 53.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.19 167.36 29.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 110.606 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.88 162.32 40.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.512 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 8.4 t80 -115.66 87.74 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.93 95.57 0.28 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HD23 ' A' ' 32' ' ' LEU . 6.0 p -108.68 154.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -1.193 . . . . 0.0 110.903 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -124.8 166.44 16.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.63 147.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.5 mtm180 -66.86 -53.99 26.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 110.033 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' CYS . 73.9 m -83.82 97.14 9.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.913 ' HA ' HD12 ' A' ' 32' ' ' LEU . 7.2 p -41.65 -30.55 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.105 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -54.87 -27.49 43.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.17 -44.03 39.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.978 HD23 HG13 ' A' ' 24' ' ' VAL . 11.5 mt -57.34 -42.36 81.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 63' ' ' PHE . 68.2 mt -67.21 -59.83 3.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.652 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.1 mpp_? -54.03 -70.48 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 27.8 mtpt -47.29 -24.59 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -73.48 -53.44 7.5 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.3 t -66.64 -11.87 55.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -1.107 . . . . 0.0 109.748 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 34' ' ' ARG . 97.5 t -82.5 -69.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.967 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -51.77 -31.89 28.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.685 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-85 -89.82 -17.95 27.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.58 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 5.5 mt-30 56.56 80.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.998 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -118.2 105.33 46.93 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 110.175 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 123.968 1.51 . . . . 0.0 110.212 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.173 0.511 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER 179.01 146.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 110.595 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mt -116.35 170.7 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.257 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.2 p -160.21 131.24 5.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.85 -1.156 . . . . 0.0 111.137 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -53.63 133.4 41.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.772 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 25.1 t80 -92.45 -13.26 30.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 110.37 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -53.7 -24.86 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 1.6 t0 -156.46 -43.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.652 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.53 54.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.59 160.88 14.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.964 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.3 pp20? -111.16 130.74 55.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.3 t -148.8 172.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.573 ' N ' HG12 ' A' ' 58' ' ' VAL . 35.3 p -115.16 158.44 22.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p-10 -70.47 -13.36 62.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -102.44 6.24 40.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 42.3 t -112.33 -36.99 5.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.686 ' CD1' HD11 ' A' ' 66' ' ' LEU . 25.6 m-85 -40.59 100.62 0.22 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.461 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -75.38 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.105 1.582 . . . . 0.0 110.275 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.32 69.29 0.52 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 63' ' ' PHE . 17.7 mt -50.37 161.76 0.58 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.209 -1.171 . . . . 0.0 110.051 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.59 167.27 26.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -45.75 153.02 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 110.103 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 27.1 m-20 43.89 37.37 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.2 117.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.761 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -82.88 107.69 15.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 110.501 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 63' ' ' PHE . 1.3 mp -118.25 137.64 52.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.805 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.68 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -115.87 131.7 56.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.926 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.998 HD11 HD23 ' A' ' 42' ' ' LEU . 11.7 tp -77.12 139.74 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -155.07 163.71 39.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.67 ' N ' HD23 ' A' ' 75' ' ' LEU . 20.2 p -147.79 168.25 22.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.09 -25.44 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.74 15.42 61.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 0.4 OUTLIER -151.96 151.65 31.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 110.344 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.782 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.91 144.26 30.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.103 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.495 ' HB2' HD12 ' A' ' 16' ' ' LEU . 9.6 t-105 -110.95 135.87 50.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -79.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 166.95 147.17 5.14 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -72.49 123.06 8.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.824 1.434 . . . . 0.0 110.183 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.69 139.91 37.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.7 t -108.1 149.06 28.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.12 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 24' ' ' VAL . 30.2 m -143.95 126.13 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -83.51 97.4 8.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -78.04 79.35 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.554 ' HG3' HD12 ' A' ' 73' ' ' LEU . 5.1 tpt180 -80.56 160.36 25.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.835 . . . . 0.0 109.705 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.93 116.93 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.041 -1.037 . . . . 0.0 110.709 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.92 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -69.28 -19.77 63.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.79 2.05 24.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.9 -161.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.38 39.86 3.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.9 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.9 p -173.41 -161.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 13.7 ptpt -150.61 -162.03 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 0.0 109.981 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -151.89 90.61 1.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.08 89.89 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.027 ' CG1' HD22 ' A' ' 32' ' ' LEU . 3.7 p -97.97 144.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -1.205 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -128.21 148.32 50.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -172.2 154.09 3.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mtm180 -63.04 -59.3 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.456 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -84.92 96.2 9.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -42.32 -34.14 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.42 -30.87 42.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.404 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -74.19 -32.87 63.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.503 -0.748 . . . . 0.0 109.779 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.027 HD22 ' CG1' ' A' ' 24' ' ' VAL . 14.8 mt -75.8 -37.52 59.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.11 -60.65 2.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.93 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -55.39 -58.58 7.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.765 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -51.33 -32.93 27.09 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.405 -0.81 . . . . 0.0 109.355 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.17 -51.94 53.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -61.36 -19.38 61.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.178 . . . . 0.0 109.864 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ARG . 89.1 t -78.96 -48.08 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -76.43 -33.14 58.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.058 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -89.7 -12.45 39.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -0.882 . . . . 0.0 109.616 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 82.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 110.424 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.93 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.31 108.76 37.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.374 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.2 Cg_endo . . . . . 0 C--N 1.305 -1.711 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.53 ' OG ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.168 0.509 . . . . 0.0 110.15 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.8 116.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 110.318 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.85 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.2 mt -99.62 111.26 23.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.3 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 73' ' ' LEU . 26.4 p -96.33 168.51 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.947 . . . . 0.0 110.768 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -98.43 116.66 31.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.552 -0.718 . . . . 0.0 110.173 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' CB ' ' OE1' ' A' ' 71' ' ' GLU . 15.3 t80 -62.26 -14.41 38.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -56.49 15.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.28 42.98 1.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.495 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.44 33.9 78.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -76.81 164.22 26.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.103 -1.233 . . . . 0.0 109.619 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.534 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.9 pt-20 -116.94 131.89 56.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.97 -1.081 . . . . 0.0 110.241 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.003 HG11 ' CE1' ' A' ' 63' ' ' PHE . 25.9 t -151.04 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.478 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.564 ' N ' HG12 ' A' ' 58' ' ' VAL . 19.3 p -130.71 165.09 23.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.471 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 10.7 p-10 -70.95 -11.86 61.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.603 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.24 -2.42 20.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.052 -1.03 . . . . 0.0 110.524 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 47.9 t -103.01 -39.55 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE1' HG11 ' A' ' 58' ' ' VAL . 16.4 m-85 -40.46 100.0 0.21 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 110.59 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.5 Cg_endo -81.9 -79.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.027 1.541 . . . . 0.0 110.491 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.79 70.91 0.51 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.997 HD11 ' CD1' ' A' ' 63' ' ' PHE . 5.5 mt -51.93 161.55 0.92 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.334 -1.098 . . . . 0.0 110.473 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.42 178.85 6.13 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.19 1.626 . . . . 0.0 109.996 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 69' ' ' ASP . 28.5 t-20 -59.82 150.27 28.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.205 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 44.35 39.03 2.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 109.723 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -40.81 109.62 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.564 -0.71 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -78.7 95.29 5.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 3.0 mp -103.96 152.92 21.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.92 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -132.65 124.76 28.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.446 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.93 HD11 HD23 ' A' ' 42' ' ' LEU . 11.6 tp -72.67 121.84 20.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.539 -0.726 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.715 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -138.69 157.45 46.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.516 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 10.6 p -135.68 179.86 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.56 63.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.75 17.35 50.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -147.23 162.64 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -1.186 . . . . 0.0 110.514 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -154.71 141.61 19.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' A' ' 82' ' ' HIS . 2.8 t-105 -115.7 125.44 52.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.449 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 3.7 t60 -62.18 -60.14 4.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' HA2' ' CE2' ' A' ' 81' ' ' TRP . . . 130.67 143.52 5.33 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.851 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 29.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.246 0.546 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 0.5 OUTLIER 66.02 -172.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 179.87 63.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 4' ' ' VAL . 3.7 m -64.13 150.15 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.22 98.29 8.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 2.8 mmt180 -87.47 48.29 1.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.817 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 6.3 pt20 172.73 113.57 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.038 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.5 139.7 28.89 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.905 1.476 . . . . 0.0 110.44 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 2.0 ttpt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.1 t -118.05 148.55 42.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.545 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 11' ' ' VAL . 22.4 m -142.37 127.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.922 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 4.0 mmpt? -82.7 107.54 15.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.976 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -88.46 86.2 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.383 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.724 ' HG3' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -86.94 157.46 19.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.579 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.42 128.87 30.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.048 -1.032 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt -72.54 -26.87 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.808 . . . . 0.0 109.716 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 36.5 t60 -85.14 13.52 6.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.408 -0.807 . . . . 0.0 109.995 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 -160.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.377 -0.827 . . . . 0.0 109.998 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 20' ' ' CYS . . . -129.54 35.88 4.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 4.8 p 174.69 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -168.07 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.0 109.9 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 2.1 t80 -143.96 90.81 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HE2' ' A' ' 12' ' ' LYS . . . -64.61 91.72 0.11 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.863 HG13 HD23 ' A' ' 32' ' ' LEU . 3.1 p -99.41 134.51 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -1.154 . . . . 0.0 110.126 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.736 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.46 149.51 40.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -168.48 145.08 3.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -59.03 -58.56 8.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.178 -0.951 . . . . 0.0 110.066 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 m -80.27 98.07 7.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -0.864 . . . . 0.0 109.93 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.056 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -40.56 -29.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -0.787 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' SER . 31.9 tt0 -60.14 -28.98 68.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.4 -45.01 66.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.802 . . . . 0.0 109.845 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.056 HD12 ' HA ' ' A' ' 29' ' ' CYS . 4.8 mt -57.8 -43.43 85.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 110.001 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 63' ' ' PHE . 2.6 mt -61.85 -65.92 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' NH1' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -43.61 -69.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -47.24 -27.36 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.49 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.42 -55.37 12.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.57 -11.64 17.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 0.0 110.032 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 34' ' ' ARG . 74.7 t -85.33 -71.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -23.51 5.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.347 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 m-85 -102.99 -16.57 15.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 54.01 85.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.86 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -129.08 99.95 21.21 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo -73.45 154.05 50.31 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.558 . . . . 0.0 110.171 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.553 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.89 -51.29 65.32 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.457 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 44' ' ' MET . 47.2 Cg_endo -76.61 157.03 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.886 1.466 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 44.06 44.71 7.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -167.98 178.0 5.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.136 . . . . 0.0 110.007 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 172.75 148.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 74' ' ' LEU . 2.1 mt -118.22 168.85 10.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.1 p -154.97 139.65 17.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 110.848 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -68.08 127.01 31.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 110.292 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -80.85 1.3 31.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' HD23 ' A' ' 51' ' ' LEU . 3.0 tt0 -59.35 -46.38 88.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.0 15.52 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.552 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 94.02 28.97 10.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.06 164.64 25.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -1.222 . . . . 0.0 109.402 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.557 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.2 mt-10 -121.46 130.67 53.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.929 -1.107 . . . . 0.0 110.497 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.912 HG11 ' CE1' ' A' ' 63' ' ' PHE . 57.3 t -153.1 173.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 36.9 p -123.35 164.95 17.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 33' ' ' LEU . 3.0 p30 -67.61 -12.17 59.81 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.325 -0.859 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -105.35 -5.41 20.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.3 t -107.42 17.2 23.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.168 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.912 ' CE1' HG11 ' A' ' 58' ' ' VAL . 6.6 m-85 -100.99 96.54 5.8 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.392 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.5 Cg_endo -72.13 -91.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.782 1.411 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -112.48 68.63 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.832 HD22 ' HB1' ' A' ' 70' ' ' ALA . 1.5 mt -42.84 152.76 0.35 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 0.0 110.343 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.44 164.51 32.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.986 1.519 . . . . 0.0 110.132 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -49.13 148.94 2.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER 43.12 37.33 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.721 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.832 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -42.86 127.6 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 110.035 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 108.72 19.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 72' ' ' LEU . 1.2 mp -117.85 145.41 44.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.724 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -128.58 137.25 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.455 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.86 HD11 HD23 ' A' ' 42' ' ' LEU . 9.9 tp -77.4 138.94 39.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.881 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.6 tt -156.0 162.33 40.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.642 ' N ' HD23 ' A' ' 75' ' ' LEU . 71.2 p -153.99 171.92 18.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.718 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.57 -25.48 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 23.35 34.13 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 17' ' ' HIS . 2.2 mt-10 -156.36 162.66 40.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -1.165 . . . . 0.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.608 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.16 151.31 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.647 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.456 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 7.5 t-105 -124.23 126.32 45.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.878 . . . . 0.0 109.791 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -66.82 -71.3 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 163.65 175.85 34.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 5.5 t80 -114.2 53.21 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.4 -1.059 . . . . 0.0 110.104 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 86' ' ' SER . 2.9 t -120.56 179.1 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 0.0 110.3 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.579 ' H ' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -114.17 59.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.329 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.202 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 1.9 ttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.364 0.602 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 171.25 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.034 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.9 78.81 0.84 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.3 126.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.168 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -132.54 135.86 46.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 15.2 mmt-85 -100.43 46.51 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 10.1 pt20 178.4 114.68 0.18 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.888 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.2 Cg_endo -72.69 120.82 6.91 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.937 1.493 . . . . 0.0 111.107 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -84.36 -166.02 1.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.684 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.8 t -153.23 154.53 34.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.981 HG22 HD22 ' A' ' 32' ' ' LEU . 32.8 m -147.04 146.26 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -107.01 96.76 6.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.742 HD23 ' CG ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -77.82 90.98 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.7 tpt180 -91.73 152.8 20.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.015 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -137.94 131.81 31.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.1 -28.15 64.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.782 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -79.83 3.05 20.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.983 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 t -123.97 -163.04 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 110.048 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.83 33.2 5.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 110.107 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 172.95 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.747 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.04 166.7 23.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.752 . . . . 0.0 109.87 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 6.3 t80 -112.48 97.74 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 110.459 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.404 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -71.81 98.5 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -115.5 150.75 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -1.175 . . . . 0.0 110.569 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -125.65 167.0 15.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 110.229 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -179.75 150.1 0.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.642 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mmm180 -62.79 -57.33 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.11 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.8 m -82.99 95.99 8.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.368 -0.833 . . . . 0.0 110.01 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.978 ' HA ' HD12 ' A' ' 32' ' ' LEU . 28.2 p -41.61 -28.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -55.55 -38.59 69.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.837 . . . . 0.0 109.741 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 1.6 tp10 -63.46 -43.95 95.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.025 HD23 HG13 ' A' ' 24' ' ' VAL . 8.4 mt -55.24 -47.62 75.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.87 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 63' ' ' PHE . 15.8 mt -63.29 -64.48 0.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.882 . . . . 0.0 109.938 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 tpp85 -47.75 -68.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.907 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -44.93 -30.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.541 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.02 -55.36 24.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.4 t -60.17 -14.36 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.865 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 34' ' ' ARG . 57.4 t -84.83 -60.35 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.377 -0.827 . . . . 0.0 110.28 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -25.32 68.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 110.339 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.742 ' CG ' HD23 ' A' ' 13' ' ' LEU . 3.1 m-85 -101.45 -17.49 16.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.86 84.22 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -123.94 105.72 31.95 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.874 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.8 Cg_endo -73.52 145.05 37.02 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.008 1.531 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.54 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -56.43 -50.49 87.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 110.116 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' MET . 49.1 Cg_endo -79.54 158.0 25.34 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.1 1.579 . . . . 0.0 110.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 44.34 51.81 7.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -172.38 174.99 3.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.136 . . . . 0.0 110.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.3 mtt85 -179.25 117.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 74' ' ' LEU . 13.0 mt -89.57 101.45 14.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.34 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' THR . 94.3 m -89.61 178.88 6.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 111.006 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.4 131.11 55.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.445 -0.784 . . . . 0.0 110.081 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.559 ' CD1' HD13 ' A' ' 73' ' ' LEU . 2.1 t80 -80.74 2.55 25.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.792 . . . . 0.0 110.495 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 4.5 tt0 -66.28 -59.5 3.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -141.54 22.39 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.333 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.544 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 83.68 48.79 5.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.33 166.2 12.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -1.183 . . . . 0.0 109.715 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -118.98 126.84 52.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.058 . . . . 0.0 110.544 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 10.3 t -144.67 179.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.626 ' H ' HG12 ' A' ' 58' ' ' VAL . 20.4 p -138.88 158.5 44.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.553 ' HB3' HD12 ' A' ' 49' ' ' LEU . 4.1 p30 -61.96 -11.49 13.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 110.26 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -106.67 -5.74 18.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 t -98.18 -48.62 5.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.441 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.169 ' CE1' HD21 ' A' ' 66' ' ' LEU . 10.1 m-85 -41.17 100.53 0.22 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 110.493 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.7 Cg_endo -79.47 -48.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.036 1.545 . . . . 0.0 110.431 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.86 69.55 0.18 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.169 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.7 mt -48.33 161.39 0.38 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 44.0 Cg_endo -72.13 -167.31 0.31 Allowed 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 124.097 1.578 . . . . 0.0 110.116 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 44.9 t30 -70.02 144.57 52.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' CYS . 54.6 t0 56.88 33.98 24.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.982 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -45.46 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.57 -0.706 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' LEU . 1.2 tt0 -78.16 111.02 13.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 71' ' ' GLU . 7.4 mp -115.06 162.79 16.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 109.99 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.89 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -136.98 122.11 19.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.416 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 HD21 ' A' ' 49' ' ' LEU . 8.5 tp -68.3 115.55 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.803 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -132.63 159.03 40.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 7.6 p -149.05 171.49 16.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 110.158 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.34 -25.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.848 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.25 14.73 62.9 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' OE1' ' CB ' ' A' ' 16' ' ' LEU . 2.9 mt-10 -153.6 144.42 22.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.73 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -135.68 131.13 35.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.485 ' CZ2' ' O ' ' A' ' 83' ' ' GLY . 5.7 t-105 -101.85 130.68 48.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -43.75 18.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 110.429 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 131.7 -172.34 20.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 26.8 t80 -118.7 62.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -1.139 . . . . 0.0 110.27 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.32 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 110.424 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.7 m -112.85 56.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 0.0 110.05 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.215 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.9 mtt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.286 0.565 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 169.98 149.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.37 56.21 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.3 151.51 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 83.0 mt -71.34 114.13 9.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.922 . . . . 0.0 110.436 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 6.8 mtt-85 -94.04 40.37 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.945 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 3.2 pt20 171.58 132.74 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.013 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.7 Cg_endo -74.37 133.52 17.71 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.882 1.464 . . . . 0.0 110.495 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.49 166.29 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' C ' HG13 ' A' ' 11' ' ' VAL . 27.8 m -139.19 155.32 47.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 HD22 ' A' ' 32' ' ' LEU . 22.3 m -150.32 131.71 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.2 mmtt -89.3 85.34 6.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.938 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.491 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.1 tp -65.29 85.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.842 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.972 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.0 tpt180 -82.52 153.05 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 109.42 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -136.0 133.02 37.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.411 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 2.8 mt -80.81 -16.58 53.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.518 ' CE1' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -82.34 -0.87 47.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 110.133 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -129.98 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.78 34.85 5.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.93 -160.63 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -138.29 -160.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 110.243 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.6 t80 -149.59 84.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -67.26 93.58 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.905 HG13 HD23 ' A' ' 32' ' ' LEU . 1.3 p -107.59 151.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -1.106 . . . . 0.0 110.171 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.449 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -125.33 153.05 43.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.51 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.974 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -167.09 132.93 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.2 mmt180 -48.42 -62.29 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.107 -0.996 . . . . 0.0 110.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -76.07 96.48 3.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.017 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.0 p -42.07 -33.32 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -32.06 58.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.536 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -72.4 -39.23 68.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.83 . . . . 0.0 109.404 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.012 HD22 HG22 ' A' ' 11' ' ' VAL . 15.9 mt -56.25 -45.36 80.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.764 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 63' ' ' PHE . 23.6 mt -65.87 -64.69 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -46.33 -70.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.937 . . . . 0.0 109.827 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 9.0 mtpt -48.95 -22.97 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.979 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.37 -45.71 45.84 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 15.5 t -76.06 -15.71 60.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -1.129 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 34' ' ' ARG . 18.8 t -79.47 -50.17 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.795 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.11 -39.36 78.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-30 -83.24 -15.22 51.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 57.41 80.3 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -120.62 110.23 35.61 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.361 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.07 167.28 27.58 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.039 1.547 . . . . 0.0 110.335 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.28 -48.53 0.59 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.557 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.6 Cg_endo -80.97 136.04 10.22 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.813 1.428 . . . . 0.0 110.741 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.48 76.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -141.61 178.23 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -1.16 . . . . 0.0 110.05 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 175.99 141.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.093 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 2.5 mt -109.13 166.71 10.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.976 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.4 m -150.14 169.17 21.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 110.41 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -98.6 129.33 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.404 -0.81 . . . . 0.0 110.16 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -80.57 -8.68 59.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' HD23 ' A' ' 51' ' ' LEU . 7.5 tt0 -58.29 -48.62 79.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.9 10.87 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 88.08 46.33 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.19 171.89 9.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -1.208 . . . . 0.0 109.709 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.1 pt-20 -118.43 129.02 55.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.058 -1.026 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.987 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.4 t -152.71 176.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.286 -0.884 . . . . 0.0 110.163 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 7.3 p -126.37 172.52 10.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.979 . . . . 0.0 110.214 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 18.7 p-10 -81.61 -4.39 55.99 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.238 -0.913 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.64 0.85 14.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.125 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.9 t -107.43 -40.15 5.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.074 ' CD1' HD11 ' A' ' 66' ' ' LEU . 4.8 m-85 -42.26 101.64 0.25 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 43.6 Cg_endo -72.41 -63.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.057 1.556 . . . . 0.0 111.063 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.68 62.47 0.34 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.074 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.3 mt -44.86 164.46 0.18 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -1.187 . . . . 0.0 110.071 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_endo -69.53 -168.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.16 1.61 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 69' ' ' ASP . 59.7 t30 -68.53 152.33 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.17 -0.956 . . . . 0.0 110.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 10' ' ' CYS . 1.1 m-20 44.04 37.26 1.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.461 -0.774 . . . . 0.0 110.13 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -48.76 106.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.0 109.492 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 27.6 mt-10 -72.97 105.62 4.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.917 . . . . 0.0 110.837 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.652 HD11 HD13 ' A' ' 66' ' ' LEU . 3.2 mp -100.94 169.85 8.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.972 HD12 ' HG3' ' A' ' 14' ' ' ARG . 2.5 tp -143.05 137.45 29.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.911 -1.118 . . . . 0.0 110.916 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.776 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -85.61 130.1 34.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.82 . . . . 0.0 109.687 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.671 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.2 tt -146.41 158.07 43.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.987 -1.07 . . . . 0.0 109.924 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -150.67 171.06 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.67 -29.87 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.054 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.16 14.9 59.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -147.75 159.68 43.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 110.49 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.671 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.91 139.71 13.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.448 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 8.0 t-105 -111.56 133.72 53.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.22 -59.52 2.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.06 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 141.12 163.29 9.47 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.58 88.89 6.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.065 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.46 -169.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m 50.92 53.42 13.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 110.183 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.255 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 146.34 15.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 110.339 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.98 70.12 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 110.186 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -93.74 112.18 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -162.4 119.72 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 6.1 mmt-85 -94.45 41.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 1.8 pt20 173.52 120.99 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.51 -0.744 . . . . 0.0 109.996 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.7 Cg_endo -73.22 138.54 27.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.844 1.444 . . . . 0.0 110.659 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.12 138.9 31.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASP . 98.2 m -115.18 149.42 37.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.424 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.693 HG22 HD22 ' A' ' 32' ' ' LEU . 10.9 m -143.28 146.87 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 10.5 mmtp -105.12 92.18 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -73.47 97.85 2.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.757 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.734 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.7 tpt180 -94.95 155.74 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.78 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -139.87 121.48 15.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.849 -1.157 . . . . 0.0 110.821 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.01 HD12 HD21 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -65.32 -21.34 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.158 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' CG ' ' OE2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -79.53 0.83 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.5 -162.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.053 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.0 27.88 7.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 7.7 p -170.76 -161.55 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.627 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.3 -169.11 2.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.511 -0.743 . . . . 0.0 109.707 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 2.7 t80 -135.81 85.89 2.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA3' ' HE2' ' A' ' 12' ' ' LYS . . . -64.86 94.49 0.17 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.011 HG13 HD23 ' A' ' 32' ' ' LEU . 4.1 p -110.58 140.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -1.095 . . . . 0.0 110.424 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -109.65 162.42 14.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.306 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.895 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 178.38 134.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.88 -58.39 8.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 t -80.26 98.83 7.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.941 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.107 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.7 p -41.85 -28.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.397 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 29.3 mt-30 -57.85 -29.62 65.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -41.42 64.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.825 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.107 HD12 ' HA ' ' A' ' 29' ' ' CYS . 7.3 mt -58.14 -43.08 87.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.776 . . . . 0.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 63' ' ' PHE . 14.9 mt -65.6 -66.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.84 -69.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.782 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -47.71 -25.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.43 -0.794 . . . . 0.0 109.504 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.78 -51.81 28.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.2 t -66.5 -14.12 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.101 -1.235 . . . . 0.0 109.816 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 34' ' ' ARG . 48.3 t -84.99 -56.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -64.38 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.994 -1.066 . . . . 0.0 110.106 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.78 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 3.3 m-85 -103.17 -13.61 16.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 80.7 mm-40 56.46 88.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.117 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.71 93.4 44.48 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.187 -0.946 . . . . 0.0 109.879 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 49.7 Cg_endo -73.0 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.02 1.537 . . . . 0.0 110.038 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 38.4 ttp -120.72 43.82 0.65 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.069 -1.019 . . . . 0.0 111.222 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' MET . 52.6 Cg_endo -77.08 -2.36 12.59 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.49 1.258 . . . . 0.0 109.791 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.14 2.66 10.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -61.07 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -1.127 . . . . 0.0 110.353 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 1.2 mtt180 175.99 158.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.215 -0.928 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 74' ' ' LEU . 2.0 mp -115.09 168.06 10.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.909 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' THR . 54.2 m -153.11 147.13 25.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 110.379 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -69.69 127.18 32.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.804 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -74.56 0.64 14.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.425 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -61.23 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.08 -1.013 . . . . 0.0 110.2 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.61 22.79 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.55 45.09 38.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.564 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.7 167.9 14.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 109.612 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.8 pt-20 -113.12 131.69 55.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.933 -1.104 . . . . 0.0 111.175 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.899 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.4 t -157.02 173.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.563 -0.711 . . . . 0.0 109.52 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' N ' HG12 ' A' ' 58' ' ' VAL . 39.9 p -131.83 160.41 35.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.057 -1.027 . . . . 0.0 110.605 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 33' ' ' LEU . 2.5 p30 -62.18 -10.96 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.02 -7.29 20.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 110.55 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -98.05 -42.31 7.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 0.0 110.411 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.899 ' CE1' HG11 ' A' ' 58' ' ' VAL . 45.8 m-85 -41.7 101.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 110.63 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -76.14 -87.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.93 74.11 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.881 HD11 ' CD1' ' A' ' 63' ' ' PHE . 58.7 mt -58.58 160.18 10.71 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.175 -1.191 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.34 -161.36 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 109.799 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.33 150.47 36.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 10' ' ' CYS . 17.0 m-20 47.52 37.29 6.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -44.06 96.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 109.928 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -62.46 98.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.718 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.664 HD21 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -111.87 161.66 16.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 110.17 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.81 133.13 31.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 110.434 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.117 HD11 HD23 ' A' ' 42' ' ' LEU . 9.8 tp -86.86 143.34 27.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.998 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -151.88 158.55 43.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 109.644 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 70.4 p -139.7 168.76 19.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.38 -22.24 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.07 21.76 40.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 75' ' ' LEU . 3.5 mt-10 -160.59 141.3 11.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 110.594 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -135.26 146.96 49.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.818 . . . . 0.0 109.834 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.56 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.5 t-105 -116.29 130.26 56.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 110.291 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.68 -75.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -178.26 166.15 35.96 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 85' ' ' VAL . 5.0 t80 -118.16 142.82 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -1.093 . . . . 0.0 110.168 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 33.2 m -80.33 167.04 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 t -99.44 63.26 1.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.128 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.262 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.7 tpt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.221 0.534 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER 170.92 175.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.264 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 2' ' ' CYS . . . 67.31 83.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 4' ' ' VAL . 5.5 p -137.29 79.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -109.7 93.78 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 110.316 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -84.67 44.98 1.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tt0 179.39 105.32 0.16 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.587 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.2 Cg_endo -71.66 132.79 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.999 1.526 . . . . 0.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -83.13 148.11 27.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.81 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 t -116.77 144.7 44.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 32' ' ' LEU . 3.8 m -139.44 144.54 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 1.7 mmmm -99.0 91.3 4.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.976 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.85 87.44 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.576 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.717 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -90.86 159.4 16.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.735 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -149.61 130.67 14.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.05 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -84.41 -14.54 49.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.891 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.96 -4.0 53.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 110.022 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -143.93 25.42 1.6 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 0.0 110.413 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 29.4 53.77 0.11 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 120.966 0.412 . . . . 0.0 111.6 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -163.53 172.78 13.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.985 -1.072 . . . . 0.0 110.603 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.04 165.53 28.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.997 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -143.33 99.15 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -68.47 95.85 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.02 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -101.01 141.72 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.158 . . . . 0.0 110.451 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -121.34 146.14 47.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.336 -0.853 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.871 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.77 140.1 6.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -52.23 -59.36 4.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.308 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -83.42 97.13 8.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.156 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' SER . 10.9 p -41.72 -29.62 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 28' ' ' SER . 4.3 mm-40 -57.89 -24.69 58.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.8 mt-10 -72.61 -55.35 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 110.052 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.02 HD22 HG13 ' A' ' 24' ' ' VAL . 37.3 mt -56.54 -35.19 67.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 0.0 110.068 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.693 HD21 HD11 ' A' ' 66' ' ' LEU . 52.8 mt -65.48 -65.85 0.62 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.33 -0.856 . . . . 0.0 110.152 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -57.75 -68.69 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 109.97 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 20.5 mtmt -42.84 -37.39 1.8 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.399 -0.813 . . . . 0.0 109.908 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.63 -48.43 84.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.1 t -63.18 -19.4 64.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.237 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 52.1 t -77.24 -41.95 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 39' ' ' ARG . 1.8 tmt_? -81.05 -28.82 35.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.761 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 1.9 m-30 -92.58 -8.15 45.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 74.2 mm-40 49.19 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.799 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -131.04 95.63 24.66 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.093 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.4 Cg_endo -73.23 144.55 37.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.063 1.559 . . . . 0.0 110.321 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.542 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -51.7 -49.43 83.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.569 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 44' ' ' MET . 50.2 Cg_endo -79.05 159.36 27.05 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.903 1.475 . . . . 0.0 110.66 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 43.63 45.88 7.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.553 ' OG ' HD13 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -171.55 171.4 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -1.189 . . . . 0.0 110.287 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.839 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -178.75 143.2 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 60' ' ' ASP . 1.4 mt -111.97 164.9 12.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.869 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' THR . 3.5 p -155.09 149.08 25.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 110.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -76.09 105.12 6.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.826 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 85.8 t80 -56.27 -22.35 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.359 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -51.63 -52.42 47.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.987 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -128.22 0.25 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 86.9 30.23 21.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -73.54 167.28 21.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.15 . . . . 0.0 109.857 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.616 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.8 pt-20 -115.45 133.23 56.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.932 -1.105 . . . . 0.0 109.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.934 HG11 ' CE1' ' A' ' 63' ' ' PHE . 59.1 t -155.52 173.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 110.508 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 30.5 p -119.01 159.6 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 49' ' ' LEU . 44.8 p30 -70.12 -2.72 13.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.95 -23.14 10.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.588 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.9 m -80.19 -37.6 32.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 110.221 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.152 ' CE2' HD21 ' A' ' 72' ' ' LEU . 20.8 m-85 -39.07 99.14 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.531 -0.73 . . . . 0.0 110.53 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 50.5 Cg_endo -76.93 -39.41 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.989 1.521 . . . . 0.0 110.415 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . 178.51 66.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.883 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.8 mp -42.5 161.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.272 -1.134 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 44.7 Cg_endo -72.85 -174.13 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.071 1.564 . . . . 0.0 110.259 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -58.41 152.64 17.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.108 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLU . 8.5 m-20 42.85 37.86 1.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 0.0 109.924 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -42.24 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -69.49 96.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.777 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.152 HD21 ' CE2' ' A' ' 63' ' ' PHE . 4.8 tp -106.48 153.16 22.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -133.68 140.02 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 110.61 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.799 HD11 HD23 ' A' ' 42' ' ' LEU . 11.8 tp -80.35 132.66 35.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.509 -0.744 . . . . 0.0 109.9 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.839 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.8 tt -145.67 159.03 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.838 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 69.1 p -149.76 -159.96 1.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.972 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.29 73.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.431 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.38 18.01 40.04 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -145.77 148.18 32.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 0.0 110.457 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -149.9 139.8 21.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t-105 -117.0 128.86 55.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.258 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -76.73 -61.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.81 147.0 4.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.05 144.69 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.283 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 85' ' ' VAL . 35.3 m -83.56 143.14 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 110.331 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 46.3 p -108.56 53.07 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 86' ' ' SER . 13.5 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.245 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 1.8 tpp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.307 0.575 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.564 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.3 OUTLIER 171.26 148.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 43.23 49.68 5.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 4' ' ' VAL . 3.1 p -161.85 75.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 mt -142.38 158.87 43.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -125.11 42.09 3.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 167.39 124.56 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.7 Cg_endo -72.59 125.15 10.37 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.734 1.386 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -79.97 137.16 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 110.234 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.529 ' C ' HG13 ' A' ' 11' ' ' VAL . 35.3 m -108.19 157.85 17.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.071 HG22 HD13 ' A' ' 32' ' ' LEU . 34.9 m -152.46 137.85 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.9 . . . . 0.0 109.976 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -96.32 107.7 20.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.272 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.605 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -84.53 83.2 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.591 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.4 tpt180 -80.26 157.24 26.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.352 -0.843 . . . . 0.0 109.877 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.25 123.0 14.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.552 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HD21 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -74.48 -20.44 60.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 110.16 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.48 -1.5 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.88 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -128.42 -160.76 1.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 0.0 109.951 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.45 38.82 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.48 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.62 -159.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.048 -1.032 . . . . 0.0 110.69 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.69 -161.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 110.072 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 19.1 t80 -145.6 98.05 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.19 101.27 1.03 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.025 HG13 HD22 ' A' ' 32' ' ' LEU . 2.9 p -116.26 149.07 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -1.149 . . . . 0.0 110.291 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.95 159.28 41.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.094 -1.004 . . . . 0.0 110.262 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.84 132.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 25.1 mmm-85 -46.21 -56.15 6.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 110.212 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -82.47 97.94 8.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.036 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 28.2 p -40.26 -27.56 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 21.7 mp0 -62.27 -28.55 69.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' ' HD2' ' A' ' 35' ' ' LYS . 4.4 tt0 -66.38 -44.62 82.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 110.249 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.071 HD13 HG22 ' A' ' 11' ' ' VAL . 38.2 mt -67.13 -35.65 80.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 29' ' ' CYS . 87.4 mt -65.23 -60.75 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tpt180 -55.23 -69.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 26.0 mtpp -46.08 -29.62 1.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -60.57 -52.37 52.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.7 t -67.13 -16.24 64.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -1.181 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 54.1 t -81.73 -52.57 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -66.94 -39.7 87.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.743 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.605 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.9 m-30 -83.28 -19.55 36.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.853 . . . . 0.0 109.783 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 44.7 mm-40 60.34 77.74 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.475 -0.766 . . . . 0.0 110.587 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.064 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -121.33 97.52 47.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 50.5 Cg_endo -75.16 -162.67 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.946 1.498 . . . . 0.0 109.714 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.568 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 1.2 ptt? -123.62 45.53 1.2 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.008 -1.058 . . . . 0.0 111.393 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 44' ' ' MET . 50.7 Cg_endo -76.29 -1.38 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.66 1.347 . . . . 0.0 109.764 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.94 0.09 5.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.722 ' HB3' HG22 ' A' ' 76' ' ' THR . 0.0 OUTLIER -63.15 -161.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.369 -1.077 . . . . 0.0 110.232 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 176.23 154.23 0.2 Allowed 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.113 -0.992 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -111.76 165.83 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 109.414 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.5 p -156.97 133.69 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.58 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.697 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -63.3 126.43 27.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.404 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 84.6 t80 -77.13 2.02 16.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.939 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -50.82 50.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.433 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.08 54.77 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 51.98 40.81 51.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.37 159.03 18.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.048 -1.266 . . . . 0.0 109.495 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.609 ' C ' HG23 ' A' ' 58' ' ' VAL . 7.3 mp0 -117.34 136.75 52.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 110.468 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.839 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.1 t -156.8 175.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.589 ' N ' HG12 ' A' ' 58' ' ' VAL . 72.2 p -130.83 160.39 34.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.58 -30.53 71.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.37 -0.831 . . . . 0.0 110.471 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.4 22.39 6.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 110.346 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 32.0 t -130.84 -35.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.198 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.141 ' CD1' HD11 ' A' ' 66' ' ' LEU . 34.2 m-85 -44.16 104.22 0.37 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.209 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.4 Cg_endo -72.96 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.009 1.531 . . . . 0.0 110.344 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.12 64.53 0.59 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.141 HD11 ' CD1' ' A' ' 63' ' ' PHE . 52.2 mt -43.71 162.81 0.18 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.303 -1.116 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ASN . 44.3 Cg_endo -72.51 164.44 35.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.169 1.615 . . . . 0.0 110.134 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' PRO . 8.8 p30 -44.49 151.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.945 . . . . 0.0 109.978 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.9 m-20 45.64 37.72 3.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.861 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -40.7 107.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.649 . . . . 0.0 110.186 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 72' ' ' LEU . 12.3 tt0 -83.25 97.87 9.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 110.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.818 HD21 ' CD1' ' A' ' 66' ' ' LEU . 9.0 mp -105.06 159.07 16.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.892 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.761 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -129.53 113.36 14.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.394 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.064 HD11 HD23 ' A' ' 42' ' ' LEU . 12.8 tp -67.89 133.47 49.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -145.98 157.7 43.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.117 -0.989 . . . . 0.0 109.493 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 47' ' ' SER . 39.6 p -132.6 -174.98 3.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.0 -12.13 46.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.92 . . . . 0.0 110.375 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.3 25.17 27.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -156.37 163.14 39.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -1.153 . . . . 0.0 110.813 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.676 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.63 139.02 14.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.563 ' CE3' HD11 ' A' ' 16' ' ' LEU . 8.3 t-105 -103.94 137.01 42.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.756 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -69.41 -79.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.324 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . -160.64 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 18.5 t80 174.88 84.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.162 -1.199 . . . . 0.0 110.179 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 85' ' ' VAL . 23.3 m -92.17 -179.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.18 -0.95 . . . . 0.0 110.136 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.59 62.01 7.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.139 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.278 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 1.3 mtp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.176 0.512 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 24.4 p -179.58 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.274 -0.891 . . . . 0.0 110.338 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 177.86 62.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 t -103.88 157.4 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 5' ' ' LEU . 6.8 mt -132.62 176.45 8.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 19.4 mmt180 -84.64 58.79 5.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.555 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 2.1 mp0 70.29 158.27 0.16 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.622 -0.674 . . . . 0.0 109.991 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.1 Cg_endo -71.58 127.11 12.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.943 1.496 . . . . 0.0 110.403 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -79.94 153.12 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 24.9 m -121.48 140.5 52.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 HD22 ' A' ' 32' ' ' LEU . 5.2 m -134.38 136.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.937 . . . . 0.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.18 92.33 5.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.541 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -73.55 94.11 2.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.59 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.912 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -88.96 158.14 18.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.442 -0.786 . . . . 0.0 109.64 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -138.51 135.8 35.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.651 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.7 -24.22 56.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.224 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 7.99 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.0 t -138.26 -164.88 1.7 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.133 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.07 24.25 8.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -161.14 -163.43 1.02 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 0.0 110.592 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -140.44 -162.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.494 -0.754 . . . . 0.0 110.177 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 6.9 t80 -138.47 79.54 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -63.94 84.3 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 32' ' ' LEU . 1.4 p -104.57 141.3 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.138 . . . . 0.0 110.122 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -117.33 146.97 43.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.448 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.876 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -160.96 144.16 13.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.232 -0.918 . . . . 0.0 110.205 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mmt180 -57.9 -61.87 2.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.095 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 1.5 t -77.97 96.89 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.955 ' HA ' HD12 ' A' ' 32' ' ' LEU . 22.0 p -42.57 -31.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 mm-40 -52.39 -30.93 31.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.106 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 9.5 mt-10 -72.31 -46.01 57.5 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.604 0.716 . . . . 0.0 109.422 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 29' ' ' CYS . 12.1 mt -56.26 -43.82 79.11 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.75 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 34' ' ' ARG . 70.5 mt -67.09 -69.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.691 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -45.76 -70.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.546 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 31' ' ' GLU . 1.9 mtmp? -46.13 -26.36 0.75 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.166 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.28 -46.01 66.72 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 42' ' ' LEU . 41.0 t -74.24 -16.51 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -1.153 . . . . 0.0 109.78 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 34' ' ' ARG . 20.1 t -84.23 -47.6 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.776 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -35.84 78.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.4 m-85 -91.14 -13.51 32.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.57 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 1.7 mt-30 56.44 83.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 110.764 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -118.17 113.62 37.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.016 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.7 Cg_endo -72.57 173.51 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.015 1.534 . . . . 0.0 110.726 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 1.2 ttm -90.69 -44.42 0.39 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.354 -0.841 . . . . 0.0 111.173 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' MET . 47.3 Cg_endo -80.84 140.32 12.77 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.655 1.345 . . . . 0.0 110.367 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.91 36.56 60.48 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -142.71 164.42 30.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -1.004 . . . . 0.0 110.128 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 172.84 150.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 110.154 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 74' ' ' LEU . 1.7 mt -115.39 168.56 9.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.0 p -157.02 146.38 20.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -70.92 118.83 14.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.713 ' HD1' HD13 ' A' ' 73' ' ' LEU . 63.1 t80 -76.34 -21.23 56.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.381 -0.824 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' TYR . 2.9 tp10 -43.38 -45.94 6.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 110.352 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -137.13 -49.53 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.383 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.24 49.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.71 164.98 12.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -1.149 . . . . 0.0 109.916 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.587 ' C ' HG23 ' A' ' 58' ' ' VAL . 5.5 pt-20 -118.18 131.42 56.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.042 -1.037 . . . . 0.0 110.543 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.6 t -154.64 170.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.523 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -119.44 157.65 27.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 11.3 p-10 -62.44 -16.62 56.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 110.596 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -102.17 6.23 40.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.47 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 1.5 m -112.19 -34.62 5.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.832 ' CE1' HG11 ' A' ' 58' ' ' VAL . 13.6 m-85 -45.57 104.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 110.399 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.8 Cg_endo -76.52 -86.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.071 1.564 . . . . 0.0 110.338 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.74 64.22 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 63' ' ' PHE . 94.5 mt -45.18 160.84 0.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.226 -1.161 . . . . 0.0 110.289 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.39 178.36 6.24 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -56.76 152.01 13.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 0.0 110.218 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' CYS . 6.1 m-20 44.36 38.85 2.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.797 . . . . 0.0 109.782 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -41.42 105.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' LEU . 18.4 mt-10 -73.18 103.02 3.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.642 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 66' ' ' LEU . 7.0 mp -113.19 159.74 18.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 109.623 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.912 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -140.09 132.91 29.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.032 -1.043 . . . . 0.0 110.475 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD11 HD23 ' A' ' 42' ' ' LEU . 11.1 tp -72.29 135.27 45.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.786 . . . . 0.0 109.889 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -146.04 155.33 42.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 0.0 109.836 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 10.9 p -146.33 178.29 8.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.57 70.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.09 7.95 53.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 160.02 39.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.219 -1.165 . . . . 0.0 110.54 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.609 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -160.01 140.69 12.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.437 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.6 t-105 -111.61 131.41 55.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.122 -0.986 . . . . 0.0 110.32 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -83.37 -61.69 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 150.53 159.62 8.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD1' ' CE2' ' A' ' 52' ' ' TYR . 2.5 t80 -86.62 94.34 9.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 163.51 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.6 p -104.75 60.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.228 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.308 0.575 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.1 p -42.95 134.75 3.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.254 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.46 51.91 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 7' ' ' GLN . 25.8 m -82.38 53.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 46.76 41.56 10.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 5' ' ' LEU . 5.7 mmm-85 39.84 52.31 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.501 ' H ' HG23 ' A' ' 4' ' ' VAL . 21.5 mt-30 58.06 163.83 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 109.674 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.62 133.52 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.803 1.423 . . . . 0.0 110.575 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -81.59 -179.59 7.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 69' ' ' ASP . 23.5 t -150.54 148.68 28.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.41 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 32' ' ' LEU . 6.3 m -144.86 136.49 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . 23.6 mmtt -95.83 94.51 7.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.064 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -72.24 89.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.593 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.908 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -86.7 150.85 23.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 17' ' ' HIS . . . -135.36 137.63 42.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.69 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 73' ' ' LEU . 1.2 mt -75.18 -22.79 57.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.903 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.747 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 28.5 p80 -84.34 6.93 21.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -161.38 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.058 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.56 27.02 6.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.38 -161.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -134.38 -176.26 4.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.387 -0.82 . . . . 0.0 110.194 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -120.79 99.32 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.58 85.59 0.35 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.991 HG13 HD22 ' A' ' 32' ' ' LEU . 3.5 p -104.14 136.87 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.299 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 146.08 47.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -163.32 133.44 4.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.099 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -50.43 -30.55 12.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 110.458 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 31' ' ' GLU . 1.4 p -104.25 94.53 5.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 26.9 p -41.88 -31.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -30.9 71.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.928 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HG2' ' CD ' ' A' ' 35' ' ' LYS . 68.1 tt0 -68.94 -32.06 71.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 HG13 ' A' ' 24' ' ' VAL . 16.5 mt -77.44 -31.47 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 63' ' ' PHE . 94.1 mt -66.15 -57.74 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -59.0 -55.86 29.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' CD ' ' HG2' ' A' ' 31' ' ' GLU . 29.7 mtpp -55.02 -27.19 42.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.633 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -68.52 -51.55 30.71 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 29.1 t -65.67 -14.37 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -1.163 . . . . 0.0 109.604 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.69 -45.71 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -24.1 60.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-30 -102.6 -16.54 16.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.507 -0.746 . . . . 0.0 109.64 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 61.99 88.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.529 -0.732 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.055 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -133.82 97.44 15.49 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.939 . . . . 0.0 110.034 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.461 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 49.6 Cg_endo -74.86 -162.84 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.912 1.48 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 3.8 ttm -121.35 44.51 0.77 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.494 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 44' ' ' MET . 49.9 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.503 1.265 . . . . 0.0 109.836 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.9 -2.09 5.94 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 76' ' ' THR . 48.9 m -63.56 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -1.09 . . . . 0.0 110.148 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 176.05 154.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 110.922 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -114.9 116.77 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 56' ' ' THR . 29.0 m -94.41 -179.2 4.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -108.72 122.94 48.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 110.247 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -68.72 -7.61 35.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.17 -46.34 90.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 33.35 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 110.503 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 69.22 33.31 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.58 165.75 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -1.191 . . . . 0.0 109.834 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' C ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -119.54 128.45 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.39 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.986 HG11 ' CE1' ' A' ' 63' ' ' PHE . 14.3 t -150.08 -179.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.633 ' H ' HG12 ' A' ' 58' ' ' VAL . 22.9 p -131.4 159.82 36.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.002 . . . . 0.0 110.39 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.654 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.3 p30 -73.61 0.15 13.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.291 -0.881 . . . . 0.0 110.44 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -115.11 -1.29 13.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 110.515 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.6 t -108.07 -36.08 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.923 . . . . 0.0 110.192 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.081 ' CE1' HD21 ' A' ' 66' ' ' LEU . 19.8 m-85 -39.62 99.29 0.19 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.436 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.5 Cg_endo -77.7 -33.28 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.044 1.55 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.84 68.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.081 HD21 ' CE1' ' A' ' 63' ' ' PHE . 1.1 mp -50.0 163.61 0.41 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.242 -1.152 . . . . 0.0 110.075 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 42.2 Cg_endo -69.43 178.67 4.14 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.109 1.584 . . . . 0.0 110.172 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.72 150.03 20.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 10' ' ' CYS . 3.2 m-20 48.84 35.88 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.455 -0.778 . . . . 0.0 110.198 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' CB ' ' A' ' 66' ' ' LEU . . . -50.2 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.74 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 mm-40 -72.58 96.93 2.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -96.4 164.8 12.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HG3' ' A' ' 14' ' ' ARG . 1.4 tp -134.96 118.7 17.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.966 -1.084 . . . . 0.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.055 HD11 HD23 ' A' ' 42' ' ' LEU . 15.4 tp -69.43 127.47 33.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -140.46 158.45 43.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 47' ' ' SER . 32.1 p -141.92 174.23 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.99 19.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.43 23.47 21.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.31 149.0 25.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 110.593 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -144.25 158.62 43.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 0.0 109.696 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.575 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -125.48 122.57 37.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.312 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.26 -82.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 0.0 110.115 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 55' ' ' GLY . . . -175.75 172.93 45.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -113.63 67.54 0.67 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -1.107 . . . . 0.0 110.087 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -80.02 169.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.937 . . . . 0.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ASP . 2.9 p -151.92 67.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 86' ' ' SER . 18.6 t0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.246 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.278 0.561 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.63 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 0.5 OUTLIER -45.54 139.04 4.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 173.63 101.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 32.8 t -118.05 162.43 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER 63.98 93.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 110.46 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 1.9 mmt180 -84.44 45.43 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.91 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 170.85 124.22 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 0.0 110.047 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.7 Cg_endo -75.17 132.05 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.974 1.513 . . . . 0.0 110.789 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.39 159.81 25.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 69' ' ' ASP . 42.8 t -135.15 149.6 50.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.7 m -146.95 134.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.323 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 69' ' ' ASP . 37.6 mmtt -86.27 89.33 7.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -70.79 79.96 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.998 . . . . 0.0 110.201 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.837 ' CG ' HD12 ' A' ' 73' ' ' LEU . 6.5 tpt180 -83.8 159.12 21.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -150.8 122.44 8.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.278 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.895 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -76.79 -8.66 57.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 6.5 t-80 -94.54 10.44 34.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.512 ' O ' ' C ' ' A' ' 19' ' ' ALA . 4.5 m -149.49 30.28 0.75 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.514 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 18' ' ' SER . . . 27.28 49.86 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.095 0.474 . . . . 0.0 111.744 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -174.06 -176.02 1.11 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -145.03 -171.67 3.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 110.0 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 10.5 t80 -153.21 84.54 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.8 94.65 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.979 HG13 HD22 ' A' ' 32' ' ' LEU . 5.4 p -102.89 151.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -1.104 . . . . 0.0 110.769 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.43 151.86 51.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.441 -0.787 . . . . 0.0 110.012 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.875 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.8 136.0 0.89 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.71 -61.43 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.063 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 29' ' ' CYS . 17.7 m -78.3 96.71 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' C ' ' O ' ' A' ' 28' ' ' SER . 25.8 p -41.29 -28.73 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.524 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' SER . 6.9 tt0 -59.56 -25.6 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 110.192 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -70.53 -52.12 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HG13 ' A' ' 24' ' ' VAL . 32.1 mt -60.46 -34.61 74.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.867 . . . . 0.0 110.207 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 63' ' ' PHE . 11.0 mt -67.54 -64.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.066 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -56.69 -64.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' CB ' ' NZ ' ' A' ' 35' ' ' LYS . 7.6 mtmp? -49.45 -28.92 5.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.7 -48.78 78.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -71.42 -14.56 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.0 109.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.509 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 94.4 t -79.69 -49.43 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.929 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -28.9 62.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.019 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.8 m-30 -93.51 -11.56 31.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 30.4 mm-40 51.16 83.89 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.962 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -128.37 109.12 19.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.953 . . . . 0.0 110.779 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 47' ' ' SER . 47.4 Cg_endo -77.24 167.8 24.14 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.929 1.489 . . . . 0.0 110.205 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -87.42 -45.37 0.51 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.5 Cg_endo -80.39 127.38 6.57 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.824 1.434 . . . . 0.0 110.699 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.23 -40.77 3.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -84.98 -177.31 6.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.42 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -179.87 140.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.733 . . . . 0.0 109.892 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 4.4 mt -109.26 165.81 11.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.059 -1.026 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 73' ' ' LEU . 4.7 p -154.46 157.38 38.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.431 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -85.97 124.44 32.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.706 ' HD2' HD13 ' A' ' 73' ' ' LEU . 35.7 t80 -73.44 -14.3 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.25 -57.06 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.84 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.99 5.09 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.473 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 95.46 32.88 6.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.8 176.78 8.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -1.231 . . . . 0.0 109.706 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.605 ' C ' HG23 ' A' ' 58' ' ' VAL . 40.4 mt-10 -125.29 138.11 54.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.03 . . . . 0.0 110.775 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 63' ' ' PHE . 77.1 t -156.46 173.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 58' ' ' VAL . 29.9 p -121.52 158.37 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.511 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.1 p-10 -66.07 -7.81 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -108.62 -18.09 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.5 t -84.05 -39.34 19.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 58' ' ' VAL . 24.9 m-85 -42.32 101.6 0.25 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.1 Cg_endo -79.18 -90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.048 1.552 . . . . 0.0 110.666 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.98 66.37 0.3 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.99 HD22 ' HB1' ' A' ' 70' ' ' ALA . 3.6 mt -43.94 149.92 0.63 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.403 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -161.06 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.976 1.514 . . . . 0.0 110.115 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' ASP . 31.6 p-10 -77.2 150.93 35.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . 5.8 t0 42.08 37.05 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.74 . . . . 0.0 110.016 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.99 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -46.43 120.27 2.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 3.4 mp0 -83.2 106.94 15.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.943 . . . . 0.0 110.85 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 3.2 mp -110.92 154.59 23.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.895 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -138.73 127.99 24.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.014 -1.054 . . . . 0.0 110.662 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.705 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -74.08 134.82 42.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 110.24 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.787 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.9 OUTLIER -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.628 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 79' ' ' GLU . 4.4 p -147.51 169.66 19.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.072 . . . . 0.0 109.843 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.14 -33.67 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.3 17.97 39.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -1.193 . . . . 0.0 110.544 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.787 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.19 172.39 13.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.223 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.553 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.7 t-105 -141.24 122.88 15.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -70.15 -79.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.485 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . 179.09 171.87 42.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -98.17 118.44 34.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -1.166 . . . . 0.0 110.239 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.21 156.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.939 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.82 80.14 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.125 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.257 0.551 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 1' ' ' MET . 25.3 p -179.66 163.29 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 110.131 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 42.75 48.39 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.207 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 4' ' ' VAL . 4.1 p -97.01 139.68 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 110.364 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.24 118.54 14.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.855 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 1.7 mmm180 -101.02 44.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 174.68 116.1 0.1 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.279 -0.888 . . . . 0.0 110.205 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.1 Cg_endo -72.87 125.53 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.835 1.439 . . . . 0.0 110.537 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 160.2 24.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 69' ' ' ASP . 37.3 m -130.76 152.96 49.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.038 HG22 HD22 ' A' ' 32' ' ' LEU . 9.2 m -141.55 125.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . 10.0 mmtt -87.95 85.45 7.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.6 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -74.81 81.41 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 110.607 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.642 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -79.72 160.47 26.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.815 . . . . 0.0 109.325 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -135.06 124.24 24.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.773 -1.204 . . . . 0.0 110.679 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 81' ' ' TRP . 2.2 mt -75.72 -20.88 58.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -79.41 2.88 20.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.884 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -140.66 -175.12 4.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.873 . . . . 0.0 109.783 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.04 33.42 4.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.267 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.04 -167.91 2.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -143.62 -164.88 1.97 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.911 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 8.5 t80 -144.58 77.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.44 92.54 0.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.986 HG13 HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -116.96 151.58 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -128.25 173.79 9.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.386 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.1 126.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.035 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.94 -55.98 3.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -81.42 97.82 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.729 ' HA ' HD12 ' A' ' 32' ' ' LEU . 26.4 p -41.6 -30.79 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -0.824 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -53.23 -34.95 59.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 1.6 mp0 -67.11 -46.46 74.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.689 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG22 ' A' ' 11' ' ' VAL . 18.0 mt -54.42 -42.46 70.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -63.17 -70.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.11 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -59.64 2.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -49.45 -26.6 3.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -70.39 -58.08 6.26 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 44.6 t -64.85 -13.65 56.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' GLN . 31.1 t -85.76 -72.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 109.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.13 -29.82 1.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 13' ' ' LEU . 4.5 m-30 -96.69 -17.94 20.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.567 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.4 mt-30 57.11 84.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.744 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -124.08 101.57 35.16 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 109.977 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 51.0 Cg_endo -75.84 -160.65 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.177 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.6 ttt -119.95 43.75 0.59 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 111.075 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 44' ' ' MET . 49.8 Cg_endo -76.23 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.533 1.28 . . . . 0.0 109.626 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.33 10.26 3.25 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 34.7 m -72.85 -159.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.351 -1.088 . . . . 0.0 110.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.41 158.23 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 110.514 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -110.59 165.9 11.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 109.228 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 73' ' ' LEU . 6.1 p -159.35 133.33 7.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.099 . . . . 0.0 110.769 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -62.4 120.92 11.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.484 -0.76 . . . . 0.0 110.3 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -70.31 -6.2 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 19.4 tt0 -54.11 -65.58 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.35 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -131.6 23.86 4.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 83.2 28.52 36.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.39 165.11 25.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.183 -1.186 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' C ' HG23 ' A' ' 58' ' ' VAL . 35.5 mt-10 -119.24 135.54 54.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.3 t -154.3 175.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 58' ' ' VAL . 42.8 p -122.39 166.66 14.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.9 p-10 -66.57 -7.37 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.288 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -22.43 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.7 m -84.24 13.89 4.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.955 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -100.42 97.82 7.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.017 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 45.9 Cg_endo -71.3 -92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.896 1.472 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -128.95 64.86 0.6 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' PHE . 12.0 mt -42.92 161.78 0.18 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -1.096 . . . . 0.0 110.174 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.6 Cg_endo -71.95 162.91 40.46 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.075 1.566 . . . . 0.0 110.225 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -42.29 150.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.59 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 42.98 38.35 1.4 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.881 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -40.85 110.35 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 110.175 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 12' ' ' LYS . 2.3 tp10 -70.48 99.76 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.357 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 66' ' ' LEU . 6.5 mp -114.6 158.09 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -140.14 116.86 10.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 110.434 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.955 HD11 HD23 ' A' ' 42' ' ' LEU . 6.8 tp -70.64 149.12 47.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -153.51 155.3 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.091 -1.005 . . . . 0.0 110.007 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 19.2 p -135.88 172.46 12.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.157 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.08 -31.77 31.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.865 . . . . 0.0 110.291 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.92 17.47 41.04 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' CA ' ' OE1' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -149.97 149.38 30.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -1.21 . . . . 0.0 110.574 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.753 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.26 134.84 22.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.861 ' HB2' HD12 ' A' ' 16' ' ' LEU . 7.1 t-105 -103.16 133.25 48.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -0.929 . . . . 0.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -83.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -169.82 158.11 30.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 34.7 t80 -75.9 92.09 3.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 110.13 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -87.52 145.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 86' ' ' SER . 5.0 p -103.56 106.34 16.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.232 -179.896 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.178 0.513 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 6.1 p 175.89 46.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 110.223 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 2' ' ' CYS . . . 56.99 61.7 2.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 4' ' ' VAL . 4.7 p -56.47 101.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 27' ' ' ARG . 1.1 mt -111.42 -165.13 0.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.5 mtt180 -108.03 67.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 109.904 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 68.91 148.27 0.12 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.801 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 7' ' ' GLN . 45.8 Cg_endo -72.58 133.85 21.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.977 1.514 . . . . 0.0 110.586 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -171.91 3.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.636 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 50.6 t -149.16 149.45 31.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.001 -1.062 . . . . 0.0 110.505 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG2' HG12 ' A' ' 24' ' ' VAL . 6.2 m -148.26 134.71 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 8.6 mmtp -97.28 95.15 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -74.25 89.45 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.984 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.626 ' HG3' HD12 ' A' ' 73' ' ' LEU . 2.8 tpt180 -89.39 151.72 21.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.963 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.05 131.31 30.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 110.576 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -70.73 -24.47 62.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.416 ' HB2' ' OE2' ' A' ' 79' ' ' GLU . 3.6 t-160 -86.72 16.08 5.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -135.1 -161.28 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 20' ' ' CYS . . . -125.43 29.79 5.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.296 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 174.84 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 110.666 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -139.37 164.37 30.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 15.0 t80 -102.5 79.66 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -61.92 87.84 0.04 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.038 HG13 HD22 ' A' ' 32' ' ' LEU . 8.6 p -103.37 140.59 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.616 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.15 39.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.761 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.79 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -173.99 148.8 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 11.0 mmt180 -62.97 -48.16 80.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -84.57 89.19 7.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 110.104 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 28' ' ' SER . 6.6 p -42.64 -31.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.08 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.14 -36.09 78.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 109.907 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 2.7 tp10 -62.41 -51.41 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.778 . . . . 0.0 110.019 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 HG13 ' A' ' 24' ' ' VAL . 43.7 mt -53.41 -39.26 64.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 63' ' ' PHE . 4.5 mt -57.26 -69.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 110.148 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.735 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.27 -60.14 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.849 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 14.0 mtpt -46.97 -27.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.486 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -69.98 -56.09 8.53 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.6 -15.18 25.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.196 . . . . 0.0 109.937 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 34' ' ' ARG . 24.5 t -87.97 -55.48 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.733 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.64 70.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 3.2 m-30 -95.79 -21.99 17.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.382 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.26 84.05 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.516 -0.74 . . . . 0.0 110.732 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.025 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.15 98.47 38.8 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 110.159 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 52.6 Cg_endo -74.37 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.958 1.504 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 19.4 ttm -124.05 43.86 0.91 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.081 -1.012 . . . . 0.0 111.262 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 44' ' ' MET . 51.7 Cg_endo -77.43 2.28 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.533 1.281 . . . . 0.0 109.984 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.0 12.35 5.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' HD11 ' A' ' 42' ' ' LEU . 49.1 m -74.18 -161.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -1.11 . . . . 0.0 110.42 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER 178.61 150.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 60' ' ' ASP . 5.1 mp -115.81 115.15 25.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 56' ' ' THR . 99.9 m -92.46 -171.13 2.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 111.058 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD12 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -121.72 126.85 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.647 -0.658 . . . . 0.0 109.729 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.31 -15.45 63.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 110.816 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -44.9 -68.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.995 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 54' ' ' ASP . 26.3 t70 -143.07 40.09 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.467 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.549 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 72.23 38.5 58.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -80.47 160.03 25.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -1.193 . . . . 0.0 109.834 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' CG2' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -114.49 128.77 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 110.383 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.045 HG11 ' CE1' ' A' ' 63' ' ' PHE . 3.1 t -147.93 -171.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.743 ' H ' HG12 ' A' ' 58' ' ' VAL . 53.9 p -145.41 165.51 28.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.049 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.653 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.7 p-10 -79.23 8.65 5.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -124.92 5.52 8.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 110.354 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t -119.78 -36.56 3.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.045 ' CE1' HG11 ' A' ' 58' ' ' VAL . 4.8 m-85 -40.86 100.58 0.22 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.6 Cg_endo -76.67 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.039 1.547 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -110.47 67.68 0.22 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.6 mp -41.95 146.13 0.66 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 110.425 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.65 158.08 43.77 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.116 1.587 . . . . 0.0 110.281 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 12.4 p30 -44.27 147.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 109.89 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.7 OUTLIER 43.88 36.4 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.684 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -44.98 119.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -82.49 101.51 10.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.741 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 1.2 mp -110.24 152.76 25.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -131.02 104.83 7.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.59 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.025 HD11 HD23 ' A' ' 42' ' ' LEU . 10.2 tp -60.5 126.66 28.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -139.16 158.57 43.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.982 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 47' ' ' SER . 49.8 p -134.24 176.39 8.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.16 -32.51 36.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.85 20.95 29.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -145.3 148.62 33.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.721 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -146.76 138.0 24.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.451 -0.781 . . . . 0.0 109.855 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.467 ' HB2' ' CD2' ' A' ' 73' ' ' LEU . 5.5 t-105 -107.89 123.94 49.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.991 -1.068 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -67.33 -62.47 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 153.69 6.07 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 14.1 t80 -88.98 166.04 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -1.089 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 m -86.62 174.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.341 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.38 47.05 1.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.303 -179.857 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.265 0.555 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.1 t -43.42 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -163.86 47.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.2 p -157.16 62.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.18 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 27' ' ' ARG . 76.0 mt -111.2 128.46 55.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 15.4 mmt180 -105.65 40.84 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER 166.16 119.39 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.574 -0.704 . . . . 0.0 110.022 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.8 Cg_endo -72.46 130.79 16.59 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.871 1.459 . . . . 0.0 110.566 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 4.3 ttpt -79.98 155.13 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.85 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' VAL . 7.4 t -129.52 153.46 47.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.622 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.619 HG22 HD13 ' A' ' 32' ' ' LEU . 10.6 m -148.66 135.0 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.08 96.21 10.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 110.355 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -76.33 81.58 3.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.92 . . . . 0.0 110.024 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.718 ' CG ' HD12 ' A' ' 73' ' ' LEU . 5.3 tpt180 -80.59 158.72 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -140.26 112.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -62.5 -30.38 71.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.857 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.572 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 52.1 t60 -82.19 8.1 11.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 28.6 t -121.2 -160.59 0.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -119.23 19.51 12.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 175.84 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.108 -0.995 . . . . 0.0 110.781 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -135.97 168.8 18.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.552 -0.718 . . . . 0.0 109.883 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -122.52 99.85 6.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.323 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.41 92.58 0.27 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.998 HG13 HD22 ' A' ' 32' ' ' LEU . 4.1 p -97.39 146.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 0.0 110.354 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.596 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -134.92 144.88 47.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.37 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -170.51 123.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.5 mtt180 -42.29 -29.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -100.67 95.64 6.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.277 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 30' ' ' GLN . 21.1 p -44.98 -33.27 1.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.449 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 8.5 mp0 -62.55 -20.64 64.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.73 -48.3 16.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.934 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.998 HD22 HG13 ' A' ' 24' ' ' VAL . 22.3 mt -58.98 -38.86 80.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.022 HD21 ' CD1' ' A' ' 66' ' ' LEU . 52.8 mt -66.36 -63.63 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.687 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.4 mmm-85 -52.78 -65.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.804 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 28.0 mtpt -50.61 -24.21 3.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.607 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -71.7 -52.55 11.93 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -63.28 -16.11 59.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -1.203 . . . . 0.0 110.056 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 34' ' ' ARG . 99.3 t -78.16 -59.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.008 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -35.1 79.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.942 . . . . 0.0 109.982 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.7 m-30 -84.87 -14.72 46.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 58.2 mm-40 53.1 78.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.398 -0.814 . . . . 0.0 110.554 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -116.82 97.63 50.77 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 47' ' ' SER . 45.9 Cg_endo -72.15 161.47 44.52 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.693 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.24 -48.23 13.26 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 0.0 110.654 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 44' ' ' MET . 48.0 Cg_endo -76.6 150.26 31.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.759 1.399 . . . . 0.0 110.649 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 44.34 51.38 7.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -165.74 164.79 18.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -1.122 . . . . 0.0 110.25 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -177.63 146.52 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.01 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.715 ' CD2' HD12 ' A' ' 74' ' ' LEU . 2.2 mt -114.65 169.12 9.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 3.6 p -151.98 161.92 41.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.945 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.752 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -92.47 115.97 28.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.65 -0.656 . . . . 0.0 109.955 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.47 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . 7.5 t80 -64.22 -15.43 59.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.409 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -48.77 -51.69 27.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.47 20.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 82.57 22.26 58.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -65.8 174.34 2.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.127 -1.22 . . . . 0.0 109.672 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 4.9 mm-40 -126.17 137.05 53.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.513 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 51' ' ' LEU . 90.5 t -156.64 173.96 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.193 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 58' ' ' VAL . 22.7 p -121.87 159.9 25.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.896 . . . . 0.0 110.023 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.57 -7.79 11.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.637 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -15.38 14.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.02 -1.05 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.2 m -88.34 -40.63 13.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.045 . . . . 0.0 110.45 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.602 ' CE1' HD21 ' A' ' 72' ' ' LEU . 47.8 m-85 -39.77 99.75 0.2 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.462 -0.774 . . . . 0.0 110.357 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.8 Cg_endo -76.74 -87.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.071 1.563 . . . . 0.0 110.406 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -117.63 67.31 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.022 ' CD1' HD21 ' A' ' 33' ' ' LEU . 1.6 mt -43.03 143.23 1.31 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.957 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 44.1 Cg_endo -72.32 167.36 27.12 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.019 1.537 . . . . 0.0 110.47 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 69' ' ' ASP . 4.2 t-20 -52.1 152.91 2.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 110.457 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER 42.49 38.92 1.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.809 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.994 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -54.33 116.9 2.88 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mt-10 -89.12 108.06 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.6 mp -117.08 159.75 22.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.0 110.004 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.718 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -134.7 139.97 45.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.646 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.036 HD11 HD23 ' A' ' 42' ' ' LEU . 12.2 tp -79.99 144.73 33.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 75' ' ' LEU . 3.1 tt -154.02 159.96 41.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 21.9 p -152.17 167.81 27.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -45.89 -29.89 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.147 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.81 22.45 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -155.81 152.69 28.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.613 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.573 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.789 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.523 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 9.5 t-105 -107.8 135.28 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.008 -1.058 . . . . 0.0 110.786 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -78.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.336 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.483 ' O ' ' CZ2' ' A' ' 81' ' ' TRP . . . 174.22 177.92 43.74 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -83.9 131.48 34.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -1.142 . . . . 0.0 110.271 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 85' ' ' VAL . 10.5 m -84.55 136.44 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 110.385 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.2 t -111.25 95.89 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 110.083 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.261 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.274 0.559 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 t -161.13 127.0 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.27 86.68 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 110.102 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 4' ' ' VAL . 5.6 p -147.82 98.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.122 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.9 166.39 12.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 110.334 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 0.6 OUTLIER -82.17 59.89 4.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.318 -0.864 . . . . 0.0 109.439 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 74.93 159.04 0.16 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.69 -0.631 . . . . 0.0 109.799 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 7' ' ' GLN . 43.9 Cg_endo -71.15 134.14 24.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.924 1.487 . . . . 0.0 110.814 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 152.5 22.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.969 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 69' ' ' ASP . 39.2 m -121.75 153.67 37.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 110.383 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.831 HG22 HD22 ' A' ' 32' ' ' LEU . 11.3 m -147.2 132.77 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -97.46 99.59 11.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.919 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -81.52 95.04 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.639 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 4.7 tpt180 -91.61 157.59 16.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.572 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.78 120.06 10.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -64.86 -17.44 64.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.893 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -79.69 -0.54 34.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -134.18 -159.17 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.858 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.16 34.2 5.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.435 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 6.7 p -177.18 -162.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 110.706 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -140.21 -169.15 2.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.522 -0.736 . . . . 0.0 110.038 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 3.7 t80 -130.41 81.29 2.0 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 110.28 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.27 85.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HD23 ' A' ' 32' ' ' LEU . 2.1 p -107.21 146.6 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -1.14 . . . . 0.0 110.117 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.68 ' CA ' HD21 ' A' ' 32' ' ' LEU . . . -124.13 163.63 21.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.002 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.912 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 179.45 135.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -0.863 . . . . 0.0 110.202 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -52.39 -61.69 2.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' CYS . 70.7 m -75.22 93.87 2.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.868 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.752 ' HA ' HD12 ' A' ' 32' ' ' LEU . 21.3 p -40.98 -30.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.28 -38.49 58.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -68.07 -43.16 79.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.751 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.082 HD23 HG13 ' A' ' 24' ' ' VAL . 17.0 mt -53.75 -46.81 71.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.563 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.659 HD11 HD11 ' A' ' 66' ' ' LEU . 27.8 mt -66.87 -67.18 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 109.898 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -43.73 -68.31 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.61 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 5.6 mtpp -46.83 -27.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.87 -55.64 16.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.22 -13.77 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.179 . . . . 0.0 109.714 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 78.4 t -87.27 -52.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.77 . . . . 0.0 109.997 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -63.83 -29.25 70.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.4 m-30 -99.24 -18.86 17.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 109.503 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER 60.34 85.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 110.699 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.717 ' CG ' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -124.89 92.4 47.74 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.07 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 48.3 Cg_endo -73.51 -160.5 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.009 1.531 . . . . 0.0 110.153 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 3.7 ttt -120.78 43.35 0.61 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.117 -0.99 . . . . 0.0 111.426 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 44' ' ' MET . 53.2 Cg_endo -77.25 -0.48 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.537 1.282 . . . . 0.0 109.844 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.98 6.09 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 76' ' ' THR . 39.4 m -73.05 -161.82 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -1.102 . . . . 0.0 110.512 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.1 OUTLIER 176.41 167.62 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.49 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 60' ' ' ASP . 0.6 OUTLIER -120.57 170.25 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 109.556 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 56' ' ' THR . 74.1 m -148.36 -178.99 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.477 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -116.1 120.08 37.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.973 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -5.98 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 110.538 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -50.05 -62.59 1.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.471 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -147.53 20.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 110.724 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.546 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 96.33 44.56 2.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -94.88 167.57 11.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 109.985 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.526 ' C ' HG23 ' A' ' 58' ' ' VAL . 9.5 mm-40 -122.03 136.81 54.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.888 HG11 ' CE1' ' A' ' 63' ' ' PHE . 11.7 t -151.73 179.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.621 ' H ' HG12 ' A' ' 58' ' ' VAL . 18.4 p -129.91 164.76 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.553 ' N ' HD13 ' A' ' 49' ' ' LEU . 17.5 p-10 -73.96 1.2 11.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.44 -23.95 7.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 37.4 t -79.96 -41.24 26.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.401 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.933 ' HB3' HD11 ' A' ' 66' ' ' LEU . 12.6 m-85 -40.49 99.78 0.21 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.488 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.9 Cg_endo -80.59 -87.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 110.595 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.8 67.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.933 HD11 ' HB3' ' A' ' 63' ' ' PHE . 3.3 mp -44.38 148.16 0.9 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.305 -1.115 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.81 157.58 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.935 1.492 . . . . 0.0 109.976 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.98 146.46 0.81 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.038 -1.039 . . . . 0.0 110.067 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.9 m-20 45.58 36.47 2.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.709 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -42.58 116.45 0.86 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.85 95.45 9.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.0 mp -103.92 162.8 12.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.744 HD21 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -136.43 106.5 6.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.551 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 42' ' ' LEU . 17.1 tp -55.3 148.35 14.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.719 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.65 156.57 32.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 47' ' ' SER . 21.5 p -138.83 165.74 26.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 110.359 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 76' ' ' THR . . . -43.76 -32.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.98 27.79 7.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -154.73 155.87 35.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 110.587 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.719 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.1 141.07 16.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.847 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.488 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.1 t-105 -110.69 130.1 55.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.0 110.338 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -72.54 -61.79 1.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.93 . . . . 0.0 110.099 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.7 162.7 10.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 26.3 t80 -86.02 48.44 1.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -1.055 . . . . 0.0 110.218 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG12 ' H ' ' A' ' 86' ' ' SER . 2.5 t -106.22 -172.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 110.016 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.696 ' H ' HG12 ' A' ' 85' ' ' VAL . 2.8 m -147.18 66.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.208 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.245 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.291 0.567 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.26 61.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 4' ' ' VAL . . . -141.3 79.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.209 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 3' ' ' ALA . 4.2 t 40.74 79.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 0.0 110.617 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.57 138.43 31.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 2.2 mmm180 -111.67 45.54 1.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 167.79 113.83 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 110.332 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.4 Cg_endo -73.77 126.3 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 110.314 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -79.61 152.57 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 0.0 110.034 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.896 ' SG ' ' HB2' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -124.36 151.01 44.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.597 HG22 HD13 ' A' ' 32' ' ' LEU . 22.8 m -148.02 141.03 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.73 102.61 15.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 1.3 tp -78.63 89.52 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.607 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.1 tpt180 -91.49 154.68 18.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -140.34 113.1 8.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.036 -1.04 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -58.09 -20.8 42.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -81.5 -0.18 40.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -127.1 -160.91 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.98 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.76 28.54 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.347 -0.845 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -179.39 -159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.603 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -141.38 -176.03 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 110.033 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.7 t80 -133.83 91.13 2.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.97 95.02 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.868 HG13 HD22 ' A' ' 32' ' ' LEU . 4.2 p -101.56 147.14 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -1.083 . . . . 0.0 110.3 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.896 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . . . -128.09 147.74 50.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 110.35 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -169.79 150.84 4.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.6 mmt180 -62.0 -55.94 24.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 7.8 p -83.49 96.97 8.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 31.2 p -41.29 -29.65 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.566 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.8 mm100 -60.34 -23.55 64.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.076 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -74.12 -46.78 40.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HG13 ' A' ' 24' ' ' VAL . 24.3 mt -59.7 -38.25 81.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.976 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 30' ' ' GLN . 18.4 mt -67.16 -54.98 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.859 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -58.74 -65.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.764 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 19.5 mtpp -49.9 -29.37 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -68.43 -53.04 23.09 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.6 t -57.53 -17.0 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.554 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 34' ' ' ARG . 47.6 t -84.24 -56.3 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.985 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -62.92 -33.54 75.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' HB3' HD22 ' A' ' 74' ' ' LEU . 4.7 m-30 -94.13 -13.25 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.707 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.88 84.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.698 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -127.34 96.78 32.76 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.0 -1.062 . . . . 0.0 110.257 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 47' ' ' SER . 43.7 Cg_endo -71.84 127.53 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.086 1.572 . . . . 0.0 110.332 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.532 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -41.44 -53.22 7.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.403 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 50.9 Cg_endo -77.81 164.14 28.09 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.025 1.539 . . . . 0.0 110.618 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 43.38 30.8 1.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -163.49 -177.64 5.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -1.177 . . . . 0.0 110.214 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 175.99 153.74 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.182 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.578 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.1 mt -122.84 160.08 26.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.647 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 56' ' ' THR . 63.7 m -147.78 139.18 23.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 110.348 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -67.32 120.3 13.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.487 -0.758 . . . . 0.0 110.463 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 21.5 t80 -69.54 -12.58 61.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.765 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.06 -41.14 74.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 110.319 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.58 40.2 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.182 -0.948 . . . . 0.0 110.645 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 57.38 29.75 60.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -74.2 161.08 30.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.249 . . . . 0.0 109.7 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.6 pt-20 -114.75 133.0 56.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.048 -1.032 . . . . 0.0 110.599 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.77 HG11 ' CE1' ' A' ' 63' ' ' PHE . 81.3 t -156.67 173.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.588 ' N ' HG12 ' A' ' 58' ' ' VAL . 24.2 p -122.58 158.81 29.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.1 p-10 -63.16 -16.19 59.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 110.405 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -1.49 31.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.0 t -101.06 -41.46 6.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.875 ' CD1' HD21 ' A' ' 66' ' ' LEU . 35.2 m-85 -39.61 99.27 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.726 . . . . 0.0 110.246 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.5 Cg_endo -73.65 -55.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.008 1.531 . . . . 0.0 110.462 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.6 68.51 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.875 HD21 ' CD1' ' A' ' 63' ' ' PHE . 1.5 mp -48.09 160.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.126 . . . . 0.0 109.879 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.12 165.6 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -44.64 150.38 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.248 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . 68.0 m-20 47.43 35.74 4.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -52.22 125.84 17.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.753 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.595 ' C ' HD22 ' A' ' 72' ' ' LEU . 31.5 mp0 -96.25 110.24 22.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.163 -0.96 . . . . 0.0 110.914 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.758 HD21 HD22 ' A' ' 66' ' ' LEU . 2.7 mm? -114.48 141.26 47.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 0.0 109.788 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -115.9 149.25 38.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 0.0 110.416 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.8 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.7 tp -86.98 147.1 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.824 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.3 tt -158.99 157.06 30.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.8 p -152.29 173.21 15.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.59 -36.14 6.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.175 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -87.36 23.24 12.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 76' ' ' THR . 3.4 mt-10 -157.65 150.71 23.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.093 -1.239 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.53 133.17 20.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.518 ' NE1' ' HA2' ' A' ' 55' ' ' GLY . 3.3 t-105 -96.88 125.52 41.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.248 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.418 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 26.4 m80 -67.8 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 110.166 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.5 128.65 1.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 85' ' ' VAL . 59.0 t80 -59.93 132.62 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 11.7 m -80.19 166.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 86' ' ' SER . 9.6 p -99.6 61.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.185 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.173 0.511 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 65.7 m -52.57 146.28 10.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.14 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.84 51.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.45 45.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 27' ' ' ARG . 0.6 OUTLIER 52.38 46.59 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.847 . . . . 0.0 110.302 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.1 mmt-85 43.19 47.71 5.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.988 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 68.53 163.22 0.14 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.334 -0.854 . . . . 0.0 110.268 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 45.0 Cg_endo -71.65 137.53 30.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.864 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 169.24 16.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.745 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.445 ' C ' HG13 ' A' ' 11' ' ' VAL . 26.5 m -141.38 152.32 44.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.6 m -148.07 142.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 55.2 mmtt -98.33 92.4 5.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.566 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -72.61 84.31 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 110.382 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.729 ' CG ' HD12 ' A' ' 73' ' ' LEU . 4.0 tpt180 -81.59 159.82 23.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.825 . . . . 0.0 109.693 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -141.31 126.64 18.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 110.589 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.793 HD12 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -68.57 -24.51 64.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.951 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -79.93 5.98 12.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.81 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -150.81 148.88 29.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 110.019 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.42 54.94 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 110.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.2 p -173.65 -172.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -146.25 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.473 -0.767 . . . . 0.0 109.931 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 24' ' ' VAL . 14.2 t80 -147.71 79.0 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.0 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -62.49 81.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.015 HG13 HD22 ' A' ' 32' ' ' LEU . 4.8 p -93.83 144.99 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -1.102 . . . . 0.0 110.728 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -123.68 154.42 39.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 110.059 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -177.12 130.05 0.17 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' O ' HD13 ' A' ' 5' ' ' LEU . 4.6 ttp180 -45.51 -57.15 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 29' ' ' CYS . 2.2 p -82.26 97.18 8.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 31.5 p -41.83 -29.42 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 110.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' OE1' ' SG ' ' A' ' 29' ' ' CYS . 1.4 mp0 -56.69 -24.02 46.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.37 -46.2 42.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.373 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.015 HD22 HG13 ' A' ' 24' ' ' VAL . 20.4 mt -61.68 -39.46 91.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.515 HD13 ' HB2' ' A' ' 63' ' ' PHE . 29.1 mt -63.03 -58.78 6.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.053 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' LYS . 4.4 mmt180 -59.42 -71.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 0.0 109.86 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' ARG . 32.6 mtpt -42.96 -34.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.776 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -63.96 -54.66 29.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 42.0 t -61.5 -13.5 21.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.15 -1.206 . . . . 0.0 109.872 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.6 -49.98 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.0 109.687 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -25.51 63.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.534 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 2.1 m-30 -99.63 -18.96 17.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -0.797 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER 60.57 83.23 0.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.739 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -125.06 102.85 30.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.99 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.9 Cg_endo -71.54 156.14 58.37 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.938 1.494 . . . . 0.0 110.531 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -74.5 -48.54 5.3 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.139 -0.976 . . . . 0.0 110.234 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 44' ' ' MET . 51.1 Cg_endo -79.99 133.49 10.07 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.015 1.534 . . . . 0.0 110.391 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.1 44.35 95.9 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -166.98 174.94 7.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -1.152 . . . . 0.0 109.993 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 174.2 147.05 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.893 -1.129 . . . . 0.0 110.948 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 59' ' ' THR . 1.1 mp -110.09 175.76 5.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.36 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HD23 ' A' ' 73' ' ' LEU . 1.9 p -159.07 146.6 17.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 0.0 110.673 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -71.55 111.51 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 110.121 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.751 ' CD1' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -68.97 -14.54 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -53.05 -44.51 67.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.285 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t70 -136.47 -33.78 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.468 ' HA2' ' NE1' ' A' ' 81' ' ' TRP . . . 131.3 38.59 0.27 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.523 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.3 171.5 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.102 . . . . 0.0 110.018 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.558 ' C ' HG23 ' A' ' 58' ' ' VAL . 2.7 mm-40 -121.24 135.94 55.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 109.73 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 63' ' ' PHE . 82.5 t -155.38 168.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.601 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 49' ' ' LEU . 55.0 p -110.14 159.46 17.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 110.12 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.8 p-10 -67.06 -8.01 27.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 110.433 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.32 -17.1 14.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 5.6 m -84.58 -41.61 16.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.718 ' CE1' HG11 ' A' ' 58' ' ' VAL . 18.6 m-85 -40.0 100.18 0.21 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.401 -0.812 . . . . 0.0 110.57 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -75.84 -89.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.07 1.563 . . . . 0.0 110.36 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -125.98 65.83 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 17.5 mt -42.76 163.37 0.15 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -73.0 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.214 1.639 . . . . 0.0 109.921 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -74.44 150.28 40.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.126 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 70' ' ' ALA . 38.7 m-20 42.75 37.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.86 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -41.03 100.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.63 . . . . 0.0 110.253 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.7 tt0 -71.35 106.07 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.367 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 71' ' ' GLU . 6.0 mp -111.37 166.42 11.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -142.39 138.33 31.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.739 ' CG ' HD23 ' A' ' 42' ' ' LEU . 10.2 tp -80.89 146.23 30.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -157.82 159.45 36.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.092 -1.005 . . . . 0.0 109.899 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.2 p -150.98 174.08 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.41 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.931 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.28 18.47 57.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -151.49 161.22 43.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -1.145 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -157.13 142.64 17.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.827 . . . . 0.0 110.166 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ2' ' C ' ' A' ' 83' ' ' GLY . 6.7 t-105 -116.26 133.12 56.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.125 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.28 -80.23 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' C ' ' CZ2' ' A' ' 81' ' ' TRP . . . -168.36 154.19 23.85 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.5 96.02 9.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.14 . . . . 0.0 110.28 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 85' ' ' VAL . 19.6 m -91.62 151.52 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m -99.44 74.57 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 t0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.238 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.266 0.555 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.5 OUTLIER 59.55 -168.54 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 44.1 61.19 2.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.96 128.12 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.62 -177.61 6.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.471 ' O ' ' CB ' ' A' ' 7' ' ' GLN . 4.0 mmt180 -121.94 73.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.1 tt0 69.57 144.14 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.272 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.3 Cg_endo -73.3 123.58 8.84 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.129 1.594 . . . . 0.0 110.953 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 29' ' ' CYS . 1.9 ttpm? -80.92 155.87 26.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.743 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' ASP . 25.0 t -125.38 151.84 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 24' ' ' VAL . 8.9 m -144.53 149.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -99.31 101.24 12.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -79.27 75.28 5.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.431 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.844 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.8 tpt180 -83.73 157.31 22.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 18' ' ' SER . . . -135.83 122.4 20.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.049 -1.032 . . . . 0.0 110.661 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.011 HD12 HD21 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -71.36 -30.6 66.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CA ' ' OE2' ' A' ' 79' ' ' GLU . 61.0 t-80 -79.89 5.76 12.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 110.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 58.0 m -127.18 -163.79 1.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.961 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.14 33.05 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -171.88 -162.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.822 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.95 -164.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.769 . . . . 0.0 109.853 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 7.0 t80 -156.08 89.56 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.447 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.56 96.1 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 32' ' ' LEU . 2.3 p -105.74 151.83 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 110.43 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -134.06 161.81 33.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.059 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -178.52 141.91 0.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 0.0 110.478 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.38 -65.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.99 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.3 OUTLIER -79.72 95.03 5.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.846 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 29.5 p -41.44 -28.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.808 . . . . 0.0 110.423 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' SER . 13.0 tt0 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' CD ' ' A' ' 35' ' ' LYS . 1.2 tp10 -74.41 -46.13 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.385 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 24' ' ' VAL . 22.0 mt -60.97 -36.89 80.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 66' ' ' LEU . 63.8 mt -66.37 -59.89 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.838 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -70.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 24.0 mtpp -45.48 -32.03 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.863 . . . . 0.0 109.598 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 13' ' ' LEU . . . -61.6 -51.27 58.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 40.3 t -65.76 -15.78 63.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.696 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 82.5 t -80.53 -46.5 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -32.57 64.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.671 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.516 ' CD2' HD22 ' A' ' 74' ' ' LEU . 2.0 m-30 -90.6 -10.55 42.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.77 82.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.322 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.8 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -124.63 111.26 27.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 110.153 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 47' ' ' SER . 46.7 Cg_endo -73.04 162.34 41.15 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.015 1.534 . . . . 0.0 110.301 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.536 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 2.1 ttp -76.36 -54.31 1.93 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 48.8 Cg_endo -77.61 153.39 30.26 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.901 1.474 . . . . 0.0 110.44 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.32 38.93 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -155.05 172.32 18.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 110.196 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.914 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 178.95 140.03 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 60' ' ' ASP . 2.0 mp -112.1 118.73 36.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.374 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 75' ' ' LEU . 71.6 m -103.34 155.11 18.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.056 -1.028 . . . . 0.0 110.753 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -83.27 124.09 30.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.014 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 73' ' ' LEU . 6.5 t80 -73.93 1.24 11.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.741 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' HD23 ' A' ' 51' ' ' LEU . 1.1 tp10 -59.73 -54.97 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.35 21.19 1.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' CA ' ' HA2' ' A' ' 83' ' ' GLY . . . 87.63 35.9 9.0 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.11 163.15 22.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -1.175 . . . . 0.0 110.013 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' C ' HG23 ' A' ' 58' ' ' VAL . 14.7 pt-20 -116.04 134.81 54.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.054 HG11 ' CE1' ' A' ' 63' ' ' PHE . 21.2 t -153.09 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.589 ' H ' HG12 ' A' ' 58' ' ' VAL . 44.5 p -131.48 161.44 32.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.003 -1.061 . . . . 0.0 109.99 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.7 p-10 -72.61 -0.75 13.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.923 . . . . 0.0 110.579 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -113.0 -11.52 13.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 110.379 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 3.3 t -98.39 -38.2 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.48 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.105 ' CE1' HD21 ' A' ' 66' ' ' LEU . 6.9 m-85 -39.99 99.48 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 49.2 Cg_endo -81.35 -67.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.935 1.492 . . . . 0.0 110.349 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . -147.97 64.78 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.105 HD21 ' CE1' ' A' ' 63' ' ' PHE . 4.7 mt -42.31 163.45 0.13 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 66' ' ' LEU . 43.5 Cg_endo -71.24 161.98 44.01 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.209 1.636 . . . . 0.0 110.2 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.45 153.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 4.8 m-20 45.02 37.22 2.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.81 . . . . 0.0 110.107 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -49.54 112.83 0.7 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.406 -0.808 . . . . 0.0 109.864 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 111.64 18.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.574 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 mp -109.22 148.32 31.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.752 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 16' ' ' LEU . 1.1 tp -132.18 126.03 32.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.943 -1.098 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.8 HD11 HD23 ' A' ' 42' ' ' LEU . 9.0 tp -67.74 131.24 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 109.929 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.914 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.3 tt -147.77 159.48 43.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 109.656 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 20.3 p -146.79 -178.03 5.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.94 73.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.14 11.13 58.82 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' OE2' ' CA ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER -141.96 154.16 44.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -1.184 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.576 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -150.59 141.61 23.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -114.51 129.53 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.351 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -66.81 -69.92 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.235 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 55' ' ' GLY . . . 148.63 131.81 2.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.39 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -1.182 . . . . 0.0 110.477 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 85' ' ' VAL . 31.6 m -96.0 127.92 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.3 m -130.94 50.83 2.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.244 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t 60.27 72.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.333 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.4 64.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.242 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.65 137.84 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 109.992 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.85 -165.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.454 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 3.7 mmt180 -136.2 81.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 67.82 143.7 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.451 -0.781 . . . . 0.0 109.632 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 44.3 Cg_endo -72.0 125.52 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.981 1.517 . . . . 0.0 110.97 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -85.89 153.35 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' ASP . 13.5 t -127.61 158.83 36.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.381 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG2' HG12 ' A' ' 24' ' ' VAL . 5.4 m -149.02 135.87 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -92.89 96.47 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -75.84 82.42 2.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.877 ' CG ' HD12 ' A' ' 73' ' ' LEU . 3.5 tpt180 -81.01 160.53 24.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -142.39 132.31 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 110.519 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.559 HD12 HD21 ' A' ' 73' ' ' LEU . 4.6 mt -74.55 -20.86 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 109.941 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.529 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 21.4 t60 -79.96 3.34 20.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.899 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 165.48 31.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.96 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 53.2 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -174.98 -172.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 111.09 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -145.62 -162.11 1.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.501 -0.749 . . . . 0.0 109.919 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 9.0 t80 -144.86 87.23 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 110.491 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.07 83.47 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.04 HG13 HD22 ' A' ' 32' ' ' LEU . 7.5 p -95.1 152.14 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -1.158 . . . . 0.0 110.239 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.7 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -132.57 164.29 26.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 177.92 133.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 3.8 mtm180 -50.14 -33.41 18.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' GLN . 3.2 m -107.35 93.74 4.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.898 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 13.9 p -38.77 -28.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.581 -0.699 . . . . 0.0 110.466 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.12 -33.88 72.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.5 tt0 -68.13 -31.33 70.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HG13 ' A' ' 24' ' ' VAL . 30.0 mt -76.38 -34.34 58.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.94 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 63' ' ' PHE . 79.9 mt -66.91 -61.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 tpt180 -53.25 -53.8 45.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtpm? -56.78 -28.25 60.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.341 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -65.46 -51.98 43.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.9 t -67.09 -18.07 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -1.228 . . . . 0.0 109.84 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 34' ' ' ARG . 77.9 t -81.11 -53.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.891 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -66.79 -42.03 86.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.5 m-30 -84.95 -13.22 51.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.558 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.77 80.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.437 -0.789 . . . . 0.0 110.281 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -111.5 105.13 56.73 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 110.105 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo -71.64 168.86 22.5 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.048 1.552 . . . . 0.0 110.495 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -88.57 -44.98 0.46 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.816 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.3 Cg_endo -80.02 120.06 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.683 1.36 . . . . 0.0 110.668 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.11 28.58 55.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -144.58 174.11 11.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -1.207 . . . . 0.0 110.505 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER 174.57 142.55 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.925 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.604 HD21 HD12 ' A' ' 74' ' ' LEU . 3.5 mt -108.72 162.49 14.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.594 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' THR . 6.3 p -149.78 162.59 39.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.614 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.36 115.7 27.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -70.19 -5.96 31.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.376 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.64 -54.26 47.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.5 8.56 3.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 91.5 29.0 12.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.544 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -74.66 176.65 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 109.888 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' HG23 ' A' ' 58' ' ' VAL . 12.2 mt-10 -126.83 137.06 53.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 110.733 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 63' ' ' PHE . 49.0 t -155.77 174.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.578 ' N ' HG12 ' A' ' 58' ' ' VAL . 43.3 p -122.92 165.22 17.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 110.261 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 p-10 -69.79 -4.1 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.892 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.87 -8.12 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.315 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 1.7 m -105.07 18.69 21.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.197 -0.939 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.877 ' CD1' HD11 ' A' ' 66' ' ' LEU . 10.9 m-85 -100.87 98.58 8.68 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 47.9 Cg_endo -72.98 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . . . -127.45 66.54 0.56 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.877 HD11 ' CD1' ' A' ' 63' ' ' PHE . 16.1 mt -41.44 162.98 0.12 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.311 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 68' ' ' ASN . 43.1 Cg_endo -70.75 154.89 63.57 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.232 1.649 . . . . 0.0 109.854 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' PRO . 2.3 t-20 -41.91 143.99 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 10' ' ' CYS . 2.6 m-20 54.38 36.18 24.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.713 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -42.81 111.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.586 -0.696 . . . . 0.0 109.93 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 98.23 5.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 mp -108.34 156.03 19.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.911 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.877 HD12 ' CG ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -139.11 123.99 18.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.834 HD11 HD23 ' A' ' 42' ' ' LEU . 11.5 tp -67.77 138.45 56.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 110.184 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.7 OUTLIER -148.76 157.67 43.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.47 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 5.9 p -148.02 176.8 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.25 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.46 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.42 15.03 52.87 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 2.4 mt-10 -143.42 145.88 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -1.13 . . . . 0.0 110.513 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.722 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.77 157.77 43.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.822 . . . . 0.0 109.812 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.536 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 3.7 t-105 -129.73 126.69 38.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.459 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.54 -59.28 3.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.391 -0.818 . . . . 0.0 110.11 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.46 161.34 8.69 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -76.03 146.46 39.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 110.144 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.31 166.05 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.7 t -146.69 51.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.271 0.558 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.06 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -170.05 59.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.36 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -144.23 152.71 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.033 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.338 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -108.9 44.72 1.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 110.033 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 4.9 pt20 -178.14 113.37 0.23 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.36 -0.838 . . . . 0.0 109.812 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -73.16 125.73 10.54 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.945 1.497 . . . . 0.0 110.794 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -80.92 171.4 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.917 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ASP . 44.5 m -138.68 151.16 46.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' VAL . 5.5 m -146.32 129.51 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 13.7 mmmt -85.65 96.69 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -75.76 87.21 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 110.698 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.884 ' HG3' HD12 ' A' ' 73' ' ' LEU . 3.6 tpt180 -81.99 154.83 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.705 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 14' ' ' ARG . . . -143.43 117.23 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.818 HD12 HD21 ' A' ' 73' ' ' LEU . 1.5 mt -60.81 -27.44 68.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.201 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -83.1 10.77 7.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.13 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -128.19 -161.76 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.82 14.17 15.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.399 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 -155.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.644 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -130.36 176.0 8.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 110.301 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 24' ' ' VAL . 19.2 t80 -120.19 84.93 2.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.82 85.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 32' ' ' LEU . 7.0 p -96.3 148.4 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -1.096 . . . . 0.0 110.41 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.574 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -130.25 151.09 51.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.854 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -171.93 142.35 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 110.468 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -47.03 -66.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 110.008 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 29' ' ' CYS . 0.9 OUTLIER -81.59 96.24 7.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' SER . 24.7 p -41.94 -31.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.707 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -54.79 -29.24 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HG3' ' HD2' ' A' ' 35' ' ' LYS . 4.0 tp10 -72.79 -35.43 67.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.501 -0.749 . . . . 0.0 109.817 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 24' ' ' VAL . 18.1 mt -69.1 -32.84 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.718 HD22 ' CB ' ' A' ' 63' ' ' PHE . 42.3 mt -67.98 -53.41 26.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 38' ' ' VAL . 5.0 mmt180 -61.29 -61.8 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.826 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 11.2 mtpt -53.79 -27.95 32.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -64.61 -44.07 95.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' LEU . 20.7 t -73.81 -20.65 60.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -1.199 . . . . 0.0 110.169 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 34' ' ' ARG . 55.0 t -70.94 -49.3 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -75.72 -26.92 57.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 74' ' ' LEU . 2.5 m-30 -92.76 -3.72 54.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 38' ' ' VAL . 78.3 mm-40 46.32 72.18 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' CG ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -115.45 105.34 52.31 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 110.466 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 47' ' ' SER . 40.9 Cg_endo -71.46 157.84 55.44 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.862 1.454 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.615 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 21.1 ttt -87.22 -39.28 0.51 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 111.929 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 44' ' ' MET . 48.2 Cg_endo -77.27 -52.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.275 1.145 . . . . 0.0 111.336 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -101.03 64.25 0.54 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -175.74 -178.11 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -1.121 . . . . 0.0 110.67 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.892 ' HG2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -178.01 137.04 0.18 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.672 HD21 HD12 ' A' ' 74' ' ' LEU . 3.4 mt -109.63 163.88 13.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.719 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 73' ' ' LEU . 7.2 p -154.97 136.95 14.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.947 . . . . 0.0 110.368 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.3 112.22 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.75 -17.84 38.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.274 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.67 -53.54 30.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.178 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.13 23.17 2.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 81' ' ' TRP . . . 72.54 26.38 71.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.562 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -67.8 165.43 17.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -1.221 . . . . 0.0 109.791 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 58' ' ' VAL . 11.4 pm0 -113.88 135.56 53.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.003 -1.061 . . . . 0.0 110.96 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 ' CE1' ' A' ' 63' ' ' PHE . 98.7 t -157.53 173.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.685 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' VAL . 58.0 p -128.45 158.83 37.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 52.3 p30 -62.2 -11.47 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.7 t0 -107.63 4.45 25.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 37.7 t -112.21 -40.24 4.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.176 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CD1' HD11 ' A' ' 66' ' ' LEU . 44.6 m-85 -40.04 99.95 0.21 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -74.41 -90.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.005 1.529 . . . . 0.0 110.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.73 66.27 0.57 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 ' CD1' ' A' ' 63' ' ' PHE . 40.2 mt -44.62 163.73 0.18 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.31 -1.112 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.26 -174.34 1.76 Allowed 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.173 1.617 . . . . 0.0 109.847 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 69' ' ' ASP . 33.6 p30 -63.79 154.05 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 110.039 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.5 m-20 42.65 38.79 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.855 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.34 112.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.493 -0.755 . . . . 0.0 109.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 72' ' ' LEU . 4.2 mm-40 -81.76 103.59 11.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 66' ' ' LEU . 8.7 mp -114.86 156.63 24.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.32 -0.863 . . . . 0.0 110.106 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HG3' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -133.21 125.89 30.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.476 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.823 ' CG ' HD23 ' A' ' 42' ' ' LEU . 12.3 tp -71.79 133.66 45.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.465 -0.772 . . . . 0.0 109.949 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HG2' ' A' ' 48' ' ' ARG . 1.5 tt -147.47 160.82 42.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.134 -0.979 . . . . 0.0 109.547 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 75' ' ' LEU . 4.6 p -148.83 173.11 13.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 109.96 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.47 -24.34 7.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.959 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.98 16.52 60.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -150.72 156.59 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -1.081 . . . . 0.0 110.242 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.27 153.84 39.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.224 -0.923 . . . . 0.0 110.401 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.494 ' CD1' ' HA2' ' A' ' 55' ' ' GLY . 5.3 t-105 -130.9 116.95 18.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.347 -0.845 . . . . 0.0 110.254 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -63.47 -72.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.058 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.42 167.01 19.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 12.9 t80 -88.31 108.71 19.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -1.186 . . . . 0.0 110.349 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.2 144.99 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 110.169 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 60.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.158 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 24.5 mtt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.233 0.539 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 173.67 -170.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.6 87.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.339 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.1 p -168.88 74.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.07 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 5' ' ' LEU . 13.8 mt -101.9 144.62 30.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.526 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 7' ' ' GLN . 5.1 mmm-85 -122.32 45.92 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.388 -0.82 . . . . 0.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.9 pt20 174.26 99.35 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 43.9 Cg_endo -71.88 124.15 9.91 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.98 1.516 . . . . 0.0 110.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 158.71 23.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.699 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.8 t -127.85 151.64 48.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 24' ' ' VAL . 3.0 m -140.06 152.7 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.977 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HE3' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mmtt -110.32 99.28 8.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -82.23 88.79 6.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.975 . . . . 0.0 110.689 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 2.4 tpt180 -95.4 157.31 15.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.03 139.27 44.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.931 -1.105 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD21 ' A' ' 73' ' ' LEU . 1.6 mt -76.26 -21.14 56.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' OE2' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -79.38 -2.04 39.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -155.79 138.13 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.94 53.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.19 167.36 29.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 110.606 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -148.88 162.32 40.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.512 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 8.4 t80 -115.66 87.74 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.93 95.57 0.28 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HD23 ' A' ' 32' ' ' LEU . 6.0 p -108.68 154.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -1.193 . . . . 0.0 110.903 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -124.8 166.44 16.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . 174.63 147.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.5 mtm180 -66.86 -53.99 26.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 110.033 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 29' ' ' CYS . 73.9 m -83.82 97.14 9.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.153 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.913 ' HA ' HD12 ' A' ' 32' ' ' LEU . 7.2 p -41.65 -30.55 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.105 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -54.87 -27.49 43.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.728 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -76.17 -44.03 39.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.978 HD23 HG13 ' A' ' 24' ' ' VAL . 11.5 mt -57.34 -42.36 81.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 63' ' ' PHE . 68.2 mt -67.21 -59.83 3.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.652 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.1 mpp_? -54.03 -70.48 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 27.8 mtpt -47.29 -24.59 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -73.48 -53.44 7.5 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.3 t -66.64 -11.87 55.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -1.107 . . . . 0.0 109.748 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 34' ' ' ARG . 97.5 t -82.5 -69.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.967 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -51.77 -31.89 28.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.685 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 13' ' ' LEU . 2.9 m-85 -89.82 -17.95 27.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.58 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 5.5 mt-30 56.56 80.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.998 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -118.2 105.33 46.93 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 110.175 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 47' ' ' SER . 44.4 Cg_endo -71.1 155.85 60.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.968 1.51 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.545 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -65.53 -54.67 29.03 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.094 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 44' ' ' MET . 52.8 Cg_endo -78.02 165.93 25.56 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.978 1.515 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' PRO . . . 41.95 34.76 1.44 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -154.41 171.23 19.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.931 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER 179.01 146.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 110.595 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 60' ' ' ASP . 1.1 mt -116.35 170.7 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.257 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' THR . 5.2 p -160.21 131.24 5.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.85 -1.156 . . . . 0.0 111.137 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -53.63 133.4 41.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.837 . . . . 0.0 109.772 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' CZ2' ' A' ' 81' ' ' TRP . 25.1 t80 -92.45 -13.26 30.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 110.37 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -53.7 -24.86 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 1.6 t0 -156.46 -43.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.652 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.53 54.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.59 160.88 14.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.964 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 58' ' ' VAL . 1.3 pp20? -111.16 130.74 55.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 0.0 110.278 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG11 ' CE1' ' A' ' 63' ' ' PHE . 52.3 t -148.8 172.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.573 ' N ' HG12 ' A' ' 58' ' ' VAL . 35.3 p -115.16 158.44 22.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p-10 -70.47 -13.36 62.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -102.44 6.24 40.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 42.3 t -112.33 -36.99 5.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.686 ' CD1' HD11 ' A' ' 66' ' ' LEU . 25.6 m-85 -40.59 100.62 0.22 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.461 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 48.6 Cg_endo -75.38 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.105 1.582 . . . . 0.0 110.275 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.32 69.29 0.52 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 63' ' ' PHE . 17.7 mt -50.37 161.76 0.58 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.209 -1.171 . . . . 0.0 110.051 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.59 167.27 26.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -45.75 153.02 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 110.103 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' CYS . 27.1 m-20 43.89 37.37 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -43.2 117.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.761 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -82.88 107.69 15.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 110.501 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 63' ' ' PHE . 1.3 mp -118.25 137.64 52.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.805 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -115.87 131.7 56.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.926 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.998 HD11 HD23 ' A' ' 42' ' ' LEU . 11.7 tp -77.12 139.74 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 80' ' ' THR . 1.1 tt -155.07 163.71 39.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.67 ' N ' HD23 ' A' ' 75' ' ' LEU . 20.2 p -147.79 168.25 22.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.09 -25.44 2.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.74 15.42 61.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 17' ' ' HIS . 0.4 OUTLIER -151.96 151.65 31.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 110.344 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.782 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -145.91 144.26 30.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.103 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.495 ' HB2' HD12 ' A' ' 16' ' ' LEU . 9.6 t-105 -110.95 135.87 50.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -79.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 54' ' ' ASP . . . 166.95 147.17 5.14 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -81.64 146.25 30.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.16 177.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -113.35 79.99 1.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 86' ' ' SER . 1.7 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.252 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' ALA . 1.9 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.266 0.555 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -57.83 86.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.224 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -164.21 81.89 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.113 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 4' ' ' VAL . 27.2 m -71.41 59.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.442 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.48 106.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 44.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.878 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -179.41 113.13 0.21 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.879 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 46.0 Cg_endo -72.49 123.06 8.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.824 1.434 . . . . 0.0 110.183 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.69 139.91 37.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 69' ' ' ASP . 17.7 t -108.1 149.06 28.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.12 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 24' ' ' VAL . 30.2 m -143.95 126.13 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -83.51 97.4 8.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 110.223 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -78.04 79.35 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.554 ' HG3' HD12 ' A' ' 73' ' ' LEU . 5.1 tpt180 -80.56 160.36 25.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.835 . . . . 0.0 109.705 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.93 116.93 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.041 -1.037 . . . . 0.0 110.709 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.92 HD12 HD21 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -69.28 -19.77 63.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.79 2.05 24.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.9 -161.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.38 39.86 3.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.9 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 30.9 p -173.41 -161.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 14' ' ' ARG . 13.7 ptpt -150.61 -162.03 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 0.0 109.981 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -151.89 90.61 1.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.08 89.89 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.027 ' CG1' HD22 ' A' ' 32' ' ' LEU . 3.7 p -97.97 144.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -1.205 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' C ' HD11 ' A' ' 32' ' ' LEU . . . -128.21 148.32 50.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . . . -172.2 154.09 3.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.3 mtm180 -63.04 -59.3 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 110.456 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 29' ' ' CYS . 1.4 p -84.92 96.2 9.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 p -42.32 -34.14 0.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.42 -30.87 42.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.404 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -74.19 -32.87 63.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.503 -0.748 . . . . 0.0 109.779 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.027 HD22 ' CG1' ' A' ' 24' ' ' VAL . 14.8 mt -75.8 -37.52 59.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -65.11 -60.65 2.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.93 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -55.39 -58.58 7.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.765 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 47.1 mtpt -51.33 -32.93 27.09 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.405 -0.81 . . . . 0.0 109.355 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -62.17 -51.94 53.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -61.36 -19.38 61.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.178 . . . . 0.0 109.864 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ARG . 89.1 t -78.96 -48.08 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -76.43 -33.14 58.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.058 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m-30 -89.7 -12.45 39.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -0.882 . . . . 0.0 109.616 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 82.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 110.424 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.93 HD23 HD11 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.31 108.76 37.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.989 . . . . 0.0 110.374 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 47' ' ' SER . 46.2 Cg_endo -73.07 170.49 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.55 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -79.33 -50.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 44' ' ' MET . 48.3 Cg_endo -76.54 158.26 36.17 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.766 1.403 . . . . 0.0 110.462 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 77' ' ' ALA . . . 44.13 36.09 3.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.53 ' OG ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -137.26 169.12 18.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.8 116.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 110.318 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.85 ' CD2' HD12 ' A' ' 74' ' ' LEU . 1.2 mt -99.62 111.26 23.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.3 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 73' ' ' LEU . 26.4 p -96.33 168.51 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.947 . . . . 0.0 110.768 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -98.43 116.66 31.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.552 -0.718 . . . . 0.0 110.173 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' CB ' ' OE1' ' A' ' 71' ' ' GLU . 15.3 t80 -62.26 -14.41 38.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -56.49 15.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.28 42.98 1.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.495 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.44 33.9 78.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -76.81 164.22 26.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.103 -1.233 . . . . 0.0 109.619 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.534 ' C ' HG23 ' A' ' 58' ' ' VAL . 16.9 pt-20 -116.94 131.89 56.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.97 -1.081 . . . . 0.0 110.241 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.003 HG11 ' CE1' ' A' ' 63' ' ' PHE . 25.9 t -151.04 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.478 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.564 ' N ' HG12 ' A' ' 58' ' ' VAL . 19.3 p -130.71 165.09 23.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.471 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 10.7 p-10 -70.95 -11.86 61.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.603 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.24 -2.42 20.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.052 -1.03 . . . . 0.0 110.524 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' PHE . 47.9 t -103.01 -39.55 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE1' HG11 ' A' ' 58' ' ' VAL . 16.4 m-85 -40.46 100.0 0.21 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 110.59 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' CYS . 46.5 Cg_endo -81.9 -79.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.027 1.541 . . . . 0.0 110.491 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.79 70.91 0.51 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.997 HD11 ' CD1' ' A' ' 63' ' ' PHE . 5.5 mt -51.93 161.55 0.92 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.334 -1.098 . . . . 0.0 110.473 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.42 178.85 6.13 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.19 1.626 . . . . 0.0 109.996 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 69' ' ' ASP . 28.5 t-20 -59.82 150.27 28.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.205 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 44.35 39.03 2.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 109.723 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . . . -40.81 109.62 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.564 -0.71 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -78.7 95.29 5.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 3.0 mp -103.96 152.92 21.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.92 HD21 HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -132.65 124.76 28.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.446 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.93 HD11 HD23 ' A' ' 42' ' ' LEU . 11.6 tp -72.67 121.84 20.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.539 -0.726 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.715 HD11 ' HA ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -138.69 157.45 46.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.516 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 10.6 p -135.68 179.86 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . . . -58.64 -26.56 63.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.338 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.75 17.35 50.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -147.23 162.64 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -1.186 . . . . 0.0 110.514 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -154.71 141.61 19.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' A' ' 82' ' ' HIS . 2.8 t-105 -115.7 125.44 52.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.205 -0.935 . . . . 0.0 110.3 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.449 ' N ' ' CE3' ' A' ' 81' ' ' TRP . 3.7 t60 -62.18 -60.14 4.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' HA2' ' CE2' ' A' ' 81' ' ' TRP . . . 130.67 143.52 5.33 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -62.41 115.92 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.851 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 85' ' ' VAL . 35.4 m -83.8 146.68 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 110.306 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.12 86.29 2.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.923 . . . . 0.0 110.191 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.148 -179.961 . . . . . . . . 0 0 . 1 stop_ save_